0001493152-21-011314.txt : 20210513 0001493152-21-011314.hdr.sgml : 20210513 20210513163357 ACCESSION NUMBER: 0001493152-21-011314 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 68 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210513 DATE AS OF CHANGE: 20210513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stereotaxis, Inc. CENTRAL INDEX KEY: 0001289340 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943120386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36159 FILM NUMBER: 21920174 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 314-678-6100 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVENUE STREET 2: SUITE 100 CITY: ST.LOUIS STATE: MO ZIP: 63108 10-Q 1 form10-q.htm
0001289340 false --12-31 Q1 2021 Non-accelerated Filer P0Y9M0D P10Y P5Y P1Y 0001289340 2021-01-01 2021-03-31 0001289340 2021-04-30 0001289340 2021-03-31 0001289340 2020-12-31 0001289340 2020-01-01 2020-03-31 0001289340 STXS:SystemsMember 2021-01-01 2021-03-31 0001289340 STXS:SystemsMember 2020-01-01 2020-03-31 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2021-01-01 2021-03-31 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2020-01-01 2020-03-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2019-12-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2019-12-31 0001289340 us-gaap:CommonStockMember 2019-12-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001289340 us-gaap:TreasuryStockMember 2019-12-31 0001289340 us-gaap:RetainedEarningsMember 2019-12-31 0001289340 2019-12-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2020-01-01 2020-03-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2020-01-01 2020-03-31 0001289340 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001289340 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001289340 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2020-03-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2020-03-31 0001289340 us-gaap:CommonStockMember 2020-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001289340 us-gaap:TreasuryStockMember 2020-03-31 0001289340 us-gaap:RetainedEarningsMember 2020-03-31 0001289340 2020-03-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2020-12-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2020-12-31 0001289340 us-gaap:CommonStockMember 2020-12-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001289340 us-gaap:TreasuryStockMember 2020-12-31 0001289340 us-gaap:RetainedEarningsMember 2020-12-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2021-01-01 2021-03-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2021-01-01 2021-03-31 0001289340 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001289340 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001289340 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2021-03-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2021-03-31 0001289340 us-gaap:CommonStockMember 2021-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001289340 us-gaap:TreasuryStockMember 2021-03-31 0001289340 us-gaap:RetainedEarningsMember 2021-03-31 0001289340 us-gaap:LetterOfCreditMember 2020-07-31 0001289340 STXS:SystemsMember 2021-03-31 0001289340 STXS:SystemsMember 2020-12-31 0001289340 STXS:SystemsMember srt:MaximumMember 2021-01-01 2021-03-31 0001289340 STXS:RevenueFromSystemDeliveryAndInstallationMember 2021-01-01 2021-03-31 0001289340 STXS:DisposableRevenueMember 2021-01-01 2021-03-31 0001289340 STXS:DisposableRevenueMember 2020-01-01 2020-03-31 0001289340 STXS:RoyaltyRevenueMember 2021-01-01 2021-03-31 0001289340 STXS:RoyaltyRevenueMember 2020-01-01 2020-03-31 0001289340 STXS:OtherRecurringRevenueMember 2021-01-01 2021-03-31 0001289340 STXS:OtherRecurringRevenueMember 2020-01-01 2020-03-31 0001289340 STXS:SubleaseRevenueMember 2021-01-01 2021-03-31 0001289340 STXS:SubleaseRevenueMember 2020-01-01 2020-03-31 0001289340 STXS:CustomerDepositsMember 2021-03-31 0001289340 STXS:CustomerDepositsMember 2020-12-31 0001289340 STXS:ProductShippedRevenueDeferredMember 2021-03-31 0001289340 STXS:ProductShippedRevenueDeferredMember 2020-12-31 0001289340 STXS:DeferredServiceAndLicenseFeesMember 2021-03-31 0001289340 STXS:DeferredServiceAndLicenseFeesMember 2020-12-31 0001289340 STXS:StockOptionsandStockAppreciationRightsMember 2021-01-01 2021-03-31 0001289340 STXS:StockOptionsandStockAppreciationRightsMember 2021-03-31 0001289340 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001289340 us-gaap:WarrantMember 2021-03-31 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-03-31 0001289340 STXS:SeriesBConvertiblePreferredStockMember 2021-01-01 2021-03-31 0001289340 us-gaap:RestrictedStockMember 2021-03-31 0001289340 us-gaap:EquipmentMember 2021-03-31 0001289340 us-gaap:EquipmentMember 2020-12-31 0001289340 us-gaap:LeaseholdImprovementsMember 2021-03-31 0001289340 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001289340 us-gaap:ConstructionInProgressMember 2021-03-31 0001289340 us-gaap:ConstructionInProgressMember 2020-12-31 0001289340 STXS:OfficeLeaseAgreementMember STXS:GlobeBuildingCompanyMember STXS:OfficeSpaceAndManufacturingFacilitiesMember 2021-03-01 0001289340 STXS:OfficeLeaseAgreementMember STXS:GlobeBuildingCompanyMember STXS:OfficeSpaceAndManufacturingFacilitiesMember 2021-02-27 2021-03-01 0001289340 STXS:OfficeLeaseAgreementMember STXS:GlobeBuildingCompanyMember STXS:OfficeSpaceAndManufacturingFacilitiesMember STXS:MinimumAnnualRentInTwoThousandTwentyTwoMember 2021-02-27 2021-03-01 0001289340 STXS:OfficeLeaseAgreementMember STXS:GlobeBuildingCompanyMember STXS:OfficeSpaceAndManufacturingFacilitiesMember STXS:MinimumAnnualRentInTwoThousandThirtyOneMember 2021-02-27 2021-03-01 0001289340 us-gaap:RevolvingCreditFacilityMember STXS:PrimaryLenderMember 2021-01-01 2021-03-31 0001289340 STXS:PaycheckProtectionProgramMember 2020-04-19 2020-04-20 0001289340 STXS:CaresActMember 2020-04-19 2020-04-20 0001289340 STXS:PaycheckProtectionProgramMember 2020-04-20 0001289340 STXS:DirectRegisteredOfferingMember us-gaap:CommonStockMember 2020-05-24 2020-05-25 0001289340 STXS:DirectRegisteredOfferingMember us-gaap:CommonStockMember 2020-05-25 0001289340 STXS:DirectRegisteredOfferingMember 2020-05-24 2020-05-25 0001289340 us-gaap:PrivatePlacementMember STXS:SeriesBConvertiblePreferredStockMember 2019-08-06 2019-08-07 0001289340 us-gaap:PrivatePlacementMember STXS:SeriesBConvertiblePreferredStockMember 2019-08-07 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2016-09-01 2016-09-30 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2016-09-30 0001289340 2016-09-01 2016-09-30 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember srt:MaximumMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheFourMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheFourMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheFiveMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheFiveMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheSixMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheSixMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheSevenMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheSevenMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheEightMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheEightMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheNineMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheNineMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheTenMember 2021-02-22 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember STXS:ShareBasedCompensationAwardTrancheTenMember 2021-02-23 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember 2021-01-01 2021-03-31 0001289340 STXS:PerformanceShareUnitAwardAgreementMember STXS:Mr.FischelMember 2021-03-31 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2021-01-01 2021-03-31 0001289340 STXS:StockAwardPlansMember 2021-03-31 0001289340 srt:MinimumMember 2020-12-31 0001289340 srt:MaximumMember 2020-12-31 0001289340 srt:MinimumMember 2021-01-01 2021-03-31 0001289340 srt:MaximumMember 2021-01-01 2021-03-31 0001289340 srt:MinimumMember 2021-03-31 0001289340 srt:MaximumMember 2021-03-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member STXS:CashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member STXS:CashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member STXS:CashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member STXS:CashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member STXS:CashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member STXS:CashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001289340 us-gaap:FairValueInputsLevel2Member STXS:RestrictedCashandCashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueInputsLevel2Member STXS:RestrictedCashandCashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 2020-01-01 2020-12-31 0001289340 us-gaap:LetterOfCreditMember 2021-02-28 0001289340 us-gaap:LetterOfCreditMember 2021-02-01 2021-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft STXS:Segments

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

(MARK ONE)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM               TO               

 

COMMISSION FILE NUMBER 001-36159

 

STEREOTAXIS, INC.

(Exact name of the Registrant as Specified in its Charter)

 

delaware   94-3120386

(State or Other Jurisdiction of

Incorporation or Organization)

  

(I.R.S. Employer

Identification Number)

 

4320 Forest Park Avenue, Suite 100

St. Louis, MO 63108

(Address of Principal Executive Offices including Zip Code)

 

(314) 678-6100

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   STXS   NYSE American LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T “See 232.405 of this Chapter” during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated Filer ☐   Non-accelerated filer ☒   Smaller reporting company ☒
Emerging growth company ☐            

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

The number of outstanding shares of the registrant’s common stock on April 30, 2021 was 74,113,969.

 

 

 

 

 

 

Table of Contents

 

STEREOTAXIS, INC.

INDEX TO FORM 10-Q

 

      Page
       
Part I Financial Information  
   
Item 1.   Financial Statements (unaudited) 3
    Balance Sheets 3
    Statements of Operations 4
    Statements of Convertible Preferred Stock and Stockholders’ Equity 5
    Statements of Cash Flows 6
    Notes to Financial Statements 7-17
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations 18-24
Item 3.   [Reserved] 24
Item 4.   Controls and Procedures 24
       
Part II Other Information  
   
Item 1.   Legal Proceedings 24
Item 1A.   Risk Factors 24-25
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds 25
Item 3.   Defaults upon Senior Securities 25
Item 4.   [Reserved] 25
Item 5.   Other Information 25
Item 6.   Exhibits 26
Signatures     27

 

2
 

 

ITEM 1. FINANCIAL STATEMENTS

 

STEREOTAXIS, INC.

BALANCE SHEETS

 

   March 31, 2021   December 31, 2020 
  (Unaudited)     
Assets        
Current assets:          
Cash and cash equivalents  $42,452,713   $43,939,512 
Restricted cash - current   1,336,000    - 
Compensating cash arrangement   250,919    250,620 
Accounts receivable, net of allowance of $122,570 and $123,614 at 2021 and 2020, respectively   7,290,762    3,515,136 
Inventories, net   3,536,300    3,295,457 
Prepaid expenses and other current assets   1,674,554    1,716,014 
Total current assets   56,541,248    52,716,739 
Property and equipment, net   202,504    195,129 
Restricted cash   93,331    - 
Operating lease right-of-use assets   1,695,664    2,235,442 
Other assets   284,946    308,515 
Total assets  $58,817,693   $55,455,825 
           
Liabilities and stockholders’ equity          
Current liabilities:          
Short-term debt  $1,914,692   $1,185,058 
Accounts payable   2,270,432    1,608,636 
Accrued liabilities   2,578,298    3,209,235 
Deferred revenue   8,188,296    5,282,770 
Current portion of operating lease liabilities   1,734,699    2,287,487 
Total current liabilities   16,686,417    13,573,186 
Long-term debt   243,617    973,252 
Long-term deferred revenue   1,328,272    548,915 
Other liabilities   210,096    131,231 
Total liabilities   18,468,402    15,226,584 
           
Series A - Convertible preferred stock:          
Convertible preferred stock, Series A, par value $0.001; 22,408 and 22,513 shares outstanding at 2021 and 2020, respectively   5,578,437    5,605,323 
           
Stockholders’ equity:          
Convertible preferred stock, Series B, par value $0.001; 10,000,000 shares authorized, 5,610,121 shares outstanding at 2021 and 2020   5,610    5,610 
           
Common stock, par value $0.001; 300,000,000 shares authorized,74,089,659 and 73,694,203 shares issued at 2021 and 2020, respectively   74,090    73,694 
Additional paid in capital   524,388,783    522,709,846 
Treasury stock, 4,015 shares at 2021 and 2020   (205,999)   (205,999)
Accumulated deficit   (489,491,630)   (487,959,233)
Total stockholders’ equity   34,770,854    34,623,918 
Total liabilities and stockholders’ equity  $58,817,693   $55,455,825 

 

See accompanying notes.

 

3
 

 

STEREOTAXIS, INC.

STATEMENTS OF OPERATIONS

(Unaudited)

 

   2021   2020 
   Three Months Ended March 31, 
   2021   2020 
Revenue:        
Systems  $2,602,512   $- 
Disposables, service and accessories   5,773,516    5,509,711 
Sublease   246,530    246,530 
Total revenue   8,622,558    5,756,241 
           
Cost of revenue:          
Systems   1,435,535    65,022 
Disposables, service and accessories   924,618    639,863 
Sublease   246,530    246,530 
Total cost of revenue   2,606,683    951,415 
           
Gross margin   6,015,875    4,804,826 
           
Operating expenses:          
Research and development   2,367,041    2,109,170 
Sales and marketing   2,947,216    2,915,424 
General and administrative   2,229,739    1,832,726 
Total operating expenses   7,543,996    6,857,320 
Operating loss   (1,528,121)   (2,052,494)
           
Interest (expense) income, net   (4,276)   80,963 
Net loss  $(1,532,397)  $(1,971,531)
           
Cumulative dividend on Series A convertible preferred stock   (332,551)   (343,723)
Loss attributable to common stockholders  $(1,864,948)  $(2,315,254)
           
Net loss per share attributable to common stockholders:          
Basic  $(0.02)  $(0.03)
Diluted  $(0.02)  $(0.03)
           
Weighted average number of common shares and equivalents:          
Basic   75,175,412    69,870,040 
Diluted   75,175,412    69,870,040 

 

See accompanying notes.

 

4
 

 

STEREOTAXIS, INC

STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY

(Unaudited)

Three Months Ended March 31, 2020

 

       Amount       Amount       Amount   Amount   Amount   Amount   Amount 
   Convertible Preferred Stock Series A (Mezzanine)   Convertible  Preferred Stock Series B   Common Stock  

Additional

Paid-In

   Treasury   Accumulated  

Total Stockholders’

Equity

 
   Shares   Amount   Shares   Amount   Shares   Amount  

Capital

  

Stock

  

Deficit

   (Deficit) 
Balance at December 30, 2019   23,110   $5,758,190    5,610,121   $5,610    68,529,623   $68,530   $504,211,040   $(205,999)  $(481,312,774)  $22,766,407 
Issuance of common stock and warrants                       40,816    41    (23,891)             (23,850)
Share-based compensation                       109,489    109    722,203              722,312 
Components of net loss                                           (1,971,531)   (1,971,531)
Employee stock purchase plan                       6,406    7    32,216              32,223 
Preferred stock conversion   (192)   (49,163)   -    -    354,447    354    48,809    -         49,163 
Balance at March 31, 2020   22,918   $5,709,027    5,610,121   $5,610    69,040,781   $69,041   $504,990,377   $(205,999)  $(483,284,305)  $21,574,724 

 

Three Months Ended March 31, 2021

 

   Convertible Preferred Stock Series A (Mezzanine)   Convertible  Preferred Stock Series B   Common Stock  

Additional 

Paid-In		   Treasury   Accumulated  

Total Stockholders’

Equity

 
   Shares   Amount   Shares   Amount   Shares   Amount  

Capital

  

Stock

  

Deficit

   (Deficit) 
                                         
Balance at December 31, 2020   22,513   $5,605,323    5,610,121   $5,610    73,694,203   $73,694   $522,709,846   $(205,999)  $(487,959,233)  $34,623,918 
Issuance of common stock                       154,806    156    252,679              252,835 
Share-based compensation                       30,250    30    1,370,527              1,370,557 
Components of net loss                                           (1,532,397)   (1,532,397)
Employee stock purchase plan                       6,003    6    29,049              29,055 
Preferred stock conversion   (105)   (26,886)   -    -    204,397    204    26,682    -         26,886 
Balance at March 31, 2021   22,408   $5,578,437    5,610,121   $5,610    74,089,659   $74,090   $524,388,783   $(205,999)  $(489,491,630)  $34,770,854 

 

See accompanying notes.

 

5
 

 

STEREOTAXIS, INC.

STATEMENTS OF CASH FLOWS

(Unaudited)

 

   2021   2020 
   Three Months Ended March 31, 
   2021   2020 
Cash flows from operating activities          
Net loss  $(1,532,397)  $(1,971,531)
Adjustments to reconcile net loss to cash used in operating activities:          
Depreciation   26,817    30,119 
Non-cash lease expense   582,712    585,586 
Share-based compensation   1,370,557    722,312 
Changes in operating assets and liabilities:          
Accounts receivable   (3,775,626)   714,499 
Inventories   (240,843)   (1,322,610)
Prepaid expenses and other current assets   41,460    80,419 
Compensating cash arrangement   (299)   - 
Other assets   23,569    (74,054)
Accounts payable   661,796    (96,800)
Accrued liabilities   (630,937)   (378,907)
Deferred revenue   3,684,883    130,691 
Operating lease liability   (595,723)   (585,489)
Other liabilities   78,865    - 
Net cash used in operating activities   (305,166)   (2,165,765)
Cash flows from investing activities          
Purchase of equipment   (34,192)   - 
Net cash used in investing activities   (34,192)   - 
Cash flows from financing activities          
Proceeds from issuance of stock, net of issuance costs   281,890    8,373 
Net cash provided by financing activities   281,890    8,373 
Net decrease in cash and cash equivalents   (57,468)   (2,157,392)
Cash and cash equivalents at beginning of period   43,939,512    30,182,115 
Cash and cash equivalents at end of period  $43,882,044   $28,024,723 
           
Reconciliation of cash, cash equivalents, and restricted cash to balance sheet as of March 31st:          
Cash and cash equivalents  $42,452,713   $28,024,723 
Restricted cash - current   1,336,000    - 
Restricted cash   93,331    - 
Total cash, cash equivalents, and restricted cash  $43,882,044   $28,024,723 

 

See accompanying notes.

 

6
 

 

STEREOTAXIS, INC.

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

 

Notes to Financial Statements

 

In this report, “Stereotaxis”, the “Company”, “Registrant”, “we”, “us”, and “our” refer to Stereotaxis, Inc. and its wholly owned subsidiaries. Genesis RMN®, Niobe®, Navigant®, Odyssey®, Odyssey Cinema™, Vdrive®, Vdrive Duo™, V-CAS™, V-Loop™, V-Sono™, QuikCAS™ and Cardiodrive® are trademarks of Stereotaxis, Inc. All other trademarks that appear in this report are the property of their respective owners.

 

1. Description of Business

 

Stereotaxis designs, manufactures and markets an advanced robotic magnetic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our primary products include the Genesis RMN System, the Niobe System, the Odyssey Solution, and related devices. We also offer to our customers the Stereotaxis Imaging Model S x-ray System.

 

The Genesis RMN and Niobe Systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and reduced x-ray exposure.

 

In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the Odyssey Solution, which consolidates lab information enabling physicians to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training.

 

We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond the warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.

 

We have received regulatory clearance, licensing and/or CE Mark approvals necessary for us to market the Genesis RMN System in the U.S. and Europe, and we are in the process of obtaining necessary registrations for extending our markets in other countries. The Niobe System, Odyssey Solution, Cardiodrive, and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo Systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and Europe. Stereotaxis Imaging Model S is CE marked and FDA cleared.

 

We have strategic relationships with technology leaders and innovators in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic navigation system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships will continue and efforts are ongoing to ensure the availability of integrated next generation systems and/or equivalent alternatives. We cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by GAAP for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or for future operating periods.

 

7
 

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission (SEC) on March 12, 2021.

 

Risks and Uncertainties

 

The novel coronavirus COVID-19 (“COVID-19”) pandemic has resulted, and is likely to continue to result, in significant disruptions to the economy, as well as business and capital markets around the world. The full extent of the impact of the COVID-19 pandemic on our business, results of operations and financial condition will depend on numerous evolving factors that we may not be able to accurately predict.

 

As a result of the COVID-19 outbreak, we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which have negatively affected our complex sales, marketing, installation, distribution and service network relating to our products and services. The COVID-19 pandemic may continue to negatively affect demand for both our systems and our disposable products by limiting the ability of our sales personnel to maintain their customary contacts with customers as governmental authorities institute prolonged quarantines, travel restrictions, and shelter-in-place orders, or as our customers impose limitations on contacts and in-person meetings that go beyond those imposed by governmental authorities.

 

In addition, many of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable sales and installation cycles for our robotic magnetic navigation systems. We may also experience significant reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) continue to re-prioritize the treatment of patients and divert resources away from non-coronavirus areas, which we anticipate will lead to the performance of fewer procedures in which our disposable products are used. In addition, patients may consider foregoing or deferring procedures utilizing our products, even if physicians and hospitals are willing to perform them, which could also reduce demand for, and sales of, our disposable products.

 

As of the date of the filing of this Quarterly Report on Form 10-Q, we believe our manufacturing operations and supply chains have been minimally interrupted, but we cannot guarantee that they will not be interrupted more severely in the future. If our manufacturing operations or supply chains are materially interrupted, it may not be possible for us to timely manufacture relevant products at required levels, or at all. A material reduction or interruption to any of our manufacturing processes would have a material adverse effect on our business, operating results, and financial condition.

 

If governmental authorities around the world continue to institute prolonged mandatory closures, social distancing protocols and shelter-in-place orders, or as private parties on whom we rely to operate our business put in place their own protocols that go beyond those instituted by relevant governmental authorities, our ability to adequately staff and maintain our operations or further our product development could be negatively impacted.

 

Any disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Continued disruptions to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects, a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products as well as an increased risk of customer defaults or delays in payments for our systems, installation, service contracts and disposable products.

 

We continue to evaluate and, where appropriate, take actions to reduce costs and spending across our organization. We will continue to actively monitor the situation and may take further actions that alter our business operations that may be required by federal, state, or local governmental authorities or that may be implemented by our vendors, suppliers or customers, or that we determine are in the best interests of our employees, customers, suppliers and stockholders.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments purchased with original maturities of three months or less to be cash equivalents. The Company places its cash with high-credit-quality financial institutions and invests primarily in money market accounts.

 

Restricted Cash

 

Restricted cash primarily consists of cash that the Company is obligated to maintain in accordance with contractual obligations. The Company’s restricted cash was $1.4 million at March 31, 2021. No cash was restricted at December 31, 2020.

 

8
 

 

Compensating Cash Arrangement

 

In July 2020, the Company entered into a letter of credit to support a commitment of less than $0.3 million. As a condition of the letter of credit, the Company is required to maintain a $0.3 million compensating balance until the expiration of the letter of credit.

 

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

 

The Company’s financial assets consist of restricted cash and cash equivalents invested in money market funds which totaled $1.4 million as of March 31, 2021 and December 31, 2020, respectively. The financial assets consisting of cash equivalents invested in money market funds are classified as Level 2 as described above and total interest income recorded for these investments was insignificant for the three months ended March 31, 2021. As of March 31, 2021, the Company did not have any financial liabilities valued at fair value on a recurring basis. As of March 31, 2020, the Company did not have any financial assets or liabilities valued at fair value on a recurring basis.

 

Revenue and Costs of Revenue

 

The Company accounts for revenue in accordance with Accounting Standards Codification Topic 606 (“ASC 606”), “Revenue from Contracts with Customers”.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services, the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.

 

Our revenue recognition policy affects the following revenue streams in our business as follows:

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were less than $0.1 million for the periods presented. Revenue from system delivery and installation represented 30% of revenue for the three months ended March 31, 2021. There was no revenue from system delivery and installation for the three months ended March 31, 2020.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 24% and 34% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

9
 

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 7% and 10% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation of our systems. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 36% and 52% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

Sublease Revenue:

 

A portion of our principal executive office is subleased to a third party through 2021. In accordance with Accounting Standards Update (ASU) 2016-02, “Leases” (Topic 842), the Company records sublease income as revenue. Sublease revenue represented 3% and 4% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

   Three Months Ended March 31, 
   2021   2020 
Systems  $2,602,512   $- 
Disposables, service and accessories   5,773,516    5,509,711 
Sublease   246,530    246,530 
Total revenue  $8,622,558   $5,756,241 

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $10.1 million as of March 31, 2021. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

   March 31, 2021   December 31, 2020 
Contract Assets - unbilled receivables  $207,964   $284,415 
           
Customer deposits  $1,955,573   $- 
Product shipped, revenue deferred   1,547,957    645,200 
Deferred service and license fees   6,013,038    5,186,485 
Total deferred revenue  $9,516,568   $5,831,685 
Less: Long-term deferred revenue   (1,328,272)   (548,915)
Total current deferred revenue  $8,188,296   $5,282,770 

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the three months ended March 31, 2021 and 2020, that was included in the deferred revenue balance at the beginning of each reporting period remained consistent at $2.6 million.

 

10
 

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.2 million and $0.3 million as of March 31, 2021 and December 31, 2020, respectively. The Company did not incur any impairment losses during any of the periods presented.

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recognized at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are recognized when incurred.

 

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

For time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

 

For market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.

 

Shares purchased by employees under the 2009 Employee Stock Purchase Plan are considered to be non-compensatory.

 

Net Earnings (Loss) per Common Share

 

Basic earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our convertible preferred stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our convertible preferred stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our convertible preferred stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

Schedule of Computation of Basic and Diluted Earnings Per Share

   2021   2020 
   Three Months Ended March 31, 
   2021   2020 
Net loss  $(1,532,397)  $(1,971,531)
Cumulative dividend on Series A Convertible Preferred Stock   (332,551)   (343,723)
Net loss attributable to common stockholders  $(1,864,948)  $(2,315,254)
           
Weighted average number of common shares and equivalents:   75,175,412    69,870,040 
Basic EPS  $(0.02)  $(0.03)
Diluted EPS  $(0.02)  $(0.03)

 

The Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights, warrants or convertible preferred stock in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented. The application of the two-class method of computing earnings per share under general accounting principles for participating securities is not applicable during these periods because those securities do not contractually participate in its losses.

 

11
 

 

As of March 31, 2021, the Company had 3,030,178 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $3.95 per share, 15,385 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 43,790,285 shares of our common stock issuable upon conversion of our Series A Convertible Preferred Stock, 5,610,121 shares of our common stock issuable upon conversion of our Series B Convertible Preferred Stock and 1,287,223 shares of unvested restricted share units. The Company had no unearned restricted shares outstanding for the period ended March 31, 2021.

 

Recently Issued Accounting Pronouncements

 

In December 2019, the FASB issued Accounting Standards Update (ASU) 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” as part of its effort to reduce the complexity of accounting standards. The ASU is effective for fiscal years beginning after December 15, 2020. The Company adopted with no impact to the Company’s financial statements.

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance under ASU 2018-19, ASU 2019-04 and ASU 2019-05. The standard modifies the measurement approach for credit losses on financial instruments, including trade receivables, from an incurred loss method to a current expected credit loss method, otherwise known as “CECL.” The standard requires the measurement of expected credit losses to be based on relevant information, including historical experience, current conditions and a forecast that is supportable. The standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The standard must be adopted by applying a cumulative adjustment to retained earnings. The Company anticipates adopting the standard in the first quarter of 2023, although it does not expect a significant impact to the Company’s financial results.

 

3. Inventories

 

Inventories consist of the following:

Schedule of Inventories

   March 31, 2021   December 31, 2020 
Raw materials  $2,883,285   $2,950,912 
Work in process   800,034    433,026 
Finished goods   2,569,654    2,987,039 
Reserve for excess and obsolescence   (2,716,673)   (3,075,520)
Total inventory  $3,536,300   $3,295,457 

 

4. Prepaid Expenses and Other Assets

 

Prepaid expenses and other assets consist of the following:

   March 31, 2021   December 31, 2020 
Prepaid expenses  $608,485   $754,062 
Prepaid commissions   244,974    271,174 
Deposits   979,081    855,970 
Other assets   126,960    143,323 
Total prepaid expenses and other assets   1,959,500    2,024,529 
Less: Noncurrent prepaid expenses and other assets   (284,946)   (308,515)
Total current prepaid expenses and other assets  $1,674,554   $1,716,014 

 

5. Property and Equipment

 

Property and Equipment consist of the following:

   March 31, 2021   December 31, 2020 
Equipment  $6,488,984   $6,488,984 
Leasehold improvements   2,338,441    2,338,441 
Construction in process   34,192    - 
    8,861,617    8,827,425 
Less: Accumulated depreciation   (8,659,113)   (8,632,296)
Net property and equipment  $202,504   $195,129 

 

12
 

 

6. Leases

 

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The Company accounts for leases in accordance with Accounting Standards Update No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842 (“ASC 842”). The Company determines if an arrangement contains a lease at inception.

 

The Company leases its facilities under operating leases. In accordance with ASC 842, operating lease agreements are recognized on the balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.

 

The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e. leases with initial terms of twelve months or less) on the balance sheet.

 

The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At March 31, 2021, the weighted average discount rate for operating leases was 9.0% and the weighted average remaining lease term for operating lease term is 0.75 years.

 

The following table represents lease costs and other lease information.

 

   Three Months Ended   Three Months Ended 
   Three Months Ended 
   March 31, 2021   March 31, 2020 
Operating lease cost  $582,712   $585,586 
Short-term lease cost   16,663    15,470 
Sublease income   (246,530)   (246,530)
Total net lease cost  $352,845   $354,526 
           
Cash paid within operating cash flows  $631,086   $636,350 

 

Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.

 

Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2021, excluding sublease income, were as follows:

 

   March 31, 2021 
2021     
Total lease payments  $1,786,995 
Less: Interest   (52,296)
Present value of lease liabilities  $1,734,699 

 

The remaining undiscounted future cash flows to be received under the sublease are $0.8 million in 2021.

 

On March 1, 2021, the Company entered into an office lease agreement (the “Lease”) with Globe Building Company (the “Landlord”), under which the Company will lease executive office space and manufacturing facilities of approximately 43,100 square feet of rentable space located at 710 N. Tucker Boulevard, St. Louis, Missouri (the “Premises”) that will serve as the Company’s new principal executive and administrative offices and manufacturing facility. The Lease for the Premises is effective at the later of January 1, 2022 or the date on which the Company has received an occupancy permit, and has a term of ten years, with two renewal options of five years each. The minimum annual rent under the terms of the Lease ranges from approximately $0.8 million in 2022 to $1.0 million in 2031. At the Lease commencement, the Company will relocate its current St. Louis, Missouri operations to the Premises in the new building.

 

13
 

 

7. Accrued Liabilities

 

Accrued liabilities consist of the following:

 

   March 31, 2021   December 31, 2020 
Accrued salaries, bonus, and benefits  $1,348,077   $2,044,826 
Accrued licenses and maintenance fees   483,879    483,879 
Accrued warranties   188,591    157,615 
Accrued taxes   195,577    172,744 
Accrued professional services   223,298    138,359 
Other   348,972    343,043 
Total accrued liabilities   2,788,394    3,340,466 
Less: Long term accrued liabilities   (210,096)   (131,231)
Total current accrued liabilities  $2,578,298   $3,209,235 

 

8. Debt and Credit Facilities

 

The Company had a working capital line of credit with its primary lender, Silicon Valley Bank, that matured on June 30, 2020 and was not renewed.

 

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 in the United States. Among the provisions contained in the CARES Act was the creation of the Paycheck Protection Program that provides for Small Business Administration (“SBA”) Section 7(a) loans for qualified small businesses. In general, the loan can be forgiven as long as the funds are used for payroll related expenses as well as rent and utilities paid during the twenty-four week period from the date of the loan and as long as certain headcount and salary/wage levels are maintained. On April 10, 2020, the Company was informed by its lender, Midwest BankCentre (the “Bank”), that the Bank received approval from the SBA to fund the Company’s request for a loan under the SBA’s Paycheck Protection Program (“PPP Loan”). Per the terms of the PPP Loan, the Company received total proceeds of $2,158,310 from the Bank on April 20, 2020. In March 2021, the Company applied for loan forgiveness with the Bank and on April 27, 2021 the application was accepted by the SBA for review. In accordance with the loan forgiveness requirements of the CARES Act, the Company used the full proceeds from the PPP Loan primarily for payroll costs, rent and utilities, thus, the Company anticipates that the loan will be substantially forgiven. To the extent it is not forgiven, the Company would be required to repay that portion beginning in August 2021 with a final installment in April 2022. Interest would be assessed on the amount of the loan not forgiven at a rate of 1% per annum beginning on the date of the loan, April 20, 2020.

 

In accordance with general accounting principles for fair value measurement, the Company’s debt was measured at fair value (Level 2), which approximated the carrying value of the debt, as of March 31, 2021 and December 31, 2020.

 

9. Convertible Preferred Stock and Stockholders’ Equity

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends. No dividends have been declared or paid as of March 31, 2021.

 

2020 Equity Financing

 

On May 25, 2020, the Company entered into a Securities Purchase Agreement with certain accredited investors, whereby it, in a direct registered offering, agreed to issue and sell to the investors an aggregate of 3,658,537 shares of the Company’s common stock, $0.001 par value per share, at a price of $4.10 per share. The Company received net proceeds of approximately $15.0 million, after offering expenses.

 

Series B Convertible Preferred Stock

 

On August 7, 2019, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors, whereby it, as part of a private placement, agreed to issue and sell to the 5,610,121 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share which are convertible into shares of the Company’s Common Stock, at a price of $2.05 per share. The Series B Preferred Stock, which is a Common Stock equivalent but non-voting and with a blocker on conversion if the holder would exceed a specified threshold of voting security ownership, is convertible into Common Stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like as provided in the Purchase Agreement. The Series B Convertible Preferred Stock is reported in the stockholders’ equity section of the Company’s balance sheet.

 

14
 

 

Series A Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued (i) 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 per share, with a stated value of $1,000 per share (the “Series A Preferred Stock”), which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share, subject to adjustment for events such as stock splits, combinations and the like as provided in the certificate of designations covering such Series A Preferred Stock, and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The shares of Series A Preferred Stock are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The Series A Preferred Stock bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the Series A Preferred Stock. Each holder of convertible preferred shares has the right to require us to redeem such holder’s shares of Series A Preferred Stock upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the Series A Preferred Stock in the event of a defined change of control. The Series A Preferred Stock ranks senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the Series A Preferred Stock are subject to conditions for redemption that are outside the Company’s control, the Series A Preferred Stock are presently reported in the mezzanine section of the balance sheet.

 

The warrants issued in conjunction with the Series A Preferred Stock (the “SPA Warrants”) have an exercise price of $0.70 per share subject to adjustments for events such as stock splits, combinations, and the like as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations.

 

2021 CEO Performance Award Unit Grant

 

On February 23, 2021, the Company`s Board of Directors, upon recommendation of the Compensation Committee, approved the grant of the CEO Performance Award to David L. Fischel, the Company’s Chief Executive Officer. The CEO Performance award is a 10-year performance award of up to 13,000,000 shares, tied to the achievement of market capitalization milestones and subject to minimum service requirements.

 

As detailed in the table below, the CEO Performance Award consists of ten vesting tranches. The first market capitalization milestone is $1 billion, and each of the remaining nine market capitalization milestones are in additional $500 million increments, up to $5.5 billion.

 

Tranche #  

No. of Shares

Subject to PSU

   Market Capitalization Milestones(1) 
 1    1,000,000   $1,000,000,000 
 2    1,500,000   $1,500,000,000 
 3    1,500,000   $2,000,000,000 
 4    2,000,000   $2,500,000,000 
 5    1,000,000   $3,000,000,000 
 6    1,000,000   $3,500,000,000 
 7    1,000,000   $4,000,000,000 
 8    2,000,000   $4,500,000,000 
 9    1,000,000   $5,000,000,000 
 10    1,000,000   $5,500,000,000 
 Total:    13,000,000      

 

Each tranche represents a portion of the PSUs covering the number of shares outlined in the table above. Each tranche vests upon (i) satisfaction of the market capitalization milestones and (ii) Mr. Fischel continuing to serve as CEO from the grant date through December 31, 2030. Absent an earlier termination, the PSUs will expire on December 31, 2030. If Mr. Fischel ceases to be the CEO for any reason including death, disability, termination for cause or without cause (as defined in the award agreement), or Mr. Fischel’s voluntary termination after service as CEO for at least five years, the remaining service period will be waived and he will retain any PSUs that have vested through the date of termination.

 

The Company is seeking Shareholder approval at its annual meeting on May 20, 2021 for shares to be issued under the award.

 

The market capitalization requirement is considered a market condition under FASB Accounting Standards Codification Topic 718 “Compensation – Stock Compensation” and is estimated on the grant date using Monte Carlo simulations. Recognition of stock-based compensation expense of all the tranches commenced on February 23, 2021, the date of grant, as the probability of meeting the ten market capitalization milestones is not considered in determining the timing of expense recognition. The expense will be recognized on an accelerated basis through 2030. Key assumptions for estimating the performance-based awards fair value at the date of grant included share price on grant date, volatility of the Company’s common stock price, risk free interest rate, and grant term.

 

15
 

 

Total stock-based compensation recorded as operating expense for the CEO Performance Award was $0.7 million for the quarter ended March 31, 2021. As of March 31, 2021, the Company had approximately $56.7 million of total unrecognized stock-based compensation expense remaining under the CEO Performance Award if Mr. Fischel continues to serve as CEO, or in a similar capacity through 2030.

 

2012 Stock Award Plan

 

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.

 

At March 31, 2021, the Company had 1,114,086 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

 

At March 31, 2021, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $6.4 million, excluding compensation not yet recognized related to the CEO Performance Award discussed above. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.

 

A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2021 is as follows:

   Number of Options/SARs   Range of Exercise Price   Weighted Average Exercise
Price per Share		 
Outstanding, December 31, 2020   2,456,979   $0.74 - $35.20   $2.90 
Granted   815,000   $6.96   $6.96 
Exercised   (165,962)  $0.74 - $4.52   $1.85 
Forfeited   (75,839)  $0.74 - $35.20   $6.66 
Outstanding, March 31, 2021   3,030,178   $0.74 - $32.30   $3.95 

 

A summary of the restricted stock unit activity for the three month period ended March 31, 2021 is as follows:

   Number of Restricted Stock Units   Weighted Average Grant Date Fair Value per Unit 
Outstanding, December 31, 2020   1,112,473   $2.46 
Granted   205,000   $5.16 
Vested   (30,250)  $5.12 
Forfeited   -   $- 
Outstanding, March 31, 2021   1,287,223   $2.83 

 

10. Fair Value Measurements

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including certain cash equivalents. Generally accepted accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described below:

 

Level 1:   Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
     
Level 2:   Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market.
     
Level 3:  

Values are generated from model-based techniques that use significant assumptions not observable in the market.

 

16
 

 

The following table sets forth the Company’s assets measured at fair value on a recurring basis by level within the fair value hierarchy. As required by the Fair Value Measurements and Disclosures topic of the Accounting Standards Codification, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

   Fair Value Measurement Using 
   Total   Quoted Prices in
Active Markets
for Identical
Instruments
(Level 1)		   Significant
Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets at March 31, 2021:                    
Cash invested in money market accounts  $1,429,331    —   $1,429,331   $— 
Total assets at fair value  $1,429,331    —   $1,429,331   $— 
Assets at December 31, 2020:                    
Cash invested in money market accounts  $1,429,331    —   $1,429,331   $— 
Total assets at fair value  $1,429,331    —   $1,429,331   $— 

 

The Company did not have any financial liabilities valued at fair value on a recurring basis as of March 31, 2021 or December 31, 2020.

 

Level 1

 

The Company does not have any financial assets or liabilities classified as Level 1.

 

Level 2

 

The Company’s financial assets consist of restricted cash and cash equivalents invested in money market funds in the amount of $1,429,331 at March 31, 2021 and December 31, 2020, respectively. These assets are classified as Level 2, as described above, and total interest income recorded for these investments was insignificant during the three months ended March 31, 2021 and year ended December 31, 2020.

 

Level 3

 

The Company does not have any financial assets or liabilities classified as Level 3.

 

11. Product Warranty Provisions

 

The Company’s standard policy is to warrant all capital systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

 

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

   March 31, 2021   December 31, 2020 
Warranty accrual, beginning of the fiscal period  $157,615   $141,697 
Accrual adjustment for product warranty   94,596    49,974 
Payments made   (63,620)   (34,056)
Warranty accrual, end of the fiscal period  $188,591   $157,615 

 

12. Commitments and Contingencies

 

The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

 

In February 2021, the Company entered into letters of credit to support commitments totaling approximately $1.3 million. The letters of credit are valid through 2022.

 

13. Subsequent Events

 

On April 29, 2021, a putative class action complaint was filed in Delaware Chancery Court by Richard Barre, a purported shareholder. The defendants are the Company and its current directors. The complaint alleges breaches of fiduciary duty against the defendants based on alleged disclosure deficiencies in the definitive proxy statement (the “Proxy Statement”) filed by the Company on April 9, 2021 relative to the vote at the Company’s 2021 Annual Meeting of Stockholders to be held on May 20, 2021 (the “2021 Stockholder Meeting”) seeking stockholder approval of issuance of shares under the Performance Share Unit Award (the “CEO Performance Award”) granted to David L. Fischel, the Company’s chief executive officer. The complaint seeks various remedies, including a preliminary injunction seeking to enjoin the vote at the 2021 Stockholder Meeting to approve the issuance of shares for the CEO Performance Award. Following discussions with the plaintiff’s counsel and the Delaware Chancery Court, the parties agreed to an expedited discovery and briefing schedule, with the Chancery Court scheduled to hear arguments on the plaintiff’s motion for a preliminary injunction on May 18, 2021.

 

Although the Company believes that the claims were wholly without merit and that no further disclosure was required to supplement the Proxy Statement under applicable law, the Company filed a supplement to the Proxy Statement on May 10, 2021 addressing the alleged disclosure claims in order to eliminate the burden, expense, and uncertainties inherent in such litigation, and without admitting any liability or wrongdoing. On May 12, 2021, the plaintiff withdrew the motion for a preliminary injunction and indicated that the plaintiff intends to voluntarily dismiss, with prejudice, all claims set forth in the complaint, subject to court approval and reserving the right to apply for an award of attorneys’ fees and reimbursement of expenses.

 

17
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our financial statements and notes thereto included in this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2020. Operating results are not necessarily indicative of results that may occur in future periods.

 

This report includes various forward-looking statements that are subject to risks and uncertainties, many of which are beyond our control. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in “Part II - Item 1A. Risk Factors” included in this Quarterly Report on Form 10-Q and in Part I, Item 1A, “Risk Factors,” included in our Annual Report on Form 10-K for the year ended December 31, 2020. Forward-looking statements discuss matters that are not historical facts. Forward-looking statements include, but are not limited to, discussions regarding our operating strategy, sales and marketing strategy, regulatory strategy, industry, economic conditions, financial condition, liquidity, capital resources, results of operations, and the impact of the recent coronavirus (“COVID-19”) pandemic and our response to it. Such statements include, but are not limited to, statements preceded by, followed by, or that otherwise include the words “believe”, “expects”, “anticipates”, “intends”, “estimates”, “projects”, “can”, “could”, “may”, “would”, or similar expressions. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. You should not unduly rely on these forward-looking statements, which speak only as of the date on which they are made. They give our expectations regarding the future, but are not guarantees. We undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

 

Overview

 

Stereotaxis designs, manufactures and markets an advanced robotic magnetic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our primary products include the Genesis RMN System, the Niobe System, the Odyssey Solution, and related devices. We also offer to our customers the Stereotaxis Imaging Model S x-ray System.

 

The Genesis RMN and Niobe Systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and reduced x-ray exposure.

 

In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the Odyssey Solution, which consolidates lab information enabling physicians to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training.

 

We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.

 

We have received regulatory clearance, licensing and/or CE Mark approvals necessary for us to market the Genesis RMN System in the U.S. and Europe, and we are in the process of obtaining necessary registrations for extending our markets in other countries. The Niobe System, Odyssey Solution, Cardiodrive, and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo Systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and Europe. Stereotaxis Imaging Model S is CE marked and FDA cleared.

 

We have strategic relationships with technology leaders and innovators in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic navigation system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships will continue and efforts are ongoing to ensure the availability of integrated next generation systems and/or equivalent alternatives. We cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

 

18
 

 

COVID-19 Pandemic

 

First Quarter of 2021

 

During the first quarter of 2021, periodic resurgences of COVID-19 and the delayed rollout of vaccines in some geographies continued to impact our procedure volumes. Overall, procedure volumes improved slightly compared to the fourth quarter 2020 and are approximately 5% higher than the first quarter of 2020. While procedures in the Asia Pacific region have recovered to pre-pandemic levels, procedures in other geographies remain impacted with total procedures still approximately 15% below those seen in the first quarter of 2019.

 

While travel restrictions do remain in some areas, we are generally able to conduct normal business activities albeit in a more deliberate manner than prior to the pandemic.

 

Ongoing

 

Even with the rollout of effective vaccines, we do not expect all markets to recover at the same pace. The impact that the pandemic will have on our business will likely continue to vary by individual geography based on the extent of the outbreak in each area, the timing of vaccine distribution, specific governmental restrictions and the availability of testing capabilities, personal protective equipment, and hospital facilities, as well as decisions by our vendors, suppliers, customers and, ultimately, patients in response to the pandemic, none of which we are able to currently and accurately predict. While we cannot reliably estimate the depth or length of the impact, we continue to anticipate significant, periodic disruptions to our procedures volumes, service activities and system placements in 2021. In addition, we would expect that capital system orders will experience some delay.

 

Capital markets and worldwide economies have also been significantly impacted by the COVID-19 pandemic, and the outlook for 2021 depends on future developments, including but not limited to: the length and severity of the outbreak (including new strains, which may be more contagious, more severe or less responsive to treatment or vaccines), the effectiveness of containment actions, and the timing of vaccinations and achievement of herd immunity. The impact on local and/or global economies is uncertain, including ongoing risk of recession. Such economic disruptions, including a recession, could have a material adverse effect on our long-term business as hospitals curtail and reduce capital and overall spending or redirect such spending to treatments related directly to the pandemic. To date, our manufacturing operations and supply chains have been minimally interrupted, but we cannot guarantee that such will not be interrupted further in the future. If our manufacturing operations or supply chains are interrupted, it may not be possible for us to timely manufacture relevant products at required levels, or at all. A material reduction or interruption to any of our manufacturing processes could have a material adverse effect on our business, operating results, and financial condition. Further, the COVID-19 pandemic and local actions, such as “shelter-in-place” orders and restrictions on our ability to travel and access our customers or temporary closures of our facilities or the facilities of our suppliers and their contract manufacturers, could also significantly impact our sales and our ability to ship our products and supply our customers. Any of these events could negatively impact the number of procedures performed and the number of system placements and have a material adverse effect on our business, financial condition, results of operations, or cash flows.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. We review our estimates and judgments on an on-going basis. We base our estimates and judgments on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. We believe the following accounting policies are critical to the judgments and estimates we use in preparing our financial statements. For a complete listing of our critical accounting policies, please refer to our Annual Report on Form 10-K for the year ended December 31, 2020.

 

19
 

 

Revenue Recognition

 

We generate revenue from the initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from other recurring revenue including ongoing software updates and service contracts.

 

In accordance with Accounting Standards Codification Topic 606 (“ASC 606”), “Revenue from Contracts with Customers,” we account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates as necessary.

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were less than $0.1 million for the periods presented.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented.

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation of our systems. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed.

 

Sublease Revenue:

 

A portion of our principal executive office is subleased to a third party through 2021. In accordance with Accounting Standards Update (ASU) 2016-02, “Leases” (Topic 842), the Company records sublease income as revenue.

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. See Note 2 for additional detail on deferred revenue. The Company did not have any impairment losses on its contract assets for the periods presented.

 

20
 

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets in the Company’s balance sheets were $0.2 million and $0.3 million as of March 31, 2021 and December 31, 2020, respectively. The Company did not incur any impairment losses during any of the periods presented.

 

Leases

 

The Company accounts for leases in accordance with ASU No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842. A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The Company determines if a contract contains a lease at inception. For contracts where the Company is the lessee, operating leases are included in operating lease right-of-use (“ROU”) assets and operating lease liability on the Company’s balance sheet. The Company currently does not have any finance leases.

 

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. ROU assets also include any initial direct costs incurred and any lease payments made at or before the lease commencement date, less lease incentives received. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the lease liabilities as the Company’s leases generally do not provide an implicit rate. Lease terms may include options to extend or terminate when the Company is reasonably certain that the option will be exercised. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company’s operating leases. Additionally, the Company applies the short-term lease measurement and recognition exemption in which right of use assets and lease liabilities are not recognized for leases less than twelve months.

 

Cost of Contracts

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recognized at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are recognized when incurred. Cost of sublease revenue is recognized on a straight-line basis.

 

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

For time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

 

For market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.

 

Shares purchased by employees under the 2009 Employee Stock Purchase Plan are considered to be non-compensatory.

 

Results of Operations

 

Comparison of the Three Months Ended March 31, 2021 and 2020

 

Revenue. Revenue increased from $5.8 million for the three months ended March 31, 2020, to $8.6 million for the three months ended March 31, 2021, an increase of 50%. Revenue from the sales of systems was $2.6 million for the three months ended March 31, 2021. There was no revenue from the sales of systems for the three months ended March 31, 2020. Revenue from sales of disposable interventional devices, service, and accessories increased to $5.8 million for the three months ended March 31, 2021, from $5.5 million for the three months ended March 31, 2020, an increase of approximately 5%, driven by increased time and material and higher procedure volumes as the Company recovers from the COVID pandemic. The Company recognized $0.2 million of sublease revenue for both the three month periods ended March 31, 2021 and 2020.

 

21
 

 

Cost of Revenue. Cost of revenue increased from $1.0 million for the three months ended March 31, 2020, to $2.6 million for the three months ended March 31, 2021, an increase of approximately 174%. As a percentage of our total revenue, overall gross margin decreased to 70% for the three months ended March 31, 2021, from 83% for the three months ended March 31, 2020 primarily due to changes in product mix. Cost of revenue for systems sold increased to $1.4 million for the three months ended March 31, 2021, from less than $0.1 million for the three months ended March 31, 2020, driven by increased system sales volumes in the current year period. Gross margin for systems was less than negative $0.1 million for the three months ended March 31, 2020, compared to $1.2 million for the three months ended March 31, 2021. Cost of revenue for disposables, service, and accessories increased to $0.9 million for the three months ended March 31, 2021, from $0.6 million for the three months ended March 31, 2020, primarily due to higher expenses incurred under service contracts in the current year period. Gross margin for disposables, service, and accessories was 84% for the current year period compared to 88% for the three months ended March 31, 2020. Cost of sublease revenue was $0.2 million for both the three month periods ended March 31, 2021 and 2020.

 

Research and Development Expenses. Research and development expenses increased from $2.1 million for the three months ended March 31, 2020, to $2.4 million for the three months ended March 31, 2021, an increase of approximately 12%. This increase was primarily due to higher project spending in the current year period.

 

Sales and Marketing Expenses. Sales and marketing expenses remained relatively consistent at $2.9 million for the three months ended March 31, 2020, and March 31, 2021.

 

General and Administrative Expenses. General and administrative expenses include finance, information systems, legal, and general management. General and administrative expenses increased from $1.8 million for the three months ended March 31, 2020, to $2.2 million for the three months ended March 31, 2021, an increase of approximately 22%, driven by stock-based compensation expense for the CEO Performance Award.

 

Interest Income (Expense). Interest expense was less than $0.1 million for the three months ended March 31, 2021, and interest income was less than $0.1 million for the three months ended March 31, 2020.

 

Liquidity and Capital Resources

 

Liquidity refers to the liquid financial assets available to fund our business operations and pay for near-term obligations. These liquid financial assets consist of cash and cash equivalents. We are continuously and critically reviewing our liquidity and anticipated capital requirements in light of the significant uncertainty created by the COVID-19 pandemic.

 

At March 31, 2021 we had $44.1 million of cash and cash equivalents, inclusive of restricted cash and the compensating cash arrangement. We had working capital of $39.9 million as of March 31, 2021, compared to $39.1 million as of December 31, 2020.

 

The following table summarizes our cash flow by operating, investing and financing activities for the three months ended March 31, 2021 and 2020 (in thousands):

 

   Three Months Ended March 31, 
   2021   2020 
Cash flow used in operating activities  $(305)  $(2,166)
Cash flow used in investing activities   (34)   - 
Cash flow provided by financing activities   282    8 

 

Net cash used in operating activities. We used approximately $0.3 million and $2.2 million of cash for operating activities during the three months ended March 31, 2021 and 2020, respectively. The decrease in cash used in operating activities was driven by the decrease in operating loss and decreased use of working capital in the current year period.

 

Net cash used in investing activities. We used less than $0.1 million during the three months ended March 31, 2021, for the purchase of equipment.

 

Net cash provided by financing activities. We generated $0.3 million and less than $0.1 million of cash for the three months ended March 31, 2021 and 2020, respectively. The cash generated in both periods was driven by the proceeds from issuance of stock, net of issuance costs.

 

Capital Resources

 

As of March 31, 2021, our borrowing facilities were comprised of the Paycheck Protection Program debt as discussed in the following section.

 

22
 

 

Revolving Line of Credit

 

The Company had a working capital line of credit with its primary lender, Silicon Valley Bank that matured on June 30, 2020 and was not renewed.

 

Paycheck Protection Program

 

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 in the United States. Among the provisions contained in the CARES Act was the creation of the Paycheck Protection Program that provides for Small Business Administration (“SBA”) Section 7(a) loans for qualified small businesses. In general, the loan can be forgiven as long as the funds are used for payroll related expenses as well as rent and utilities paid during the twenty-four week period from the date of the loan and as long as certain headcount and salary/wage levels are maintained. On April 10, 2020, the Company was informed by its lender, Midwest BankCentre (the “Bank”), that the Bank received approval from the SBA to fund the Company’s request for a loan under the SBA’s Paycheck Protection Program (“PPP Loan”). Per the terms of the PPP Loan, the Company received total proceeds of $2,158,310 from the Bank on April 20, 2020. In March 2021, the Company applied for loan forgiveness with the Bank and on April 27, 2021 the application was accepted by the SBA for review. In accordance with the loan forgiveness requirements of the CARES Act, the Company used the full proceeds from the PPP Loan primarily for payroll costs, rent and utilities, thus, the Company anticipates that the loan will be substantially forgiven. To the extent it is not forgiven, the Company would be required to repay that portion beginning in August 2021 with a final installment in April 2022. Interest would be assessed on the amount of the loan not forgiven at a rate of 1% per annum beginning on the date of the loan, April 20, 2020.

 

Common Stock

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends. No dividends have been declared or paid as of March 31, 2021.

 

2020 Equity Financing

 

On May 25, 2020, the Company entered into a Securities Purchase Agreement with certain accredited investors, whereby it, in a direct registered offering, agreed to issue and sell to the investors an aggregate of 3,658,537 shares of the Company’s common stock, $0.001 par value per share, at a price of $4.10 per share. The Company received net proceeds of approximately $15.0 million, after offering expenses.

 

Series B Convertible Preferred Stock

 

As disclosed in Note 9, on August 7, 2019, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors, whereby it, as part of the private placement, agreed to issue and sell to the investors 5,610,121 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share which are convertible into shares of the Company’s Common Stock, at a price of $2.05 per share. The Series B Preferred Stock, which is a Common Stock equivalent but non-voting and with a blocker on conversion if the holder would exceed a specified threshold of voting security ownership, is convertible into Common Stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like as provided in the Purchase Agreement. The Series B Convertible Preferred Stock is reported in the stockholders’ equity section of the balance sheet.

 

Series A Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued (i) 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 per share, with a stated value of $1,000 per share (the “Series A Preferred Stock”), which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share, subject to adjustment for events such as stock splits, combinations and the like as provided in the certificate of designations covering such Series A Preferred Stock, and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The shares of Series A Preferred Stock are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The Series A Preferred Stock bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the Series A Preferred Stock. Each holder of convertible preferred shares has the right to require us to redeem such holder’s shares of Series A Preferred Stock upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the Series A Preferred Stock in the event of a defined change of control. The Series A Preferred Stock ranks senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the Series A Preferred Stock are subject to conditions for redemption that are outside the Company’s control, the Series A Preferred Stock are presently reported in the mezzanine section of the balance sheet.

 

23
 

 

The warrants issued in conjunction with the Series A Preferred Stock (the “SPA Warrants”) have an exercise price of $0.70 per share subject to adjustments for events such as stock splits, combinations, and the like as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations

 

Off-Balance Sheet Arrangements

 

We do not currently have, nor have we ever had, any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts. As a result, we are not materially exposed to any financing, liquidity, market, or credit risk that could have arisen if we had engaged in these relationships.

 

ITEM 3. [RESERVED]

 

None.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.

 

Changes In Internal Control Over Financial Reporting: The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, also conducted an evaluation of the Company’s internal control over financial reporting to determine whether any changes occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. Based on that evaluation, there has been no such change during the period covered by this report.

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The Company is involved from time to time in various lawsuits and claims arising in the normal course of business. Although the outcomes of these lawsuits and claims are uncertain, the Company does not believe any of them will have a material adverse effect on its business, financial condition or results of operations.

 

On April 29, 2021, a putative class action complaint was filed in Delaware Chancery Court by Richard Barre, a purported shareholder. The defendants are the Company and its current directors. The complaint alleges breaches of fiduciary duty against the defendants based on alleged disclosure deficiencies in the definitive proxy statement (the “Proxy Statement”) filed by the Company on April 9, 2021 relative to the vote at the Company’s 2021 Annual Meeting of Stockholders to be held on May 20, 2021 (the “2021 Stockholder Meeting”) seeking stockholder approval of issuance of shares under the Performance Share Unit Award (the “CEO Performance Award”) granted to David L. Fischel, the Company’s chief executive officer. The complaint seeks various remedies, including a preliminary injunction seeking to enjoin the vote at the 2021 Stockholder Meeting to approve the issuance of shares for the CEO Performance Award. Following discussions with the plaintiff’s counsel and the Delaware Chancery Court, the parties agreed to an expedited discovery and briefing schedule, with the Chancery Court scheduled to hear arguments on the plaintiff’s motion for a preliminary injunction on May 18, 2021.

 

Although the Company believes that the claims were wholly without merit and that no further disclosure was required to supplement the Proxy Statement under applicable law, the Company filed a supplement to the Proxy Statement on May 10, 2021 addressing the alleged disclosure claims in order to eliminate the burden, expense, and uncertainties inherent in such litigation, and without admitting any liability or wrongdoing. On May 12, 2021, the plaintiff withdrew the motion for a preliminary injunction and indicated that the plaintiff intends to voluntarily dismiss, with prejudice, all claims set forth in the complaint, subject to court approval and reserving the right to apply for an award of attorneys’ fees and reimbursement of expenses.

 

ITEM 1A. RISK FACTORS

 

The following risk factor is provided to update the risk factors previously disclosed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

 

Risks Related to the February 2021 CEO Performance Stock Unit Grant

 

We will incur significant additional stock-based compensation expense over the term of the CEO Performance Award regardless of whether or not any of the milestones are achieved.

 

As described in Note 9 of the accompanying notes to the consolidated financial statements in Part I, Item 1 of this Form 10-Q, on February 23, 2021, the Company`s Board of Directors, upon recommendation of the Compensation Committee, approved the grant of the Performance Share Unit Award (“CEO Performance Award”) pursuant to the CEO Performance Share Unit Award Agreement (the “PSU Agreement”), to David L. Fischel, the Company’s Chief Executive Officer. Under the terms of the PSU Agreement, we will incur significant additional stock-based compensation expense over the term of the award regardless of whether or not any of the milestones are achieved as the probability of meeting the ten market capitalization milestones is not considered in determining the timing of expense recognition. The expense will be recognized on an accelerated basis through 2030. Total stock-based compensation recorded as operating expense for the CEO Performance Award was $0.7 million for the quarter ended March 31, 2021. As of March 31, 2021, the Company had approximately $56.7 million of total unrecognized stock-based compensation expense remaining under the CEO Performance Award if Mr. Fischel continues to serve as CEO, or in a similar capacity, through 2030. This additional stock-based compensation expense, incurred regardless of whether or not any milestones are achieved, increases the difficulty for the Company to achieve a profitable position as measured by generally accepted accounting principles.

 

24
 

 

Our stockholders may experience substantial dilution upon payout of shares under the CEO Performance Award.

 

If Mr. Fischel achieves all the milestones specified in the CEO Performance Award, by increasing the Company’s market capitalization to $5.5 billion for the specified period, he will receive 13,000,000 shares of common stock subject to the vesting requirements in the agreement. If (i) all 13,000,000 shares of common stock subject to the PSU Agreement were to become fully vested, outstanding and held by Mr. Fischel; (ii) all other shares of common stock and stock units held by Mr. Fischel were fully vested and were outstanding; (iii) estimated dilution as a result of potential exercises or conversions from existing grants to employees and non-employee directors and the outstanding convertible warrants and preferred stock were to be considered; and (iv) there were no other dilutive events of any kind, Mr. Fischel would beneficially own approximately 10% of the outstanding shares of Stereotaxis common stock after the dilutive events described above and without considering the impact of any other potential future dilutive events or the potential sale of stock required to pay taxes upon the vesting of the restricted stock units.

 

Certain provisions in the PSU Agreement may discourage a change in control of the Company even if such a transaction would otherwise be beneficial to our stockholders.

 

Under the terms of the CEO Performance Award, in the event of a change in control of the Company, the market capitalization formula will be modified to equal the total amount of consideration paid to all equity holders of the Company, with the number of shares to be issued pursuant to the CEO Performance Grant giving effect to such valuation. For all valuations above $1 billion in connection with a change in control, partial credit for the next following tranche shall be allocated pro rata based on the market capitalization in such change in control. Any vested shares upon such a change in control will vest and be paid at the time of the consummation of the change in control, and the service component of the CEO Performance Award will otherwise be disregarded. These terms may discourage potential business partners from pursuing a merger or acquisition, even if the merger or acquisition would be viewed favorably by, or be beneficial to, our other stockholders.

 

We are highly dependent on the services of Mr. Fischel, and our compensation package, including the CEO Performance Award, may fail to retain him.

 

Since assuming the role of CEO in February 2017, Mr. Fischel has revitalized the Company’s commercial capabilities, strengthened its financial position, and led the development of a robust innovation strategy, and stockholders have benefited substantially, with Stereotaxis’ stock appreciating approximately 10-fold. However, between February 2017 and December 2020, Mr. Fischel served as CEO without drawing a salary or any other form of cash or equity compensation for his work as CEO, and currently his only compensation is an annual salary of $60,000, which is substantially below market. Although our Board of Directors has determined that the CEO Performance Award and the grant of shares thereunder is in the stockholders’ best interests, has included a proposal to approve of such agreement on the Proxy Statement dated April 9, 2020 and has unanimously recommended that our stockholders approve the shares associated with this equity compensation arrangement, the terms of the CEO Performance Award nevertheless provide that the Company is not obligated to issue shares underlying the award until the Stereotaxis stockholders have voted to approve the issuance of such shares. While the Board believes that the CEO Performance Award provides substantial future benefit to all its stockholders and incentivizes Mr. Fischel to serve as CEO for the long term, there is no assurance that the shares associated with the CEO Performance Award will receive stockholder approval, or that Mr. Fischel will continue as CEO even if stockholder approval is received.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. [RESERVED]

 

None.

 

ITEM 5. OTHER INFORMATION

 

None.

 

25
 

 

ITEM 6. EXHIBITS

 

Number   Description
     
3.1   Restated Articles of Incorporation of the Registrant, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004.
     
3.2   Certificate of Amendment to Amended and Restated Certificate of Incorporation, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K (File No. 000-50884) filed on July 10, 2012.
     
3.3   Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock, incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 001-36159) filed on September 30, 2016.
     
3.4   Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock, incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K (File No. 001-36159) filed on August 8, 2019.
     
3.5  

Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.2 of the Registrant’s Form 10-Q (File No. 000-50884) for the fiscal quarter ended September 30, 2004.

 

10.1a  

Office Lease dated March 1, 2021, between the Registrant and Globe Building Company, GP, incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K (File No. 001-36159) filed on March 4, 2021.

 

10.1b   First Amendment to Office Lease dated March 30, 2021, between Registrant and Globe Building Company, GP, filed herewith.
     
10.2   Performance Share Unit Award Agreement, dated February 23, 2021, by and between Stereotaxis, Inc. and David L. Fischel, incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K (File No. 001-36159) filed on February 24, 2021.
     
31.1   Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).
     
31.2   Rule 13a-14(a)/15d-14(a) Certification (pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).
     
32.1   Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Executive Officer).
     
32.2   Section 1350 Certification (pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Chief Financial Officer).
     
101.INS   XBRL Instance Document.
     
101.SCH   XBRL Taxonomy Extension Schema Document.
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document.

 

26
 


 

STEREOTAXIS, INC.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  STEREOTAXIS, INC. (Registrant)
     
Date: May 13, 2021 By: /s/ David L. Fischel
   

David L. Fischel

Chief Executive Officer

     
Date: May 13, 2021 By: /s/ Kimberly R. Peery
   

Kimberly R. Peery

Chief Financial Officer

 

27

 EX-10.1B 2 ex10-1b.htm

 

Exhibit 10.1b

 

FIRST AMENDMENT TO LEASE AGREEMENT

 

THIS FIRST AMENDMENT TO LEASE AGREEMENT (the “First Amendment”) is made as of the 30th day of March 2021, by and between Globe Building Company, a Missouri general partnership (“Landlord”), and Stereotaxis, Inc., a Delaware corporation (“Tenant”).

 

WITNESSETH:

 

WHEREAS, Landlord and Tenant entered into that certain Lease Agreement dated March 1, 2021 (the “Original Lease”), for space on the ground floor of the building known as the Globe Building, located at 710 N. Tucker, St. Louis, Missouri; and

 

WHEREAS, the parties hereto have agreed to modify the Original Lease in the manner hereinafter described (the Original Lease as amended by this First Amendment is referred to as the “Lease”); and

 

WHEREAS, words and phrases having defined meanings in the Lease shall have the same respective meanings when used herein, unless otherwise expressly defined herein.

 

NOW, THEREFORE, in consideration of the mutual covenants herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant agree as follows:

 

1. Substitution of Revised Exhibit E. Exhibit E to the Original Lease is deleted from the Lease, and the revised version of Exhibit E attached to this First Amendment is hereby substituted as the new Exhibit E to the Lease.

 

2. Substitution of Revised Exhibit J. Exhibit J to the Original Lease is deleted from the Lease, and the revised version of Exhibit J attached to this First Amendment is hereby substituted as the new Exhibit J to the Lease.

 

3. Miscellaneous.

 

a. This First Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all such counterparts, taken together, shall constitute but one and the same instrument. Facsimile signatures on any counterpart shall be effective as an original signature, but the parties hereto agree to deliver to the other original signatures within thirty (30) days after the date of this First Amendment.

 

b. Except as expressly amended and modified hereby, all of the terms and provisions of the Lease shall remain unchanged and in full force and effect and are hereby ratified and confirmed.

 

c. In the event of any conflict between the terms of this First Amendment and the terms of the Lease, the terms of this First Amendment shall govern and control.

 

d. This First Amendment shall inure to the benefit of the parties hereto and their respective successors and assigns.

 

e. Tenant acknowledges that the Original Lease as amended by this First Amendment contains the entire agreement between Landlord and Tenant relating to Tenant’s lease of the Premises, and supersedes all prior discussions, representations, communications and agreements between them related to Tenant’s lease of the Premises.

 

[signatures commence on next page]

 

(1 First Amendment to Lease.Stereotaxis)

  
 

 

IN WITNESS WHEREOF, the parties have executed this First Amendment as of the day and year set forth above.

 

TENANT:   LANDLORD:
         
STEREOTAXIS, INC., a Delaware corporation   GLOBE BUILDING COMPANY, a Missouri general partnership
         
By: /s/ Kimberly R. Peery   By: /s/ Steven M. Stone
Name: Kimberly R. Peery   Steven M. Stone, Authorized Representative
Title: CFO      

 

(1 First Amendment to Lease.Stereotaxis)

- 2 - 
 

 

NEW EXHIBIT E

 

DESIGN / CONSTRUCTION OF TENANT IMPROVEMENTS

 

A. The following steps shall be followed in connection with design and construction of Tenant’s interior finish work for the Premises (the “Tenant Improvements”).

 

  (i) Promptly following the date on which this Lease has been signed (2/26/2021) by both parties, Landlord and Tenant shall work with the companies described on Exhibit F (and any additional companies as either party wants to include in the process, including Tenant’s project manager Cresa St. Louis, Inc.) to convert the Schematic Design Plans (Tenant (Improvements) attached to Exhibit D at Lease execution into design development plans and specifications for the Tenant Improvements (the “Design Development Tenant Improvement Plans”). Preliminary Landlord’s Delivery Condition Plans are attached to Exhibit C-2 at Lease execution. In parallel, Landlord (with Tenant’s input and after agreement with Tenant on issues like mechanical closet locations) shall work to finalize plans and specifications for Landlord’s Delivery Condition (“Final Landlord Delivery Condition Plans”) and generate preliminary plans for the mechanical, electrical, and plumbing systems (“Preliminary MEP Plans”).

 

  (ii) Thereafter, by 4/09/2021 per Exhibit J, Tenant shall submit said Design Development Tenant Improvement Plans to Landlord for its approval, and Landlord and Tenant shall work together to promptly resolve any issues, and once the issues, if any, are resolved (by 4/16/2021 per Exhibit J), Tenant and Landlord shall give their written approval to the design development plans (after approval called the “Approved Design Development Tenant Improvement Plans”).

 

Thereafter, Tenant shall generate and submit to Landlord by 4/30/2021, per Exhibit J, construction documents (“Approved Construction Document Tenant Improvement Plans”) which represent and contain further development of the Approved Design Development Tenant Improvement Plans.

 

  (iii) Landlord and Tenant shall submit the Approved Construction Document Tenant Improvement Plans, plus the Preliminary MEP Plans (which will govern work in both Landlord’s Delivery Condition and the Tenant Improvements), to the contractor selected as Landlord’s general contractor, which is expected to be Wright Building Systems, LLC (the “GC”) to construct the Tenant Improvements, and Landlord shall sign a construction contract with its general contractor (the “GC Contract”). Starting on 5/1/2021, GC will obtain competitive bids from at least three (3) subcontractors for each work category to be subcontracted and submit the same to Landlord and Tenant for approval. If Tenant is not satisfied with such bids, Landlord, Tenant, and GC shall work together to modify the Approved Construction Document Tenant Improvement Plans and Preliminary MEP Plans to arrive at a bid from GC that is reasonably acceptable to Tenant (by 6/11/2021 per Exhibit J). Once Tenant has given written approval to this bid from GC, this bid is referred to as the “Final Tenant Improvement Bid” and the plans approved in writing by Landlord, Tenant and GC that relate to such Final Tenant Improvement Bid are referred to as the “Final Tenant Improvement Plans” (which incorporates the portions of the Final MEP Plans that will be constructed as part of the Tenant Improvements).

 

(1 First Amendment to Lease.Stereotaxis)

- 3 - 
 

 

  (iv) Landlord agrees to require in the GC Contract that the GC provide a written warranty covering any defects in the workmanship or materials with respect to the Tenant Improvements for a minimum period of one (1) year from the Commencement Date, and such warranty shall be assigned to Tenant.

 

  (v) Promptly after Landlord has given its written approval to the Final Tenant Improvement Bid, the Final Tenant Improvement Plans and the GC Contract, and a building permit from the City of St. Louis has been issued, Landlord shall cause GC to commence construction of the Tenant Improvements in accordance with the Final Tenant Improvement Plans (by 6/03/2021 per Exhibit J).

 

B. Landlord shall provide a Tenant Improvement Allowance (sometimes referred to as the “Allowance”) in the amount set forth under the Basic Lease Data Section to be disbursed solely to pay for the Tenant Improvements costs incurred by Tenant, subject to the terms and conditions in the Lease. Tenant shall pay (i) all Tenant Improvement costs that are in excess of the applicable Allowance payable for said costs, and (ii) any other improvement costs that Landlord is not responsible for per the terms of the Lease and which are not eligible to be paid from the Allowance per the terms of this Lease. Paragraph C below of this Exhibit shall govern the procedure for Tenant to pay the Tenant Improvement costs that are to be paid by Tenant. With respect to disbursement of the Allowance, Landlord may make payments directly to the GC as it receives and approves invoices from the GC. Landlord in its sole discretion may also disburse Allowance funds directly to subcontractors and other third parties, including Tenant, upon receipt of documentation satisfactory to Landlord for the amounts to be paid. Landlord may collect lien waivers and such other documentation as it deems appropriate in connection with disbursing the Allowance. Landlord may impose other conditions on disbursement pursuant to Section 12 of this Lease.

 

C. Landlord shall keep track of the cost of the Tenant Improvements (the “TI Costs”) and calculate from time to time whether or not the cost of the Tenant Improvements exceeds the Allowance Funds available to pay those TI Costs. The amount by which the TI Costs exceed the Allowance Funds available is referred to as the “TI Shortfall”. Tenant shall pay the TI Shortfall to Landlord in the manner described in this paragraph, and Landlord shall use those payments to (i) pay Tenant Improvement costs, and (ii) to reimburse to Landlord any portion of the TI Shortfall that was paid by Landlord. Tenant shall pay the TI Shortfall on a prorated basis in the manner hereafter described. Landlord shall calculate the amount of the TI Shortfall, and the total remaining cost of the Tenant Improvements. At the time of each disbursement by Landlord, Tenant shall pay to Landlord an amount equal to the total amount to be disbursed multiplied by a fraction in which the numerator is the TI Shortfall, and the denominator is the total remaining cost of the Tenant Improvements. Within 30 days of final completion of the Tenant Improvements, Landlord shall make a final determination of the total cost of the Tenant Improvements, the total amount of the Allowance applied toward payment of the Tenant Improvement costs, the total amount of the TI Shortfall, and the total amount Tenant has paid toward the TI Shortfall, and Landlord shall provide Tenant with a copy of said calculations. If said calculations show Tenant has underpaid its obligations toward paying for Tenant Improvements, Tenant shall pay to Landlord the amount of said underpayment within 30 days of being billed for the underpayment. If said calculations show Tenant has overpaid the amount it was to pay for Tenant Improvements, Landlord shall pay to Tenant the amount of said overpayment within 60 days after final completion of the Tenant Improvements, or alternatively, Landlord may give Tenant a credit against Base Rent equal to the amount of the overpayment. Landlord’s books and records relating to the matters described in this paragraph may be inspected by Tenant.

 

(1 First Amendment to Lease.Stereotaxis)

- 4 - 
 

 

D. Except as otherwise permitted in the next sentence, the Allowance may only be used to pay for permanent improvements to the Building (and costs associated with such permanent improvements, such as charges paid for space planning and architectural services incurred in preparing plans for such improvements), and it may not be used to pay for anything that is not a permanent improvement (for example, it cannot be used to pay for furniture, office equipment or equipment and supplies used by Tenant in its business). In the event the actual construction costs are less than the stated Allowance, Tenant requires the ability to apply the remaining Allowance to its phone/data cabling, finish upgrades, moving costs, etc., but in no event to rent reduction.

 

E. From time to time during the course of construction of the Tenant Improvements, Tenant, Landlord or GC may request changes to the GC Contract, pursuant to a change order (“Change Order”), and Landlord agrees to use commercially reasonable efforts to secure any such Change Order that may be requested by Tenant. A Change Order is a written amendment to the GC Contract signed by Landlord, Tenant and GC, authorizing a change in the terms of the GC Contract, however, no material change shall be made to the Final Tenant Improvement Plans and no change shall be made which increases Tenant’s costs without first obtaining Tenant’s, Landlord’s and GC’s prior written approval of such change, which approval will not be unreasonably withheld or delayed. Landlord’s approval of a change order does not waive any rights that Landlord may have as a consequence of such Change Order, including, but not limited to, the right pursuant to Section 3.A of the Lease to accelerate the Commencement Date if the approved Change Order constitutes a Tenant’s Delay that has delayed the Commencement Date.

 

F. GC shall provide to Landlord and Tenant, prior to the start of construction, a copy of the construction schedule. GC shall keep Landlord and Tenant advised of any changes to the construction schedule.

 

G. Tenant shall have access to the Premises at all times during construction and shall promptly inform GC and Landlord in writing if Tenant discovers any defects in or other problems with the construction work.

 

H. Tenant shall participate in any inspections of the construction work conducted at substantial completion and at final completion of the Tenant Improvements. Tenant or Tenant’s architect shall, if requested by Landlord, sign an acceptance of the Tenant Improvements at the time of such inspection(s), subject to noting any punchlist items still to be completed, and any defects to be corrected and to latent defects.

 

Landlord’s review and approval of Plans, construction contracts, construction work and anything else, is solely for the protection of Landlord. Landlord shall have no liability to Tenant for any loss, damage, liability or expense suffered by Tenant as a result of any defects in any Plans, construction contracts, construction work or anything else that has been approved by Landlord, and Tenant is responsible for paying for the cost of correcting any such defects (except to the extent there are unused Allowance funds available for that purpose), to the extent such defects are not corrected by the architect pursuant to any warranties theyhave given to Tenant.

 

(1 First Amendment to Lease.Stereotaxis)

- 5 - 
 

 

NEW EXHIBIT J

 

MILESTONE SCHEDULE

 

2/26/2021 Lease fully executed; Preliminary Landlord’s Delivery Condition Plans attached to Exhibit C-2; Schematic Design Plans (Tenant Improvement) attached to Exhibit D

 

3/01/2021 Landlord Delivery Condition construction work begins, starting with demolition

 

4/9/2021 Tenant delivers to Landlord for review Design Development Tenant Improvement Plans; Final Landlord’s Delivery Condition Plans approved and attached to Exhibit C-2 to Lease; Preliminary MEP Plans delivered to Tenant for review

 

4/16/2021 Landlord and Tenant complete process to resolve any issues, and Landlord and Tenant give written approval to Design Development Tenant Improvement Plans, which now Approved Design Development Tenant Improvement Plans are attached to Exhibit D to the Lease

 

4/30/2021 Approved Construction Document Tenant Improvement Plans completed by Tenant and delivered to the Landlord and GC for bidding (Landlord only agrees to this abbreviated timeframe for Landlord review and approval if Matt O’Leary, Landlord’s project manager, is included in the design development process and weekly meetings starting after Lease execution and has rights to provide input which is considered and incorporated, if reasonable and in areas Landlord has rights to input on, during the design development process)

 

5/1/2021 Bidding begins

 

5/21/2021 Building permit applied for

 

6/1/2021 All bids received and qualified; value engineering starts including any needed modifications to Approved Construction Document Tenant Improvement Plans and Preliminary MEP Plans

 

6/11/2021 Value engineering completed with costs and scope approved by Tenant and Landlord; Final Tenant Improvement Bid accepted; Final Tenant Improvement Plans and Final MEP Plans approved by Landlord, Tenant and GC and attached to Lease; general contract between Landlord and GC executed; building permit applied for

 

6/18/2021 Building permit for Tenant Improvements obtained; Tenant Improvement construction begins

 

9/20/2021 Manufacturing Space and Storage Space delivered to Tenant for early access

 

10/01/2021 Substantial completion for Manufacturing Space and Storage Space, punchlist prepared

 

10/22/2021 Punchlist completed for Manufacturing Space and Storage Space

 

11/16/2021 Substantial completion achieved for Office Space, punchlist prepared, and Office Space delivered to Tenant for early access

 

12/07/2021 All municipal inspections completed; Tenant applies for occupancy permit

 

12/14/2021 Occupancy permit issued, possession delivered to Tenant

 

1/01/2022 Lease Commencement Date occurs

 

Landlord’s review and approval of Plans, construction contracts, construction work and anything else, is solely for the protection of Landlord. Landlord shall have no liability to Tenant for any loss, damage, liability or expense suffered by Tenant as a result of any defects in any Plans, construction contracts, construction work or anything else that has been approved by Landlord, and Tenant is responsible for paying for the cost of correcting any such defects (except to the extent there are unused Allowance funds available for that purpose), to the extent such defects are not corrected by the architect pursuant to any warranties they have given to Tenant.

 

(1 First Amendment to Lease.Stereotaxis)

- 6 - 
 

 

NEW EXHIBIT J

 

MILESTONE SCHEDULE

 

2/26/2021 Lease fully executed; Preliminary Landlord’s Delivery Condition Plans attached to Exhibit C-2; Schematic Design Plans (Tenant Improvement) attached to Exhibit D

 

3/01/2021 Landlord Delivery Condition construction work begins, starting with demolition

 

4/9/2021 Tenant delivers to Landlord for review Design Development Tenant Improvement Plans; Final Landlord’s Delivery Condition Plans approved and attached to Exhibit C-2 to Lease; Preliminary MEP Plans delivered to Tenant for review

 

4/16/2021 Landlord and Tenant complete process to resolve any issues, and Landlord and Tenant give written approval to Design Development Tenant Improvement Plans, which now Approved Design Development Tenant Improvement Plans are attached to Exhibit D to the Lease

 

4/30/2021 Approved Construction Document Tenant Improvement Plans completed by Tenant and delivered to the Landlord and GC for bidding (Landlord only agrees to this abbreviated timeframe for Landlord review and approval if Matt O’Leary, Landlord’s project manager, is included in the design development process and weekly meetings starting after Lease execution and has rights to provide input which is considered and incorporated, if reasonable and in areas Landlord has rights to input on, during the design development process)

 

5/1/2021 Bidding begins

 

5/21/2021 Building permit applied for

 

6/1/2021 All bids received and qualified; value engineering starts including any needed modifications to Approved Construction Document Tenant Improvement Plans and Preliminary MEP Plans

 

6/11/2021 Value engineering completed with costs and scope approved by Tenant and Landlord; Final Tenant Improvement Bid accepted; Final Tenant Improvement Plans and Final MEP Plans approved by Landlord, Tenant and GC and attached to Lease; general contract between Landlord and GC executed; building permit applied for

 

6/18/2021 Building permit for Tenant Improvements obtained; Tenant Improvement construction begins

 

9/20/2021 Manufacturing Space and Storage Space delivered to Tenant for early access

 

10/01/2021 Substantial completion for Manufacturing Space and Storage Space, punchlist prepared

 

10/22/2021 Punchlist completed for Manufacturing Space and Storage Space

 

11/16/2021 Substantial completion achieved for Office Space, punchlist prepared, and Office Space delivered to Tenant for early access

 

12/07/2021 All municipal inspections completed; Tenant applies for occupancy permit

 

12/14/2021 Occupancy permit issued, possession delivered to Tenant

 

1/01/2022 Lease Commencement Date occurs

 

(1 First Amendment to Lease.Stereotaxis)

- 7 - 

 

 EX-31.1 3 ex31-1.htm

 

Exhibit 31.1

 

Certification of Principal Executive Officer

 

I, David L. Fischel, certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
     
  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 13, 2021 /s/ David L. Fischel
  David L. Fischel
  Chief Executive Officer
  Stereotaxis, Inc.
  (Principal Executive Officer)

 

 

 

 EX-31.2 4 ex31-2.htm

 

Exhibit 31.2

 

Certification of Principal Financial Officer

 

I, Kimberly R. Peery, certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Stereotaxis, Inc.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:
     

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 13, 2021 /s/ Kimberly R. Peery
  Kimberly R. Peery
  Chief Financial Officer
  Stereotaxis, Inc.
  (Principal Financial Officer)

 

 
 EX-32.1 5 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David L. Fischel, Chief Executive Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 13, 2021 /s/ David L. Fischel
  David L. Fischel
  Chief Executive Officer
  Stereotaxis, Inc.

 

 

 

 EX-32.2 6 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Stereotaxis, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kimberly R. Peery, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 13, 2021 /s/ Kimberly R. Peery
  Kimberly R. Peery
  Chief Financial Officer
  Stereotaxis, Inc.

 

 

 

 EX-101.SCH 7 stxs-20210331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Prepaid Expenses and Other Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Debt and Credit Facilities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Convertible Preferred Stock and Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Product Warranty Provisions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Prepaid Expenses and Other Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Convertible Preferred Stock and Stockholders’ Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Product Warranty Provisions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Schedule of Revenue Disaggregated by Type (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Summary of Contract Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Schedule of Prepaid Expenses and Other Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Schedule of Lease Costs and Other Lease Information (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Future Minimum Operating Lease Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Schedule of Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Debt and Credit Facilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Summary of Performance Award And Market Capitalization Milestones (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Summary of Option and Stock Appreciation Rights Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Summary of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Convertible Preferred Stock and Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Fair Value Measurements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Schedule of Accrued Warranty (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Product Warranty Provisions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 stxs-20210331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 stxs-20210331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 stxs-20210331_lab.xml XBRL LABEL FILE Product and Service [Axis] Systems [Member] Disposables, Service and Accessories [Member] Equity Components [Axis] Convertible Preferred Stock Series A [Member] Convertible Preferred Stocks Series B [Member] Common Stock [Member] Additional Paid-in Capital [Member] Treasury Stock [Member] Retained Earnings [Member] Credit Facility [Axis] Letter of Credit [Member] Statistical Measurement [Axis] Maximum [Member] Concentration Risk Benchmark [Axis] Revenue From System Delivery and Installation [Member] Disposable Revenue [Member] Royalty Revenue [Member] Other Recurring Revenue [Member] Sublease Revenue [Member]. Customer Deposits [Member] Product Shipped, Revenue Deferred [Member] Deferred Service and License Fees [Member] Award Type [Axis] Stock Options and Stock Appreciation Rights [Member] Warrant [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Restricted Stock [Member] Long-Lived Tangible Asset [Axis] Equipment [Member] Leasehold Improvements [Member] Construction in Progress [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Office Lease Agreement [Member] Series [Axis] Globe Building Company [Member] Office Space and Manufacturing Facilities [Member] Scenario [Axis] Minimum Annual Rent in 2022 [Member] Minimum Annual Rent in 2031 [Member] Revolving Credit Facility [Member] Income Tax Authority [Axis] Primary Lender [Member] Plan Name [Axis] Paycheck Protection Program [Member] Cares Act [Member] Sale of Stock [Axis] Direct Registered Offering [Member] Private Placement [Member] PSU Agreement [Member] Title of Individual [Axis] Mr. Fischel [Member] Vesting [Axis] Share-based Payment Arrangement, Tranche One [Member] Share-based Payment Arrangement, Tranche Two [Member] Share-based Payment Arrangement, Tranche Three [Member] Share Based Compensation Award Tranche Four [Member] Share Based Compensation Award Tranche Five [Member] Share Based Compensation Award Tranche Six [Member] Share Based Compensation Award Tranche Seven [Member] Share Based Compensation Award Tranche Eight [Member] Share Based Compensation Award Tranche Nine [Member] Share Based Compensation Award Tranche Ten [Member] 2012 Stock Incentive Plan [Member] Stock Award Plans [Member] Minimum [Member] Restricted Stock Units (RSUs) [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Financial Instrument [Axis] Cash invested in Money Market Accounts [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Restricted Cash and Cash Invested In Money Market Accounts [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Restricted cash - current Compensating cash arrangement Accounts receivable, net of allowance of $122,570 and $123,614 at 2021 and 2020, respectively Inventories, net Prepaid expenses and other current assets Total current assets Property and equipment, net Restricted cash Operating lease right-of-use assets Other assets Total assets Liabilities and stockholders’ equity Current liabilities: Short-term debt Accounts payable Accrued liabilities Deferred revenue Current portion of operating lease liabilities Total current liabilities Long-term debt Long-term deferred revenue Other liabilities Total liabilities Series A - Convertible preferred stock: Convertible preferred stock, Series A, par value $0.001; 22,408 and 22,513 shares outstanding at 2021 and 2020, respectively Stockholders’ equity: Convertible preferred stock, Series B, par value $0.001; 10,000,000 shares authorized, 5,610,121 shares outstanding at 2021 and 2020 Common stock, par value $0.001; 300,000,000 shares authorized,74,089,659 and 73,694,203 shares issued at 2021 and 2020, respectively Additional paid in capital Treasury stock, 4,015 shares at 2021 and 2020 Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Accounts receivable, allowance Series A Convertible Preferred Stock, par value Series A Convertible Preferred Stock, shares outstanding Series B Convertible Preferred Stock, par value Series B Convertible Preferred Stock, shares authorized Series B Convertible Preferred Stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Treasury stock, shares Statement [Table] Statement [Line Items] Revenue: Total revenue Sublease Cost of revenue: Total cost of revenue Sublease Gross margin Operating expenses: Research and development Sales and marketing General and administrative Total operating expenses Operating loss Interest (expense) income, net Net loss Cumulative dividend on Series A convertible preferred stock Loss attributable to common stockholders Net loss per share attributable to common stockholders: Basic Diluted Weighted average number of common shares and equivalents: Basic Diluted Beginning balance, value Beginning Balance, Shares Issuance of common stock Issuance of common stock, Shares Share-based compensation Share-based compensation, Shares Components of net loss Employee stock purchase plan Employee stock purchase plan, Shares Preferred stock conversion Preferred stock conversion, Shares Ending balance, value Ending Balance, Shares Statement of Cash Flows [Abstract] Cash flows from operating activities Net loss Adjustments to reconcile net loss to cash used in operating activities: Depreciation Non-cash lease expense Share-based compensation Changes in operating assets and liabilities: Accounts receivable Inventories Prepaid expenses and other current assets Compensating cash arrangement Other assets Accounts payable Accrued liabilities Deferred revenue Operating lease liability Other liabilities Net cash used in operating activities Cash flows from investing activities Purchase of equipment Net cash used in investing activities Cash flows from financing activities Proceeds from issuance of stock, net of issuance costs Net cash provided by financing activities Net decrease in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Reconciliation of cash, cash equivalents, and restricted cash to balance sheet as of March 31st: Cash and cash equivalents Restricted cash - current Restricted cash Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Business Accounting Policies [Abstract] Summary of Significant Accounting Policies Inventory Disclosure [Abstract] Inventories Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid Expenses and Other Assets Property, Plant and Equipment [Abstract] Property and Equipment Leases [Abstract] Leases Payables and Accruals [Abstract] Accrued Liabilities Debt Disclosure [Abstract] Debt and Credit Facilities Equity [Abstract] Convertible Preferred Stock and Stockholders’ Equity Fair Value Disclosures [Abstract] Fair Value Measurements Guarantees and Product Warranties [Abstract] Product Warranty Provisions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Basis of Presentation Risks and Uncertainties Cash and Cash Equivalents Restricted Cash Compensating Cash Arrangement Financial Instruments Revenue and Costs of Revenue Assets Recognized from the Costs to Obtain a Contract with a Customer Share-Based Compensation Net Earnings (Loss) per Common Share Recently Issued Accounting Pronouncements Schedule of Revenue Disaggregated by Type Summary of Contract Assets and Liabilities Schedule of Computation of Basic and Diluted Earnings Per Share Schedule of Inventories Schedule of Prepaid Expenses and Other Assets Schedule of Property and Equipment Schedule of Lease Costs and Other Lease Information Schedule of Future Minimum Operating Lease Payments Schedule of Accrued Liabilities Summary of Performance Award And Market Capitalization Milestones Summary of Option and Stock Appreciation Rights Activity Summary of Restricted Stock Unit Activity Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy Schedule of Accrued Warranty Schedule of Product Information [Table] Product Information [Line Items] Sub lease Contract Assets - unbilled receivables Total deferred revenue Less: Long-term deferred revenue Total current deferred revenue Cumulative dividend on Series A Convertible Preferred Stock Net loss attributable to common stockholders Weighted average number of common shares and equivalents: Basic EPS Diluted EPS Restricted cash Long-term Line of Credit Compensating Balance, Amount Money market funds Product Warranty Expense Revenues percentage Remaining performance obligation Contract with Customer, Liability, Revenue Recognized Capitalized Contract Cost, Net Potential common shares excluded from diluted earnings per share Weighted average exercise price Exercise price of warrants Number of unvested restricted share units Raw materials Work in process Finished goods Reserve for excess and obsolescence Total inventory Prepaid expenses Prepaid commissions Deposits Other assets Total prepaid expenses and other assets Less: Noncurrent prepaid expenses and other assets Total current prepaid expenses and other assets Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Gross property and equipment Less: Accumulated depreciation Net property and equipment Operating lease cost Short-term lease cost Sublease income Total net lease cost Cash paid within operating cash flows 2021 Total lease payments Less: Interest Present value of lease liabilities Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Weighted average discount rate for operating leases Weighted average remaining lease term for operating lease term Undiscounted future cash flows to be received under the sublease 2020 Area of Land Lease effective date Operating lease, term of contract Operating lease, option to extend Operating lease, renewal term Annual rent under the terms, lease Accrued salaries, bonus, and benefits Accrued licenses and maintenance fees Accrued warranties Accrued taxes Accrued professional services Other Total accrued liabilities Less: Long term accrued liabilities Total current accrued liabilities Line of Credit Facility [Table] Line of Credit Facility [Line Items] Line of Credit Facility, Expiration Date Proceeds from bank Loan description Interest rate Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] No. of Shares Subject to PSU Market Capitalization Milestones SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items] Number of Options/SARs, Outstanding, Beginning Balance Range of Exercise Price, Beginning Balance Weighted Average Exercise Price per Share, Outstanding, Beginning Balance Number of Options/SARs, Granted Range of Exercise Price, Granted Weighted Average Exercise Price per Share, Granted Number of Options/SARs, Exercised Range of Exercise Price, Exercised Weighted Average Exercise Price per Share, Exercised Number of Options/SARs, Forfeited Range of Exercise Price, Forfeited Weighted Average Exercise Price per Share, Forfeited Number of Options/SARs, Outstanding, Ending Balance Range of Exercise Price, Ending Balance Weighted Average Exercise Price per Share, Outstanding, Ending Balance Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of Restricted Stock Units, Outstanding, Beginning Weighted Average Grant Date Fair Value Per Unit, Outstanding, Beginning Number of Restricted Stock Units, Granted Weighted Average Grant Date Fair Value Per Unit, Granted Number of Restricted Stock Units, Vested Weighted Average Grant Date Fair Value Per Unit, Vested Number of Restricted Stock Units, Forfeited Weighted Average Grant Date Fair Value Per Unit, Forfeited Number of Restricted Stock Units, Outstanding, Ending Weighted Average Grant Date Fair Value Per Unit, Outstanding, Ending Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Number of stockholders votes, description Dividends declared Sale of stock, number of shares sold Common Stock, Par or Stated Value Per Share Sale of Stock, Price Per Share Sale of Stock, Consideration Received on Transaction Convertible preferred stock, par value Convertible securities, conversion price per share Preferred stock, par value Redemption price per share Common stock issuable from warrants Preferred stock dividend rate Preferred stock redemption, triggering event, percent of common stock sold threshold Warrants exercisable date Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Number of shares granted Market capitalization milestone, amount Increase in market capitalization milestone, amount Maximum market capitalization milestone, amount Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights Share based compensation Total compensation cost not yet recognized Stock plan expiration date Reserved shares of common stock Weighted average amortization period of total compensation cost not yet recognized, description Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Total assets at fair value Fair value of asset Warranty accrual, beginning of the fiscal period Accrual adjustment for product warranty Payments made Warranty accrual, end of the fiscal period Standard product warranty coverage term Obligation with Joint and Several Liability Arrangement [Line Items] Line of credit, description Operating lease right of use assets non current. Systems [Member] Disposables, Service and Accessories [Member] Cost of subleased portion of operating lease. Compensating cash arrangement. Convertible Preferred Stock Series A [Member] Convertible Preferred Stocks Series B [Member] Revenue From System Delivery and Installation [Member] Disposable Revenue [Member] Royalty Revenue [Member] Other Recurring Revenue [Member] Sublease Revenue [Member]. Stock Options and Stock Appreciation Rights [Member] Series A Convertible Preferred Stock [Member] Series B Convertible Preferred Stock [Member] Product Shipped, Revenue Deferred [Member] Deferred Service and License Fees [Member] Customer Deposits [Member] Prepaid commissions, current and noncurrent. Undiscounted future cash flows to be received under the sublease reminder of fiscal year. Office Lease Agreement [Member] Globe Building Company [Member] Office Space and Manufacturing Facilities [Member] Lease effective date. Minimum Annual Rent in 2022 [Member] Minimum Annual Rent in 2031 [Member] Carrying value as of the balance sheet date of obligations incurred through that date and payable for license and maintenance fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Standard product warranty coverage term. Cash invested in Money Market Accounts [Member] Restricted Cash and Cash Invested In Money Market Accounts [Member] Cares Act [Member] Paycheck Protection Program [Member] Primary Lender [Member] Number of stockholders votes, description. Direct Registered Offering [Member] Convertible securities, Conversion price per share. Preferred stock par value per share. Stock plan expiration date. 2012 Stock Incentive Plan [Member] Stock Award Plans [Member] Weighted average amortization period of total compensation cost not yet recognized, description. PSU Agreement [Member] Mr. Fischel [Member] Increase in market capitalization milestone, amount. Maximum market capitalization milestone, amount. Summary of Performance Award And Market Capitalization Milestones Contract with customer liability noncurrent. Assets, Current Assets [Default Label] Liabilities, Current Liabilities Treasury Stock, Common, Value Stockholders' Equity Attributable to Parent Liabilities and Equity CostOfSublease Gross Profit Operating Expenses Operating Income (Loss) Preferred Stock Dividends, Income Statement Impact Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets IncreaseDecreaseCompensatingCashArrangement Increase (Decrease) in Other Operating Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Contract with Customer, Liability Increase (Decrease) in Other Operating Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Productive Assets Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ContractWithCustomerLiabilityNoncurrent1 Restricted Cash [Default Label] Inventory Valuation Reserves Other Assets Prepaid Expense and Other Assets Prepaid Expense and Other Assets, Noncurrent Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Lease, Cost Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Accrued Liabilities [Default Label] Other Accrued Liabilities, Noncurrent Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Product Warranty Accrual, Current Standard and Extended Product Warranty Accrual, Decrease for Payments EX-101.PRE 11 stxs-20210331_pre.xml XBRL PRESENTATION FILE XML 12 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001289340 2021-01-01 2021-03-31 0001289340 2021-04-30 0001289340 2021-03-31 0001289340 2020-12-31 0001289340 2020-01-01 2020-03-31 0001289340 STXS:SystemsMember 2021-01-01 2021-03-31 0001289340 STXS:SystemsMember 2020-01-01 2020-03-31 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2021-01-01 2021-03-31 0001289340 STXS:DisposablesServiceAndAccessoriesMember 2020-01-01 2020-03-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2019-12-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2019-12-31 0001289340 us-gaap:CommonStockMember 2019-12-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001289340 us-gaap:TreasuryStockMember 2019-12-31 0001289340 us-gaap:RetainedEarningsMember 2019-12-31 0001289340 2019-12-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2020-01-01 2020-03-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2020-01-01 2020-03-31 0001289340 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001289340 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001289340 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2020-03-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2020-03-31 0001289340 us-gaap:CommonStockMember 2020-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001289340 us-gaap:TreasuryStockMember 2020-03-31 0001289340 us-gaap:RetainedEarningsMember 2020-03-31 0001289340 2020-03-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2020-12-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2020-12-31 0001289340 us-gaap:CommonStockMember 2020-12-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001289340 us-gaap:TreasuryStockMember 2020-12-31 0001289340 us-gaap:RetainedEarningsMember 2020-12-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2021-01-01 2021-03-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2021-01-01 2021-03-31 0001289340 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001289340 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001289340 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001289340 STXS:ConvertiblePreferredStockSeriesAMember 2021-03-31 0001289340 STXS:ConvertiblePreferredStocksSeriesBMember 2021-03-31 0001289340 us-gaap:CommonStockMember 2021-03-31 0001289340 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001289340 us-gaap:TreasuryStockMember 2021-03-31 0001289340 us-gaap:RetainedEarningsMember 2021-03-31 0001289340 us-gaap:LetterOfCreditMember 2020-07-31 0001289340 STXS:SystemsMember 2021-03-31 0001289340 STXS:SystemsMember 2020-12-31 0001289340 STXS:SystemsMember srt:MaximumMember 2021-01-01 2021-03-31 0001289340 STXS:RevenueFromSystemDeliveryAndInstallationMember 2021-01-01 2021-03-31 0001289340 STXS:DisposableRevenueMember 2021-01-01 2021-03-31 0001289340 STXS:DisposableRevenueMember 2020-01-01 2020-03-31 0001289340 STXS:RoyaltyRevenueMember 2021-01-01 2021-03-31 0001289340 STXS:RoyaltyRevenueMember 2020-01-01 2020-03-31 0001289340 STXS:OtherRecurringRevenueMember 2021-01-01 2021-03-31 0001289340 STXS:OtherRecurringRevenueMember 2020-01-01 2020-03-31 0001289340 STXS:SubleaseRevenueMember 2021-01-01 2021-03-31 0001289340 STXS:SubleaseRevenueMember 2020-01-01 2020-03-31 0001289340 STXS:CustomerDepositsMember 2021-03-31 0001289340 STXS:CustomerDepositsMember 2020-12-31 0001289340 STXS:ProductShippedRevenueDeferredMember 2021-03-31 0001289340 STXS:ProductShippedRevenueDeferredMember 2020-12-31 0001289340 STXS:DeferredServiceAndLicenseFeesMember 2021-03-31 0001289340 STXS:DeferredServiceAndLicenseFeesMember 2020-12-31 0001289340 STXS:StockOptionsandStockAppreciationRightsMember 2021-01-01 2021-03-31 0001289340 STXS:StockOptionsandStockAppreciationRightsMember 2021-03-31 0001289340 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001289340 us-gaap:WarrantMember 2021-03-31 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-03-31 0001289340 STXS:SeriesBConvertiblePreferredStockMember 2021-01-01 2021-03-31 0001289340 us-gaap:RestrictedStockMember 2021-03-31 0001289340 us-gaap:EquipmentMember 2021-03-31 0001289340 us-gaap:EquipmentMember 2020-12-31 0001289340 us-gaap:LeaseholdImprovementsMember 2021-03-31 0001289340 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001289340 us-gaap:ConstructionInProgressMember 2021-03-31 0001289340 us-gaap:ConstructionInProgressMember 2020-12-31 0001289340 STXS:OfficeSpaceAndManufacturingFacilitiesMember STXS:OfficeLeaseAgreementMember STXS:GlobeBuildingCompanyMember 2021-03-01 0001289340 STXS:OfficeSpaceAndManufacturingFacilitiesMember STXS:OfficeLeaseAgreementMember STXS:GlobeBuildingCompanyMember 2021-02-27 2021-03-01 0001289340 STXS:MinimumAnnualRentInTwoThousandTwentyTwoMember STXS:OfficeSpaceAndManufacturingFacilitiesMember STXS:OfficeLeaseAgreementMember STXS:GlobeBuildingCompanyMember 2021-02-27 2021-03-01 0001289340 STXS:MinimumAnnualRentInTwoThousandThirtyOneMember STXS:OfficeSpaceAndManufacturingFacilitiesMember STXS:OfficeLeaseAgreementMember STXS:GlobeBuildingCompanyMember 2021-02-27 2021-03-01 0001289340 us-gaap:RevolvingCreditFacilityMember STXS:PrimaryLenderMember 2021-01-01 2021-03-31 0001289340 STXS:PaycheckProtectionProgramMember 2020-04-19 2020-04-20 0001289340 STXS:CaresActMember 2020-04-19 2020-04-20 0001289340 STXS:PaycheckProtectionProgramMember 2020-04-20 0001289340 us-gaap:CommonStockMember STXS:DirectRegisteredOfferingMember 2020-05-24 2020-05-25 0001289340 us-gaap:CommonStockMember STXS:DirectRegisteredOfferingMember 2020-05-25 0001289340 STXS:DirectRegisteredOfferingMember 2020-05-24 2020-05-25 0001289340 STXS:SeriesBConvertiblePreferredStockMember us-gaap:PrivatePlacementMember 2019-08-06 2019-08-07 0001289340 STXS:SeriesBConvertiblePreferredStockMember us-gaap:PrivatePlacementMember 2019-08-07 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2016-09-01 2016-09-30 0001289340 STXS:SeriesAConvertiblePreferredStockMember 2016-09-30 0001289340 2016-09-01 2016-09-30 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember 2021-02-22 2021-02-23 0001289340 srt:MaximumMember STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheFourMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheFourMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheFiveMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheFiveMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheSixMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheSixMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheSevenMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheSevenMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheEightMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheEightMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheNineMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheNineMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheTenMember 2021-02-22 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember STXS:ShareBasedCompensationAwardTrancheTenMember 2021-02-23 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember 2021-01-01 2021-03-31 0001289340 STXS:Mr.FischelMember STXS:PerformanceShareUnitAwardAgreementMember 2021-03-31 0001289340 STXS:TwoThousandAndTwelveStockIncentivePlanMember 2021-01-01 2021-03-31 0001289340 STXS:StockAwardPlansMember 2021-03-31 0001289340 srt:MinimumMember 2020-12-31 0001289340 srt:MaximumMember 2020-12-31 0001289340 srt:MinimumMember 2021-01-01 2021-03-31 0001289340 srt:MaximumMember 2021-01-01 2021-03-31 0001289340 srt:MinimumMember 2021-03-31 0001289340 srt:MaximumMember 2021-03-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001289340 us-gaap:RestrictedStockUnitsRSUMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001289340 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001289340 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001289340 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember STXS:CashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001289340 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001289340 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001289340 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001289340 us-gaap:FairValueInputsLevel2Member STXS:RestrictedCashandCashInvestedInMoneyMarketAccountsMember 2021-03-31 0001289340 us-gaap:FairValueInputsLevel2Member STXS:RestrictedCashandCashInvestedInMoneyMarketAccountsMember 2020-12-31 0001289340 2020-01-01 2020-12-31 0001289340 us-gaap:LetterOfCreditMember 2021-02-28 0001289340 us-gaap:LetterOfCreditMember 2021-02-01 2021-02-28 iso4217:USD shares iso4217:USD shares pure utr:sqft STXS:Segments 0001289340 false --12-31 Q1 2021 Non-accelerated Filer P0Y9M0D P10Y P5Y P1Y 10-Q true 2021-03-31 false 001-36159 STEREOTAXIS, INC. DE 94-3120386 4320 Forest Park Avenue Suite 100 St. Louis MO 63108 (314) 678-6100 Common Stock, par value $0.001 per share STXS NYSE Yes Yes true false false 74113969 42452713 43939512 1336000 250919 250620 122570 123614 7290762 3515136 3536300 3295457 1674554 1716014 56541248 52716739 202504 195129 93331 1695664 2235442 284946 308515 58817693 55455825 1914692 1185058 2270432 1608636 2578298 3209235 8188296 5282770 1734699 2287487 16686417 13573186 243617 973252 1328272 548915 210096 131231 18468402 15226584 0.001 0.001 22408 22513 5578437 5605323 0.001 0.001 10000000 10000000 5610121 5610121 5610 5610 0.001 0.001 300000000 300000000 74089659 73694203 74090 73694 524388783 522709846 4015 4015 205999 205999 -489491630 -487959233 34770854 34623918 58817693 55455825 2602512 5773516 5509711 246530 246530 8622558 5756241 1435535 65022 924618 639863 246530 246530 2606683 951415 6015875 4804826 2367041 2109170 2947216 2915424 2229739 1832726 7543996 6857320 -1528121 -2052494 -4276 80963 -1532397 -1971531 332551 343723 -1864948 -2315254 -0.02 -0.03 -0.02 -0.03 75175412 69870040 75175412 69870040 23110 5758190 5610121 5610 68529623 68530 504211040 -205999 -481312774 22766407 40816 41 -23891 -23850 109489 109 722203 722312 -1971531 -1971531 6406 7 32216 32223 -192 -49163 354447 354 48809 49163 22918 5709027 5610121 5610 69040781 69041 504990377 -205999 -483284305 21574724 22513 5605323 5610121 5610 73694203 73694 522709846 -205999 -487959233 34623918 154806 156 252679 252835 30250 30 1370527 1370557 -1532397 -1532397 6003 6 29049 29055 -105 -26886 204397 204 26682 26886 22408 5578437 5610121 5610 74089659 74090 524388783 -205999 -489491630 34770854 -1532397 -1971531 26817 30119 582712 585586 1370557 722312 3775626 -714499 240843 1322610 -41460 -80419 299 -23569 74054 661796 -96800 -630937 -378907 3684883 130691 -595723 -585489 78865 -305166 -2165765 34192 -34192 281890 8373 281890 8373 -57468 -2157392 43939512 30182115 43882044 28024723 42452713 28024723 1336000 93331 <p id="xdx_808_eus-gaap--NatureOfOperations_zp3Ca6AZwRJ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>1. <span id="xdx_822_zKcRL5pDtfBb">Description of Business</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Stereotaxis designs, manufactures and markets an advanced robotic magnetic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our primary products include the <i>Genesis RMN</i> System, the <i>Niobe</i> System, the <i>Odyssey </i>Solution, and related devices. We also offer to our customers the Stereotaxis Imaging Model S x-ray System.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The <i>Genesis RMN </i>and <i>Niobe</i> Systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and reduced x-ray exposure.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the <i>Odyssey</i> Solution, which consolidates lab information enabling physicians to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called <i>Odyssey Cinema</i>, which is an innovative solution that delivers synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global <i>Odyssey</i> Network providing physicians with a tool for clinical collaboration, remote consultation, and training.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond the warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We have received regulatory clearance, licensing and/or CE Mark approvals necessary for us to market the <i>Genesis RMN</i> System in the U.S. and Europe, and we are in the process of obtaining necessary registrations for extending our markets in other countries. The <i>Niobe </i>System, <i>Odyssey</i> Solution, <i>Cardiodrive</i>, and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the <i>Vdrive</i> and <i>Vdrive Duo</i> Systems with the <i>V-CAS</i>, <i>V-Loop </i>and <i>V-Sono </i>devices in the U.S., Canada and Europe. Stereotaxis Imaging Model S is CE marked and FDA cleared.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We have strategic relationships with technology leaders and innovators in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic navigation system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships will continue and efforts are ongoing to ensure the availability of integrated next generation systems and/or equivalent alternatives. We cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_800_eus-gaap--SignificantAccountingPoliciesTextBlock_z285T17pL5nh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2. <span id="xdx_825_zkhwP2AL8lz5">Summary of Significant Accounting Policies</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zyIgPHxHScXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_865_zjFU9G1bzt9i">Basis of Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by GAAP for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or for future operating periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission (SEC) on March 12, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_ecustom--RisksAndUncertaintiesPolicyTextBlock_zSWWjFdm0erk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86B_zLwot3Mn7cP8">Risks and Uncertainties</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The novel coronavirus COVID-19 (“COVID-19”) pandemic has resulted, and is likely to continue to result, in significant disruptions to the economy, as well as business and capital markets around the world. The full extent of the impact of the COVID-19 pandemic on our business, results of operations and financial condition will depend on numerous evolving factors that we may not be able to accurately predict.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">As a result of the COVID-19 outbreak, we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which have negatively affected our complex sales, marketing, installation, distribution and service network relating to our products and services. The COVID-19 pandemic may continue to negatively affect demand for both our systems and our disposable products by limiting the ability of our sales personnel to maintain their customary contacts with customers as governmental authorities institute prolonged quarantines, travel restrictions, and shelter-in-place orders, or as our customers impose limitations on contacts and in-person meetings that go beyond those imposed by governmental authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">In addition, many of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable sales and installation cycles for our robotic magnetic navigation systems. We may also experience significant reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) continue to re-prioritize the treatment of patients and divert resources away from non-coronavirus areas, which we anticipate will lead to the performance of fewer procedures in which our disposable products are used. In addition, patients may consider foregoing or deferring procedures utilizing our products, even if physicians and hospitals are willing to perform them, which could also reduce demand for, and sales of, our disposable products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">As of the date of the filing of this Quarterly Report on Form 10-Q, we believe our manufacturing operations and supply chains have been minimally interrupted, but we cannot guarantee that they will not be interrupted more severely in the future. If our manufacturing operations or supply chains are materially interrupted, it may not be possible for us to timely manufacture relevant products at required levels, or at all. A material reduction or interruption to any of our manufacturing processes would have a material adverse effect on our business, operating results, and financial condition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">If governmental authorities around the world continue to institute prolonged mandatory closures, social distancing protocols and shelter-in-place orders, or as private parties on whom we rely to operate our business put in place their own protocols that go beyond those instituted by relevant governmental authorities, our ability to adequately staff and maintain our operations or further our product development could be negatively impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Any disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Continued disruptions to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects, a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products as well as an increased risk of customer defaults or delays in payments for our systems, installation, service contracts and disposable products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We continue to evaluate and, where appropriate, take actions to reduce costs and spending across our organization. We will continue to actively monitor the situation and may take further actions that alter our business operations that may be required by federal, state, or local governmental authorities or that may be implemented by our vendors, suppliers or customers, or that we determine are in the best interests of our employees, customers, suppliers and stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zHXvYtQdZ6sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.5pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_867_zHAunHqdVAG2">Cash and Cash Equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The Company considers all short-term investments purchased with original maturities of three months or less to be cash equivalents. The Company places its cash with high-credit-quality financial institutions and invests primarily in money market accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_ecustom--RestrictedCashPolicyTextBlock_ziWLtOHMm50j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.5pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_865_z83eStc7aSq4">Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Restricted cash primarily consists of cash that the Company is obligated to maintain in accordance with contractual obligations. The Company’s restricted cash was $<span id="xdx_903_eus-gaap--RestrictedCash_iI_pn5n6_c20210331_zK3kH0drG6p" title="Restricted cash">1.4</span> million at March 31, 2021. <span id="xdx_908_eus-gaap--RestrictedCash_iI_pn5n6_do_c20201231_zkYuiNBjriw9" title="Restricted cash">No</span> cash was restricted at December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_ecustom--CompensatingCashArrangementPolicyTextBlock_zgO2RwUWj59b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_861_zKgP0ypFFs8k">Compensating Cash Arrangement</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">In July 2020, the Company entered into a letter of credit to support a commitment of less than $<span id="xdx_90A_eus-gaap--LineOfCredit_iI_pn5n6_c20200731__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_z45jpp1KwQue" title="Long-term Line of Credit">0.3</span> million. As a condition of the letter of credit, the Company is required to maintain a $<span id="xdx_901_eus-gaap--CompensatingBalanceAmount_iI_pn5n6_c20200731__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_z8RETT6W1Bfk" title="Compensating Balance, Amount">0.3</span> million compensating balance until the expiration of the letter of credit. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ziLEx4Mwbyv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86F_zcCGYS9V5F06">Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s financial assets consist of restricted cash and cash equivalents invested in money market funds which totaled $<span id="xdx_905_eus-gaap--MoneyMarketFundsAtCarryingValue_iI_pn5n6_c20210331__srt--ProductOrServiceAxis__custom--SystemsMember_z5JHWqeaeAYa" title="Money market funds"><span id="xdx_906_eus-gaap--MoneyMarketFundsAtCarryingValue_iI_pn5n6_c20201231__srt--ProductOrServiceAxis__custom--SystemsMember_z77YSDbCtYE" title="Money market funds">1.4</span></span> million as of March 31, 2021 and December 31, 2020, respectively. The financial assets consisting of cash equivalents invested in money market funds are classified as Level 2 as described above and total interest income recorded for these investments was insignificant for the three months ended March 31, 2021. As of March 31, 2021, the Company did not have any financial liabilities valued at fair value on a recurring basis. As of March 31, 2020, the Company did not have any financial assets or liabilities valued at fair value on a recurring basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zuIbZoVVZ4Gh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86A_zF3R50S8UUb">Revenue and Costs of Revenue</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for revenue in accordance with Accounting Standards Codification Topic 606 (“ASC 606”), “Revenue from Contracts with Customers”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from revenue including ongoing software updates and service contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif">For contracts containing multiple products and services, the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">For arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Our revenue recognition policy affects the following revenue streams in our business as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Systems:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were less than $<span id="xdx_907_eus-gaap--ProductWarrantyExpense_pn5n6_c20210101__20210331__srt--ProductOrServiceAxis__custom--SystemsMember__srt--RangeAxis__srt--MaximumMember_z2FLhJuM98k7">0.1 </span></span><span style="font: 10pt Times New Roman, Times, Serif">million</span><span style="font: 10pt Times New Roman, Times, Serif"> for the periods presented. Revenue from system delivery and installation represented <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueFromSystemDeliveryAndInstallationMember_zxY6XGktdfvb">30</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of revenue for the three months ended March 31, 2021. There was <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dpo_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueFromSystemDeliveryAndInstallationMember_zejnHmyb973i">no </span></span><span style="font: 10pt Times New Roman, Times, Serif">revenue from system delivery and installation for the three months ended March 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Disposables:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--DisposableRevenueMember_zx4WVorAqzLj" title="Revenues percentage">24</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--DisposableRevenueMember_zaX9totyh1j1" title="Revenues percentage">34</span>% of revenue for the three months ended March 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Royalty: </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RoyaltyRevenueMember_z474Whu5UVpb" title="Revenues percentage">7</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RoyaltyRevenueMember_zNLRxVSAFV65" title="Revenues percentage">10</span>% of revenue for the three months ended March 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Other Recurring Revenue: </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation of our systems. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPercent_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--OtherRecurringRevenueMember_zPZWEiJNVNq3" title="Revenues percentage">36</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPercent_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--OtherRecurringRevenueMember_z5cFwpZ9Y5i2" title="Revenues percentage">52</span>% of revenue for the three months ended March 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Sublease Revenue:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A portion of our principal executive office is subleased to a third party through 2021. In accordance with Accounting Standards Update (ASU) 2016-02, “Leases” (Topic 842), the Company records sublease income as revenue. Sublease revenue represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPercent_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SubleaseRevenueMember_zNBpe7OZYx0l">3</span></span><span style="font: 10pt Times New Roman, Times, Serif">% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPercent_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SubleaseRevenueMember_zo5wzoyDNwS">4</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of revenue for the three months ended March 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqUAdHtEUfol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zAp46DSJJ7B2" style="display: none">Schedule of Revenue Disaggregated by Type</span></span><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%">Systems</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331__srt--ProductOrServiceAxis__custom--SystemsMember_zVq4Qs8YWEJ3" style="width: 18%; text-align: right" title="Total revenue">2,602,512</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331__srt--ProductOrServiceAxis__custom--SystemsMember_z3i562WXBGYj" style="width: 18%; text-align: right" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Disposables, service and accessories</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331__srt--ProductOrServiceAxis__custom--DisposablesServiceAndAccessoriesMember_z3MOwNvn2AD9" style="text-align: right" title="Total revenue">5,773,516</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331__srt--ProductOrServiceAxis__custom--DisposablesServiceAndAccessoriesMember_zINJmgZgCub9" style="text-align: right" title="Total revenue">5,509,711</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Sublease</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--SubleaseIncome_pp0p0_c20210101__20210331_zYMKTmhHjVK2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sub lease">246,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SubleaseIncome_pp0p0_c20200101__20200331_znTzAZNP4ix8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sub lease">246,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331_zn1j34jfrGy3" style="text-align: right" title="Total revenue">8,622,558</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331_z5KMVXQUXqh9" style="text-align: right" title="Total revenue">5,756,241</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8AC_zo81JKR2E4F9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $<span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn5n6_c20210331_zMpS3qqKMi33" title="Remaining performance obligation">10.1</span> million as of March 31, 2021. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_z8Z3xCx9Wmci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following information summarizes the Company’s contract assets and liabilities:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_zY7vRvhkaY29" style="display: none">Summary of Contract Assets and Liabilities</span></span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Contract Assets - unbilled receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ContractWithCustomerAssetNet_iI_pp0p0_c20210331_zIs7viG8CA65" style="width: 18%; text-align: right" title="Contract Assets - unbilled receivables">207,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ContractWithCustomerAssetNet_iI_pp0p0_c20201231_zSjkrXogxEXa" style="width: 18%; text-align: right" title="Contract Assets - unbilled receivables">284,415</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer deposits</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--CustomerDepositsMember_z2zMVP5sZ07d" style="text-align: right" title="Total deferred revenue">1,955,573</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--CustomerDepositsMember_zFxBVClwinf8" style="text-align: right" title="Total deferred revenue"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product shipped, revenue deferred</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--ProductShippedRevenueDeferredMember_zlAEsiPHg59" style="text-align: right" title="Total deferred revenue">1,547,957</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--ProductShippedRevenueDeferredMember_zVxCBV1E0NOk" style="text-align: right" title="Total deferred revenue">645,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred service and license fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--DeferredServiceAndLicenseFeesMember_zfEA0VJBlwud" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total deferred revenue">6,013,038</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--DeferredServiceAndLicenseFeesMember_zVpms5C5Hftc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total deferred revenue">5,186,485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total deferred revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331_zvzJKIWEIrJ6" style="text-align: right" title="Total deferred revenue">9,516,568</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231_z7uwq5rqFnRg" style="text-align: right" title="Total deferred revenue">5,831,685</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Long-term deferred revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ContractWithCustomerLiabilityNoncurrent1_iNI_pp0p0_di_c20210331_zzJ6hQ5YapDh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Long-term deferred revenue">(1,328,272</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ContractWithCustomerLiabilityNoncurrent1_iNI_pp0p0_di_c20201231_zG41WKBFe9Pd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Long-term deferred revenue">(548,915</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total current deferred revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p0_c20210331_zMp6M1P0ZVTe" style="text-align: right" title="Total current deferred revenue">8,188,296</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p0_c20201231_zew9BMYoEAJa" style="text-align: right" title="Total current deferred revenue">5,282,770</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"/> <p id="xdx_8A3_zBeTDZH6AUEc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Revenue recognized for the three months ended March 31, 2021 and 2020, that was included in the deferred revenue balance at the beginning of each reporting period remained consistent at $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pn5n6_c20210101__20210331_zug0mK04kfse" title="Contract with Customer, Liability, Revenue Recognized"><span id="xdx_90F_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pn5n6_c20200101__20200331_zthNSLZi04i9" title="Contract with Customer, Liability, Revenue Recognized">2.6</span></span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"/> <p id="xdx_84A_ecustom--ContractAssetAndLiabilityPolicyTextBlock_zUEm0QYEPs7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_866_zzylTSBbsxX3">Assets Recognized from the Costs to Obtain a Contract with a Customer</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $<span id="xdx_909_eus-gaap--CapitalizedContractCostNet_iI_pn5n6_c20210331_zF2YlW7s6vPc">0.2</span></span> <span style="font: 10pt Times New Roman, Times, Serif">million and $<span id="xdx_909_eus-gaap--CapitalizedContractCostNet_iI_pn5n6_c20201231_zM7P8k2e2Qd6">0.3</span></span> <span style="font: 10pt Times New Roman, Times, Serif">million as of March 31, 2021 and December 31, 2020, respectively. The Company did not incur any impairment losses during any of the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recognized at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are recognized when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zxP7k8r0F1Q" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_861_zFdcdpctVXM5">Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">For time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.05pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.05pt"><span style="font: 10pt Times New Roman, Times, Serif">For market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Shares purchased by employees under the 2009 Employee Stock Purchase Plan are considered to be non-compensatory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_z9VXGC3xTjB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_869_zEcvj3UZuAnb">Net Earnings (Loss) per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Basic earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our convertible preferred stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our convertible preferred stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our convertible preferred stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWdzQGmVXX59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the computation of basic and diluted EPS:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="display: none"><span id="xdx_8B1_zExXc5Wx5KAc">Schedule of Computation of Basic and Diluted Earnings Per Share</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20210331_zs737cL5orO4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20200101__20200331_zOyJpLyzJtW7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLoss_z8AC5xvY6LHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,532,397</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,971,531</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zX2J7busbnqh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Cumulative dividend on Series A Convertible Preferred Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(332,551</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(343,723</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z2eRSPWyYiie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,864,948</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,315,254</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zxiY6izrzkHd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average number of common shares and equivalents:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,175,412</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,870,040</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasic_zpS4P2j1gjr" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic EPS</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--EarningsPerShareDiluted_zQSlIciZc1Me" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted EPS</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8A2_zWT1atnLhRDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights, warrants or convertible preferred stock in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented. The application of the two-class method of computing earnings per share under general accounting principles for participating securities is not applicable during these periods because those securities do not contractually participate in its losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">As of March 31, 2021, the Company had <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_c20210101__20210331__us-gaap--AwardTypeAxis__custom--StockOptionsandStockAppreciationRightsMember_zsjbXjqfa6w1" title="Potential common shares excluded from diluted earnings per share">3,030,178</span> shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pii_c20210331__us-gaap--AwardTypeAxis__custom--StockOptionsandStockAppreciationRightsMember_zVomYWVy0175" title="Weighted average exercise price">3.95</span> per share, <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPrA1MuNmWJf" title="Potential common shares excluded from diluted earnings per share">15,385 </span>shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pii_c20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRDUjIhevF09" title="Exercise price of warrants">0.70</span> per share, <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_c20210101__20210331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zM1SDuF6beC2" title="Potential common shares excluded from diluted earnings per share">43,790,285 </span>shares of our common stock issuable upon conversion of our Series A Convertible Preferred Stock, <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_c20210101__20210331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zA0DRYydNNZ1" title="Potential common shares excluded from diluted earnings per share">5,610,121</span> shares of our common stock issuable upon conversion of our Series B Convertible Preferred Stock and <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_pii_c20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zOe2dgyZBmLc" title="Number of unvested restricted share units">1,287,223</span> shares of unvested restricted share units. The Company had no unearned restricted shares outstanding for the period ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWUmY47Hccah" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86B_z0fUTINNnrv">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019, the FASB issued Accounting Standards Update (ASU) 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” as part of its effort to reduce the complexity of accounting standards. The ASU is effective for fiscal years beginning after December 15, 2020. The Company adopted with no impact to the Company’s financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance under ASU 2018-19, ASU 2019-04 and ASU 2019-05. The standard modifies the measurement approach for credit losses on financial instruments, including trade receivables, from an incurred loss method to a current expected credit loss method, otherwise known as “CECL.” The standard requires the measurement of expected credit losses to be based on relevant information, including historical experience, current conditions and a forecast that is supportable. The standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The standard must be adopted by applying a cumulative adjustment to retained earnings. The Company anticipates adopting the standard in the first quarter of 2023, although it does not expect a significant impact to the Company’s financial results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zyIgPHxHScXa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_865_zjFU9G1bzt9i">Basis of Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by GAAP for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or for future operating periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission (SEC) on March 12, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_ecustom--RisksAndUncertaintiesPolicyTextBlock_zSWWjFdm0erk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86B_zLwot3Mn7cP8">Risks and Uncertainties</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The novel coronavirus COVID-19 (“COVID-19”) pandemic has resulted, and is likely to continue to result, in significant disruptions to the economy, as well as business and capital markets around the world. The full extent of the impact of the COVID-19 pandemic on our business, results of operations and financial condition will depend on numerous evolving factors that we may not be able to accurately predict.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">As a result of the COVID-19 outbreak, we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which have negatively affected our complex sales, marketing, installation, distribution and service network relating to our products and services. The COVID-19 pandemic may continue to negatively affect demand for both our systems and our disposable products by limiting the ability of our sales personnel to maintain their customary contacts with customers as governmental authorities institute prolonged quarantines, travel restrictions, and shelter-in-place orders, or as our customers impose limitations on contacts and in-person meetings that go beyond those imposed by governmental authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">In addition, many of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable sales and installation cycles for our robotic magnetic navigation systems. We may also experience significant reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) continue to re-prioritize the treatment of patients and divert resources away from non-coronavirus areas, which we anticipate will lead to the performance of fewer procedures in which our disposable products are used. In addition, patients may consider foregoing or deferring procedures utilizing our products, even if physicians and hospitals are willing to perform them, which could also reduce demand for, and sales of, our disposable products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">As of the date of the filing of this Quarterly Report on Form 10-Q, we believe our manufacturing operations and supply chains have been minimally interrupted, but we cannot guarantee that they will not be interrupted more severely in the future. If our manufacturing operations or supply chains are materially interrupted, it may not be possible for us to timely manufacture relevant products at required levels, or at all. A material reduction or interruption to any of our manufacturing processes would have a material adverse effect on our business, operating results, and financial condition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">If governmental authorities around the world continue to institute prolonged mandatory closures, social distancing protocols and shelter-in-place orders, or as private parties on whom we rely to operate our business put in place their own protocols that go beyond those instituted by relevant governmental authorities, our ability to adequately staff and maintain our operations or further our product development could be negatively impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Any disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Continued disruptions to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects, a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products as well as an increased risk of customer defaults or delays in payments for our systems, installation, service contracts and disposable products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We continue to evaluate and, where appropriate, take actions to reduce costs and spending across our organization. We will continue to actively monitor the situation and may take further actions that alter our business operations that may be required by federal, state, or local governmental authorities or that may be implemented by our vendors, suppliers or customers, or that we determine are in the best interests of our employees, customers, suppliers and stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zHXvYtQdZ6sh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.5pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_867_zHAunHqdVAG2">Cash and Cash Equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The Company considers all short-term investments purchased with original maturities of three months or less to be cash equivalents. The Company places its cash with high-credit-quality financial institutions and invests primarily in money market accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_ecustom--RestrictedCashPolicyTextBlock_ziWLtOHMm50j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.5pt; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_865_z83eStc7aSq4">Restricted Cash</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Restricted cash primarily consists of cash that the Company is obligated to maintain in accordance with contractual obligations. The Company’s restricted cash was $<span id="xdx_903_eus-gaap--RestrictedCash_iI_pn5n6_c20210331_zK3kH0drG6p" title="Restricted cash">1.4</span> million at March 31, 2021. <span id="xdx_908_eus-gaap--RestrictedCash_iI_pn5n6_do_c20201231_zkYuiNBjriw9" title="Restricted cash">No</span> cash was restricted at December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 1400000 0 <p id="xdx_841_ecustom--CompensatingCashArrangementPolicyTextBlock_zgO2RwUWj59b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_861_zKgP0ypFFs8k">Compensating Cash Arrangement</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">In July 2020, the Company entered into a letter of credit to support a commitment of less than $<span id="xdx_90A_eus-gaap--LineOfCredit_iI_pn5n6_c20200731__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_z45jpp1KwQue" title="Long-term Line of Credit">0.3</span> million. As a condition of the letter of credit, the Company is required to maintain a $<span id="xdx_901_eus-gaap--CompensatingBalanceAmount_iI_pn5n6_c20200731__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_z8RETT6W1Bfk" title="Compensating Balance, Amount">0.3</span> million compensating balance until the expiration of the letter of credit. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 300000 300000 <p id="xdx_843_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ziLEx4Mwbyv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86F_zcCGYS9V5F06">Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s financial assets consist of restricted cash and cash equivalents invested in money market funds which totaled $<span id="xdx_905_eus-gaap--MoneyMarketFundsAtCarryingValue_iI_pn5n6_c20210331__srt--ProductOrServiceAxis__custom--SystemsMember_z5JHWqeaeAYa" title="Money market funds"><span id="xdx_906_eus-gaap--MoneyMarketFundsAtCarryingValue_iI_pn5n6_c20201231__srt--ProductOrServiceAxis__custom--SystemsMember_z77YSDbCtYE" title="Money market funds">1.4</span></span> million as of March 31, 2021 and December 31, 2020, respectively. The financial assets consisting of cash equivalents invested in money market funds are classified as Level 2 as described above and total interest income recorded for these investments was insignificant for the three months ended March 31, 2021. As of March 31, 2021, the Company did not have any financial liabilities valued at fair value on a recurring basis. As of March 31, 2020, the Company did not have any financial assets or liabilities valued at fair value on a recurring basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 1400000 1400000 <p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zuIbZoVVZ4Gh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86A_zF3R50S8UUb">Revenue and Costs of Revenue</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for revenue in accordance with Accounting Standards Codification Topic 606 (“ASC 606”), “Revenue from Contracts with Customers”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from revenue including ongoing software updates and service contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif">For contracts containing multiple products and services, the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">For arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Our revenue recognition policy affects the following revenue streams in our business as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Systems:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were less than $<span id="xdx_907_eus-gaap--ProductWarrantyExpense_pn5n6_c20210101__20210331__srt--ProductOrServiceAxis__custom--SystemsMember__srt--RangeAxis__srt--MaximumMember_z2FLhJuM98k7">0.1 </span></span><span style="font: 10pt Times New Roman, Times, Serif">million</span><span style="font: 10pt Times New Roman, Times, Serif"> for the periods presented. Revenue from system delivery and installation represented <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueFromSystemDeliveryAndInstallationMember_zxY6XGktdfvb">30</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of revenue for the three months ended March 31, 2021. There was <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dpo_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenueFromSystemDeliveryAndInstallationMember_zejnHmyb973i">no </span></span><span style="font: 10pt Times New Roman, Times, Serif">revenue from system delivery and installation for the three months ended March 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Disposables:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--DisposableRevenueMember_zx4WVorAqzLj" title="Revenues percentage">24</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--DisposableRevenueMember_zaX9totyh1j1" title="Revenues percentage">34</span>% of revenue for the three months ended March 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Royalty: </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RoyaltyRevenueMember_z474Whu5UVpb" title="Revenues percentage">7</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RoyaltyRevenueMember_zNLRxVSAFV65" title="Revenues percentage">10</span>% of revenue for the three months ended March 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Other Recurring Revenue: </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation of our systems. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPercent_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--OtherRecurringRevenueMember_zPZWEiJNVNq3" title="Revenues percentage">36</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPercent_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--OtherRecurringRevenueMember_z5cFwpZ9Y5i2" title="Revenues percentage">52</span>% of revenue for the three months ended March 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Sublease Revenue:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A portion of our principal executive office is subleased to a third party through 2021. In accordance with Accounting Standards Update (ASU) 2016-02, “Leases” (Topic 842), the Company records sublease income as revenue. Sublease revenue represented <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPercent_c20210101__20210331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SubleaseRevenueMember_zNBpe7OZYx0l">3</span></span><span style="font: 10pt Times New Roman, Times, Serif">% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPercent_c20200101__20200331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--SubleaseRevenueMember_zo5wzoyDNwS">4</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of revenue for the three months ended March 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqUAdHtEUfol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zAp46DSJJ7B2" style="display: none">Schedule of Revenue Disaggregated by Type</span></span><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%">Systems</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331__srt--ProductOrServiceAxis__custom--SystemsMember_zVq4Qs8YWEJ3" style="width: 18%; text-align: right" title="Total revenue">2,602,512</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331__srt--ProductOrServiceAxis__custom--SystemsMember_z3i562WXBGYj" style="width: 18%; text-align: right" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Disposables, service and accessories</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331__srt--ProductOrServiceAxis__custom--DisposablesServiceAndAccessoriesMember_z3MOwNvn2AD9" style="text-align: right" title="Total revenue">5,773,516</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331__srt--ProductOrServiceAxis__custom--DisposablesServiceAndAccessoriesMember_zINJmgZgCub9" style="text-align: right" title="Total revenue">5,509,711</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Sublease</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--SubleaseIncome_pp0p0_c20210101__20210331_zYMKTmhHjVK2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sub lease">246,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SubleaseIncome_pp0p0_c20200101__20200331_znTzAZNP4ix8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sub lease">246,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331_zn1j34jfrGy3" style="text-align: right" title="Total revenue">8,622,558</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331_z5KMVXQUXqh9" style="text-align: right" title="Total revenue">5,756,241</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8AC_zo81JKR2E4F9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $<span id="xdx_902_eus-gaap--RevenueRemainingPerformanceObligation_iI_pn5n6_c20210331_zMpS3qqKMi33" title="Remaining performance obligation">10.1</span> million as of March 31, 2021. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_z8Z3xCx9Wmci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following information summarizes the Company’s contract assets and liabilities:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_zY7vRvhkaY29" style="display: none">Summary of Contract Assets and Liabilities</span></span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Contract Assets - unbilled receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ContractWithCustomerAssetNet_iI_pp0p0_c20210331_zIs7viG8CA65" style="width: 18%; text-align: right" title="Contract Assets - unbilled receivables">207,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ContractWithCustomerAssetNet_iI_pp0p0_c20201231_zSjkrXogxEXa" style="width: 18%; text-align: right" title="Contract Assets - unbilled receivables">284,415</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer deposits</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--CustomerDepositsMember_z2zMVP5sZ07d" style="text-align: right" title="Total deferred revenue">1,955,573</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--CustomerDepositsMember_zFxBVClwinf8" style="text-align: right" title="Total deferred revenue"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product shipped, revenue deferred</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--ProductShippedRevenueDeferredMember_zlAEsiPHg59" style="text-align: right" title="Total deferred revenue">1,547,957</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--ProductShippedRevenueDeferredMember_zVxCBV1E0NOk" style="text-align: right" title="Total deferred revenue">645,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred service and license fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--DeferredServiceAndLicenseFeesMember_zfEA0VJBlwud" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total deferred revenue">6,013,038</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--DeferredServiceAndLicenseFeesMember_zVpms5C5Hftc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total deferred revenue">5,186,485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total deferred revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331_zvzJKIWEIrJ6" style="text-align: right" title="Total deferred revenue">9,516,568</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231_z7uwq5rqFnRg" style="text-align: right" title="Total deferred revenue">5,831,685</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Long-term deferred revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ContractWithCustomerLiabilityNoncurrent1_iNI_pp0p0_di_c20210331_zzJ6hQ5YapDh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Long-term deferred revenue">(1,328,272</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ContractWithCustomerLiabilityNoncurrent1_iNI_pp0p0_di_c20201231_zG41WKBFe9Pd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Long-term deferred revenue">(548,915</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total current deferred revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p0_c20210331_zMp6M1P0ZVTe" style="text-align: right" title="Total current deferred revenue">8,188,296</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p0_c20201231_zew9BMYoEAJa" style="text-align: right" title="Total current deferred revenue">5,282,770</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"/> <p id="xdx_8A3_zBeTDZH6AUEc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Revenue recognized for the three months ended March 31, 2021 and 2020, that was included in the deferred revenue balance at the beginning of each reporting period remained consistent at $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pn5n6_c20210101__20210331_zug0mK04kfse" title="Contract with Customer, Liability, Revenue Recognized"><span id="xdx_90F_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_pn5n6_c20200101__20200331_zthNSLZi04i9" title="Contract with Customer, Liability, Revenue Recognized">2.6</span></span> million.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"/> 100000 0.30 0.24 0.34 0.07 0.10 0.36 0.52 0.03 0.04 <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zqUAdHtEUfol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B4_zAp46DSJJ7B2" style="display: none">Schedule of Revenue Disaggregated by Type</span></span><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%">Systems</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331__srt--ProductOrServiceAxis__custom--SystemsMember_zVq4Qs8YWEJ3" style="width: 18%; text-align: right" title="Total revenue">2,602,512</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331__srt--ProductOrServiceAxis__custom--SystemsMember_z3i562WXBGYj" style="width: 18%; text-align: right" title="Total revenue"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Disposables, service and accessories</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331__srt--ProductOrServiceAxis__custom--DisposablesServiceAndAccessoriesMember_z3MOwNvn2AD9" style="text-align: right" title="Total revenue">5,773,516</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331__srt--ProductOrServiceAxis__custom--DisposablesServiceAndAccessoriesMember_zINJmgZgCub9" style="text-align: right" title="Total revenue">5,509,711</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Sublease</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--SubleaseIncome_pp0p0_c20210101__20210331_zYMKTmhHjVK2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sub lease">246,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--SubleaseIncome_pp0p0_c20200101__20200331_znTzAZNP4ix8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Sub lease">246,530</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20210331_zn1j34jfrGy3" style="text-align: right" title="Total revenue">8,622,558</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20200101__20200331_z5KMVXQUXqh9" style="text-align: right" title="Total revenue">5,756,241</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 2602512 5773516 5509711 246530 246530 8622558 5756241 10100000 <p id="xdx_89A_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_z8Z3xCx9Wmci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following information summarizes the Company’s contract assets and liabilities:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_zY7vRvhkaY29" style="display: none">Summary of Contract Assets and Liabilities</span></span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Contract Assets - unbilled receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ContractWithCustomerAssetNet_iI_pp0p0_c20210331_zIs7viG8CA65" style="width: 18%; text-align: right" title="Contract Assets - unbilled receivables">207,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ContractWithCustomerAssetNet_iI_pp0p0_c20201231_zSjkrXogxEXa" style="width: 18%; text-align: right" title="Contract Assets - unbilled receivables">284,415</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer deposits</td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--CustomerDepositsMember_z2zMVP5sZ07d" style="text-align: right" title="Total deferred revenue">1,955,573</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--CustomerDepositsMember_zFxBVClwinf8" style="text-align: right" title="Total deferred revenue"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Product shipped, revenue deferred</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--ProductShippedRevenueDeferredMember_zlAEsiPHg59" style="text-align: right" title="Total deferred revenue">1,547,957</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--ProductShippedRevenueDeferredMember_zVxCBV1E0NOk" style="text-align: right" title="Total deferred revenue">645,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred service and license fees</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331__srt--ProductOrServiceAxis__custom--DeferredServiceAndLicenseFeesMember_zfEA0VJBlwud" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total deferred revenue">6,013,038</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231__srt--ProductOrServiceAxis__custom--DeferredServiceAndLicenseFeesMember_zVpms5C5Hftc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total deferred revenue">5,186,485</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total deferred revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20210331_zvzJKIWEIrJ6" style="text-align: right" title="Total deferred revenue">9,516,568</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ContractWithCustomerLiability_iI_pp0p0_c20201231_z7uwq5rqFnRg" style="text-align: right" title="Total deferred revenue">5,831,685</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Long-term deferred revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ContractWithCustomerLiabilityNoncurrent1_iNI_pp0p0_di_c20210331_zzJ6hQ5YapDh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Long-term deferred revenue">(1,328,272</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ContractWithCustomerLiabilityNoncurrent1_iNI_pp0p0_di_c20201231_zG41WKBFe9Pd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Long-term deferred revenue">(548,915</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Total current deferred revenue</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p0_c20210331_zMp6M1P0ZVTe" style="text-align: right" title="Total current deferred revenue">8,188,296</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ContractWithCustomerLiabilityCurrent_iI_pp0p0_c20201231_zew9BMYoEAJa" style="text-align: right" title="Total current deferred revenue">5,282,770</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"/> 207964 284415 1955573 1547957 645200 6013038 5186485 9516568 5831685 1328272 548915 8188296 5282770 2600000 2600000 <p id="xdx_84A_ecustom--ContractAssetAndLiabilityPolicyTextBlock_zUEm0QYEPs7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_866_zzylTSBbsxX3">Assets Recognized from the Costs to Obtain a Contract with a Customer</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $<span id="xdx_909_eus-gaap--CapitalizedContractCostNet_iI_pn5n6_c20210331_zF2YlW7s6vPc">0.2</span></span> <span style="font: 10pt Times New Roman, Times, Serif">million and $<span id="xdx_909_eus-gaap--CapitalizedContractCostNet_iI_pn5n6_c20201231_zM7P8k2e2Qd6">0.3</span></span> <span style="font: 10pt Times New Roman, Times, Serif">million as of March 31, 2021 and December 31, 2020, respectively. The Company did not incur any impairment losses during any of the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recognized at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are recognized when incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 200000 300000 <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zxP7k8r0F1Q" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_861_zFdcdpctVXM5">Share-Based Compensation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">For time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.05pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.05pt"><span style="font: 10pt Times New Roman, Times, Serif">For market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Shares purchased by employees under the 2009 Employee Stock Purchase Plan are considered to be non-compensatory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_z9VXGC3xTjB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_869_zEcvj3UZuAnb">Net Earnings (Loss) per Common Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Basic earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our convertible preferred stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our convertible preferred stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our convertible preferred stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWdzQGmVXX59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the computation of basic and diluted EPS:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="display: none"><span id="xdx_8B1_zExXc5Wx5KAc">Schedule of Computation of Basic and Diluted Earnings Per Share</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20210331_zs737cL5orO4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20200101__20200331_zOyJpLyzJtW7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLoss_z8AC5xvY6LHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,532,397</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,971,531</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zX2J7busbnqh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Cumulative dividend on Series A Convertible Preferred Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(332,551</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(343,723</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z2eRSPWyYiie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,864,948</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,315,254</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zxiY6izrzkHd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average number of common shares and equivalents:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,175,412</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,870,040</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasic_zpS4P2j1gjr" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic EPS</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--EarningsPerShareDiluted_zQSlIciZc1Me" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted EPS</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8A2_zWT1atnLhRDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights, warrants or convertible preferred stock in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented. The application of the two-class method of computing earnings per share under general accounting principles for participating securities is not applicable during these periods because those securities do not contractually participate in its losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">As of March 31, 2021, the Company had <span id="xdx_90B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_c20210101__20210331__us-gaap--AwardTypeAxis__custom--StockOptionsandStockAppreciationRightsMember_zsjbXjqfa6w1" title="Potential common shares excluded from diluted earnings per share">3,030,178</span> shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pii_c20210331__us-gaap--AwardTypeAxis__custom--StockOptionsandStockAppreciationRightsMember_zVomYWVy0175" title="Weighted average exercise price">3.95</span> per share, <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_c20210101__20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zPrA1MuNmWJf" title="Potential common shares excluded from diluted earnings per share">15,385 </span>shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pii_c20210331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRDUjIhevF09" title="Exercise price of warrants">0.70</span> per share, <span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_c20210101__20210331__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zM1SDuF6beC2" title="Potential common shares excluded from diluted earnings per share">43,790,285 </span>shares of our common stock issuable upon conversion of our Series A Convertible Preferred Stock, <span id="xdx_902_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_c20210101__20210331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zA0DRYydNNZ1" title="Potential common shares excluded from diluted earnings per share">5,610,121</span> shares of our common stock issuable upon conversion of our Series B Convertible Preferred Stock and <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iI_pii_c20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zOe2dgyZBmLc" title="Number of unvested restricted share units">1,287,223</span> shares of unvested restricted share units. The Company had no unearned restricted shares outstanding for the period ended March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWdzQGmVXX59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the computation of basic and diluted EPS:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="display: none"><span id="xdx_8B1_zExXc5Wx5KAc">Schedule of Computation of Basic and Diluted Earnings Per Share</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20210331_zs737cL5orO4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20200101__20200331_zOyJpLyzJtW7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended March 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_408_eus-gaap--NetIncomeLoss_z8AC5xvY6LHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,532,397</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(1,971,531</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zX2J7busbnqh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Cumulative dividend on Series A Convertible Preferred Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(332,551</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(343,723</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z2eRSPWyYiie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss attributable to common stockholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,864,948</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,315,254</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zxiY6izrzkHd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average number of common shares and equivalents:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,175,412</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,870,040</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasic_zpS4P2j1gjr" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Basic EPS</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--EarningsPerShareDiluted_zQSlIciZc1Me" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted EPS</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> -1532397 -1971531 332551 343723 -1864948 -2315254 75175412 69870040 -0.02 -0.03 -0.02 -0.03 3030178 3.95 15385 0.70 43790285 5610121 1287223 <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zWUmY47Hccah" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_86B_z0fUTINNnrv">Recently Issued Accounting Pronouncements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.05pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">In December 2019, the FASB issued Accounting Standards Update (ASU) 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” as part of its effort to reduce the complexity of accounting standards. The ASU is effective for fiscal years beginning after December 15, 2020. The Company adopted with no impact to the Company’s financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance under ASU 2018-19, ASU 2019-04 and ASU 2019-05. The standard modifies the measurement approach for credit losses on financial instruments, including trade receivables, from an incurred loss method to a current expected credit loss method, otherwise known as “CECL.” The standard requires the measurement of expected credit losses to be based on relevant information, including historical experience, current conditions and a forecast that is supportable. The standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The standard must be adopted by applying a cumulative adjustment to retained earnings. The Company anticipates adopting the standard in the first quarter of 2023, although it does not expect a significant impact to the Company’s financial results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_802_eus-gaap--InventoryDisclosureTextBlock_zJSPKLStP8V2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>3. <span id="xdx_825_zCN0t3IMiyDj">Inventories</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zBKS2B4Y2XAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Inventories consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B7_ze4iWW5mfdRc">Schedule of Inventories</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210331_z47gUZTgdwMl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20201231_zxsLbOer0SSg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzrsY_maINzPCb_z0GcNy5jOiNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,883,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,950,912</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzrsY_maINzPCb_zrMQb7EVr0je" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">800,034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">433,026</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzrsY_maINzPCb_zHbuCHEPV688" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Finished goods</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,569,654</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,987,039</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzrsY_msINzPCb_zYtMcb1F0Z1g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Reserve for excess and obsolescence</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,716,673</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,075,520</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--InventoryNet_iTI_pp0p0_mtINzrsY_mtINzPCb_zmn1X8aU8ad7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,536,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,295,457</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_z2zs7v1FrzK5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zBKS2B4Y2XAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Inventories consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B7_ze4iWW5mfdRc">Schedule of Inventories</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210331_z47gUZTgdwMl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20201231_zxsLbOer0SSg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzrsY_maINzPCb_z0GcNy5jOiNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,883,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,950,912</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzrsY_maINzPCb_zrMQb7EVr0je" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">800,034</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">433,026</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzrsY_maINzPCb_zHbuCHEPV688" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Finished goods</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,569,654</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,987,039</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzrsY_msINzPCb_zYtMcb1F0Z1g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Reserve for excess and obsolescence</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,716,673</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,075,520</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--InventoryNet_iTI_pp0p0_mtINzrsY_mtINzPCb_zmn1X8aU8ad7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventory</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,536,300</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,295,457</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2883285 2950912 800034 433026 2569654 2987039 2716673 3075520 3536300 3295457 <p id="xdx_807_eus-gaap--OtherAssetsDisclosureTextBlock_zcMhESMyN4Eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>4. <span id="xdx_82C_zuMzFibqYbrh">Prepaid Expenses and Other Assets</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zGouGjSpeAU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses and other assets consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B7_zR7loA36jXXe" style="display: none">Schedule of Prepaid Expenses and Other Assets</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210331_zw8kRX1jVKSh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20201231_zV9LG8cQZQ82" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_pp0p0_maPEAOAzZSW_zzCoo2T99414" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Prepaid expenses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">608,485</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">754,062</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--PrepaidCommissionsCurrentAndNoncurrent_iI_pp0p0_maPEAOAzZSW_zPVv5RAnAeGc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">244,974</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">271,174</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DepositsAssets_iI_pp0p0_maPEAOAzZSW_zX3cDAy0Nybh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">979,081</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">855,970</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAssets_iI_pp0p0_maPEAOAzZSW_zVMWNUWSqo1g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">126,960</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">143,323</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssets_iTI_pp0p0_mtPEAOAzZSW_zEaCbjDchT4a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total prepaid expenses and other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,959,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,024,529</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsNoncurrent_iNI_pp0p0_di_z9NtowMpxrp5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Noncurrent prepaid expenses and other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(284,946</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(308,515</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pp0p0_zbCKjEkw8A39" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total current prepaid expenses and other assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,674,554</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,716,014</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_z8rlSO7vCVPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zGouGjSpeAU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses and other assets consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B7_zR7loA36jXXe" style="display: none">Schedule of Prepaid Expenses and Other Assets</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20210331_zw8kRX1jVKSh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20201231_zV9LG8cQZQ82" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--PrepaidExpenseCurrentAndNoncurrent_iI_pp0p0_maPEAOAzZSW_zzCoo2T99414" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Prepaid expenses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">608,485</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">754,062</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--PrepaidCommissionsCurrentAndNoncurrent_iI_pp0p0_maPEAOAzZSW_zPVv5RAnAeGc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">244,974</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">271,174</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DepositsAssets_iI_pp0p0_maPEAOAzZSW_zX3cDAy0Nybh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">979,081</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">855,970</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAssets_iI_pp0p0_maPEAOAzZSW_zVMWNUWSqo1g" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">126,960</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">143,323</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PrepaidExpenseAndOtherAssets_iTI_pp0p0_mtPEAOAzZSW_zEaCbjDchT4a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Total prepaid expenses and other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,959,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,024,529</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsNoncurrent_iNI_pp0p0_di_z9NtowMpxrp5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Noncurrent prepaid expenses and other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(284,946</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(308,515</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pp0p0_zbCKjEkw8A39" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total current prepaid expenses and other assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,674,554</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,716,014</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 608485 754062 244974 271174 979081 855970 126960 143323 1959500 2024529 284946 308515 1674554 1716014 <p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNAoVb984dv4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>5. <span id="xdx_828_zeZJtus6cAV3">Property and Equipment</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zdVqfr9jCa4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Property and Equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zWWcA027zKxd" style="display: none">Schedule of Property and Equipment</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%">Equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20210331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zlmTFLDYfX78" style="width: 18%; text-align: right" title="Gross property and equipment">6,488,984</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zj8leTy5Kajc" style="width: 18%; text-align: right" title="Gross property and equipment">6,488,984</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20210331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zajqIbDAl8Hd" style="text-align: right" title="Gross property and equipment">2,338,441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zpzeDydwEqOd" style="text-align: right" title="Gross property and equipment">2,338,441</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Construction in process</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20210331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zc3fIq8hlq52" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross property and equipment">34,192</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zqbBJsAoJGlg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl0722">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20210331_z3t016G7Hpnh" style="text-align: right" title="Gross property and equipment">8,861,617</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231_zb6WhM5ySwDl" style="text-align: right" title="Gross property and equipment">8,827,425</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210331_zxPgdXqlGZ33" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated depreciation">(8,659,113</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_z79WtaTVUYOc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated depreciation">(8,632,296</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net property and equipment</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20210331_zU2CQyEjE0F7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net property and equipment">202,504</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_ziO9lor9PsJf" style="border-bottom: Black 2.5pt double; text-align: right" title="Net property and equipment">195,129</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zttHS0Rbkb95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"/> <p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zdVqfr9jCa4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Property and Equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zWWcA027zKxd" style="display: none">Schedule of Property and Equipment</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%">Equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20210331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zlmTFLDYfX78" style="width: 18%; text-align: right" title="Gross property and equipment">6,488,984</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zj8leTy5Kajc" style="width: 18%; text-align: right" title="Gross property and equipment">6,488,984</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20210331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zajqIbDAl8Hd" style="text-align: right" title="Gross property and equipment">2,338,441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zpzeDydwEqOd" style="text-align: right" title="Gross property and equipment">2,338,441</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Construction in process</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20210331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zc3fIq8hlq52" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross property and equipment">34,192</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zqbBJsAoJGlg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Gross property and equipment"><span style="-sec-ix-hidden: xdx2ixbrl0722">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20210331_z3t016G7Hpnh" style="text-align: right" title="Gross property and equipment">8,861,617</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231_zb6WhM5ySwDl" style="text-align: right" title="Gross property and equipment">8,827,425</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20210331_zxPgdXqlGZ33" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated depreciation">(8,659,113</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_z79WtaTVUYOc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Accumulated depreciation">(8,632,296</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net property and equipment</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20210331_zU2CQyEjE0F7" style="border-bottom: Black 2.5pt double; text-align: right" title="Net property and equipment">202,504</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_ziO9lor9PsJf" style="border-bottom: Black 2.5pt double; text-align: right" title="Net property and equipment">195,129</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6488984 6488984 2338441 2338441 34192 8861617 8827425 8659113 8632296 202504 195129 <p id="xdx_805_eus-gaap--LeasesOfLesseeDisclosureTextBlock_z0dmgqRkiev2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>6. <span id="xdx_827_zEtdhTF8ynP1">Leases</span> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The Company accounts for leases in accordance with Accounting Standards Update No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842 (“ASC 842”). The Company determines if an arrangement contains a lease at inception.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company leases its facilities under operating leases. In accordance with ASC 842, operating lease agreements are recognized on the balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e. leases with initial terms of twelve months or less) on the balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At March 31, 2021, the weighted average discount rate for operating leases was <span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pii_dp_c20210331_zgrHv5eIaeG1" title="Weighted average discount rate for operating leases">9.0</span>% and the weighted average remaining lease term for operating lease term is <span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtYxL_c20210331_zwKZNYPiupXg" title="Weighted average remaining lease term for operating lease term::XDX::P0Y9M0D"><span style="-sec-ix-hidden: xdx2ixbrl0740">0.75 years</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_891_eus-gaap--LeaseCostTableTextBlock_zrjpD7SOHbf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The following table represents lease costs and other lease information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_zhDTv02G0pM3" style="display: none">Schedule of Lease Costs and Other Lease Information</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20210101__20210331_zNXzYKSXBG1b" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20200101__20200331_zVyKB5bdcWvb" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseCost_maLCz2MH_zx6dHjKIRv29" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">582,712</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">585,586</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ShortTermLeaseCost_maLCz2MH_znVAv1Ym1lC8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short-term lease cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,663</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,470</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pp0p0_di_msLCz2MH_z0t5QIPWkjTh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Sublease income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(246,530</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(246,530</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--LeaseCost_iT_pp0p0_mtLCz2MH_zuwavhmLPAc4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total net lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">352,845</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">354,526</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeasePayments_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash paid within operating cash flows</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">631,086</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">636,350</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zDKIITSVvQ1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z74KgTgRFBEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2021, excluding sublease income, were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zx1vsxKyaKX7" style="display: none">Schedule of Future Minimum Operating Lease Payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20210331_zJDh0nyhSXR" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_zkaqTB2Jd7M4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: middle; text-align: left">2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTIC_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 78%; text-align: left">Total lease payments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,786,995</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_ztHATc7Yvobb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Less: Interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(52,296</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,734,699</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zdrKl7Vp56Kk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The remaining undiscounted future cash flows to be received under the sublease are $<span id="xdx_90A_ecustom--LesseeOperatingSubLeaseReceivableOnUndiscountedExcessAmountReminderofFiscalYear_iI_pn5n6_c20210331_zYe60zdhGAeb">0.8 </span></span><span style="font: 10pt Times New Roman, Times, Serif">million in 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif">On March 1, 2021, the Company entered into an office lease agreement (the “Lease”) with Globe Building Company (the “Landlord”), under which the Company will lease executive office space and manufacturing facilities of approximately <span id="xdx_907_eus-gaap--AreaOfLand_iI_pii_usqft_c20210301__us-gaap--TypeOfArrangementAxis__custom--OfficeLeaseAgreementMember__dei--LegalEntityAxis__custom--GlobeBuildingCompanyMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeSpaceAndManufacturingFacilitiesMember_zUOSgw7DU0xc" title="Area of Land">43,100</span> square feet of rentable space located at 710 N. Tucker Boulevard, St. Louis, Missouri (the “Premises”) that will serve as the Company’s new principal executive and administrative offices and manufacturing facility. The Lease for the Premises is effective at the later of <span id="xdx_90D_ecustom--LeaseEffectiveDate_c20210227__20210301__us-gaap--TypeOfArrangementAxis__custom--OfficeLeaseAgreementMember__dei--LegalEntityAxis__custom--GlobeBuildingCompanyMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeSpaceAndManufacturingFacilitiesMember_zactkSXh8K8j">January 1, 2022</span> or the date on which the Company has received an occupancy permit, and has a term of <span id="xdx_90C_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtYxL_c20210301__us-gaap--TypeOfArrangementAxis__custom--OfficeLeaseAgreementMember__dei--LegalEntityAxis__custom--GlobeBuildingCompanyMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeSpaceAndManufacturingFacilitiesMember_zlZjhw2xl2l4" title="Operating lease, term of contract::XDX::P10Y"><span style="-sec-ix-hidden: xdx2ixbrl0773">ten years</span></span>, with <span id="xdx_90A_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20210227__20210301__us-gaap--TypeOfArrangementAxis__custom--OfficeLeaseAgreementMember__dei--LegalEntityAxis__custom--GlobeBuildingCompanyMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeSpaceAndManufacturingFacilitiesMember_zz6bldzZrt0l" title="Operating lease, option to extend">two renewal options of <span id="xdx_90C_eus-gaap--LesseeOperatingLeaseRenewalTerm_iI_dtYxL_c20210301__us-gaap--TypeOfArrangementAxis__custom--OfficeLeaseAgreementMember__dei--LegalEntityAxis__custom--GlobeBuildingCompanyMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeSpaceAndManufacturingFacilitiesMember_zyvpJYm9n91g" title="Operating lease, renewal term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0777">five</span></span> years each</span>. The minimum annual rent under the terms of the Lease ranges from approximately $<span id="xdx_908_eus-gaap--OperatingLeaseCost_pn5n6_c20210227__20210301__us-gaap--TypeOfArrangementAxis__custom--OfficeLeaseAgreementMember__dei--LegalEntityAxis__custom--GlobeBuildingCompanyMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeSpaceAndManufacturingFacilitiesMember__srt--StatementScenarioAxis__custom--MinimumAnnualRentInTwoThousandTwentyTwoMember_zsc3883Ku904" title="Annual rent under the terms, lease">0.8</span> million in 2022 to $<span id="xdx_90F_eus-gaap--OperatingLeaseCost_pn5n6_c20210227__20210301__us-gaap--TypeOfArrangementAxis__custom--OfficeLeaseAgreementMember__dei--LegalEntityAxis__custom--GlobeBuildingCompanyMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OfficeSpaceAndManufacturingFacilitiesMember__srt--StatementScenarioAxis__custom--MinimumAnnualRentInTwoThousandThirtyOneMember_zbroS94ohv4a" title="Annual rent under the terms, lease">1.0</span> million in 2031. At the Lease commencement, the Company will relocate its current St. Louis, Missouri operations to the Premises in the new building.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 0.090 <p id="xdx_891_eus-gaap--LeaseCostTableTextBlock_zrjpD7SOHbf2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The following table represents lease costs and other lease information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_zhDTv02G0pM3" style="display: none">Schedule of Lease Costs and Other Lease Information</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20210101__20210331_zNXzYKSXBG1b" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20200101__20200331_zVyKB5bdcWvb" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Three Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseCost_maLCz2MH_zx6dHjKIRv29" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Operating lease cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">582,712</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">585,586</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ShortTermLeaseCost_maLCz2MH_znVAv1Ym1lC8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Short-term lease cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,663</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,470</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SubleaseIncome_iN_pp0p0_di_msLCz2MH_z0t5QIPWkjTh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Sublease income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(246,530</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(246,530</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--LeaseCost_iT_pp0p0_mtLCz2MH_zuwavhmLPAc4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total net lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">352,845</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">354,526</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeasePayments_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash paid within operating cash flows</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">631,086</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">636,350</td><td style="text-align: left"> </td></tr> </table> 582712 585586 16663 15470 246530 246530 352845 354526 631086 636350 <p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z74KgTgRFBEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2021, excluding sublease income, were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zx1vsxKyaKX7" style="display: none">Schedule of Future Minimum Operating Lease Payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20210331_zJDh0nyhSXR" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_pp0p0_zkaqTB2Jd7M4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: middle; text-align: left">2021</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTIC_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 78%; text-align: left">Total lease payments</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,786,995</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_ztHATc7Yvobb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Less: Interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(52,296</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Present value of lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,734,699</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1786995 52296 1734699 800000 43100 2022-01-01 two renewal options of five years each 800000 1000000.0 <p id="xdx_80C_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_ztVfaZwIRJIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>7. <span id="xdx_821_zuEv2Ynnke16">Accrued Liabilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zJkawhaxPBVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Accrued liabilities consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B5_zn2ESayYVzA1" style="display: none">Schedule of Accrued Liabilities</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20210331_zuDuNyKNB9Rb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20201231_zflvzECdCioh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCANzNGc_zqZzPFoDUrFb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Accrued salaries, bonus, and benefits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,348,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,044,826</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--AccruedLicensesAndMaintenanceFeesCurrentAndNoncurrent_iI_pp0p0_maALCANzNGc_zmigd3aOtwO6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued licenses and maintenance fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">483,879</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">483,879</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ProductWarrantyAccrual_iI_pp0p0_maALCANzNGc_ztmVbcfG39Uh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued warranties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">188,591</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">157,615</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedIncomeTaxes_iI_pp0p0_maALCANzNGc_zWNBlmetbUqc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">195,577</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">172,744</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maALCANzNGc_zI2cbGcPmnja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">223,298</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,359</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCANzNGc_z6sVhRWMejK7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">348,972</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">343,043</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_pp0p0_mtALCANzNGc_zBNVSuvxO7l4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,788,394</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,340,466</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iNI_pp0p0_di_zVVS6LgPPE07" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Long term accrued liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(210,096</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131,231</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total current accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,578,298</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,209,235</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zwFyA9VQ32oj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zJkawhaxPBVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Accrued liabilities consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8B5_zn2ESayYVzA1" style="display: none">Schedule of Accrued Liabilities</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20210331_zuDuNyKNB9Rb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20201231_zflvzECdCioh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCANzNGc_zqZzPFoDUrFb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left">Accrued salaries, bonus, and benefits</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">1,348,077</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">2,044,826</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--AccruedLicensesAndMaintenanceFeesCurrentAndNoncurrent_iI_pp0p0_maALCANzNGc_zmigd3aOtwO6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued licenses and maintenance fees</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">483,879</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">483,879</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ProductWarrantyAccrual_iI_pp0p0_maALCANzNGc_ztmVbcfG39Uh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued warranties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">188,591</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">157,615</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedIncomeTaxes_iI_pp0p0_maALCANzNGc_zWNBlmetbUqc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">195,577</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">172,744</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pp0p0_maALCANzNGc_zI2cbGcPmnja" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued professional services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">223,298</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,359</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherAccruedLiabilitiesCurrentAndNoncurrent_iI_pp0p0_maALCANzNGc_z6sVhRWMejK7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">348,972</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">343,043</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_pp0p0_mtALCANzNGc_zBNVSuvxO7l4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,788,394</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,340,466</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iNI_pp0p0_di_zVVS6LgPPE07" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Long term accrued liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(210,096</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131,231</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total current accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,578,298</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,209,235</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1348077 2044826 483879 483879 188591 157615 195577 172744 223298 138359 348972 343043 2788394 3340466 210096 131231 2578298 3209235 <p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zPeJGCpgA2re" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>8. <span id="xdx_82F_z5wHaHVDhY53">Debt and Credit Facilities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company had a working capital line of credit with its primary lender, Silicon Valley Bank, that matured on <span id="xdx_90A_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20210101__20210331__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--IncomeTaxAuthorityAxis__custom--PrimaryLenderMember_zkCiccHgvbCg">June 30, 2020</span></span> <span style="font: 10pt Times New Roman, Times, Serif">and was not renewed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 in the United States. Among the provisions contained in the CARES Act was the creation of the Paycheck Protection Program that provides for Small Business Administration (“SBA”) Section 7(a) loans for qualified small businesses. In general, the loan can be forgiven as long as the funds are used for payroll related expenses as well as rent and utilities paid during the twenty-four week period from the date of the loan and as long as certain headcount and salary/wage levels are maintained. On April 10, 2020, the Company was informed by its lender, Midwest BankCentre (the “Bank”), that the Bank received approval from the SBA to fund the Company’s request for a loan under the SBA’s Paycheck Protection Program (“PPP Loan”). Per the terms of the PPP Loan, the Company received total proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromBankDebt_c20200419__20200420__us-gaap--PlanNameAxis__custom--PaycheckProtectionProgramMember_z4y3MzycJef9" title="Proceeds from bank">2,158,310</span> from the Bank on April 20, 2020. In March 2021, the Company applied for loan forgiveness with the Bank and on April 27, 2021 the application was accepted by the SBA for review. <span id="xdx_90F_eus-gaap--DebtInstrumentDescription_c20200419__20200420__us-gaap--TypeOfArrangementAxis__custom--CaresActMember_ztdYc6zThiCj" title="Loan description">In accordance with the loan forgiveness requirements of the CARES Act, the Company used the full proceeds from the PPP Loan primarily for payroll costs, rent and utilities, thus, the Company anticipates that the loan will be substantially forgiven.</span> To the extent it is not forgiven, the Company would be required to repay that portion beginning in August 2021 with a final installment in April 2022. Interest would be assessed on the amount of the loan not forgiven at a rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20200420__us-gaap--PlanNameAxis__custom--PaycheckProtectionProgramMember_zehUcCqzYgHa" title="Interest rate">1</span>% per annum beginning on the date of the loan, April 20, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">In accordance with general accounting principles for fair value measurement, the Company’s debt was measured at fair value (Level 2), which approximated the carrying value of the debt, as of March 31, 2021 and December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 2020-06-30 2158310 In accordance with the loan forgiveness requirements of the CARES Act, the Company used the full proceeds from the PPP Loan primarily for payroll costs, rent and utilities, thus, the Company anticipates that the loan will be substantially forgiven. 0.01 <p id="xdx_803_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z2LYRTJqH1S8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>9. <span id="xdx_821_zDR8N39thnj9">Convertible Preferred Stock and Stockholders’ Equity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The holders of common stock are entitled to <span id="xdx_904_ecustom--NumberOfStockholdersVotesDescription_c20210101__20210331_zTKD5t5JdHc2" title="Number of stockholders votes, description">one</span> vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends. <span id="xdx_902_eus-gaap--PaymentsOfDividendsCommonStock_pp0p0_do_c20210101__20210331_zu3vLBEteA4b" title="Dividends declared">No</span> dividends have been declared or paid as of March 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2020 Equity Financing</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">On May 25, 2020, the Company entered into a Securities Purchase Agreement with certain accredited investors, whereby it, in a direct registered offering, agreed to issue and sell to the investors an aggregate of <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pii_c20200524__20200525__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectRegisteredOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmhXzYRFLUWd">3,658,537 </span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of the Company’s common stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pii_c20200525__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectRegisteredOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ9Ps8Ynk891">0.001 </span></span><span style="font: 10pt Times New Roman, Times, Serif">par value per share, at a price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_pii_c20200525__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectRegisteredOfferingMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zN15anQfV1c">4.10 </span></span><span style="font: 10pt Times New Roman, Times, Serif">per share. The Company received net proceeds of approximately $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn5n6_c20200524__20200525__us-gaap--SubsidiarySaleOfStockAxis__custom--DirectRegisteredOfferingMember_zYLOH27ctxp5">15</span></span><span style="font: 10pt Times New Roman, Times, Serif">.0 million, after offering expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series B Convertible Preferred Stock</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">On August 7, 2019, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors, whereby it, as part of a private placement, agreed to issue and sell to the <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20190806__20190807__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBConvertiblePreferredStockMember_zOEcYGY323k4" title="Sale of stock, consideration received on transaction">5,610,121 </span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of the Company’s Series B Convertible Preferred Stock, $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20190807__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBConvertiblePreferredStockMember_z4TuwGmoku9c" title="Common stock, par or stated value per share">0.001 </span></span><span style="font: 10pt Times New Roman, Times, Serif">par value per share which are convertible into shares of the Company’s Common Stock, at a price of $<span id="xdx_903_ecustom--ConvertibleSecuritiesConversionPricePerShare_iI_pid_c20190807__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--StatementEquityComponentsAxis__custom--SeriesBConvertiblePreferredStockMember_z5JyGQGni9xd" title="Convertible securities, conversion price per share">2.05 </span></span><span style="font: 10pt Times New Roman, Times, Serif">per share. The Series B Preferred Stock, which is a Common Stock equivalent but non-voting and with a blocker on conversion if the holder would exceed a specified threshold of voting security ownership, is convertible into Common Stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like as provided in the Purchase Agreement. The Series B Convertible Preferred Stock is reported in the stockholders’ equity section of the Company’s balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Series A Convertible Preferred Stock and Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">In September 2016, the Company issued (i) <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20160901__20160930__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zduc20NRhbdf" title="Sale of stock, number of shares sold">24,000</span> shares of Series A Convertible Preferred Stock, par value $<span id="xdx_90D_ecustom--PreferredStockParValuePerShare_iI_pii_c20160930__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zNC0I3sUS9g8" title="Preferred stock, par value">0.001</span> per share, with a stated value of $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pii_c20160930__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_ztZXiRrSzr3k" title="Convertible preferred stock, par value">1,000</span> per share (the “Series A Preferred Stock”), which are convertible into shares of the Company’s common stock at an initial conversion rate of $<span id="xdx_908_eus-gaap--PreferredStockRedemptionPricePerShare_iI_pii_c20160930__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zTpuZL8EF2W4" title="Redemption price per share">0.65</span> per share, subject to adjustment for events such as stock splits, combinations and the like as provided in the certificate of designations covering such Series A Preferred Stock, and (ii) warrants to purchase an aggregate of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pii_c20160930__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zdicyjGDZwe" title="Common stock issuable from warrants">36,923,078</span> shares of common stock. The shares of Series A Preferred Stock are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The Series A Preferred Stock bear dividends at a rate of six percent (<span id="xdx_901_eus-gaap--PreferredStockDividendRatePercentage_pii_dp_uPercent_c20160901__20160930__us-gaap--StatementClassOfStockAxis__custom--SeriesAConvertiblePreferredStockMember_zNiK3Sc7h7ob" title="Preferred stock dividend rate">6</span>%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the Series A Preferred Stock. Each holder of convertible preferred shares has the right to require us to redeem such holder’s shares of Series A Preferred Stock upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than <span id="xdx_909_ecustom--PreferredStockRedemptionTriggeringEventPercentOfCommonStockSoldThreshold_dp_c20160901__20160930_zCRNbxEk1gvf" title="Preferred stock redemption, triggering event, percent of common stock sold threshold">50</span>% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the Series A Preferred Stock in the event of a defined change of control. The Series A Preferred Stock ranks senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the Series A Preferred Stock are subject to conditions for redemption that are outside the Company’s control, the Series A Preferred Stock are presently reported in the mezzanine section of the balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The warrants issued in conjunction with the Series A Preferred Stock (the “SPA Warrants”) have an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210331_zws73yd5ebm3" title="Exercise price of warrants">0.70</span> per share subject to adjustments for events such as stock splits, combinations, and the like as provided under the terms of the warrants. The warrants are exercisable through <span id="xdx_906_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20210101__20210331_zJCt3RYi34J3" title="Warrants exercisable date">September 29, 2021</span>, subject to specified beneficial ownership issuance limitations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2021 CEO Performance Award Unit Grant</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On February 23, 2021, the Company`s Board of Directors, upon recommendation of the Compensation Committee, approved the grant of the CEO Performance Award to David L. Fischel, the Company’s Chief Executive Officer. The CEO Performance award is a <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_pii_dtY_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_zqFgFNMQl5Ai">10</span>-year performance award of up to <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pii_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__srt--RangeAxis__srt--MaximumMember_z4r3GyCTBwJf" title="Number of shares granted">13,000,000</span> shares, tied to the achievement of market capitalization milestones and subject to minimum service requirements. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">As detailed in the table below, the CEO Performance Award consists of <span title="Number of tranches::XDX::10">ten</span> vesting tranches. The first market capitalization milestone is $<span id="xdx_90A_ecustom--MarketCapitalizationMilestone_iI_pn9n9_dt_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_zzmXDP9p0Kb8" title="Market capitalization milestone, amount">1</span> billion, and each of the remaining nine market capitalization milestones are in additional $<span id="xdx_906_ecustom--IncreaseInMarketCapitalizationMilestone_iI_pn6n6_dt_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_zV6a7owIiKA7" title="Increase in market capitalization milestone, amount">500</span> million increments, up to $<span id="xdx_904_ecustom--MaximumMarketCapitalizationMilestone_iI_pn5n9_dt_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_z8Ts6D95yauk" title="Maximum market capitalization milestone, amount">5.5</span> billion.</span></p> <p id="xdx_890_ecustom--SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock_z9UmvRUkuGp5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_zVMfxvWQMB6i" style="display: none">Summary of Performance Award And Market Capitalization Milestones</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tranche #</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>No. of Shares</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Subject to PSU</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Market Capitalization Milestones<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: center"> </td><td style="width: 30%; text-align: center">1</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zkYxxPoDd9zi" style="width: 30%; text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zvb4CrNKZM0f" style="width: 30%; text-align: right" title="Market Capitalization Milestones">1,000,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zeZepVDLdcy2" style="text-align: right" title="No. of Shares Subject to PSU">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zXhLjSUIJ4md" style="text-align: right" title="Market Capitalization Milestones">1,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center">3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zDDRRLhH2x7" style="text-align: right" title="No. of Shares Subject to PSU">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zgBofZKQt3N6" style="text-align: right" title="Market Capitalization Milestones">2,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zUK2w4a6FDC1" style="text-align: right" title="No. of Shares Subject to PSU">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_z7OTgwL6bwTd" style="text-align: right" title="Market Capitalization Milestones">2,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveMember_zf13OKPsYZI5" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveMember_zzJqxnXWmTe9" style="text-align: right" title="Market Capitalization Milestones">3,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheSixMember_zbaoCWavIpPl" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheSixMember_ztSYMXbjpkyj" style="text-align: right" title="Market Capitalization Milestones">3,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheSevenMember_z9nj2Rr0vkpj" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheSevenMember_z1FRi1RO1uTd" style="text-align: right" title="Market Capitalization Milestones">4,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">8</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheEightMember_zghNyVLZoLbg" style="text-align: right" title="No. of Shares Subject to PSU">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheEightMember_zw7gELwfXkWl" style="text-align: right" title="Market Capitalization Milestones">4,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center">9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheNineMember_zlpUeIAfoxP3" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheNineMember_zZYHGpFDHwXb" style="text-align: right" title="Market Capitalization Milestones">5,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTenMember_zc4018IfJYJi" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTenMember_zuGox2kpCMB8" style="text-align: right" title="Market Capitalization Milestones">5,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total:</b></span></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_zl9NkNzIxWYb" style="font-weight: bold; text-align: right" title="No. of Shares Subject to PSU">13,000,000</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A9_z6Qu7DO6hHy9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Each tranche represents a portion of the PSUs covering the number of shares outlined in the table above. <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_pii_dt_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_z0QKXYdPd1wd">Each tranche vests upon (i) satisfaction of the market capitalization milestones and (ii) Mr. Fischel continuing to serve as CEO from the grant date through December 31, 2030. Absent an earlier termination, the PSUs will expire on December 31, 2030. If Mr. Fischel ceases to be the CEO for any reason including death, disability, termination for cause or without cause (as defined in the award agreement), or Mr. Fischel’s voluntary termination after service as CEO for at least five years, the remaining service period will be waived and he will retain any PSUs that have vested through the date of termination.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The Company is seeking Shareholder approval at its annual meeting on May 20, 2021 for shares to be issued under the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">The market capitalization requirement is considered a market condition under FASB Accounting Standards Codification Topic 718 “Compensation – Stock Compensation” and is estimated on the grant date using Monte Carlo simulations. Recognition of stock-based compensation expense of all the tranches commenced on February 23, 2021, the date of grant, as the probability of meeting the ten market capitalization milestones is not considered in determining the timing of expense recognition. The expense will be recognized on an accelerated basis through 2030. Key assumptions for estimating the performance-based awards fair value at the date of grant included share price on grant date, volatility of the Company’s common stock price, risk free interest rate, and grant term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font: 10pt Times New Roman, Times, Serif">Total stock-based compensation recorded as operating expense for the CEO Performance Award was $<span id="xdx_904_eus-gaap--ShareBasedCompensation_pn5n6_dt_c20210101__20210331__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_z8L7jiOOdEz" title="Share based compensation">0.7</span> million for the quarter ended March 31, 2021. As of March 31, 2021, the Company had approximately $<span id="xdx_90C_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn5n6_dt_c20210331__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_z5fqDmcpzRKa" title="Unrecognized stock-based compensation expense">56.7</span> million of total unrecognized stock-based compensation expense remaining under the CEO Performance Award if Mr. Fischel continues to serve as CEO, or in a similar capacity through 2030.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>2012 Stock Award Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on <span id="xdx_90B_ecustom--StockPlanExpirationDate_c20210101__20210331__us-gaap--PlanNameAxis__custom--TwoThousandAndTwelveStockIncentivePlanMember_zyl5ZXyyRQn6" title="Stock plan expiration date">March 25, 2012</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">At March 31, 2021, the Company had <span id="xdx_900_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pii_uShares_c20210331__us-gaap--PlanNameAxis__custom--StockAwardPlansMember_zC9g9hYhIRxj" title="Reserved shares of common stock">1,114,086</span> remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">At March 31, 2021, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pn5n6_c20210331_zhx9daHjSyrc" title="Total compensation cost not yet recognized">6.4</span> million, excluding compensation not yet recognized related to the CEO Performance Award discussed above. This cost will be amortized over a period of up to <span id="xdx_901_ecustom--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognitionDescription_c20210101__20210331_zcMqd0KOF8Fa" title="Weighted average amortization period of total compensation cost not yet recognized, description">four years</span> over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_z1grGxZDaOAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2021 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BD_zFKEy2NKqucg" style="display: none">Summary of Option and Stock Appreciation Rights Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options/SARs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Range of Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Exercise <br/> Price per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding, December 31, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20201231_zaxfu1ghcE4j" style="width: 12%; text-align: right" title="Number of Options/SARs, Outstanding, Beginning Balance">2,456,979</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iS_c20201231__srt--RangeAxis__srt--MinimumMember_zBtX1UudWbF5" title="Range of Exercise Price, Beginning Balance">0.74</span> - $<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iS_c20201231__srt--RangeAxis__srt--MaximumMember_zJy2B3UHq3ie" title="Range of Exercise Price, Beginning Balance">35.20</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_uUSDPShares_c20201231_zBYYYHI0bBAl" style="width: 12%; text-align: right" title="Weighted Average Exercise Price per Share, Outstanding, Beginning Balance">2.90</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pii_c20210101__20210331_zPrfP3nczRq3" style="text-align: right" title="Number of Options/SARs, Granted">815,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceGranted_c20210101__20210331_z026rc3tTUbl" title="Range of Exercise Price, Granted">6.96</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pii_uUSDPShares_c20210101__20210331_zaWM7dQVPbne" style="text-align: right" title="Weighted Average Exercise Price per Share, Granted">6.96</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20210331_zLmFIoAcK4L4" style="text-align: right" title="Number of Options/SARs, Exercised">(165,962</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceExercised_c20210101__20210331__srt--RangeAxis__srt--MinimumMember_zlPmyirgZCoj" title="Range of Exercise Price, Exercised">0.74</span> - $<span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceExercised_c20210101__20210331__srt--RangeAxis__srt--MaximumMember_z9nTvsaQJ9yi" title="Range of Exercise Price, Exercised">4.52</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pii_uUSDPShares_c20210101__20210331_zIO3C4gawbpb" style="text-align: right" title="Weighted Average Exercise Price per Share, Exercised">1.85</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20210101__20210331_zagNdMv9R8cc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options/SARs, Forfeited">(75,839</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceForfeited_c20210101__20210331__srt--RangeAxis__srt--MinimumMember_z1Qq9wwvzzzc" title="Range of Exercise Price, Forfeited">0.74</span></span> - $<span><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceForfeited_c20210101__20210331__srt--RangeAxis__srt--MaximumMember_zOXTI3Nzsfx5" title="Range of Exercise Price, Forfeited">35.20</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pii_uUSDPShares_c20210101__20210331_z44abPhwb905" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price per Share, Forfeited">6.66</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2021</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20210331_zNRscNfM3pKh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options/SARs, Outstanding, Ending Balance">3,030,178</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iE_c20210331__srt--RangeAxis__srt--MinimumMember_zf0qYdLhyUyl" title="Range of Exercise Price, Ending Balance">0.74</span> - $<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iE_c20210331__srt--RangeAxis__srt--MaximumMember_z7Xh7EOPJNV6" title="Range of Exercise Price, Ending Balance">32.30</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_uUSDPShares_c20210331_zXmoF5NW70jc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price per Share, Outstanding, Ending Balance">3.95</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zRUoOFoKjgz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zk3iQPVFpSBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">A summary of the restricted stock unit activity for the three month period ended March 31, 2021 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zPNKhCldXtyk" style="display: none">Summary of Restricted Stock Unit Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Restricted Stock Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Grant Date Fair Value per Unit</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pii_c20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zq6fDD9w4Rk" style="width: 16%; text-align: right" title="Number of Restricted Stock Units, Outstanding, Beginning">1,112,473</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pii_uUSDPShares_c20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1qbQub9r171" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Outstanding, Beginning">2.46</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pii_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9ous5UcZP2g" style="text-align: right" title="Number of Restricted Stock Units, Granted">205,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pii_uUSDPShares_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYoYEJzlcwr7" style="text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Granted">5.16</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pii_di_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhy7yE7m5wGb" style="text-align: right" title="Number of Restricted Stock Units, Vested">(30,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pii_uUSDPShares_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zmfHg8OPDi11" style="text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Vested">5.12</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pii_di_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXKMaNARwTk4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Restricted Stock Units, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pii_uUSDPShares_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zy2boYunDLhg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2021</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pii_c20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjyx8g6I6gJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Restricted Stock Units, Outstanding, Ending">1,287,223</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pii_uUSDPShares_c20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXsofcug0Gwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Outstanding, Ending">2.83</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zInfmT5XVIbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> one 0 3658537 0.001 4.10 15000000 5610121 0.001 2.05 24000 0.001 1000 0.65 36923078 0.06 0.50 0.70 2021-09-29 P10Y 13000000 1000000000 500000000 5500000000 <p id="xdx_890_ecustom--SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock_z9UmvRUkuGp5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_zVMfxvWQMB6i" style="display: none">Summary of Performance Award And Market Capitalization Milestones</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tranche #</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>No. of Shares</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Subject to PSU</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Market Capitalization Milestones<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: center"> </td><td style="width: 30%; text-align: center">1</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zkYxxPoDd9zi" style="width: 30%; text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zvb4CrNKZM0f" style="width: 30%; text-align: right" title="Market Capitalization Milestones">1,000,000,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">2</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zeZepVDLdcy2" style="text-align: right" title="No. of Shares Subject to PSU">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zXhLjSUIJ4md" style="text-align: right" title="Market Capitalization Milestones">1,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center">3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zDDRRLhH2x7" style="text-align: right" title="No. of Shares Subject to PSU">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_zgBofZKQt3N6" style="text-align: right" title="Market Capitalization Milestones">2,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_zUK2w4a6FDC1" style="text-align: right" title="No. of Shares Subject to PSU">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFourMember_z7OTgwL6bwTd" style="text-align: right" title="Market Capitalization Milestones">2,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center">5</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveMember_zf13OKPsYZI5" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheFiveMember_zzJqxnXWmTe9" style="text-align: right" title="Market Capitalization Milestones">3,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheSixMember_zbaoCWavIpPl" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheSixMember_ztSYMXbjpkyj" style="text-align: right" title="Market Capitalization Milestones">3,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center">7</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheSevenMember_z9nj2Rr0vkpj" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheSevenMember_z1FRi1RO1uTd" style="text-align: right" title="Market Capitalization Milestones">4,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">8</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheEightMember_zghNyVLZoLbg" style="text-align: right" title="No. of Shares Subject to PSU">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheEightMember_zw7gELwfXkWl" style="text-align: right" title="Market Capitalization Milestones">4,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center">9</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheNineMember_zlpUeIAfoxP3" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheNineMember_zZYHGpFDHwXb" style="text-align: right" title="Market Capitalization Milestones">5,000,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center">10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTenMember_zc4018IfJYJi" style="text-align: right" title="No. of Shares Subject to PSU">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--MarketCapitalizationMilestone_iI_c20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember__us-gaap--VestingAxis__custom--ShareBasedCompensationAwardTrancheTenMember_zuGox2kpCMB8" style="text-align: right" title="Market Capitalization Milestones">5,500,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total:</b></span></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210222__20210223__us-gaap--TypeOfArrangementAxis__custom--PerformanceShareUnitAwardAgreementMember__srt--TitleOfIndividualAxis__custom--Mr.FischelMember_zl9NkNzIxWYb" style="font-weight: bold; text-align: right" title="No. of Shares Subject to PSU">13,000,000</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> 1000000 1000000000 1500000 1500000000 1500000 2000000000 2000000 2500000000 1000000 3000000000 1000000 3500000000 1000000 4000000000 2000000 4500000000 1000000 5000000000 1000000 5500000000 13000000 Each tranche vests upon (i) satisfaction of the market capitalization milestones and (ii) Mr. Fischel continuing to serve as CEO from the grant date through December 31, 2030. 700000 56700000 2012-03-25 1114086 6400000 four years <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_z1grGxZDaOAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2021 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BD_zFKEy2NKqucg" style="display: none">Summary of Option and Stock Appreciation Rights Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Options/SARs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Range of Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Exercise <br/> Price per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding, December 31, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20201231_zaxfu1ghcE4j" style="width: 12%; text-align: right" title="Number of Options/SARs, Outstanding, Beginning Balance">2,456,979</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iS_c20201231__srt--RangeAxis__srt--MinimumMember_zBtX1UudWbF5" title="Range of Exercise Price, Beginning Balance">0.74</span> - $<span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iS_c20201231__srt--RangeAxis__srt--MaximumMember_zJy2B3UHq3ie" title="Range of Exercise Price, Beginning Balance">35.20</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_uUSDPShares_c20201231_zBYYYHI0bBAl" style="width: 12%; text-align: right" title="Weighted Average Exercise Price per Share, Outstanding, Beginning Balance">2.90</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pii_c20210101__20210331_zPrfP3nczRq3" style="text-align: right" title="Number of Options/SARs, Granted">815,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceGranted_c20210101__20210331_z026rc3tTUbl" title="Range of Exercise Price, Granted">6.96</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pii_uUSDPShares_c20210101__20210331_zaWM7dQVPbne" style="text-align: right" title="Weighted Average Exercise Price per Share, Granted">6.96</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20210101__20210331_zLmFIoAcK4L4" style="text-align: right" title="Number of Options/SARs, Exercised">(165,962</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceExercised_c20210101__20210331__srt--RangeAxis__srt--MinimumMember_zlPmyirgZCoj" title="Range of Exercise Price, Exercised">0.74</span> - $<span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceExercised_c20210101__20210331__srt--RangeAxis__srt--MaximumMember_z9nTvsaQJ9yi" title="Range of Exercise Price, Exercised">4.52</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pii_uUSDPShares_c20210101__20210331_zIO3C4gawbpb" style="text-align: right" title="Weighted Average Exercise Price per Share, Exercised">1.85</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20210101__20210331_zagNdMv9R8cc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Options/SARs, Forfeited">(75,839</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceForfeited_c20210101__20210331__srt--RangeAxis__srt--MinimumMember_z1Qq9wwvzzzc" title="Range of Exercise Price, Forfeited">0.74</span></span> - $<span><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceForfeited_c20210101__20210331__srt--RangeAxis__srt--MaximumMember_zOXTI3Nzsfx5" title="Range of Exercise Price, Forfeited">35.20</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pii_uUSDPShares_c20210101__20210331_z44abPhwb905" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price per Share, Forfeited">6.66</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2021</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20210331_zNRscNfM3pKh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options/SARs, Outstanding, Ending Balance">3,030,178</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left">$</td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iE_c20210331__srt--RangeAxis__srt--MinimumMember_zf0qYdLhyUyl" title="Range of Exercise Price, Ending Balance">0.74</span> - $<span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_iE_c20210331__srt--RangeAxis__srt--MaximumMember_z7Xh7EOPJNV6" title="Range of Exercise Price, Ending Balance">32.30</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_uUSDPShares_c20210331_zXmoF5NW70jc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price per Share, Outstanding, Ending Balance">3.95</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2456979 0.74 35.20 2.90 815000 6.96 6.96 165962 0.74 4.52 1.85 75839 0.74 35.20 6.66 3030178 0.74 32.30 3.95 <p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zk3iQPVFpSBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">A summary of the restricted stock unit activity for the three month period ended March 31, 2021 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B6_zPNKhCldXtyk" style="display: none">Summary of Restricted Stock Unit Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Restricted Stock Units</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average Grant Date Fair Value per Unit</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Outstanding, December 31, 2020</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pii_c20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zq6fDD9w4Rk" style="width: 16%; text-align: right" title="Number of Restricted Stock Units, Outstanding, Beginning">1,112,473</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pii_uUSDPShares_c20201231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1qbQub9r171" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Outstanding, Beginning">2.46</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pii_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z9ous5UcZP2g" style="text-align: right" title="Number of Restricted Stock Units, Granted">205,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pii_uUSDPShares_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zYoYEJzlcwr7" style="text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Granted">5.16</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pii_di_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zhy7yE7m5wGb" style="text-align: right" title="Number of Restricted Stock Units, Vested">(30,250</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pii_uUSDPShares_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zmfHg8OPDi11" style="text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Vested">5.12</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pii_di_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXKMaNARwTk4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of Restricted Stock Units, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pii_uUSDPShares_c20210101__20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zy2boYunDLhg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0979">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, March 31, 2021</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pii_c20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjyx8g6I6gJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Restricted Stock Units, Outstanding, Ending">1,287,223</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pii_uUSDPShares_c20210331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zXsofcug0Gwl" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value Per Unit, Outstanding, Ending">2.83</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1112473 2.46 205000 5.16 30250 5.12 1287223 2.83 <p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zfppHy7E5Tce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>10. <span id="xdx_82D_z0nhedAVwQv6">Fair Value Measurements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including certain cash equivalents. Generally accepted accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Level 1:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Level 2:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Level 3:</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Values are generated from model-based techniques that use significant assumptions not observable in the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"/></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the Company’s assets measured at fair value on a recurring basis by level within the fair value hierarchy. As required by the Fair Value Measurements and Disclosures topic of the Accounting Standards Codification, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p id="xdx_899_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z0CLlRbZGNeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BF_zFbnJTz525qk" style="display: none">Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurement Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted Prices in<br/> Active Markets<br/> for Identical<br/> Instruments<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs <br/> (Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets at March 31, 2021:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: left; padding-bottom: 1.5pt">Cash invested in money market accounts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zQSYRV6tS6de" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Total assets at fair value">1,429,331</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zVJmjXXqOfN3" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl0991">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zeR4HirG5wHf" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Total assets at fair value">1,429,331</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_z5c97mlLBdOh" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl0995">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total assets at fair value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zr5ioGUs7l4i" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZjcQiMoOOF4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl0999">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zH4B2fTMAMph" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3bvQSmMs8B" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1003">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Assets at December 31, 2020:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Cash invested in money market accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zYi07MPjwrbl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zyVMKWF3j7X7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1007">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zRJpIj5yQF6a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_z0zK4EtxefV5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1011">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total assets at fair value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsE2DqySJ2Wd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zYCRR3aJ9VU" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1015">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9WWoMdDbi8h" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zywrypWiA5ug" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1019">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zRmENx4EAMtj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif">The Company did not have any financial liabilities valued at fair value on a recurring basis as of March 31, 2021 or December 31, 2020. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Level 1</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The Company does not have any financial assets or liabilities classified as Level 1.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Level 2</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s financial assets consist of restricted cash and cash equivalents invested in money market funds in the amount of $<span id="xdx_901_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--RestrictedCashandCashInvestedInMoneyMarketAccountsMember_zY1fXp9tkV9j" title="Fair value of asset"><span id="xdx_90F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--RestrictedCashandCashInvestedInMoneyMarketAccountsMember_zfwV4lbQWhb7" title="Fair value of asset">1,429,331</span></span> at March 31, 2021 and December 31, 2020, respectively. These assets are classified as Level 2, as described above, and total interest income recorded for these investments was insignificant during the three months ended March 31, 2021 and year ended December 31, 2020. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><i>Level 3</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The Company does not have any financial assets or liabilities classified as Level 3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p id="xdx_899_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z0CLlRbZGNeh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8BF_zFbnJTz525qk" style="display: none">Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value Measurement Using</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Quoted Prices in<br/> Active Markets<br/> for Identical<br/> Instruments<br/> (Level 1)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs <br/> (Level 2)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets at March 31, 2021:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 36%; text-align: left; padding-bottom: 1.5pt">Cash invested in money market accounts</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zQSYRV6tS6de" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Total assets at fair value">1,429,331</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zVJmjXXqOfN3" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl0991">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zeR4HirG5wHf" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Total assets at fair value">1,429,331</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_z5c97mlLBdOh" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl0995">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total assets at fair value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zr5ioGUs7l4i" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZjcQiMoOOF4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl0999">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zH4B2fTMAMph" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20210331__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3bvQSmMs8B" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1003">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Assets at December 31, 2020:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Cash invested in money market accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zYi07MPjwrbl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zyVMKWF3j7X7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1007">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_zRJpIj5yQF6a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--CashInvestedInMoneyMarketAccountsMember_z0zK4EtxefV5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1011">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total assets at fair value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsE2DqySJ2Wd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zYCRR3aJ9VU" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1015">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9WWoMdDbi8h" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value">1,429,331</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zywrypWiA5ug" style="border-bottom: Black 2.5pt double; text-align: right" title="Total assets at fair value"><span style="-sec-ix-hidden: xdx2ixbrl1019">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1429331 1429331 1429331 1429331 1429331 1429331 1429331 1429331 1429331 1429331 <p id="xdx_801_eus-gaap--ProductWarrantyDisclosureTextBlock_zph8f8HwHda7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>11. <span id="xdx_829_zzr2mSIDvhcf">Product Warranty Provisions</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s standard policy is to warrant all capital systems against defects in material or workmanship for <span id="xdx_908_ecustom--StandardProductWarrantyCoverageTerm_dtxL_c20210101__20210331_z8ILnLvdVrBj" title="Standard product warranty coverage term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl1027">one year</span></span> following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zrMkruJo1O75" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Accrued warranty, which is included in other accrued liabilities, consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B5_zvegLtoxhC99" style="display: none">Schedule of Accrued Warranty</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20210331_zj6Ohv0UEJS7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200101__20201231_zoWOaN7BTwje" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_z5l0yoXC3S7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Warranty accrual, beginning of the fiscal period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">157,615</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">141,697</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ProductWarrantyAccrualPreexistingIncreaseDecrease_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrual adjustment for product warranty</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">94,596</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">49,974</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_zIAb07vlSnJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Payments made</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(63,620</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,056</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Warranty accrual, end of the fiscal period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">188,591</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">157,615</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zEnvTvOrZAGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zrMkruJo1O75" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">Accrued warranty, which is included in other accrued liabilities, consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B5_zvegLtoxhC99" style="display: none">Schedule of Accrued Warranty</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20210331_zj6Ohv0UEJS7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200101__20201231_zoWOaN7BTwje" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_z5l0yoXC3S7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Warranty accrual, beginning of the fiscal period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">157,615</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">141,697</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ProductWarrantyAccrualPreexistingIncreaseDecrease_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrual adjustment for product warranty</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">94,596</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">49,974</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_zIAb07vlSnJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Payments made</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(63,620</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,056</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Warranty accrual, end of the fiscal period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">188,591</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">157,615</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 157615 141697 94596 49974 63620 34056 188591 157615 <p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zKVPz72ljhPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>12. <span id="xdx_82D_zGlFF1lAP30l">Commitments and Contingencies</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif">In February 2021, the Company entered into letters of credit to support commitments totaling approximately $<span id="xdx_90C_eus-gaap--LineOfCredit_iI_pn5n6_c20210228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_zvKQ2lHu31Z" title="Long-term Line of Credit">1.3</span> million. <span id="xdx_903_eus-gaap--LineOfCreditFacilityDescription_c20210201__20210228__us-gaap--CreditFacilityAxis__us-gaap--LetterOfCreditMember_zekJtdVio4pi" title="Line of credit, description">The letters of credit are valid through 2022.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 1300000 The letters of credit are valid through 2022. <p id="xdx_80F_eus-gaap--SubsequentEventsTextBlock_zDAH08HJK9Ej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>13. </i></b></span><span style="font: 10pt Times New Roman, Times, Serif"><b><i><span id="xdx_823_zthm4U94Z4zk">Subsequent Events</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">On April 29, 2021, a putative class action complaint was filed in Delaware Chancery Court by Richard Barre, a purported shareholder. The defendants are the Company and its current directors. The complaint alleges breaches of fiduciary duty against the defendants based on alleged disclosure deficiencies in the definitive proxy statement (the “Proxy Statement”) filed by the Company on April 9, 2021 relative to the vote at the Company’s 2021 Annual Meeting of Stockholders to be held on May 20, 2021 (the “2021 Stockholder Meeting”) seeking stockholder approval of issuance of shares under the Performance Share Unit Award <span>(the “CEO Performance Award”) </span>granted to David L. Fischel, the Company’s chief executive officer. The complaint seeks various remedies, including a preliminary injunction seeking to enjoin the vote at the 2021 Stockholder Meeting to approve the issuance of shares for the CEO Performance Award. Following discussions with the plaintiff’s counsel and the Delaware Chancery Court, the parties agreed to an expedited discovery and briefing schedule, with the Chancery Court scheduled to hear arguments on the plaintiff’s motion for a preliminary injunction on May 18, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in">Although the Company believes that the claims were wholly without merit and that no further disclosure was required to supplement the Proxy Statement under applicable law, the Company filed a supplement to the Proxy Statement on May 10, 2021 addressing the alleged disclosure claims in order to eliminate the burden, expense, and uncertainties inherent in such litigation, and without admitting any liability or wrongdoing. On May 12, 2021, the plaintiff withdrew the motion for a preliminary injunction and indicated that the plaintiff intends to voluntarily dismiss, with prejudice, all claims set forth in the complaint, subject to court approval and reserving the right to apply for an award of attorneys’ fees and reimbursement of expenses.</p> XML 13 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover - shares
 3 Months Ended
Mar. 31, 2021
Apr. 30, 2021
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2021  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2021  
Current Fiscal Year End Date --12-31  
Entity File Number 001-36159  
Entity Registrant Name STEREOTAXIS, INC.  
Entity Central Index Key 0001289340  
Entity Tax Identification Number 94-3120386  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 4320 Forest Park Avenue  
Entity Address, Address Line Two Suite 100  
Entity Address, City or Town St. Louis  
Entity Address, State or Province MO  
Entity Address, Postal Zip Code 63108  
City Area Code (314)  
Local Phone Number 678-6100  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol STXS  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   74,113,969
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 42,452,713 $ 43,939,512
Restricted cash - current 1,336,000
Compensating cash arrangement 250,919 250,620
Accounts receivable, net of allowance of $122,570 and $123,614 at 2021 and 2020, respectively 7,290,762 3,515,136
Inventories, net 3,536,300 3,295,457
Prepaid expenses and other current assets 1,674,554 1,716,014
Total current assets 56,541,248 52,716,739
Property and equipment, net 202,504 195,129
Restricted cash 93,331
Operating lease right-of-use assets 1,695,664 2,235,442
Other assets 284,946 308,515
Total assets 58,817,693 55,455,825
Current liabilities:    
Short-term debt 1,914,692 1,185,058
Accounts payable 2,270,432 1,608,636
Accrued liabilities 2,578,298 3,209,235
Deferred revenue 8,188,296 5,282,770
Current portion of operating lease liabilities 1,734,699 2,287,487
Total current liabilities 16,686,417 13,573,186
Long-term debt 243,617 973,252
Long-term deferred revenue 1,328,272 548,915
Other liabilities 210,096 131,231
Total liabilities 18,468,402 15,226,584
Series A - Convertible preferred stock:    
Convertible preferred stock, Series A, par value $0.001; 22,408 and 22,513 shares outstanding at 2021 and 2020, respectively 5,578,437 5,605,323
Stockholders’ equity:    
Convertible preferred stock, Series B, par value $0.001; 10,000,000 shares authorized, 5,610,121 shares outstanding at 2021 and 2020 5,610 5,610
Common stock, par value $0.001; 300,000,000 shares authorized,74,089,659 and 73,694,203 shares issued at 2021 and 2020, respectively 74,090 73,694
Additional paid in capital 524,388,783 522,709,846
Treasury stock, 4,015 shares at 2021 and 2020 (205,999) (205,999)
Accumulated deficit (489,491,630) (487,959,233)
Total stockholders’ equity 34,770,854 34,623,918
Total liabilities and stockholders’ equity $ 58,817,693 $ 55,455,825
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Balance Sheets (Parenthetical) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Statement of Financial Position [Abstract]    
Accounts receivable, allowance $ 122,570 $ 123,614
Series A Convertible Preferred Stock, par value $ 0.001 $ 0.001
Series A Convertible Preferred Stock, shares outstanding 22,408 22,513
Series B Convertible Preferred Stock, par value $ 0.001 $ 0.001
Series B Convertible Preferred Stock, shares authorized 10,000,000 10,000,000
Series B Convertible Preferred Stock, shares outstanding 5,610,121 5,610,121
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 74,089,659 73,694,203
Treasury stock, shares 4,015 4,015
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue:    
Total revenue $ 8,622,558 $ 5,756,241
Sublease 246,530 246,530
Cost of revenue:    
Total cost of revenue 2,606,683 951,415
Sublease 246,530 246,530
Gross margin 6,015,875 4,804,826
Operating expenses:    
Research and development 2,367,041 2,109,170
Sales and marketing 2,947,216 2,915,424
General and administrative 2,229,739 1,832,726
Total operating expenses 7,543,996 6,857,320
Operating loss (1,528,121) (2,052,494)
Interest (expense) income, net (4,276) 80,963
Net loss (1,532,397) (1,971,531)
Cumulative dividend on Series A convertible preferred stock (332,551) (343,723)
Loss attributable to common stockholders $ (1,864,948) $ (2,315,254)
Net loss per share attributable to common stockholders:    
Basic $ (0.02) $ (0.03)
Diluted $ (0.02) $ (0.03)
Weighted average number of common shares and equivalents:    
Basic 75,175,412 69,870,040
Diluted 75,175,412 69,870,040
Systems [Member]    
Revenue:    
Total revenue $ 2,602,512
Cost of revenue:    
Total cost of revenue 1,435,535 65,022
Disposables, Service and Accessories [Member]    
Revenue:    
Total revenue 5,773,516 5,509,711
Cost of revenue:    
Total cost of revenue $ 924,618 $ 639,863
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
Convertible Preferred Stock Series A [Member]
Convertible Preferred Stocks Series B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 5,758,190 $ 5,610 $ 68,530 $ 504,211,040 $ (205,999) $ (481,312,774) $ 22,766,407
Beginning Balance, Shares at Dec. 31, 2019 23,110 5,610,121 68,529,623        
Issuance of common stock     $ 41 (23,891)     (23,850)
Issuance of common stock, Shares     40,816        
Share-based compensation     $ 109 722,203     722,312
Share-based compensation, Shares     109,489        
Components of net loss           (1,971,531) (1,971,531)
Employee stock purchase plan     $ 7 32,216     32,223
Employee stock purchase plan, Shares     6,406        
Preferred stock conversion $ (49,163) $ 354 48,809   49,163
Preferred stock conversion, Shares (192)   354,447        
Ending balance, value at Mar. 31, 2020 $ 5,709,027 $ 5,610 $ 69,041 504,990,377 (205,999) (483,284,305) 21,574,724
Ending Balance, Shares at Mar. 31, 2020 22,918 5,610,121 69,040,781        
Beginning balance, value at Dec. 31, 2020 $ 5,605,323 $ 5,610 $ 73,694 522,709,846 (205,999) (487,959,233) 34,623,918
Beginning Balance, Shares at Dec. 31, 2020 22,513 5,610,121 73,694,203        
Issuance of common stock     $ 156 252,679     252,835
Issuance of common stock, Shares     154,806        
Share-based compensation     $ 30 1,370,527     1,370,557
Share-based compensation, Shares     30,250        
Components of net loss           (1,532,397) (1,532,397)
Employee stock purchase plan     $ 6 29,049     29,055
Employee stock purchase plan, Shares     6,003        
Preferred stock conversion $ (26,886) $ 204 26,682   26,886
Preferred stock conversion, Shares (105)   204,397        
Ending balance, value at Mar. 31, 2021 $ 5,578,437 $ 5,610 $ 74,090 $ 524,388,783 $ (205,999) $ (489,491,630) $ 34,770,854
Ending Balance, Shares at Mar. 31, 2021 22,408 5,610,121 74,089,659        
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net loss $ (1,532,397) $ (1,971,531)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation 26,817 30,119
Non-cash lease expense 582,712 585,586
Share-based compensation 1,370,557 722,312
Changes in operating assets and liabilities:    
Accounts receivable (3,775,626) 714,499
Inventories (240,843) (1,322,610)
Prepaid expenses and other current assets 41,460 80,419
Compensating cash arrangement (299)
Other assets 23,569 (74,054)
Accounts payable 661,796 (96,800)
Accrued liabilities (630,937) (378,907)
Deferred revenue 3,684,883 130,691
Operating lease liability (595,723) (585,489)
Other liabilities 78,865
Net cash used in operating activities (305,166) (2,165,765)
Cash flows from investing activities    
Purchase of equipment (34,192)
Net cash used in investing activities (34,192)
Cash flows from financing activities    
Proceeds from issuance of stock, net of issuance costs 281,890 8,373
Net cash provided by financing activities 281,890 8,373
Net decrease in cash and cash equivalents (57,468) (2,157,392)
Cash and cash equivalents at beginning of period 43,939,512 30,182,115
Cash and cash equivalents at end of period 43,882,044 28,024,723
Reconciliation of cash, cash equivalents, and restricted cash to balance sheet as of March 31st:    
Cash and cash equivalents 42,452,713 28,024,723
Restricted cash - current 1,336,000
Restricted cash $ 93,331
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Description of Business
 3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business

1. Description of Business

 

Stereotaxis designs, manufactures and markets an advanced robotic magnetic navigation system for use in a hospital’s interventional surgical suite, or “interventional lab”, that we believe revolutionizes the treatment of arrhythmias by enabling enhanced safety, efficiency, and efficacy for catheter-based, or interventional, procedures. Our primary products include the Genesis RMN System, the Niobe System, the Odyssey Solution, and related devices. We also offer to our customers the Stereotaxis Imaging Model S x-ray System.

 

The Genesis RMN and Niobe Systems are designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. This is achieved using externally applied magnetic fields that govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures, and reduced x-ray exposure.

 

In addition to the robotic magnetic navigation systems and their components, Stereotaxis also has developed the Odyssey Solution, which consolidates lab information enabling physicians to focus on the patient for optimal procedure efficiency. The system also features a remote viewing and recording capability called Odyssey Cinema, which is an innovative solution that delivers synchronized content for optimized workflow, advanced care, and improved productivity. This tool includes an archiving capability that allows clinicians to store and replay entire procedures or segments of procedures. This information can be accessed from locations throughout the hospital local area network and over the global Odyssey Network providing physicians with a tool for clinical collaboration, remote consultation, and training.

 

We promote our full suite of products in a typical hospital implementation, subject to regulatory approvals or clearances. This implementation requires a hospital to agree to an upfront capital payment and recurring payments. The upfront capital payment typically includes equipment and installation charges. The recurring payments typically include disposable costs for each procedure, equipment service costs beyond the warranty period, and ongoing software updates. In hospitals where our full suite of products has not been implemented, equipment upgrade or expansion can be implemented upon purchasing of the necessary upgrade or expansion.

 

We have received regulatory clearance, licensing and/or CE Mark approvals necessary for us to market the Genesis RMN System in the U.S. and Europe, and we are in the process of obtaining necessary registrations for extending our markets in other countries. The Niobe System, Odyssey Solution, Cardiodrive, and various disposable interventional devices have received regulatory clearance in the U.S., Europe, Canada, China, Japan and various other countries. We have received the regulatory clearance, licensing and/or CE Mark approvals that allow us to market the Vdrive and Vdrive Duo Systems with the V-CAS, V-Loop and V-Sono devices in the U.S., Canada and Europe. Stereotaxis Imaging Model S is CE marked and FDA cleared.

 

We have strategic relationships with technology leaders and innovators in the global interventional market. Through these strategic relationships we provide compatibility between our robotic magnetic navigation system and digital imaging and 3D catheter location sensing technology, as well as disposable interventional devices. The maintenance of these strategic relationships, or the establishment of equivalent alternatives, is critical to our commercialization efforts. There are no guarantees that any existing strategic relationships will continue and efforts are ongoing to ensure the availability of integrated next generation systems and/or equivalent alternatives. We cannot provide assurance as to the timeline of the ongoing availability of such compatible systems or our ability to obtain equivalent alternatives on competitive terms or at all.

 
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies
 3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by GAAP for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or for future operating periods.

 

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission (SEC) on March 12, 2021.

 

Risks and Uncertainties

 

The novel coronavirus COVID-19 (“COVID-19”) pandemic has resulted, and is likely to continue to result, in significant disruptions to the economy, as well as business and capital markets around the world. The full extent of the impact of the COVID-19 pandemic on our business, results of operations and financial condition will depend on numerous evolving factors that we may not be able to accurately predict.

 

As a result of the COVID-19 outbreak, we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which have negatively affected our complex sales, marketing, installation, distribution and service network relating to our products and services. The COVID-19 pandemic may continue to negatively affect demand for both our systems and our disposable products by limiting the ability of our sales personnel to maintain their customary contacts with customers as governmental authorities institute prolonged quarantines, travel restrictions, and shelter-in-place orders, or as our customers impose limitations on contacts and in-person meetings that go beyond those imposed by governmental authorities.

 

In addition, many of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable sales and installation cycles for our robotic magnetic navigation systems. We may also experience significant reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) continue to re-prioritize the treatment of patients and divert resources away from non-coronavirus areas, which we anticipate will lead to the performance of fewer procedures in which our disposable products are used. In addition, patients may consider foregoing or deferring procedures utilizing our products, even if physicians and hospitals are willing to perform them, which could also reduce demand for, and sales of, our disposable products.

 

As of the date of the filing of this Quarterly Report on Form 10-Q, we believe our manufacturing operations and supply chains have been minimally interrupted, but we cannot guarantee that they will not be interrupted more severely in the future. If our manufacturing operations or supply chains are materially interrupted, it may not be possible for us to timely manufacture relevant products at required levels, or at all. A material reduction or interruption to any of our manufacturing processes would have a material adverse effect on our business, operating results, and financial condition.

 

If governmental authorities around the world continue to institute prolonged mandatory closures, social distancing protocols and shelter-in-place orders, or as private parties on whom we rely to operate our business put in place their own protocols that go beyond those instituted by relevant governmental authorities, our ability to adequately staff and maintain our operations or further our product development could be negatively impacted.

 

Any disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Continued disruptions to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects, a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products as well as an increased risk of customer defaults or delays in payments for our systems, installation, service contracts and disposable products.

 

We continue to evaluate and, where appropriate, take actions to reduce costs and spending across our organization. We will continue to actively monitor the situation and may take further actions that alter our business operations that may be required by federal, state, or local governmental authorities or that may be implemented by our vendors, suppliers or customers, or that we determine are in the best interests of our employees, customers, suppliers and stockholders.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments purchased with original maturities of three months or less to be cash equivalents. The Company places its cash with high-credit-quality financial institutions and invests primarily in money market accounts.

 

Restricted Cash

 

Restricted cash primarily consists of cash that the Company is obligated to maintain in accordance with contractual obligations. The Company’s restricted cash was $1.4 million at March 31, 2021. No cash was restricted at December 31, 2020.

 

 

Compensating Cash Arrangement

 

In July 2020, the Company entered into a letter of credit to support a commitment of less than $0.3 million. As a condition of the letter of credit, the Company is required to maintain a $0.3 million compensating balance until the expiration of the letter of credit.

 

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

 

The Company’s financial assets consist of restricted cash and cash equivalents invested in money market funds which totaled $1.4 million as of March 31, 2021 and December 31, 2020, respectively. The financial assets consisting of cash equivalents invested in money market funds are classified as Level 2 as described above and total interest income recorded for these investments was insignificant for the three months ended March 31, 2021. As of March 31, 2021, the Company did not have any financial liabilities valued at fair value on a recurring basis. As of March 31, 2020, the Company did not have any financial assets or liabilities valued at fair value on a recurring basis.

 

Revenue and Costs of Revenue

 

The Company accounts for revenue in accordance with Accounting Standards Codification Topic 606 (“ASC 606”), “Revenue from Contracts with Customers”.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services, the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.

 

Our revenue recognition policy affects the following revenue streams in our business as follows:

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were less than $0.1 million for the periods presented. Revenue from system delivery and installation represented 30% of revenue for the three months ended March 31, 2021. There was no revenue from system delivery and installation for the three months ended March 31, 2020.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 24% and 34% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 7% and 10% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation of our systems. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 36% and 52% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

Sublease Revenue:

 

A portion of our principal executive office is subleased to a third party through 2021. In accordance with Accounting Standards Update (ASU) 2016-02, “Leases” (Topic 842), the Company records sublease income as revenue. Sublease revenue represented 3% and 4% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

   Three Months Ended March 31, 
   2021   2020 
Systems  $2,602,512   $- 
Disposables, service and accessories   5,773,516    5,509,711 
Sublease   246,530    246,530 
Total revenue  $8,622,558   $5,756,241 

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $10.1 million as of March 31, 2021. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

   March 31, 2021   December 31, 2020 
Contract Assets - unbilled receivables  $207,964   $284,415 
           
Customer deposits  $1,955,573   $- 
Product shipped, revenue deferred   1,547,957    645,200 
Deferred service and license fees   6,013,038    5,186,485 
Total deferred revenue  $9,516,568   $5,831,685 
Less: Long-term deferred revenue   (1,328,272)   (548,915)
Total current deferred revenue  $8,188,296   $5,282,770 

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the three months ended March 31, 2021 and 2020, that was included in the deferred revenue balance at the beginning of each reporting period remained consistent at $2.6 million.

 

 

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.2 million and $0.3 million as of March 31, 2021 and December 31, 2020, respectively. The Company did not incur any impairment losses during any of the periods presented.

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recognized at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are recognized when incurred.

 

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

For time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

 

For market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.

 

Shares purchased by employees under the 2009 Employee Stock Purchase Plan are considered to be non-compensatory.

 

Net Earnings (Loss) per Common Share

 

Basic earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our convertible preferred stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our convertible preferred stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our convertible preferred stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

Schedule of Computation of Basic and Diluted Earnings Per Share

   2021   2020 
   Three Months Ended March 31, 
   2021   2020 
Net loss  $(1,532,397)  $(1,971,531)
Cumulative dividend on Series A Convertible Preferred Stock   (332,551)   (343,723)
Net loss attributable to common stockholders  $(1,864,948)  $(2,315,254)
           
Weighted average number of common shares and equivalents:   75,175,412    69,870,040 
Basic EPS  $(0.02)  $(0.03)
Diluted EPS  $(0.02)  $(0.03)

 

The Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights, warrants or convertible preferred stock in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented. The application of the two-class method of computing earnings per share under general accounting principles for participating securities is not applicable during these periods because those securities do not contractually participate in its losses.

 

 

As of March 31, 2021, the Company had 3,030,178 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $3.95 per share, 15,385 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 43,790,285 shares of our common stock issuable upon conversion of our Series A Convertible Preferred Stock, 5,610,121 shares of our common stock issuable upon conversion of our Series B Convertible Preferred Stock and 1,287,223 shares of unvested restricted share units. The Company had no unearned restricted shares outstanding for the period ended March 31, 2021.

 

Recently Issued Accounting Pronouncements

 

In December 2019, the FASB issued Accounting Standards Update (ASU) 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” as part of its effort to reduce the complexity of accounting standards. The ASU is effective for fiscal years beginning after December 15, 2020. The Company adopted with no impact to the Company’s financial statements.

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance under ASU 2018-19, ASU 2019-04 and ASU 2019-05. The standard modifies the measurement approach for credit losses on financial instruments, including trade receivables, from an incurred loss method to a current expected credit loss method, otherwise known as “CECL.” The standard requires the measurement of expected credit losses to be based on relevant information, including historical experience, current conditions and a forecast that is supportable. The standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The standard must be adopted by applying a cumulative adjustment to retained earnings. The Company anticipates adopting the standard in the first quarter of 2023, although it does not expect a significant impact to the Company’s financial results.

 
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Inventories
 3 Months Ended
Mar. 31, 2021
Inventory Disclosure [Abstract]  
Inventories

3. Inventories

 

Inventories consist of the following:

Schedule of Inventories

   March 31, 2021   December 31, 2020 
Raw materials  $2,883,285   $2,950,912 
Work in process   800,034    433,026 
Finished goods   2,569,654    2,987,039 
Reserve for excess and obsolescence   (2,716,673)   (3,075,520)
Total inventory  $3,536,300   $3,295,457 

 
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Prepaid Expenses and Other Assets
 3 Months Ended
Mar. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses and Other Assets

4. Prepaid Expenses and Other Assets

 

Prepaid expenses and other assets consist of the following:

   March 31, 2021   December 31, 2020 
Prepaid expenses  $608,485   $754,062 
Prepaid commissions   244,974    271,174 
Deposits   979,081    855,970 
Other assets   126,960    143,323 
Total prepaid expenses and other assets   1,959,500    2,024,529 
Less: Noncurrent prepaid expenses and other assets   (284,946)   (308,515)
Total current prepaid expenses and other assets  $1,674,554   $1,716,014 

 
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment
 3 Months Ended
Mar. 31, 2021
Property, Plant and Equipment [Abstract]  
Property and Equipment

5. Property and Equipment

 

Property and Equipment consist of the following:

   March 31, 2021   December 31, 2020 
Equipment  $6,488,984   $6,488,984 
Leasehold improvements   2,338,441    2,338,441 
Construction in process   34,192    - 
    8,861,617    8,827,425 
Less: Accumulated depreciation   (8,659,113)   (8,632,296)
Net property and equipment  $202,504   $195,129 

 

 
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Leases
 3 Months Ended
Mar. 31, 2021
Leases [Abstract]  
Leases

6. Leases

 

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration. The Company accounts for leases in accordance with Accounting Standards Update No. 2016-02 “Leases” (Topic 842) and all subsequent ASUs that modified Topic 842 (“ASC 842”). The Company determines if an arrangement contains a lease at inception.

 

The Company leases its facilities under operating leases. In accordance with ASC 842, operating lease agreements are recognized on the balance sheet as a right-of-use (“ROU”) asset and a corresponding lease liability. These leases do not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. Further, the leases do not contain contingent rent provisions. Many of our leases include both lease (i.e., fixed payments including rent, taxes, and insurance costs) and non-lease components (i.e., common-area or other maintenance costs) which are accounted for as a single lease component as we have elected the practical expedient to group lease and non-lease components for all leases. A portion of our principal executive office is subleased to a third party through 2021. The sublease does not have significant rent escalation holidays, concessions, leasehold improvement incentives, or other build-out clauses. In addition, the sublease does not contain contingent rent provisions nor are there options to extend or terminate the sublease.

 

The Company’s lease agreements often include one or more options to renew at the Company’s discretion. If at lease inception, the Company considers the exercising of a renewal option to be reasonably certain, the Company will include the extended term in the calculation of the ROU asset and lease liability. The Company elected not to include short-term leases (i.e. leases with initial terms of twelve months or less) on the balance sheet.

 

The calculated amounts of the ROU assets and lease liabilities are impacted by the length of the lease term and the discount rate used to calculate the present value of the minimum lease payments. ASC 842 requires the use of the discount rate implicit in the lease whenever this rate is readily determinable. As this rate is rarely determinable, the Company utilizes its incremental borrowing rate at lease inception. At March 31, 2021, the weighted average discount rate for operating leases was 9.0% and the weighted average remaining lease term for operating lease term is 0.75 years.

 

The following table represents lease costs and other lease information.

 

   Three Months Ended   Three Months Ended 
   Three Months Ended 
   March 31, 2021   March 31, 2020 
Operating lease cost  $582,712   $585,586 
Short-term lease cost   16,663    15,470 
Sublease income   (246,530)   (246,530)
Total net lease cost  $352,845   $354,526 
           
Cash paid within operating cash flows  $631,086   $636,350 

 

Variable lease costs consist primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and equipment which are paid based on actual costs incurred.

 

Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2021, excluding sublease income, were as follows:

 

   March 31, 2021 
2021     
Total lease payments  $1,786,995 
Less: Interest   (52,296)
Present value of lease liabilities  $1,734,699 

 

The remaining undiscounted future cash flows to be received under the sublease are $0.8 million in 2021.

 

On March 1, 2021, the Company entered into an office lease agreement (the “Lease”) with Globe Building Company (the “Landlord”), under which the Company will lease executive office space and manufacturing facilities of approximately 43,100 square feet of rentable space located at 710 N. Tucker Boulevard, St. Louis, Missouri (the “Premises”) that will serve as the Company’s new principal executive and administrative offices and manufacturing facility. The Lease for the Premises is effective at the later of January 1, 2022 or the date on which the Company has received an occupancy permit, and has a term of ten years, with two renewal options of five years each. The minimum annual rent under the terms of the Lease ranges from approximately $0.8 million in 2022 to $1.0 million in 2031. At the Lease commencement, the Company will relocate its current St. Louis, Missouri operations to the Premises in the new building.

 

 
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Accrued Liabilities
 3 Months Ended
Mar. 31, 2021
Payables and Accruals [Abstract]  
Accrued Liabilities

7. Accrued Liabilities

 

Accrued liabilities consist of the following:

 

   March 31, 2021   December 31, 2020 
Accrued salaries, bonus, and benefits  $1,348,077   $2,044,826 
Accrued licenses and maintenance fees   483,879    483,879 
Accrued warranties   188,591    157,615 
Accrued taxes   195,577    172,744 
Accrued professional services   223,298    138,359 
Other   348,972    343,043 
Total accrued liabilities   2,788,394    3,340,466 
Less: Long term accrued liabilities   (210,096)   (131,231)
Total current accrued liabilities  $2,578,298   $3,209,235 

 
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Debt and Credit Facilities
 3 Months Ended
Mar. 31, 2021
Debt Disclosure [Abstract]  
Debt and Credit Facilities

8. Debt and Credit Facilities

 

The Company had a working capital line of credit with its primary lender, Silicon Valley Bank, that matured on June 30, 2020 and was not renewed.

 

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 in the United States. Among the provisions contained in the CARES Act was the creation of the Paycheck Protection Program that provides for Small Business Administration (“SBA”) Section 7(a) loans for qualified small businesses. In general, the loan can be forgiven as long as the funds are used for payroll related expenses as well as rent and utilities paid during the twenty-four week period from the date of the loan and as long as certain headcount and salary/wage levels are maintained. On April 10, 2020, the Company was informed by its lender, Midwest BankCentre (the “Bank”), that the Bank received approval from the SBA to fund the Company’s request for a loan under the SBA’s Paycheck Protection Program (“PPP Loan”). Per the terms of the PPP Loan, the Company received total proceeds of $2,158,310 from the Bank on April 20, 2020. In March 2021, the Company applied for loan forgiveness with the Bank and on April 27, 2021 the application was accepted by the SBA for review. In accordance with the loan forgiveness requirements of the CARES Act, the Company used the full proceeds from the PPP Loan primarily for payroll costs, rent and utilities, thus, the Company anticipates that the loan will be substantially forgiven. To the extent it is not forgiven, the Company would be required to repay that portion beginning in August 2021 with a final installment in April 2022. Interest would be assessed on the amount of the loan not forgiven at a rate of 1% per annum beginning on the date of the loan, April 20, 2020.

 

In accordance with general accounting principles for fair value measurement, the Company’s debt was measured at fair value (Level 2), which approximated the carrying value of the debt, as of March 31, 2021 and December 31, 2020.

 
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Convertible Preferred Stock and Stockholders’ Equity
 3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Convertible Preferred Stock and Stockholders’ Equity

9. Convertible Preferred Stock and Stockholders’ Equity

 

The holders of common stock are entitled to one vote for each share held and to receive dividends whenever funds are legally available and when declared by the Board of Directors subject to the rights of holders of all classes of stock having priority rights as dividends. No dividends have been declared or paid as of March 31, 2021.

 

2020 Equity Financing

 

On May 25, 2020, the Company entered into a Securities Purchase Agreement with certain accredited investors, whereby it, in a direct registered offering, agreed to issue and sell to the investors an aggregate of 3,658,537 shares of the Company’s common stock, $0.001 par value per share, at a price of $4.10 per share. The Company received net proceeds of approximately $15.0 million, after offering expenses.

 

Series B Convertible Preferred Stock

 

On August 7, 2019, the Company entered into a Securities Purchase Agreement with certain institutional and other accredited investors, whereby it, as part of a private placement, agreed to issue and sell to the 5,610,121 shares of the Company’s Series B Convertible Preferred Stock, $0.001 par value per share which are convertible into shares of the Company’s Common Stock, at a price of $2.05 per share. The Series B Preferred Stock, which is a Common Stock equivalent but non-voting and with a blocker on conversion if the holder would exceed a specified threshold of voting security ownership, is convertible into Common Stock on a one-for-one basis, subject to adjustment for events such as stock splits, combinations and the like as provided in the Purchase Agreement. The Series B Convertible Preferred Stock is reported in the stockholders’ equity section of the Company’s balance sheet.

 

 

Series A Convertible Preferred Stock and Warrants

 

In September 2016, the Company issued (i) 24,000 shares of Series A Convertible Preferred Stock, par value $0.001 per share, with a stated value of $1,000 per share (the “Series A Preferred Stock”), which are convertible into shares of the Company’s common stock at an initial conversion rate of $0.65 per share, subject to adjustment for events such as stock splits, combinations and the like as provided in the certificate of designations covering such Series A Preferred Stock, and (ii) warrants to purchase an aggregate of 36,923,078 shares of common stock. The shares of Series A Preferred Stock are entitled to vote on an as-converted basis with the common stock, subject to specified beneficial ownership issuance limitations. The Series A Preferred Stock bear dividends at a rate of six percent (6%) per annum, which are cumulative and accrue daily from the date of issuance on the $1,000 stated value. Such dividends will not be paid in cash except in connection with any liquidation, dissolution or winding up of the Company or any redemption of the Series A Preferred Stock. Each holder of convertible preferred shares has the right to require us to redeem such holder’s shares of Series A Preferred Stock upon the occurrence of specified events, which include certain business combinations, the sale of all or substantially all of the Company’s assets, or the sale of more than 50% of the outstanding shares of the Company’s common stock. In addition, the Company has the right to redeem the Series A Preferred Stock in the event of a defined change of control. The Series A Preferred Stock ranks senior to our common stock as to distributions and payments upon the liquidation, dissolution, and winding up of the Company. Since the Series A Preferred Stock are subject to conditions for redemption that are outside the Company’s control, the Series A Preferred Stock are presently reported in the mezzanine section of the balance sheet.

 

The warrants issued in conjunction with the Series A Preferred Stock (the “SPA Warrants”) have an exercise price of $0.70 per share subject to adjustments for events such as stock splits, combinations, and the like as provided under the terms of the warrants. The warrants are exercisable through September 29, 2021, subject to specified beneficial ownership issuance limitations.

 

2021 CEO Performance Award Unit Grant

 

On February 23, 2021, the Company`s Board of Directors, upon recommendation of the Compensation Committee, approved the grant of the CEO Performance Award to David L. Fischel, the Company’s Chief Executive Officer. The CEO Performance award is a 10-year performance award of up to 13,000,000 shares, tied to the achievement of market capitalization milestones and subject to minimum service requirements.

 

As detailed in the table below, the CEO Performance Award consists of ten vesting tranches. The first market capitalization milestone is $1 billion, and each of the remaining nine market capitalization milestones are in additional $500 million increments, up to $5.5 billion.

 

Tranche #  

No. of Shares

Subject to PSU

   Market Capitalization Milestones(1) 
 1    1,000,000   $1,000,000,000 
 2    1,500,000   $1,500,000,000 
 3    1,500,000   $2,000,000,000 
 4    2,000,000   $2,500,000,000 
 5    1,000,000   $3,000,000,000 
 6    1,000,000   $3,500,000,000 
 7    1,000,000   $4,000,000,000 
 8    2,000,000   $4,500,000,000 
 9    1,000,000   $5,000,000,000 
 10    1,000,000   $5,500,000,000 
 Total:    13,000,000      

 

Each tranche represents a portion of the PSUs covering the number of shares outlined in the table above. Each tranche vests upon (i) satisfaction of the market capitalization milestones and (ii) Mr. Fischel continuing to serve as CEO from the grant date through December 31, 2030. Absent an earlier termination, the PSUs will expire on December 31, 2030. If Mr. Fischel ceases to be the CEO for any reason including death, disability, termination for cause or without cause (as defined in the award agreement), or Mr. Fischel’s voluntary termination after service as CEO for at least five years, the remaining service period will be waived and he will retain any PSUs that have vested through the date of termination.

 

The Company is seeking Shareholder approval at its annual meeting on May 20, 2021 for shares to be issued under the award.

 

The market capitalization requirement is considered a market condition under FASB Accounting Standards Codification Topic 718 “Compensation – Stock Compensation” and is estimated on the grant date using Monte Carlo simulations. Recognition of stock-based compensation expense of all the tranches commenced on February 23, 2021, the date of grant, as the probability of meeting the ten market capitalization milestones is not considered in determining the timing of expense recognition. The expense will be recognized on an accelerated basis through 2030. Key assumptions for estimating the performance-based awards fair value at the date of grant included share price on grant date, volatility of the Company’s common stock price, risk free interest rate, and grant term.

 

 

Total stock-based compensation recorded as operating expense for the CEO Performance Award was $0.7 million for the quarter ended March 31, 2021. As of March 31, 2021, the Company had approximately $56.7 million of total unrecognized stock-based compensation expense remaining under the CEO Performance Award if Mr. Fischel continues to serve as CEO, or in a similar capacity through 2030.

 

2012 Stock Award Plan

 

The Company has various stock plans that permit the Company to provide incentives to employees and directors of the Company in the form of equity compensation. In July 2012, the Compensation Committee of the Board of Directors adopted the 2012 Stock Incentive Plan (the “Plan”) which was subsequently approved by the Company’s shareholders. This plan replaced the 2002 Stock Incentive Plan which expired on March 25, 2012.

 

At March 31, 2021, the Company had 1,114,086 remaining shares of the Company’s common stock to provide for current and future grants under its various equity plans.

 

At March 31, 2021, the total compensation cost related to options, stock appreciation rights, and non-vested stock granted to employees under the Company’s stock award plans but not yet recognized was approximately $6.4 million, excluding compensation not yet recognized related to the CEO Performance Award discussed above. This cost will be amortized over a period of up to four years over the underlying estimated service periods and will be adjusted for subsequent changes in actual forfeitures and anticipated vesting periods.

 

A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2021 is as follows:

   Number of Options/SARs   Range of Exercise Price   Weighted Average Exercise
Price per Share		 
Outstanding, December 31, 2020   2,456,979   $0.74 - $35.20   $2.90 
Granted   815,000   $6.96   $6.96 
Exercised   (165,962)  $0.74 - $4.52   $1.85 
Forfeited   (75,839)  $0.74 - $35.20   $6.66 
Outstanding, March 31, 2021   3,030,178   $0.74 - $32.30   $3.95 

 

A summary of the restricted stock unit activity for the three month period ended March 31, 2021 is as follows:

   Number of Restricted Stock Units   Weighted Average Grant Date Fair Value per Unit 
Outstanding, December 31, 2020   1,112,473   $2.46 
Granted   205,000   $5.16 
Vested   (30,250)  $5.12 
Forfeited   -   $- 
Outstanding, March 31, 2021   1,287,223   $2.83 

 
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements

10. Fair Value Measurements

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including certain cash equivalents. Generally accepted accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”). The three levels of the fair value hierarchy are described below:

 

Level 1:   Values are based on unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
     
Level 2:   Values are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or other model-based valuation techniques for which all significant assumptions are observable in the market.
     
Level 3:  

Values are generated from model-based techniques that use significant assumptions not observable in the market.

 

 

The following table sets forth the Company’s assets measured at fair value on a recurring basis by level within the fair value hierarchy. As required by the Fair Value Measurements and Disclosures topic of the Accounting Standards Codification, assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

   Fair Value Measurement Using 
   Total   Quoted Prices in
Active Markets
for Identical
Instruments
(Level 1)		   Significant
Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets at March 31, 2021:                    
Cash invested in money market accounts  $1,429,331    —   $1,429,331   $— 
Total assets at fair value  $1,429,331    —   $1,429,331   $— 
Assets at December 31, 2020:                    
Cash invested in money market accounts  $1,429,331    —   $1,429,331   $— 
Total assets at fair value  $1,429,331    —   $1,429,331   $— 

 

The Company did not have any financial liabilities valued at fair value on a recurring basis as of March 31, 2021 or December 31, 2020.

 

Level 1

 

The Company does not have any financial assets or liabilities classified as Level 1.

 

Level 2

 

The Company’s financial assets consist of restricted cash and cash equivalents invested in money market funds in the amount of $1,429,331 at March 31, 2021 and December 31, 2020, respectively. These assets are classified as Level 2, as described above, and total interest income recorded for these investments was insignificant during the three months ended March 31, 2021 and year ended December 31, 2020.

 

Level 3

 

The Company does not have any financial assets or liabilities classified as Level 3.

 
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Product Warranty Provisions
 3 Months Ended
Mar. 31, 2021
Guarantees and Product Warranties [Abstract]  
Product Warranty Provisions

11. Product Warranty Provisions

 

The Company’s standard policy is to warrant all capital systems against defects in material or workmanship for one year following installation. The Company’s estimate of costs to service the warranty obligations is based on historical experience and current product performance trends. A regular review of warranty obligations is performed to determine the adequacy of the reserve and adjustments are made to the estimated warranty liability as appropriate.

 

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

   March 31, 2021   December 31, 2020 
Warranty accrual, beginning of the fiscal period  $157,615   $141,697 
Accrual adjustment for product warranty   94,596    49,974 
Payments made   (63,620)   (34,056)
Warranty accrual, end of the fiscal period  $188,591   $157,615 

 
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

12. Commitments and Contingencies

 

The Company at times becomes a party to claims in the ordinary course of business. Management believes that the ultimate resolution of pending or threatened proceedings will not have a material effect on the financial position, results of operations or liquidity of the Company.

 

In February 2021, the Company entered into letters of credit to support commitments totaling approximately $1.3 million. The letters of credit are valid through 2022.

 
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Subsequent Events
 3 Months Ended
Mar. 31, 2021
Subsequent Events [Abstract]  
Subsequent Events

13. Subsequent Events

 

On April 29, 2021, a putative class action complaint was filed in Delaware Chancery Court by Richard Barre, a purported shareholder. The defendants are the Company and its current directors. The complaint alleges breaches of fiduciary duty against the defendants based on alleged disclosure deficiencies in the definitive proxy statement (the “Proxy Statement”) filed by the Company on April 9, 2021 relative to the vote at the Company’s 2021 Annual Meeting of Stockholders to be held on May 20, 2021 (the “2021 Stockholder Meeting”) seeking stockholder approval of issuance of shares under the Performance Share Unit Award (the “CEO Performance Award”) granted to David L. Fischel, the Company’s chief executive officer. The complaint seeks various remedies, including a preliminary injunction seeking to enjoin the vote at the 2021 Stockholder Meeting to approve the issuance of shares for the CEO Performance Award. Following discussions with the plaintiff’s counsel and the Delaware Chancery Court, the parties agreed to an expedited discovery and briefing schedule, with the Chancery Court scheduled to hear arguments on the plaintiff’s motion for a preliminary injunction on May 18, 2021.

 

Although the Company believes that the claims were wholly without merit and that no further disclosure was required to supplement the Proxy Statement under applicable law, the Company filed a supplement to the Proxy Statement on May 10, 2021 addressing the alleged disclosure claims in order to eliminate the burden, expense, and uncertainties inherent in such litigation, and without admitting any liability or wrongdoing. On May 12, 2021, the plaintiff withdrew the motion for a preliminary injunction and indicated that the plaintiff intends to voluntarily dismiss, with prejudice, all claims set forth in the complaint, subject to court approval and reserving the right to apply for an award of attorneys’ fees and reimbursement of expenses.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited financial statements of Stereotaxis, Inc. have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all the disclosures required by GAAP for complete financial statements. In the opinion of management, they include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Operating results for the three month period ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021 or for future operating periods.

 

 

These interim financial statements and the related notes should be read in conjunction with the annual financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission (SEC) on March 12, 2021.

 
Risks and Uncertainties

Risks and Uncertainties

 

The novel coronavirus COVID-19 (“COVID-19”) pandemic has resulted, and is likely to continue to result, in significant disruptions to the economy, as well as business and capital markets around the world. The full extent of the impact of the COVID-19 pandemic on our business, results of operations and financial condition will depend on numerous evolving factors that we may not be able to accurately predict.

 

As a result of the COVID-19 outbreak, we have experienced business disruptions, including travel restrictions on us and our third-party distributors, which have negatively affected our complex sales, marketing, installation, distribution and service network relating to our products and services. The COVID-19 pandemic may continue to negatively affect demand for both our systems and our disposable products by limiting the ability of our sales personnel to maintain their customary contacts with customers as governmental authorities institute prolonged quarantines, travel restrictions, and shelter-in-place orders, or as our customers impose limitations on contacts and in-person meetings that go beyond those imposed by governmental authorities.

 

In addition, many of our hospital customers, for whom the purchase of our system involves a significant capital purchase which may be part of a larger construction project at the customer site (typically the construction of a new building), may themselves be under economic pressures. This may cause delays or cancellations of current purchase orders and other commitments and may exacerbate the long and variable sales and installation cycles for our robotic magnetic navigation systems. We may also experience significant reductions in demand for our disposable products as our healthcare customers (physicians and hospitals) continue to re-prioritize the treatment of patients and divert resources away from non-coronavirus areas, which we anticipate will lead to the performance of fewer procedures in which our disposable products are used. In addition, patients may consider foregoing or deferring procedures utilizing our products, even if physicians and hospitals are willing to perform them, which could also reduce demand for, and sales of, our disposable products.

 

As of the date of the filing of this Quarterly Report on Form 10-Q, we believe our manufacturing operations and supply chains have been minimally interrupted, but we cannot guarantee that they will not be interrupted more severely in the future. If our manufacturing operations or supply chains are materially interrupted, it may not be possible for us to timely manufacture relevant products at required levels, or at all. A material reduction or interruption to any of our manufacturing processes would have a material adverse effect on our business, operating results, and financial condition.

 

If governmental authorities around the world continue to institute prolonged mandatory closures, social distancing protocols and shelter-in-place orders, or as private parties on whom we rely to operate our business put in place their own protocols that go beyond those instituted by relevant governmental authorities, our ability to adequately staff and maintain our operations or further our product development could be negatively impacted.

 

Any disruption to the capital markets could negatively impact our ability to raise capital. If the capital markets are disrupted for an extended period of time and we need to raise additional capital, such capital may not be available on acceptable terms, or at all. Continued disruptions to the capital markets and other financing sources could also negatively impact our hospital customers’ ability to raise capital or otherwise obtain financing to fund their operations and capital projects. Such could result in delayed spending on current projects, a longer sales cycle for new projects where a large capital commitment is required, and decreased demand for our disposable products as well as an increased risk of customer defaults or delays in payments for our systems, installation, service contracts and disposable products.

 

We continue to evaluate and, where appropriate, take actions to reduce costs and spending across our organization. We will continue to actively monitor the situation and may take further actions that alter our business operations that may be required by federal, state, or local governmental authorities or that may be implemented by our vendors, suppliers or customers, or that we determine are in the best interests of our employees, customers, suppliers and stockholders.

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all short-term investments purchased with original maturities of three months or less to be cash equivalents. The Company places its cash with high-credit-quality financial institutions and invests primarily in money market accounts.

 
Restricted Cash

Restricted Cash

 

Restricted cash primarily consists of cash that the Company is obligated to maintain in accordance with contractual obligations. The Company’s restricted cash was $1.4 million at March 31, 2021. No cash was restricted at December 31, 2020.

 

 
Compensating Cash Arrangement

Compensating Cash Arrangement

 

In July 2020, the Company entered into a letter of credit to support a commitment of less than $0.3 million. As a condition of the letter of credit, the Company is required to maintain a $0.3 million compensating balance until the expiration of the letter of credit.

 
Financial Instruments

Financial Instruments

 

Financial instruments consist of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and debt. The carrying value of such amounts reported at the applicable balance sheet dates approximates fair value.

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis. General accounting principles for fair value measurement established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (“Level 1”) and the lowest priority to unobservable inputs (“Level 3”).

 

The Company’s financial assets consist of restricted cash and cash equivalents invested in money market funds which totaled $1.4 million as of March 31, 2021 and December 31, 2020, respectively. The financial assets consisting of cash equivalents invested in money market funds are classified as Level 2 as described above and total interest income recorded for these investments was insignificant for the three months ended March 31, 2021. As of March 31, 2021, the Company did not have any financial liabilities valued at fair value on a recurring basis. As of March 31, 2020, the Company did not have any financial assets or liabilities valued at fair value on a recurring basis.

 
Revenue and Costs of Revenue

Revenue and Costs of Revenue

 

The Company accounts for revenue in accordance with Accounting Standards Codification Topic 606 (“ASC 606”), “Revenue from Contracts with Customers”.

 

We generate revenue from initial capital sales of systems as well as recurring revenue from the sale of our proprietary disposable devices, from royalties paid to the Company on the sale by Biosense Webster of co-developed catheters, and from revenue including ongoing software updates and service contracts.

 

We account for a contract with a customer when there is a legally enforceable contract between the Company and the customer, the rights of the parties are identified, the contract has commercial substance, and collectability of the contract consideration is probable. We record our revenue based on consideration specified in the contract with each customer, net of any taxes collected from customers that are remitted to government authorities.

 

For contracts containing multiple products and services, the Company accounts for individual products and services as separate performance obligations if they are distinct, which is if a product or service is separately identifiable from other items in the bundled package, and if a customer can benefit from it on its own or with other resources that are readily available to the customer. The Company recognizes revenues as the performance obligations are satisfied by transferring control of the product or service to a customer.

 

For arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable prices at which the Company separately sells the products or services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling price considering market conditions and entity-specific factors including, but not limited to, features and functionality of the products and services and market conditions. The Company regularly reviews standalone selling prices and updates these estimates if necessary.

 

Our revenue recognition policy affects the following revenue streams in our business as follows:

 

Systems:

 

Contracts related to the sale of systems typically contain separate obligations for the delivery of system(s), installation and an implied obligation to provide software enhancements if and when available for one year following installation. Revenue is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from the implied obligation to deliver software enhancements if and when available is recognized ratably over the first year following installation of the system as the customer receives the right to software updates throughout the period and is included in Other Recurring Revenue. The Company’s system contracts generally do not provide a right of return. Systems are generally covered by a one-year assurance type warranty; warranty costs were less than $0.1 million for the periods presented. Revenue from system delivery and installation represented 30% of revenue for the three months ended March 31, 2021. There was no revenue from system delivery and installation for the three months ended March 31, 2020.

 

Disposables:

 

Revenue from sales of disposable products is recognized when control is transferred to the customers, which generally occurs at the time of shipment, but can also occur at the time of delivery depending on the customer arrangement. Disposable products are covered by an assurance type warranty that provides for the return of defective products. Warranty costs were not material for the periods presented. Disposable revenue represented 24% and 34% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

 

Royalty:

 

The Company is entitled to royalty payments from Biosense Webster, payable quarterly based on net revenues from sales of the co-developed catheters. Royalty revenue from the co-developed catheters represented 7% and 10% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

Other Recurring Revenue:

 

Other recurring revenue includes revenue from product maintenance plans, other post warranty maintenance, and the implied obligation to provide software enhancements if and when available for a specified period, typically one year following installation of our systems. Revenue from services and software enhancements is deferred and amortized over the service or update period, which is typically one year. Revenue related to services performed on a time-and-materials basis is recognized when performed. Other recurring revenue represented 36% and 52% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

Sublease Revenue:

 

A portion of our principal executive office is subleased to a third party through 2021. In accordance with Accounting Standards Update (ASU) 2016-02, “Leases” (Topic 842), the Company records sublease income as revenue. Sublease revenue represented 3% and 4% of revenue for the three months ended March 31, 2021 and 2020, respectively.

 

   Three Months Ended March 31, 
   2021   2020 
Systems  $2,602,512   $- 
Disposables, service and accessories   5,773,516    5,509,711 
Sublease   246,530    246,530 
Total revenue  $8,622,558   $5,756,241 

 

Transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which the revenue has not yet been recognized. A significant portion of this amount relates to the Company’s systems contracts and obligations that will be recognized as revenue in future periods. These obligations are generally satisfied within two years after contract inception but may occasionally extend longer. Transaction price representing revenue to be earned on remaining performance obligations on system contracts was approximately $10.1 million as of March 31, 2021. Performance obligations arising from contracts for disposables, royalty and service are generally expected to be satisfied within one year after entering into the contract.

 

The following information summarizes the Company’s contract assets and liabilities:

 

   March 31, 2021   December 31, 2020 
Contract Assets - unbilled receivables  $207,964   $284,415 
           
Customer deposits  $1,955,573   $- 
Product shipped, revenue deferred   1,547,957    645,200 
Deferred service and license fees   6,013,038    5,186,485 
Total deferred revenue  $9,516,568   $5,831,685 
Less: Long-term deferred revenue   (1,328,272)   (548,915)
Total current deferred revenue  $8,188,296   $5,282,770 

 

The Company invoices its customers based on the billing schedules in its sales arrangements. Contract assets primarily represent the difference between the revenue that was earned but not billed on service contracts and revenue from system contracts that was recognized based on the relative selling price of the related performance obligations and the contractual billing terms in the arrangements. Customer deposits primarily relate to future system sales but can also include deposits on disposable sales. Deferred revenue is primarily related to service contracts, for which the service fees are billed up-front, generally quarterly or annually, and for amounts billed in advance for system contracts for which some performance obligations remain outstanding. For service contracts, the associated deferred revenue is generally recognized ratably over the service period. For system contracts, the associated deferred revenue is recognized when the remaining performance obligations are satisfied. The Company did not have any impairment losses on its contract assets for the periods presented.

 

Revenue recognized for the three months ended March 31, 2021 and 2020, that was included in the deferred revenue balance at the beginning of each reporting period remained consistent at $2.6 million.

 

 
Assets Recognized from the Costs to Obtain a Contract with a Customer

Assets Recognized from the Costs to Obtain a Contract with a Customer

 

The Company has determined that sales incentive programs for the Company’s sales team meet the requirements to be capitalized as the Company expects to generate future economic benefits from the related revenue generating contracts after the initial capital sales transaction. The costs capitalized as contract acquisition costs included in prepaid expenses and other assets, in the Company’s balance sheet was $0.2 million and $0.3 million as of March 31, 2021 and December 31, 2020, respectively. The Company did not incur any impairment losses during any of the periods presented.

 

Costs of systems revenue include direct product costs, installation labor and other costs, estimated warranty costs, and initial training and product maintenance costs. These costs are recognized at the time of sale. Costs of disposable revenue include direct product costs and estimated warranty costs and are recognized at the time of sale. Cost of revenue from services and license fees are recognized when incurred.

 
Share-Based Compensation

Share-Based Compensation

 

The Company accounts for its grants of stock options, stock appreciation rights, restricted shares, and restricted stock units and for its employee stock purchase plan in accordance with the provisions of general accounting principles for share-based payments. These accounting principles require the determination of the fair value of the share-based compensation at the grant date and the recognition of the related expense over the period in which the share-based compensation vests.

 

For time-based awards, the Company utilizes the Black-Scholes valuation model to determine the fair value of stock options and stock appreciation rights at the date of grant. The resulting compensation expense is recognized over the requisite service period, which is generally four years. Restricted shares and units granted to employees are valued at the fair market value at the date of grant. The Company amortizes the fair market value to expense over the service period. If the shares are subject to performance objectives, the resulting compensation expense is amortized over the anticipated vesting period and is subject to adjustment based on the actual achievement of objectives.

 

For market-based awards, stock-based compensation expense is recognized over the minimum service period regardless of whether or not the market target is probable of being achieved. The fair value of such awards is estimated on the grant date using Monte Carlo simulations.

 

Shares purchased by employees under the 2009 Employee Stock Purchase Plan are considered to be non-compensatory.

 
Net Earnings (Loss) per Common Share

Net Earnings (Loss) per Common Share

 

Basic earnings (loss) per common share is computed by dividing the net earnings (loss) for the period by the weighted average number of common shares outstanding during the period. In periods where there is net income, we apply the two-class method to calculate basic and diluted net income (loss) per share of common stock, as our convertible preferred stock is a participating security. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. In periods where there is a net loss, the two-class method of computing earnings per share does not apply as our convertible preferred stock does not contractually participate in our losses. We compute diluted net income (loss) per common share using net income (loss) as the “control number” in determining whether potential common shares are dilutive, after giving consideration to all potentially dilutive common shares, including stock options, warrants, unvested restricted stock units outstanding during the period and potential issuance of stock upon the conversion of our convertible preferred stock issued and outstanding during the period, except where the effect of such securities would be antidilutive.

 

The following table sets forth the computation of basic and diluted EPS:

Schedule of Computation of Basic and Diluted Earnings Per Share

   2021   2020 
   Three Months Ended March 31, 
   2021   2020 
Net loss  $(1,532,397)  $(1,971,531)
Cumulative dividend on Series A Convertible Preferred Stock   (332,551)   (343,723)
Net loss attributable to common stockholders  $(1,864,948)  $(2,315,254)
           
Weighted average number of common shares and equivalents:   75,175,412    69,870,040 
Basic EPS  $(0.02)  $(0.03)
Diluted EPS  $(0.02)  $(0.03)

 

The Company did not include any portion of unearned restricted shares, outstanding options, stock appreciation rights, warrants or convertible preferred stock in the calculation of diluted loss per common share because all such securities are anti-dilutive for all periods presented. The application of the two-class method of computing earnings per share under general accounting principles for participating securities is not applicable during these periods because those securities do not contractually participate in its losses.

 

 

As of March 31, 2021, the Company had 3,030,178 shares of common stock issuable upon the exercise of outstanding options and stock appreciation rights at a weighted average exercise price of $3.95 per share, 15,385 shares of common stock issuable upon the exercise of outstanding warrants at a weighted average exercise price of $0.70 per share, 43,790,285 shares of our common stock issuable upon conversion of our Series A Convertible Preferred Stock, 5,610,121 shares of our common stock issuable upon conversion of our Series B Convertible Preferred Stock and 1,287,223 shares of unvested restricted share units. The Company had no unearned restricted shares outstanding for the period ended March 31, 2021.

 
Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

In December 2019, the FASB issued Accounting Standards Update (ASU) 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” as part of its effort to reduce the complexity of accounting standards. The ASU is effective for fiscal years beginning after December 15, 2020. The Company adopted with no impact to the Company’s financial statements.

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance under ASU 2018-19, ASU 2019-04 and ASU 2019-05. The standard modifies the measurement approach for credit losses on financial instruments, including trade receivables, from an incurred loss method to a current expected credit loss method, otherwise known as “CECL.” The standard requires the measurement of expected credit losses to be based on relevant information, including historical experience, current conditions and a forecast that is supportable. The standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years; early adoption is permitted. The standard must be adopted by applying a cumulative adjustment to retained earnings. The Company anticipates adopting the standard in the first quarter of 2023, although it does not expect a significant impact to the Company’s financial results.

 
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Schedule of Revenue Disaggregated by Type

   Three Months Ended March 31, 
   2021   2020 
Systems  $2,602,512   $- 
Disposables, service and accessories   5,773,516    5,509,711 
Sublease   246,530    246,530 
Total revenue  $8,622,558   $5,756,241 
Summary of Contract Assets and Liabilities

The following information summarizes the Company’s contract assets and liabilities:

 

   March 31, 2021   December 31, 2020 
Contract Assets - unbilled receivables  $207,964   $284,415 
           
Customer deposits  $1,955,573   $- 
Product shipped, revenue deferred   1,547,957    645,200 
Deferred service and license fees   6,013,038    5,186,485 
Total deferred revenue  $9,516,568   $5,831,685 
Less: Long-term deferred revenue   (1,328,272)   (548,915)
Total current deferred revenue  $8,188,296   $5,282,770 
Schedule of Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted EPS:

Schedule of Computation of Basic and Diluted Earnings Per Share

   2021   2020 
   Three Months Ended March 31, 
   2021   2020 
Net loss  $(1,532,397)  $(1,971,531)
Cumulative dividend on Series A Convertible Preferred Stock   (332,551)   (343,723)
Net loss attributable to common stockholders  $(1,864,948)  $(2,315,254)
           
Weighted average number of common shares and equivalents:   75,175,412    69,870,040 
Basic EPS  $(0.02)  $(0.03)
Diluted EPS  $(0.02)  $(0.03)
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Inventories (Tables)
 3 Months Ended
Mar. 31, 2021
Inventory Disclosure [Abstract]  
Schedule of Inventories

Inventories consist of the following:

Schedule of Inventories

   March 31, 2021   December 31, 2020 
Raw materials  $2,883,285   $2,950,912 
Work in process   800,034    433,026 
Finished goods   2,569,654    2,987,039 
Reserve for excess and obsolescence   (2,716,673)   (3,075,520)
Total inventory  $3,536,300   $3,295,457 
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Prepaid Expenses and Other Assets (Tables)
 3 Months Ended
Mar. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid Expenses and Other Assets

Prepaid expenses and other assets consist of the following:

   March 31, 2021   December 31, 2020 
Prepaid expenses  $608,485   $754,062 
Prepaid commissions   244,974    271,174 
Deposits   979,081    855,970 
Other assets   126,960    143,323 
Total prepaid expenses and other assets   1,959,500    2,024,529 
Less: Noncurrent prepaid expenses and other assets   (284,946)   (308,515)
Total current prepaid expenses and other assets  $1,674,554   $1,716,014 
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Property and Equipment (Tables)
 3 Months Ended
Mar. 31, 2021
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and Equipment consist of the following:

   March 31, 2021   December 31, 2020 
Equipment  $6,488,984   $6,488,984 
Leasehold improvements   2,338,441    2,338,441 
Construction in process   34,192    - 
    8,861,617    8,827,425 
Less: Accumulated depreciation   (8,659,113)   (8,632,296)
Net property and equipment  $202,504   $195,129 
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2021
Leases [Abstract]  
Schedule of Lease Costs and Other Lease Information

The following table represents lease costs and other lease information.

 

   Three Months Ended   Three Months Ended 
   Three Months Ended 
   March 31, 2021   March 31, 2020 
Operating lease cost  $582,712   $585,586 
Short-term lease cost   16,663    15,470 
Sublease income   (246,530)   (246,530)
Total net lease cost  $352,845   $354,526 
           
Cash paid within operating cash flows  $631,086   $636,350 
Schedule of Future Minimum Operating Lease Payments

Future minimum payments for operating leases with initial or remaining terms of one year or more as of March 31, 2021, excluding sublease income, were as follows:

 

   March 31, 2021 
2021     
Total lease payments  $1,786,995 
Less: Interest   (52,296)
Present value of lease liabilities  $1,734,699 
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Accrued Liabilities (Tables)
 3 Months Ended
Mar. 31, 2021
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities

Accrued liabilities consist of the following:

 

   March 31, 2021   December 31, 2020 
Accrued salaries, bonus, and benefits  $1,348,077   $2,044,826 
Accrued licenses and maintenance fees   483,879    483,879 
Accrued warranties   188,591    157,615 
Accrued taxes   195,577    172,744 
Accrued professional services   223,298    138,359 
Other   348,972    343,043 
Total accrued liabilities   2,788,394    3,340,466 
Less: Long term accrued liabilities   (210,096)   (131,231)
Total current accrued liabilities  $2,578,298   $3,209,235 
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Convertible Preferred Stock and Stockholders’ Equity (Tables)
 3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Summary of Performance Award And Market Capitalization Milestones

 

Tranche #  

No. of Shares

Subject to PSU

   Market Capitalization Milestones(1) 
 1    1,000,000   $1,000,000,000 
 2    1,500,000   $1,500,000,000 
 3    1,500,000   $2,000,000,000 
 4    2,000,000   $2,500,000,000 
 5    1,000,000   $3,000,000,000 
 6    1,000,000   $3,500,000,000 
 7    1,000,000   $4,000,000,000 
 8    2,000,000   $4,500,000,000 
 9    1,000,000   $5,000,000,000 
 10    1,000,000   $5,500,000,000 
 Total:    13,000,000      
Summary of Option and Stock Appreciation Rights Activity

A summary of the option and stock appreciation rights activity for the three month period ended March 31, 2021 is as follows:

   Number of Options/SARs   Range of Exercise Price   Weighted Average Exercise
Price per Share		 
Outstanding, December 31, 2020   2,456,979   $0.74 - $35.20   $2.90 
Granted   815,000   $6.96   $6.96 
Exercised   (165,962)  $0.74 - $4.52   $1.85 
Forfeited   (75,839)  $0.74 - $35.20   $6.66 
Outstanding, March 31, 2021   3,030,178   $0.74 - $32.30   $3.95 
Summary of Restricted Stock Unit Activity

A summary of the restricted stock unit activity for the three month period ended March 31, 2021 is as follows:

   Number of Restricted Stock Units   Weighted Average Grant Date Fair Value per Unit 
Outstanding, December 31, 2020   1,112,473   $2.46 
Granted   205,000   $5.16 
Vested   (30,250)  $5.12 
Forfeited   -   $- 
Outstanding, March 31, 2021   1,287,223   $2.83 
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy

   Fair Value Measurement Using 
   Total   Quoted Prices in
Active Markets
for Identical
Instruments
(Level 1)		   Significant
Other
Observable
Inputs
(Level 2)		   Significant
Unobservable
Inputs
(Level 3)		 
Assets at March 31, 2021:                    
Cash invested in money market accounts  $1,429,331    —   $1,429,331   $— 
Total assets at fair value  $1,429,331    —   $1,429,331   $— 
Assets at December 31, 2020:                    
Cash invested in money market accounts  $1,429,331    —   $1,429,331   $— 
Total assets at fair value  $1,429,331    —   $1,429,331   $— 
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Product Warranty Provisions (Tables)
 3 Months Ended
Mar. 31, 2021
Guarantees and Product Warranties [Abstract]  
Schedule of Accrued Warranty

Accrued warranty, which is included in other accrued liabilities, consists of the following:

 

   March 31, 2021   December 31, 2020 
Warranty accrual, beginning of the fiscal period  $157,615   $141,697 
Accrual adjustment for product warranty   94,596    49,974 
Payments made   (63,620)   (34,056)
Warranty accrual, end of the fiscal period  $188,591   $157,615 
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Revenue Disaggregated by Type (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Product Information [Line Items]    
Total revenue $ 8,622,558 $ 5,756,241
Sub lease 246,530 246,530
Systems [Member]    
Product Information [Line Items]    
Total revenue 2,602,512
Disposables, Service and Accessories [Member]    
Product Information [Line Items]    
Total revenue $ 5,773,516 $ 5,509,711
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Contract Assets and Liabilities (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Product Information [Line Items]    
Contract Assets - unbilled receivables $ 207,964 $ 284,415
Total deferred revenue 9,516,568 5,831,685
Less: Long-term deferred revenue (1,328,272) (548,915)
Total current deferred revenue 8,188,296 5,282,770
Customer Deposits [Member]    
Product Information [Line Items]    
Total deferred revenue 1,955,573
Product Shipped, Revenue Deferred [Member]    
Product Information [Line Items]    
Total deferred revenue 1,547,957 645,200
Deferred Service and License Fees [Member]    
Product Information [Line Items]    
Total deferred revenue $ 6,013,038 $ 5,186,485
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Accounting Policies [Abstract]    
Net loss $ (1,532,397) $ (1,971,531)
Cumulative dividend on Series A Convertible Preferred Stock (332,551) (343,723)
Net loss attributable to common stockholders $ (1,864,948) $ (2,315,254)
Weighted average number of common shares and equivalents: 75,175,412 69,870,040
Basic EPS $ (0.02) $ (0.03)
Diluted EPS $ (0.02) $ (0.03)
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Feb. 28, 2021
Dec. 31, 2020
Jul. 31, 2020
Product Information [Line Items]          
Restricted cash $ 1,400,000     $ 0  
Compensating Balance, Amount 250,919     250,620  
Remaining performance obligation 10,100,000        
Contract with Customer, Liability, Revenue Recognized 2,600,000 $ 2,600,000      
Capitalized Contract Cost, Net $ 200,000     $ 300,000  
Weighted average exercise price $ 3.95     $ 2.90  
Exercise price of warrants $ 0.70        
Series A Convertible Preferred Stock [Member]          
Product Information [Line Items]          
Potential common shares excluded from diluted earnings per share 43,790,285        
Series B Convertible Preferred Stock [Member]          
Product Information [Line Items]          
Potential common shares excluded from diluted earnings per share 5,610,121        
Warrant [Member]          
Product Information [Line Items]          
Potential common shares excluded from diluted earnings per share 15,385        
Exercise price of warrants $ 0.70        
Stock Options and Stock Appreciation Rights [Member]          
Product Information [Line Items]          
Potential common shares excluded from diluted earnings per share 3,030,178        
Weighted average exercise price $ 3.95        
Restricted Stock [Member]          
Product Information [Line Items]          
Number of unvested restricted share units 1,287,223        
Revenue From System Delivery and Installation [Member]          
Product Information [Line Items]          
Revenues percentage 30.00%        
Disposable Revenue [Member]          
Product Information [Line Items]          
Revenues percentage 24.00% 34.00%      
Royalty Revenue [Member]          
Product Information [Line Items]          
Revenues percentage 7.00% 10.00%      
Other Recurring Revenue [Member]          
Product Information [Line Items]          
Revenues percentage 36.00% 52.00%      
Sublease Revenue [Member].          
Product Information [Line Items]          
Revenues percentage 3.00% 4.00%      
Systems [Member]          
Product Information [Line Items]          
Money market funds $ 1,400,000     $ 1,400,000  
Systems [Member] | Maximum [Member]          
Product Information [Line Items]          
Product Warranty Expense $ 100,000        
Letter of Credit [Member]          
Product Information [Line Items]          
Long-term Line of Credit     $ 1,300,000   $ 300,000
Compensating Balance, Amount         $ 300,000
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Inventories (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Inventory Disclosure [Abstract]    
Raw materials $ 2,883,285 $ 2,950,912
Work in process 800,034 433,026
Finished goods 2,569,654 2,987,039
Reserve for excess and obsolescence (2,716,673) (3,075,520)
Total inventory $ 3,536,300 $ 3,295,457
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Prepaid Expenses and Other Assets (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid expenses $ 608,485 $ 754,062
Prepaid commissions 244,974 271,174
Deposits 979,081 855,970
Other assets 126,960 143,323
Total prepaid expenses and other assets 1,959,500 2,024,529
Less: Noncurrent prepaid expenses and other assets (284,946) (308,515)
Total current prepaid expenses and other assets $ 1,674,554 $ 1,716,014
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Property and Equipment (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Gross property and equipment $ 8,861,617 $ 8,827,425
Less: Accumulated depreciation (8,659,113) (8,632,296)
Net property and equipment 202,504 195,129
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Gross property and equipment 6,488,984 6,488,984
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Gross property and equipment 2,338,441 2,338,441
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
Gross property and equipment $ 34,192
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Lease Costs and Other Lease Information (Details) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Leases [Abstract]    
Operating lease cost $ 582,712 $ 585,586
Short-term lease cost 16,663 15,470
Sublease income (246,530) (246,530)
Total net lease cost 352,845 354,526
Cash paid within operating cash flows $ 631,086 $ 636,350
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Future Minimum Operating Lease Payments (Details)
Mar. 31, 2021
USD ($)
Leases [Abstract]  
Total lease payments $ 1,786,995
Less: Interest (52,296)
Present value of lease liabilities $ 1,734,699
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Leases (Details Narrative)
 3 Months Ended
Mar. 01, 2021
USD ($)
ft²
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Lessee, Lease, Description [Line Items]      
Weighted average discount rate for operating leases   9.00%  
Weighted average remaining lease term for operating lease term   9 months  
Undiscounted future cash flows to be received under the sublease 2020   $ 800,000  
Annual rent under the terms, lease   $ 582,712 $ 585,586
Office Lease Agreement [Member] | Globe Building Company [Member] | Office Space and Manufacturing Facilities [Member]      
Lessee, Lease, Description [Line Items]      
Area of Land | ft² 43,100    
Lease effective date Jan. 01, 2022    
Operating lease, term of contract 10 years    
Operating lease, option to extend two renewal options of five years each    
Operating lease, renewal term 5 years    
Office Lease Agreement [Member] | Globe Building Company [Member] | Office Space and Manufacturing Facilities [Member] | Minimum Annual Rent in 2022 [Member]      
Lessee, Lease, Description [Line Items]      
Annual rent under the terms, lease $ 800,000    
Office Lease Agreement [Member] | Globe Building Company [Member] | Office Space and Manufacturing Facilities [Member] | Minimum Annual Rent in 2031 [Member]      
Lessee, Lease, Description [Line Items]      
Annual rent under the terms, lease $ 1,000,000.0    
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Accrued Liabilities (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Payables and Accruals [Abstract]    
Accrued salaries, bonus, and benefits $ 1,348,077 $ 2,044,826
Accrued licenses and maintenance fees 483,879 483,879
Accrued warranties 188,591 157,615
Accrued taxes 195,577 172,744
Accrued professional services 223,298 138,359
Other 348,972 343,043
Total accrued liabilities 2,788,394 3,340,466
Less: Long term accrued liabilities (210,096) (131,231)
Total current accrued liabilities $ 2,578,298 $ 3,209,235
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Debt and Credit Facilities (Details Narrative) - USD ($)
 3 Months Ended
Apr. 20, 2020
Mar. 31, 2021
Cares Act [Member]    
Line of Credit Facility [Line Items]    
Loan description In accordance with the loan forgiveness requirements of the CARES Act, the Company used the full proceeds from the PPP Loan primarily for payroll costs, rent and utilities, thus, the Company anticipates that the loan will be substantially forgiven.  
Paycheck Protection Program [Member]    
Line of Credit Facility [Line Items]    
Proceeds from bank $ 2,158,310  
Interest rate 1.00%  
Revolving Credit Facility [Member] | Primary Lender [Member]    
Line of Credit Facility [Line Items]    
Line of Credit Facility, Expiration Date   Jun. 30, 2020
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Performance Award And Market Capitalization Milestones (Details) - PSU Agreement [Member] - Mr. Fischel [Member]
Feb. 23, 2021
USD ($)
shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 13,000,000
Market Capitalization Milestones | $ $ 1,000,000,000
Share-based Payment Arrangement, Tranche One [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 1,000,000
Market Capitalization Milestones | $ $ 1,000,000,000
Share-based Payment Arrangement, Tranche Two [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 1,500,000
Market Capitalization Milestones | $ $ 1,500,000,000
Share-based Payment Arrangement, Tranche Three [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 1,500,000
Market Capitalization Milestones | $ $ 2,000,000,000
Share Based Compensation Award Tranche Four [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 2,000,000
Market Capitalization Milestones | $ $ 2,500,000,000
Share Based Compensation Award Tranche Five [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 1,000,000
Market Capitalization Milestones | $ $ 3,000,000,000
Share Based Compensation Award Tranche Six [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 1,000,000
Market Capitalization Milestones | $ $ 3,500,000,000
Share Based Compensation Award Tranche Seven [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 1,000,000
Market Capitalization Milestones | $ $ 4,000,000,000
Share Based Compensation Award Tranche Eight [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 2,000,000
Market Capitalization Milestones | $ $ 4,500,000,000
Share Based Compensation Award Tranche Nine [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 1,000,000
Market Capitalization Milestones | $ $ 5,000,000,000
Share Based Compensation Award Tranche Ten [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
No. of Shares Subject to PSU | shares 1,000,000
Market Capitalization Milestones | $ $ 5,500,000,000
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Option and Stock Appreciation Rights Activity (Details)
 3 Months Ended
Mar. 31, 2021
$ / shares
shares
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]  
Number of Options/SARs, Outstanding, Beginning Balance | shares 2,456,979
Weighted Average Exercise Price per Share, Outstanding, Beginning Balance $ 2.90
Number of Options/SARs, Granted | shares 815,000
Range of Exercise Price, Granted $ 6.96
Weighted Average Exercise Price per Share, Granted $ 6.96
Number of Options/SARs, Exercised | shares (165,962)
Weighted Average Exercise Price per Share, Exercised $ 1.85
Number of Options/SARs, Forfeited | shares (75,839)
Weighted Average Exercise Price per Share, Forfeited $ 6.66
Number of Options/SARs, Outstanding, Ending Balance | shares 3,030,178
Weighted Average Exercise Price per Share, Outstanding, Ending Balance $ 3.95
Minimum [Member]  
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]  
Range of Exercise Price, Beginning Balance 0.74
Range of Exercise Price, Exercised 0.74
Range of Exercise Price, Forfeited 0.74
Range of Exercise Price, Ending Balance 0.74
Maximum [Member]  
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]  
Range of Exercise Price, Beginning Balance 35.20
Range of Exercise Price, Exercised 4.52
Range of Exercise Price, Forfeited 35.20
Range of Exercise Price, Ending Balance $ 32.30
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member]
 3 Months Ended
Mar. 31, 2021
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Restricted Stock Units, Outstanding, Beginning | shares 1,112,473
Weighted Average Grant Date Fair Value Per Unit, Outstanding, Beginning | $ / shares $ 2.46
Number of Restricted Stock Units, Granted | shares 205,000
Weighted Average Grant Date Fair Value Per Unit, Granted | $ / shares $ 5.16
Number of Restricted Stock Units, Vested | shares (30,250)
Weighted Average Grant Date Fair Value Per Unit, Vested | $ / shares $ 5.12
Number of Restricted Stock Units, Forfeited | shares
Weighted Average Grant Date Fair Value Per Unit, Forfeited | $ / shares
Number of Restricted Stock Units, Outstanding, Ending | shares 1,287,223
Weighted Average Grant Date Fair Value Per Unit, Outstanding, Ending | $ / shares $ 2.83
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Convertible Preferred Stock and Stockholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended
Feb. 23, 2021
May 25, 2020
Aug. 07, 2019
Sep. 30, 2016
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]              
Number of stockholders votes, description         one    
Dividends declared         $ 0    
Common Stock, Par or Stated Value Per Share         $ 0.001   $ 0.001
Convertible preferred stock, par value         0.001   $ 0.001
Preferred stock redemption, triggering event, percent of common stock sold threshold       50.00%      
Exercise price of warrants         $ 0.70    
Warrants exercisable date         Sep. 29, 2021    
Share based compensation         $ 1,370,557 $ 722,312  
Total compensation cost not yet recognized         $ 6,400,000    
Weighted average amortization period of total compensation cost not yet recognized, description         four years    
2012 Stock Incentive Plan [Member]              
Subsidiary, Sale of Stock [Line Items]              
Stock plan expiration date         Mar. 25, 2012    
Stock Award Plans [Member]              
Subsidiary, Sale of Stock [Line Items]              
Reserved shares of common stock         1,114,086    
PSU Agreement [Member] | Mr. Fischel [Member]              
Subsidiary, Sale of Stock [Line Items]              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 10 years            
Number of shares granted 13,000,000            
Market capitalization milestone, amount $ 1,000,000,000            
Increase in market capitalization milestone, amount 500,000,000            
Maximum market capitalization milestone, amount $ 5,500,000,000            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights Each tranche vests upon (i) satisfaction of the market capitalization milestones and (ii) Mr. Fischel continuing to serve as CEO from the grant date through December 31, 2030.            
Share based compensation         $ 700,000    
Total compensation cost not yet recognized         $ 56,700,000    
PSU Agreement [Member] | Mr. Fischel [Member] | Maximum [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of shares granted 13,000,000            
Series A Convertible Preferred Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock, number of shares sold       24,000      
Convertible preferred stock, par value       $ 1,000      
Preferred stock, par value       0.001      
Redemption price per share       $ 0.65      
Common stock issuable from warrants       36,923,078      
Preferred stock dividend rate       6.00%      
Direct Registered Offering [Member]              
Subsidiary, Sale of Stock [Line Items]              
Sale of Stock, Consideration Received on Transaction   $ 15,000,000          
Direct Registered Offering [Member] | Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock, number of shares sold   3,658,537          
Common Stock, Par or Stated Value Per Share   $ 0.001          
Sale of Stock, Price Per Share   $ 4.10          
Private Placement [Member] | Series B Convertible Preferred Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Sale of stock, number of shares sold     5,610,121        
Convertible preferred stock, par value     $ 0.001        
Convertible securities, conversion price per share     $ 2.05        
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy (Details) - Fair Value, Recurring [Member] - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value $ 1,429,331 $ 1,429,331
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value 1,429,331 1,429,331
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value
Cash invested in Money Market Accounts [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value 1,429,331 1,429,331
Cash invested in Money Market Accounts [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value
Cash invested in Money Market Accounts [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value 1,429,331 1,429,331
Cash invested in Money Market Accounts [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets at fair value
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Details Narrative) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Fair Value, Inputs, Level 2 [Member] | Restricted Cash and Cash Invested In Money Market Accounts [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Fair value of asset $ 1,429,331 $ 1,429,331
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.21.1
Schedule of Accrued Warranty (Details) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Guarantees and Product Warranties [Abstract]    
Warranty accrual, beginning of the fiscal period $ 157,615 $ 141,697
Accrual adjustment for product warranty 94,596 49,974
Payments made (63,620) (34,056)
Warranty accrual, end of the fiscal period $ 188,591 $ 157,615
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.21.1
Product Warranty Provisions (Details Narrative)
 3 Months Ended
Mar. 31, 2021
Guarantees and Product Warranties [Abstract]  
Standard product warranty coverage term P1Y
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies (Details Narrative) - Letter of Credit [Member] - USD ($)
$ in Millions
 1 Months Ended
Feb. 28, 2021
Jul. 31, 2020
Obligation with Joint and Several Liability Arrangement [Line Items]    
Long-term Line of Credit $ 1.3 $ 0.3
Line of credit, description The letters of credit are valid through 2022.  
EXCEL 63 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

.H?] W8[Q@0L'FJ@H-9@D :Y'O]NX*:.\<[G(1^+3J@ 3_0 MG(;]X#C_B4F;5PZ5GLCA%=J=^^ _]X_"?N(,W'Y,HS=;CJMDHP M;#Z@G;F< :-2"DG-AK&E \]5'4(FP^9>$)O[BJVE3 @L^0#V0T3X[#? M70L'6P##)O8[9&[^<@AU,608U%E:^;MU3W>57E:?-QI:*E*FJ!_OTASZO=1?WB:_]V=_(_4$L#!!0 ( M #2$K5(?GGL"(P8 +\8 8 >&PO=V]R:W-H965T&UL MK5E=<]LH%/TKC&PT_S[!21+ MCD XV>E+(\GWPKF'>^\!.G]F_+O84BK!SUU5BYO)5LK]]6PF\BW=$?&)[6FM M?EDSOB-2O?+-3.PY)85QVE4S% 3Q;$?*>K*8FV\/?#%G!UF5-7W@0!QV.\)? M[FC%GF\F<'+Z\%ANME)_F"WF>[*A3U1^VS]P]3;K1BG*':U%R6K Z?IF<@NO MEQAK!V/Q=TF?Q=DST*&L&/NN7_XL;B:!1D0KFDL]!%%_CG1)JTJ/I'#\: >= M='-JQ_/GT^B?3? JF!41=,FJ?\I";F\FZ004=$T.E7QDSW_0-J!(CY>S2IA_ MP7-K&TQ ?A"2[5IGA6!7ULU?\K,EXLQ!C>-V0*T#&CJ$(PZX=3#,S1ID)JQ[ M(LEBSMDSX-I:C:8?##?&6T53UGH9GR17OY;*3RZ>))%4+8L4@*W!DH@M^*R6 M5H /WVIR*$I)BX]@"KX]W8,/OWV0?\0O@G@.$50 &"#CS+M[L''CBXXP^;\?#(>(:QM6%L MS=D.J/KB1);UIDG04I94>*8)NVE",TTX,LU?JJ K)H1K 1K/V'CJJCTNIC#" M"&?)?'8\9\9EF"7*%G:&K\!%';C(R\%M\:]*U":))%/%G;,Z+RL*ZA:U_IIK MH@Z"%J"LG2Q=>VB*.R2QEZ9[JGI97A+=(5Q4-=[1&0,H3N&0)]L*!Q!F;I*2 M#EKB7T%63PT'%55=!]"?JA$+Z@*96--'*4H@&J!TF451&KMAIAW,U OS:4LX MG>K&6("<[33(4393"P'$21!%0SYMNP0A?!;0*Z19AS3S5]Z6U!LJ!NDD!%59 M2.H"5"59E=7%U()!WRD#+S6W>(DB6(4#WAQ M6"8P#+.13(-G/1UZD?Y9'U4Q,F[UGA8AM!&B,$A#/ 3H,(08H1@&(Q!1#Q%Y M(3YPNB=E<:J#9LF8W%*N5(]S!;]=2V< R,(5PC .AO!MLS0(QPH9]BT?8B_V M95<7*N-,31/.=3+J%NC$BQV$GRUS"]<[J][/78L]R>G-1#4Y0?F13A; E]F] MN$"_NGPUO'OX#NV^B:/8"L VFR9A$(4CA/?Z J.W5=Z>O(R6761-'L+@IM.6%QRG89I:/<(VA#B(LY$]!>R%"/J5Z&O7U!O%//'Z MXH1K:\PTRJ($67!=AFD4IF-=H9+[52:G.3/3'H=R/=7YD2] 4*PD:;N;\\_V/!>_%#/G%S%KPRZ2UH3E$ MS1G:+Y8UU,L:"M^5#NNR)NI@\N9TZ/4)^?7I@;.40M7TAZ3:=BE.\$@!]1J&_!K6)<.>LV.I#NQ@]?(& MVEKLCM.5$[MMY\'>JQJZ<,!2V N:KU#?KU;CN$%1((5W91UK== I9'JR"4KG&'8ZA;B M#&>1=7IT6*I#;HH@'.O"O1 BOQ!Z Z%ZF^\-P5;($*>B M__I.IU=!''@[QV-[A='<)&C .I8K*Z(K$Z=J6Y*7N:1MR)*!%:E,H3=7L<1< MKGTA2C0 AD+ZSJ.X5SOL/^6-\NRB%=M'N1"%$4K@<(?DL+Q :R^;V"^;CP.B MIJ>SGA.Q+9T0XS@(AOW$/^G[!0:?W?WYM7,0CS,*;%VZ91B?W;BU,?PJD9R= M707O*-^8&W(!S/FIN63MOG:W\+?F[GGP_0Y>+YN[]'Z8YFI?Y;%J1D)MR]=J MR.!3HI:(-[?ES8MD>W/AO&)2LIUYW%)24*X-U.]KQN3I14_0_9_%XC]02P,$ M% @ -(2M4@AB!U;G!0 APT !@ !X;"]W;W)K.(T.71Z@,@5B1H$ M& "4K/SZO@4_)">1FYE>1 )<+-Z^?;N 3M?.WX6*.=)];6PXFU0Q-L]GLY!7 M7*MPX!JV^+)TOE810U_.0N-9%6E1;6;SP\-?9[72=G)^FN9N_/FI:Z/1EF\\ MA;:NE=]7YZ(?3+XJ'D==MY)(EDX=R>#U\79Y% L>$\B@>%QXJOV!AQ!!B?>Y^3 M<4M9N/L^>'^58D39A I>JM;$]V[]._?Q_"+^V>ZK[GX4<6S/L%\X2[VRBAO%91G9]ZMR8OUO F+RG4 MM!K@M)6DW$:/KQKKXODUA]SK)C'DEG39!AB$<#J+<"XFL[QW=-DYFN]Q=$QO MG(U5H)>VX.+A^AE C,7K#RIE6#/478(\54T2#BI(RB5MY7VUB56L5 M:+$AMFH!!DN\5%U402TY;J89+YLQUM+I9+YH\RC1YZ8M.$'\C9$+'>C]F[?T5KL%T[MB$P)O MZ$/%V;=?7]M,%85.5$>77/QW-KI,PE8C %-Y'@4 ^FZ,:F@^F(, M[>(?=&D)RW/9&A4=6%,-W*R 3JC.#2LOV0*U'RJ@?N@C\_RYU4FYVVW@3I6> M.;U8:INE1XM"(KO/C=HDA0A#GO/6>Q%%/YNVX;UK^I#,9DAIR 1 ,SK4-L#> M=+G(*^5+[EU^N]6WWJC0H7$!.F6D+VY&]0.L*&GDLN:(9ZR+V8YN- M^9#:V")KF](K!"3P[QO5'>8YL@%%[RR!'>:;UH.J(-BPC^"WC(P'J:'O.3H0 M%58JM8"<<;H7N_H9)3,E W)L\HOX9W!Q]9)POMSM:&R[4]? 1#1=!_Q^M69C M72A?@%J/[>GC@\=UZ^CCDZN+6_S^X5R#QZVS+AM RTD2&?T/J#NEA$HW(%[' MBB+GE77&E1M"' 7[T.O* B_B2[4ER$KC%E)3#_ME!UT4YUU;5F(9]NZ8H9D* M#[K@U"7P9:&-AFP6'-?(;E+!#_1^05CHLB]R5?:,T_'UV#[)N+Q?TZ=D&^DT M@Z+6N*&1=*-M"7P5&_J4SH=RDHMG9#FJN1?-_CA3TQ;.&,6),R!4PQ$A@H4, M4O4:;&:57!;#-$/*<83&U+^@".$!#-7LY6;0WR;DG'"^;QDH&2DIZZAL17Z1 MTY&DI"W@[$'#C:GV]N8>T>=H.=JV/!Q"XCP3KT/E @G(0Q-(T:B5TC@?NXPA M&"&D%/<%5'T?J81V_3>G@I3!GK"EKJ1(I;@'7:B _81ER5%__D1/,Z._S(NNLOUUKS[BX*6 4D'%.022P\/GOXR(=]= M^[M!=$VZ:J-0<'%/KU4J7C' ]Z7#>=D/9(/QO]?YOU!+ P04 " TA*U2 M&369AB8? :60 & 'AL+W=OR[;"NBU9)G-:L9:]3R^F%C'T"@2,(" 1H%=(OS]7LR MLVX@P98]$?M@BTVBJK*R,D]>"S\\-NT7L]&Z4U^W56U^?+;INMVKER]-OM'; MS$R;G:[QRZIIMUF'/]OU2[-K=5;PH&WU=/3%R]<_[+*UOM?=+[N/+?YZZ6SD, MU:S4?;FNRU699W6G;O.\Z>NNK-?J8U.5>:G-#R\[K$>C7N9V[CZ&(Y_"3H]L0M'[)O%DQ/^+6NGZFR>JL5L,7]BOC._^3.>[^S$ M?".[5/]SNS1="V'YWR<6./<+G/,"Y_\OW'UR;M+65V:7Y?K'9U!'H]L'_>SU M8IK\\375F\R4)L&#'VF"NLM843YO=)+AZ>TNJ_?T?%]G?5%VNE"KLL[JO,PJ M9?"PAG)VAA?J=*N;+OM:FE2]K_.IVF0/6BVUKA6(VV4M!I>D@WG3%IA"0\R[ MC?IE>C]5:UWK-JNJ/?VL=[1.YHE-=FV)%7<5R'W^'_]VO5C,OO_+[>U'_CC_ M_H4"+F%FK%]N(_+*6O"*%;\N5+?1^ X'VS,8&-4UBK1:S6>3?TR9.6V!Y:I] M2L_N5=&HNNDP)J_Z ORH*IZC*$U>-:8'OP!)O_3@*X"8X<>$4\+/'?[?%,:-T<54 M_8SO,I8B.RAQ@[I-J[7:DL;;@4J3WBMH;;[Q:JL@"\Q:1UU9T9X+2"GA\R%) MW2;KP*,]9$GIKSM@.8FA77*OLY86(9:\Q73;I6[#0GB('ESU'8X++'>$VUU- M2="-3HZ%)Y)M)SNMKC):&83CY,VFZ:N"2"([2(*-L_FMK\70L&33H*RN>TQW MP,D-;+W/-N5';@+Q/RBZ5A:X(X<.;R)JF A@0AAJ/[:X>2< M?)8XI-S_Y??IMT/*U;>)6RSU HT15A0)AHB&(!^@%C@K,H05"PW7JZ"IZGZK M09E1^J&I'DB(5UB]::U^/&I6$=(JR&2VK)A- -$>ZX"! %$-!>L =#@[2\H1 M[7#9EI#G+RG-Q_A-"M>6&@==!+9%;$ZM\!)!L)ET^IB[:TL+LJ"\ESV"%UBL M;(L);$&W3S )'EOVM >LMRDA9+QDK=>, V0-5BM1=QHLN/I5F0R6(+7GA753 MAG5@)3,T57YBA_QD&,N<)N[(/Q1-9H*;A";>M4T!HV#BAP4;1DZ5N!Q+XA&U M.+,MGRDT<]E WV@)LS=0^\ (T+AK#!^36SV!#:G*;2F4$78LRZKL&.1Y"MHV M(9=IZAILQMKD<9/ZT>/ =?$5">R)P(QVQ HOWV,@R?X:&MK6A$"0MJSO-HW% M 6)BV?6=AJ@T50,T*-3O?=9FM%=B^,CQBI;"]83*MI.RGNPJ>". W4+3H9+) M,7)VG@1H36.T[#3S,N()9JW'/+S-9*OYA*V,KQO(]KYAY:0Y9"HVOJ=V1>8V MR0I1*9*9VO,34XCB>]I2/K/'3;-E_N]ZX!Z\?7\ ?(:@CA20@', /0Y&_"B1 M:&NW2.3)R\I4E;5KW;(E=ZX(B=_L=EB#GB'^,!_*, M->*>95]6I(,O4EX1#VX1]A"56!QPALD$",N1>$?8$I?,8BT%B.U1-'&DP;3:N_0AS:)1"(:2>IXM\>8/-) M^!,1:CGTH,,JW^?T/1T'<;YMH$BL>VOH,#Z0<5G+HU:SINI70<"L,DV$6H,S M @0ZYP]*$_0T.:&23GHW.JNZ34YN2Q#DY[O-WL")SBR&.WDR+PXLU03^*XOC M/X4+'1"6^41\W6$7CF6 1$@QD6FP:DZ,><2.5BT$LF[J26Q604OF8?.1' WP MI=P1I]EP5.256!,(7K K3.S DBO]J!GT@.GLQ8(7,L^0#4E@ S8.^2C8>0W: MY&FWF&A*DC,LI=<-@1A.#\&Q%KU/+8+_L'&]"EKDI-_BS6 0T]&>R>F7%@_DV_VV$>*!:T(,1-"8+] M7ADN6'69V'6 MK "K '9:++MX=-X/ BV'H5!ZRITC]B8G;>^ASSE $&^853#,)-(9/">471Z1YK*.UQVVWVU1!?H\_^5,<$F5U'A$=:0&Y8,^60JK5RIHIN5Q@]FM1N;C)3++BGA+B(N"4 HQK/1-6$1](@W_TBTZR*LX(":Q% FAXST MA)%^J1 P/&1EQ2C(:5+*P4@,H=LM2TCB=.[.2F811P&G.!*\ ZL2$$IGVR*D M'F?9L8-F ^+D%#/IH'FY1_JR6;(LA)7Q^,JJ6=D>8K#WW\07@Q6X[[T]L>$2 M.PUPD2"T9B=)!W9>G6]DAZ;DYI&>.J>=W1G&/O+5W&-0+^"P7, +T4&8)D-5B_A=7#KK9MH,MA&#S2X@*72V%V?. MK6$]K309AELNNB+(:KT//VI7?]5)#&Q0^8ITF :DCAL[/ XHPM>(.+(OFI/V M5L2L1<\;XX(U=PI9WL+$B-ZWZZPN_YD)ZOYJ_:%X72D#(";>-G79V00*?.T^ M) O9B:;5'6YX*C:L")V%$H^"D33%^:HX0;C2!24Y4\D!,>Q6#1S[TV:!20N3 ME13_;CD+1_/1^O"8"HZ?V3*7Y)R1$B;0:YC"W6^"\1S8F]Q =V M>VA:C96:O2;8*:S#O >]?-DU%-@2PD)D-YX3H@WJ'7>-P67PH+6036MY) M-)S:--AH-R&B**C2-FGI0PR;K@(SUF7-H-*YG!7[8#[7R'NNZ!0ZLC+0))"@ M PDVE!<:$C94D' ";'J0%]F4Z\TDIQ1)-X%=872)4\EBK#Q8"+EL,[^QMJ?;+P,I67>1'_S^F$.F]V5>(M^<@Z=HYT H5E6%/H(T'N#-Y)8 M=_I(F4,[B.@?,,-E&)/6$V69 M#X3LVGY^KO#3^L:\..CNSAMFTI7<@@A0#[ MKSVHITQC.J!6LU@1MTCI<$(=JPTVQXRF#9!(D>^L;_ M_>3.(WG/(;!(2_BVC+ZUK/2<%(0?BD6J#G:=^E.C=+K&*=8P H!?RRW_ MP>EZGG8ZT*,MD)Q#*9M_C60U@SMKT;$JQ5"RA]E%D[&1CTH&2RH"3=5?I H3 ME5Y45'KA1#JF2&0*2P(?&-B(_9381N%J#/+0!FA!V>.]B'((A(TM,L!Y9*T5 M2\"^EDS-8ZA31UFA:5_4R)D MJN'2_JJ7QF%H,['Q"Q\['N_82+-7R"OX;BDC7C@J^X1/D#2[RSF1$ER M[\8QT^S)VNJA^TVXG 4/$KX;4TQ^A6&H7W-*0%,--M>\?S]XJ;M'K0>5+J\Z M;D8Q)"WU4_A.'-$M"TO)VR6Z*Y*^CD7!+5E#QNDLWT0[ MK35K,;&AR[YR9,14:GN0(>5(()IDG"F!K;0^0/ >AXGOGQ"T!9^<$^P0=AS_ M%KX^0?IXW6-HP@>:327:A[+H)4HZ'DHZ8JC2SVF$D'1,(O>#\GN!HD8IR(-8,*>.Z(6*WPLRN.C@G*4[ 554MPW#/P(CW5BM*1RV1I/ MK4F@7]3@%V&"GRTRI.[GSIFOB->1M-!L)F:0B3ADILE[D@ES8G7:,B5)"H1Q M>4<]%WY]5I4ACL'$6M>-\?O4G XN6!W9#"<^4R@Z1?+=[2<627)?[/5H+FE@ MHHQ+:7P<*6),"I(LI*]L.T(6@]T)S>68]X"00^%=]U5&^6X( W7&G=R>3.>, M2TIW MX(?-*W4O=OQ5\!$2U\EA==79;F?Q0[W-@F8 M5@S7>=%H2LJV^S#%,_-BV%- MFOE!.9@MQ<]%A(=UC-UU&FC\A"R *^!;$TC92&6KCB3QR&HU<$)+&@[^V0A)L6-=CKX>#8$1A4J6WZ]:;I M.V6#Z@80@(^O&[_?>(^V(_F1PPS /-E2 MW:^I?:_92&/:X/SMKKQ@'=68$9>[H>ILIOX]X5W9&8X;VLQH*QMSE*J2&5F) MI/TS%(RUS8VN,INJMSZ. )(-0A\?L(RE@(\UW^LX?O*N1,#"*-LG.A_.U.JT MU7LN.Q#B;4HNH*0)F2/RISBCSP\?/NLY<:337A$&^OQV+*E--?A(NNH#J0JR M9#,.++D!K45NA1HR+>221 GJ$4$D!? %P2>D+Z+6BD$2B]CB7)TAI.:P;_\J MB#L>; Y4Z$K-9X([R1'NO+(_' ?0%K3,<$GGQW)Z4]=\N+LJ(T=47'$P MNO/X$3^6AE;?,>QW\I#\65N;13&=G'T:^0G?L,3#!B(S/5#@V <[09>QC11: MT#[;-FW'*NTMD//WJ;[.UL*3Z6WW,;V!DL@E\O18MUXD*F,MGF#UB5,&(WG# M,9#Q0Z?6%!V?_ !^+]7%0MWWX#8D./%2YJ=^YZ/ <0;31(=^_B^:*)882ME@H# /8S8>IG7B.^R1'62'@-FC]QOL!W:I%>@E,7 M\P4^3Y+(>(5R(C&[2:_F\\3S97%^F5[ 2-M_ MD\^4I_2L^$Y=IY<+K'=QC<^8Z.(R79S/U6>R;U*X2R3N&L2NK=[:C,BIX%NT M@A/4+IL_F&$\EI(F0A>/.B(WF4G(E.QU)YIKC":'(E2R6#%G5^G-Y3E]NCY/S^<7 MR5WH H"24JH&.T]O+J"%5V>LOA^M-297;T<)5\=Z;Y/FZ<4YYKVX4I?G%^EB M-DO>NI]B=4=$SQ[,2H.6RW0V/TMG9]=0V/GU97I^?6'5VD\;]/N&@"&]N!3] MOL:^+_'X!X#'*_4!\B)%Y*.!S^?IV>(Z75PMU OU_.+\.KV97Z@7=AW7MC&R MWC5(PKB;2UYO<;T .,T&)0_J BY]'=EG:+T'Q@E(VZIH+-!RHH*>MUVO41YN M&F3 RDLH"WNQITF3HER!7&YMC1/I7AU8QR'-5B-_R2/>QQ+6#V(5=]O*SX(]1<$4CY@&B8Y2H8?+Q?Y3X%YZ8!'< ZP&G-J4L^EW$W"? M+H$%&#VTJ]'QQCH,.2"G#9[6VFBZSC# MAU.8)C]%.>5H9YR#,=QY2-L_4J5!RNBI#(J;6\P.)ZJ/Z$^3/[#8.K(]0*F1GHJSD-M0N4%^WE/!UO#KR@7A MI[.MHJLC]O"Y!4LB*=<@Q,5>Y_QT$1ERP9 ?] 5CBR#N H6K&)FP9Z?^CMMV MJ"_1",RR-R1]#V-%YRXX/-+?($F( V*#D.78EY%LN3P9"P%?N87DTGYJH^-6 M3)'.U(G*(0\'32F)- +-I@OE$G TD33E^&\XL3 BI$>.RF$(,J9GV 6ECD85 MK9"V;=O/'>E6$ND6"V 2)?0/D@VVE..S#,R\@X0](G\&W'"YA9]Q58Q"#5.6 M]K:B/5:F(Y3I$L@ M]@=75W$ >I2\&/AW!U,R%O/1MG1&]QO\/GG#K:RAO/!\O/E-BFNB6[@QJ M/E2-NX,H?Y(#K\DT<'J7>P<&/5Z&%K5G%7_-@_NZM,RPJR6N"=(^X&\^429J MK+O%5M<>2N,N3:V_V5#%)$W$E7+Y/B<8XS?@+9Q9E!>\')08XC8O6W2(%LEC M9MMS9K;*59=PV3F4XH9.7&(1)9AN:R_\+:(GE^2^2:E#*=\R3)S( M+2$;7;VILOS+Y#[?-,2#T"VV;0JY"AF:6X]Y,!"6T+LZD)=$Y,6QQ-W[8=8( M3DD/N$!ZM"''CJ'KX9G#Q\7W^(8>SFA-;47WA3ETCMM&K=Q*4;7V>F +\*Y3 MEQ6.M^SUE[E@N[R$&:=WYW7.IA9-,CY#UZ@C 3CTW=Y'8F==JW[)%QS#I2WK M@?TFML >_3B+DXC%(YG/KGZ! L FVQ^Z.M!( &B/HZ-+ UW< MI$3/+[5TP_,VW-7UH3)P;RK3SH4';Q8L)R(PH'+ZFM-^D(^LK1#;@.+*]1$S MAL/R^G;MY3X21[ET2C,N9K,;]8KA1G?OV/C_-A,\@J^'#S=;M,PU_*LRGN.>RDS MG]N+&!7?L@H3Q3P19GAR19A3?VN[J>E":BD5.)_2X1/D/C]NR6/EXSR'O%3" M^G5'!):&KS YQMI,*FD* 0+H%J>?K\>>GIQH0RC&*4"!;&Y#LI/R#.$*4'2K MCW.NOJB3\/LDPI;]/8;3)Y'Q61#KTO$#$"Y"I(@V3U'@ M^Q%18J3:1XS1KO5%_&.^[F+%VAV\&C_X6!D24?3C!VV;@BUXN,JQR+@K?/"= M*+&]-(D#K%U# 6-I[S.YE=RUMHI+-ZD-B=8E'6I[1R[QO=YTH71J&+UM J9 MWE;TCO$A">LC[OA*F?,@D?Y"JL5S$U[G\N@N,I)==!R;'N2QY7*?2U)8WU4$ MQ_N21Q"BWGV\?^6K1HKSUH,1;_R(MVZ$TX*/.&;&YZA<] >K2G^W6H>@\_D\ MO3A;I&)N ;/$> 0:JXOS].;\VLA#G3.+]+%Q3FF M^O5;=B+V\:*N_5?JZB*=X[_S^4)=WJ375[-T=CY+A-,X#UIH-ITM9$E\(L+? MAO,:^WT08T51M[QR"M]%]:>^MGGDD3 JEMD_$HDY;>0;:N$TDB.UL+IDC9FE MQ DAG\B1.5]J>8,%7RL[T CZG91AXOZ<$+D>).W)]O M!X"C1HYJ/F6P%?:V4, E$W**;N-RJSK:M6W=>M)R$/(YRR'O/!@F<88!V28K M%%5L9I#(:W4VO;E0$/"SZPLUFU[-%.G-S2Q=X.^+]'*.IZ#!<_Q]E2Z@3Y\T M9?&J??)>4"]^&5W;U/CLNAW>U^%-7HO9_$:H^.GV_HU#S-%[)(?%^IO)/!3K MWXM=^\S]];96?W4^>P$\XT:1U=Y!?IB;^[/B@<[DT67YK&7T)0X"B^D*6[B? MZL"TTE]MXVUT_L81+%X2J&4W?.6:D?B:56GH^A%'@DE(U8JU]+P!\VUWV"" M*QJ^,1K@/DKD98G[F^>MOX:GH;M[D3N[Y M?9#DG67[V>+R1:K^%ET?(TLR>)+>I#%VV<\?0&TOCEN*Z)8'4),SU'BP\+G> M.-FZ[DM)UHAJVEU<3TC [!\WD]DY3Q[^OA#3Z4Z-$@[4!22.47P'CJO'E$CG M5P#*=D)Y8'B7U&[GX-U9A8Z+M:DDV+*0-4L8^H*WG_D*IG\K7K2N?3"-O&%J MNJ5^.7=H=^_N/DP=3S_[?O6V<$FFXUU2M6!D,>TRZSZH]F]TB$KF\7XW)<"^ MY5MVX64]J=_103=\QF^5R3/3V9YBD]B;HW([9T#\D^JDOJ5.BYC*P[<@N@X' M!EN95O(UWY,-J*SVN6'L#OJP:^O?V#%O"O M0W[]?U!+ P04 " TA*U2P3N=.JL" "(!0 & 'AL+W=OSJFNGW)0JUGP>#X.A8\6UEG2-:S!JVQ2>T7YM'3:NH8REYC=)P)4'C9AY< M#Z;+S,7[@&\<]^;$!M?)6JD7M[@OYT'L"D*!A74,C'ZO>(-"."(JX^>!,^A2 M.N"I?62_\[U3+VMF\$:)9U[::AZ, RAQPW;"KM3^,Q[ZR1U?H83Q7]BWL6D2 M0+$S5M4',%50<]G^V=OA'$X X_@#0'( )+[N-I&O\I99MIAIM0?MHHG-&;Y5 MCZ;BN'27\F0U[7+"V<6]?$5IE>9H9I$E0N>.B@-XV8*3#\ I/"AI*P.?9(GE MG_B("NFJ28[5+).SA ],]R$=A)#$R> ,7]IUEWJ^]!_=O<,M-X509J<1OE^O MC=7T''Z"*QECN!/=HZ1="!%E5WHG"+!=9KU$=/W%NQ/3TGBYHS M8> "DG \3L-DG'M[DL?A9)#TGDE9P"4T6A5H#(SC.(S3#+(T#>-DV+OCDM,; M+&&K5&D(F \GX3#/',5X1*&3WJKMCXK6@&^>A.UME:6 ME.O-BD8E:A= ^QNE[''A$G3#=_$+4$L#!!0 ( #2$K5(H)D8W[ ( * & M 9 >&PO=V]R:W-H965TGVZT?9CI>MZ\=AEX2B'A\? M18F>[:2ZTSFB@8>RJ/3RQHIVUE*5W-!2;3Q=*^19$U06 M'O/]D5=R43F+6>.[5HN9W)I"5'BM0&_+DJL?9UC(W=P)G+WC1FQR8QW>8E;S M#=ZB^51?*UIY/4LF2JRTD!4H7,^=TV!Z%EE\ _@L<*)7!EXUG[%G"2ZZ&$ 8N,)\%S_"%?MJ@V4[BEB9%M"QS0 MUHN9!M35-._;"DM,L5S1=N?Q>[&]E",8^6,W&L=D)7'D^B/6@U)9ED+;4:&! M19$[22)@2> &23188BVU(.F39.+ZXP#&<4P ?W!U6%? 1NYDY$,0A6[(PL%' M27<"ZK]%/#J/P)W$$S?V?6"NSR(W9I/!>]1Z"A]DE6[IHE7F%33';$RJHQ&< MP'%(9<9!#">=B->S')&<44(BXJBQDV#D^D$$_[JFWL'4*%%MFMEH^[NM3#M M>F\_?D_;J?,;WLYNZN5&T,D7N*90?YC$#JAV'K8+(^MF!JVDH8G6F#E]0E!9 M .VOI33[A4W0?Y06OP!02P,$% @ -(2M4CZ%8):S @ XP4 !D !X M;"]W;W)K&ULI51-;]LP#+W[5Q#&#BO@Q?%'4B=( M J0?PP:L0]!BVV'80;&96*ALN9+L2 MT6]=;X6(E"6" :XV&/Z?&Q?4#_[+@3ES73>"G%+UZ8096%W#]T/*&;MS,0D/8 M-B/,]S@7'4[\#DX"-[(VI8;KNL#B=7U(,_6#Q8?!+N*3@#=,#2") HB'<70" M+^F))@XO^0?1 %:"U>8U7_B]7&NCZ"_RYT2KM&^5NE;I?]_I21RKQZEN6(YS MGP2G43VBOQ@-O+?QX1#V7H=S20K2!N0&3(FPD8*$R.OM%.Y(X44KT*.CMS$] M>H6\[)\!KC#':HWJ$!EZ+WT^P#A(LRR89.FQ[7U#$DTI10&\:I1\1)NM(0Z2 M) O2-'JQO$L:U:BVTRNO@=)SU!J2-(@F,7SRLB ;1\$X.@>RXO,@C4>$K_44 MEGG>5JU@!@L2)5U7SIF#^9@%X]$DB*($SIR3Q$$\&<.9]YU67G-,&X^X$+E@ M-+1,HLDHB.()O/7'"(^$5Z':NO6BZO(-Q%D0$47^1+G)DD@)-VVQ2=3C">V3X4?: EVB*6 M$K4D%++5IN".[R:W#MU$G)9.%**W4)3-B M>SM833[>SXC>$_PBQ=[VGAEYLM'Z5WIYS&X'8S)(*)$ZDL#Q[UD\"*5($,SX MK9$YZ%028_^YE?ZS]QV^;+@5#UK]768NOQTL!RP36UXK]U7O_RP:?^8D+]7* M^K]L'V@G($YKZW31,,."0I;A/W]IXM!C6(Y_P) T#(FW.RCR5OZ!.WYW8_2> M&:*&-'KPKGIN&"=+2LK:&7R5X'-W?Q5PR=Z,'&31R2AM^.X#7_(#OBG[K$N7 M6_;',A/9*?\(-G2&)*TA]\F[ C]S,V332BML!*L<*\RP&=XMAU-BXBA0],&D) M3^#-&+>,LQ01)M-CI@VKN'%,;T^.7"A[+TQR;C92J <)>S52"3Y2Y: M.UYFW&26?:\R[@3[FQX"!I/%Y3AAO__=,DG>*H_,OD$[OXIBN9LN4L^<# MR[A2:"L;"R_(A=7ZNPW!*7067.X8V$4C<;5^B/#>B/QPZD0FG# H-[(=,8?Y MQI#S/D(47+0[2E%('!1).%9UP8A:.:W_% Z>2B6=Q&N-FC&,O7[ZW,0"5)5J**+PTP&JER^RH5$F^(2<.WDLZ"/YEFI7:L9P_"V8E[-C* M%,""5?@C; I3*#91KI7,^,'&%,-46&KM>/%2\"UCL@ VGT.8*:0E]6SK"T## M*73@6JKL$M.%I8K7/FH_UX8^Q=[K4X.:3/G_\$(T)D6D1'KE0_:9\@2J'WX(D0^$%!\2"POX"UE+ 00^:N/SF&KK;,!I MJ*N1"8I-&@>.Z/KJH79#ZP.*E%V+797K-+& M#]HFEI5!=&3EA8NTID3B$X#A&QVJU7-FU*TXK)$F\SWN@&?HW^41#8)0E2TQ MTHKL_#=(8_]'I$4=TJ@^LTR2@H"VUX;] ''LB#B0&9\^TH*0^*YA*0SB!:G. MR(+0?*@5]K6@MQ'081KI(8J%/=<$H;$QH7.[8]3J1F;2I M$:&;/6Z)JAE0;9.+HQY;-PS"#$*V32H)B&%<>4U 05!.NC?4KKC5)=\H<&,2 M(6)QWQ+T/D"K=2%(I=@07! :FB?1:V>MF+F6W'( M8FLZS?HBS,MS#^P;+M#T(.P O=P;OSDT;:_RJ)M8=)UOV XF9!*; QC[J\9KA;!7R52Z)G.- MM'T.;#P+ S2A)01"2]C(I#K.8* $X5^1ACX5PG!&= HA=!R%>1B&+Y)K?'D@ M:1L,-KWW39MDM>B.>B-\Y3 6#-ILNY &T7N_XU/*8#2N+&=.4DL\'^ILC]Y[ M/1RS\?!JS@Z"HTHH_UNM5##"D>EPNHF^[9JW;1 0VE%;@>$>YJU*9P^'IFB;SGZQ,GNSEX?O4$5G<;C-#SCZ,O9=D+6LY_8?)G$ M5Y/$/\WC^7(1K<^J*U!.%O%B,663>3R[&D?KMJLB(QK+YT4R6\3SZ9A]Z#U& MWS0ELQ3N5.5TGL3+V=P_S>)YLH@>N,T!7)GYV@4 CSE*Z=,6B;"@7\";\7+A MGQ;Q=#YFOW C*3M1/R6^VUGJZ!+76 (J(3X,_F[HAQT@C'3V'T9ZP$V[?63] M19&$=)MY=)S\WIN-IPXWVQJA",(0LQJ+6T9[D:N-B-H"[I:6MV':;VL@0+7 M3H]/ZG%^J&.2$("[<<+]\7FAX)[0[$3V-(]QM!>!*X#??CQ!<#"7?6[,/2(J M@/BI,?\,B'Y+:+!PVJ*0QTE\M5S$U]=SW+0LU#TB\*@RQRX DN1Z 10]G?>\ MU_W6RYG.XL7UM2_=8VBPQS<-@-(6[.]!JAUUJR\?2D W6SRWM"6R:M3V6[6)WM NR">/HWJ&[3]_G^D](P\)X6 M'7*G%7["!0@JW$A:QC@*;@0LOAK9P8!7"Y^__'HT%[RLMP180QI[4*==H<*6 M](*J"E;THN0L@FZ[EN7_E'O MUY)"F)W_38CJ&GD,/YQTI]W/3JOP:\N1//QFA0SMZ"*HQ!:LU.('X9+5OCA= M^=]><)-PNO"/.<:;,$2 [UNM7?M""KH?X^[^#5!+ P04 " TA*U2EN?O M_ @# !]!@ &0 'AL+W=O=7$$8/+6",OV,[2 +,M+O8!:;HH--N#\4>9)N.A'QF)WIZ4_F8Z1 M/O9!FYW76'C=!8.H.>V9NU!$E>5JE>V;IJ ^! M.6IDS0CJ11"'X3KH&9?>?CO:'O1^JP8KN,0'#6;H>Z9_W*%0IYT7>6?#1W[H MK#,$^^V1'? 1[>?C@Z93L+ TO$=IN)*@L=UYM]'F+G7Q8\ _'$_F8@^NDDJI M;^[P=[/S0B<(!=;6,3!:ON-;%,(1D8S_9DYO2>F E_LS^Y]C[51+Q0R^5>(+ M;VRW\PH/&FS9(.Q'=?H+YWHRQU)!/1BK^AE,"GHNIY4]S7VX M !3A,X!X!L2C[BG1J/(=LVR_U>H$VD43F]N,I8YH$L>E^U,>K28O)YS=W]:U M'K"!>\XJ+KCE:+:!)6+G#NJ9Y&XBB9\A2>"]DK8S\(=LL/D='Y"@155\5G47 MOTCXGND;2"(?XC".7N!+EBJ3D2]YAN^!_6"50 -,-C"6S(2!K[>5L9KNQ;\O MI$B7%.F8(OU_C7R1Q+W C3FR&G<>/3&#^CMZ^_QF=84<9MM*7-AJ1:_%6% M MV ZA58(>'9>'#3S2:VX&@2MR76%;4 61GZ2%'^8Y[6,_3%._B-<+6O":'O3\1[B985$R69-4)&-: M)'Z1E^=U09V8UDR.%49%X6=E!%&6^^LH6T(L>W+>,O,S2AWEL9^GZ>(]:M6B M<8.$"7!M)1D&XCCQX[* *"G\)"M7'ZAG5#')+_.8UH3D)ZM/RA*(+07\ZC;E M(#5)F4)"18=^NEZO[BG-!NZ5/(!%W5_%O8ZCT _+-;R!UQ$U.$XB>#/GJ0>M M4=JK.-?0+"]&S:\H9QR6A,W@VNT-+D9"C_HP#CYW009II^FP6)?9>CN-E%_A MTV"FJW'@TH# EJ#A39YYH*=A-QVL.HX#IE*6QM6X[>C[@-H%D+]5RIX/+L'R MQ=G_!%!+ P04 " TA*U2>_(S O4$ #$"@ &0 'AL+W=O0'\? _C^#G_TLF7\3B3GSC:R'Q.J-6 M\^@>,%M>3D8_M@%_ECBZL54MS!%*48"([:#, :2H51 :V C8/E&L\K%0QACO4"O?CJ/&.K-A*2=BB;)P*1UC) &>_ M_'29Y[.W-ZN[=UO>B>OYVU?1 AHJ5^<"L4.6D%\D'Y0A)Q&^&,7GVR "^@FL M*FL.(SZHG7U0/$L\D-U \XK$DM)@*]K@'4J2B&.#$L;KC3C2/)3WL'$VI(E" MGP];1RIX3W4Z)0E$\Y64: @]#Z;T57"&YVX)]%Q4:"DJT7:)AGT M0A,WIRU=$$30!]31>^#KIBOA!/XPL"(.:Y@G.G;IZ)N!*ZH,7U\4W.X8*=]3 M_;,J6O1AQ!R_(?\)^8QU4X%XNZ]0:@$^Y6U*B43*,#5:S:6G_AHBI;I"L#'7 MIYXPTOSB+6?S6T-68_9%EXN&_1DEY4'P)=+U)-IL-O")('H_)[!!UU4$7>4' M_B:QY[D9@@B6)P0%(A$+/R*EGR$?SU]?CA?S&3--2&E=(8S$;G ,5>R9QCSG MP)1#NK/#8'AHK6>6._IUC-1/AI]RV/N;II/2QV=DE=8'/_X.+]E*XY]'*4Q0 M4M4\$)Z*R,Z/6L4]A?0DH8N Q:C'CD-($YA3Z*/_AIZ:+J:$:,H-0$X:LJ!3 M^^^%Y]1TXVY/J;'+Q.@/7O9FZ1;!U?*?L M;*!73_SD68".!>A\;ZD)TH(-# _7Y;]02P,$% @ -(2M4KE6*,<("P M"1P !D !X;"]W;W)K&ULO5E;;]O(%7[GKQAH M@\(!&)JD1%G.Q8#B.+MIFXUA97HMP^5NM<;(0S[5N2E?C?:&%._/C_7Z4847 =5+4JB[QZ>#>* M1MV#.[G>&'IP?O6VYFNQ$.:7^E;AV_F>2R8+46I9E4R)U;O1/'K]?D+W[85? MI7C0O<^,+%E6U3U]^92]&X6DD,A%:H@#QW];<2WRG!A!C3]:GJ.]2"+L?^ZX M?[2VPY8EU^*ZRG^3F=F\&\U&+!,KWN3FKGKX2;3V),0OK7)M_[('=S<9CUC: M:%,5+3$T*&3I_N??6C_T"&;A$P1Q2Q!;O9T@J^4';OC56U4],$6WP8T^6%,M M-923)05E811.)>C,U755;H4R=K*>N]DQ4_(&K//56DVFMV4FZ]\W"G_ M/GZ6X6>N C:.?!:'&6/+;_P$/V<8^\=\J8U"OOSS&9Z3/<^)Y3GY MOSCX65E4P*]US5/Q;H0*U4)MQ>CJ,O#^I+-?L2^E]YCL6)S9:H<_,1K#KJJAYN2,N M@E22)=APMA!IHZ210K/;1J4;5!V;KY40Z 8&!6(V+(4]:#FHZA2$TECBK8!B M2OOL80-VRQV3QF=TB652H0V@BZREMJ*\:@4W0#&?<>)L#9!:-\)Z!&TCIR>D MY)XO3G 9M]?<"/+&V)\F,S\97WAZ V=8#_7,:EVI!U[SV0L6!F$8>357;,MS M2*P%VB1Q@#(&VM9*IE; "S8)HM#;GP<4C[W78)) 2\M8B>9=JRJ%&1J&,5[C MVS>)GB7R'9A$"0M"KY!YCD8(&2NX@'4.8.(;.KP6.H#?%?G\/7LN81#(>;-& M9V(7%,KH\K\52EEJY%)#S9KG-@H5&*OG0^Q1B+EF<*8ACUGG;2D^=8Y"("G? MCW#B3Z/0C^+H.W%\S#_>D7^>C2^TENG&%D[:Y M-"!#@2[1J2CUM$?&DC&YO!I*F0,__4CW M%;9]DF\L=GDB*98\1W<%!QK_7?EZ\V<5(.M^XTIQ\L:GTEN(VHABB:BAEJ?# M6K;5DK$S^9+%$S\,0Y?9+&H_3Q,VGOJ7\=@/+V9LRI+0SHN'CGU++VVJ_-Z4 MSAB;2.;@L/F)CF=T2E;&X9O%[7ROKWT4O7G)-GQ+58P4$RJ5"$6O%L+@(F0] MJRX=/+!_O.N;+^Q6* MFR7-SZ)JQ7TIIV(\D@KK;1[%4#0 J@UV6:N"4?R'" M%1%!V <[56P[:FH+4JG3BS+CQU%#@W7/*(NE,8):/77IK7#)MK;2.XJ;+]ZI MELCI#QR9R/X>8*X2/,_]QWO%1HH5N_F&PB+(R[ZL5O".:H?'D0>XY6V;012R M:$RAM>&=:R\3:,SY(5,-IXQ:$I+W.T4?<2>"C6(TKI>)DD5(C) E0<(6#OK3 MP2G9')D)1'>/87;-:VEX+O]T3OL,)5 E)9+[*_P$R]D/0!H!\5FXMKDX%/[M MXI?O\F%GT4NO361K[8O#9_KGQ?B>],Z2WMEX!L,J";#>1-!G27 [ID0$>Q'ASV";]6<-KK?C+<<$P,T_H>#8S0)54X MIA!Z62_9X7SJW5L'+>A)V=@ZQ'DWX=QJ>)15? FB8"B(AKUVI44]B$I(K_B@ M)18NT.DPT,4AT-3OSB2H/ZM]V5"&8O8T5L6*6:!,G9[2>:6JPCM49$90 F.K M:M8;]@& RQKC=HYQ&#"L"C1AJ!=QE4N< ?X4[2SQ#RYY /@BI(6.0J6:=YD9$4FN-GX@+F:+R5FVL[OZV'I4MZ@ M4>(#]5_$H'UP!KNQQ5) O#8@KB7P;KJ]](FJI]N^T6RKO"D-%71?F(.7Y%3J MR9U;27/#4Q=:0>':>CU@0,#C@I81E:9\QKL?^ 6YU(L<=T^5<+A M?WC#.MALP-[.!%Q3VYTC:4%LBX%DUHU&"7 MH&0J&WPK,&[I*K44VFG"=L20D6V2N[BU [ IB=G>M4[TXYFK:/(KAXX="M+ M'LKBJ(ZB*H&&Z;+C^W&^>,_F:5HUI=5J8> GB"'0F %WI8[SUZJ6*;N(9MUD M[<\ES\8T>M,.X/Y1.W2M\Z$1G&L7BXRL/ZJ31I-\6O*1KB@'E)8LFMSAJH#= M83RN2]F5K\4]K^B52N:E_1G9+B06SA-(IQ[A.H);I01FAA7_Q*3NHFTUL]L! M/44DEVUQT&$70\L=0\HYUWNZD<#VLC+]B"#],"%M2NTYR<(FQFIOA#H8[09P M=]#E=GOA3V<2+SWL.R(7ROK8PMI]*KN6\S>Q@TVZ*6KK5X=N750Z->K#<&T= M;!,/=[GLEA*D](FSVHX"P6Y=:6%5V0NR3U4/29T?O[?O.AX^4U+?>RNT%$+S MW(E?$3#Q^LE!QLD![E+D88(:U63FWH[K/7%T\#D 306(+)D MBC\ O+'G$MZ=WP).#]H"8#Z\A5;4=!L#MLJR;38U1=X, #.JOMT6R)/T;F3K M>H$HZKS:B78>91UN/')@-Q%);1QY;@L8V!\ L[._-OG.:G_ ?Z< L^-]BE:Q M&E6U:8$GL6FK_E.GLG-$'X73@PY]>VZ))6=BW=)0$E10:(]GE[M'LT(?&JNF M4D!BDS<)3M"JWJD3/J&.D^I&*)6*!XR'!^Z%$FR8F_9)]T)PN,ML> ;$$T6 M3[/I4Y<-Y=XPW]**,E7DMASI)9>K.K][!P:CL=VVN4FO@+5+:;L]NTGD;MH< M=SSVV> =)L.)MQQ[FY7>.;GS5J[W\QXY.CI]OIC?:7;'R[7-[IMN^[NU;>HW^P8>ZLR!/CFN M=.?>E\9H&HKV==\1](I#(.A)@C7VXM(UAPD;)T%LX7MP&7H_MG&;14D+EJ?! MY;3]S^MD &1&T\2_G,;L9<=F$B0Q+0_!+/$^5FHE[#NLLXO$GXTO#]N17P/%QZ$=8M3O*.!C;=2&X3$Z#3#T6CCED8$-K[O\@JG<'02ZJ=I]^ M)(R/7M2G@7.K^ >:3!]I8/VZ?XM&!-\+)U4Y0GHQMA&<3/<1C,,N@DD03;U? M776>P:=Q$MIXX'G<"]4K/'KU;$@B/YY=^''L9,W&[+%?#,Y[/\\40JWMCU T M)0'8W"\U^Z?[W[GF[N>=PW7W(QG$KR5Z02Y6($42)"-7KMT74]7VQYYE94Q5 MV(\;P=%DZ +.5U5ENB\D8/_KW]6_ 5!+ P04 " TA*U2UO;XYD % "* M#@ &0 'AL+W=OO(-1% MT0*N#]G;37,8R-'M%FB --GCH>@#38TM-A2ID%2\[J_O#'6$VL1IBJ) 7VR1 MG/GFF^',D#S>&GOK"@#//I=*NY.T\+XZG$R<**#D;FPJT+BR-K;D'H=V,W&5 M!9X'I5)-LNGT^TG)I4Z7QV'NRBZ/3>V5U'!EF:O+DMO=&2BS/4EG:3=Q+3>% MIXG)\KCB&[@!_Z&ZLCB:]"BY+$$[:32SL#Y)3V>'9PN2#P(?)6Q=],W(DY4Q MMS3X.3])IT0(% A/"!S_[N$,(H%W[9MI&=+U(F:N=-V2HC@U+JYI]_;N,0 M*1Q,]RADK4(6>#>& LL+[OGRV)HMLR2-:/017 W:2$YJVI0;;W%5HIY?ON72 MLH]=0S[4GR"IGEG6 M,3O+G@6\Y';,YK,1RZ;9[!F\>>_I/.#-_][3"^F$,N2L8[^=KIRWF!R_/V-C MT=M8!!N+?Q_-9X&H% ]=Q06%Y"L?*9L$Q M =9C7;*UU%P+R17CS@%*NE& M3&JAZIPF.EC!7<'@KI:H1B3&["?08+E2NX0+ 96'',M.F%I[TJL03LA*H4'L M)K'%\L$5!L[SE9*8TJ@<"Q42L:TH=LP72!C1C$7Z?R*<+P#Y536ZYDT0YU3S MB0=1:'E7HTCM$ \76U,1\)B"%Z%OL$TTD 66--+I3.U(O]8\_P/K$M'N:D-_ MN"I0078M!LO3WE*4R4F9HT]2<)7L"?TW7W]UD&73HU_@'A2;A='LZ-L@1QRP M:SZF8%:4$ABFWNTAS+R#:7SSA05$HB67F'7 ?3*P' .3@Q-6KM"Q%;7LPR1 M)K/#)NU<0D+4"'-*E'\0CK!KI$RYX9PD]CA#9.+]S[F'8>A&: 73V2-PR*@0 MR 0EHCB.6YK9TS2'W C=R5(JCE8T M=-$3WB/'I"L:?%]J.TZDGOLC:^A1Z1 MFD&G+2M-#NJ[AF.?LRS*63*W+:0H&-84VMIHN4;+&"2,05U6).\"_B AFI & M"EU8YH.P;$*9DE]K:\H!C\AZ((]EL]+4+@ON: M*=5>?$9X4TG!VL(Y?6AH-QXENI*'"%%@1GN[K(5$*%Q$4231L$4&E$\6 ML+;[=(T*O_$.;8=";S8%_8[W!%O"%VY']31F-WB1RVO<( 0Y;9A=1A&.@A B M?-U'^*R+<--4/C41CN3?=='=;B(7HN^DY8C4 M+@F\OP,<)N=TX$B-[=DW\2N-AEV;<=U)X]@K-ALMLA]&\_F,A=S*C@9SK[K9 MEAGO#48A?#G( ]\+$%"NL+);RM/_*>7!;2&7>:CD@F/?HXF'VT*WV(.W LQB\[S2/( 4V-(GE MALRCHR;<<*B,O[SJ[-_2=:USUS5A7M+V$FB\#VU+_@^\GH_94[?82?0^*,%N MPBN(?$9RS5.AG^T?6J?-^^)!O'FEX;9N\+##MK1&U>GXS>N4V>;ETPRP5X;7 MQLIX?+N$SP(?BV!) -?7!MM .R #_?-S^1=02P,$% @ -(2M4M7DHM 3 M P C08 !D !X;"]W;W)K&ULK57);MLP$+W[ M*P9J432 $"V6M]0VX"3=#@6,ILNAZ(&6QA8;BE1)*H[_OD-*5MVB\:D7B_-&,Z/Y7NE[4R):>*R$-(N@M+:^BB*3EU@Q^*ZT[B);S MFNWP#NWG>JUI%_4H!:]0&JXD:-PN@E5R=9TY>V_PA>/>G*S!*=DH=>\V[XM% M$+N 4&!N'0*CUP/>H! .B,+XV6$&/:5S/%T?T=]X[:1EPPS>*/&5%[9=,$51,LN6YLYIN.?G9Y5JKHLDM?&5: M,VD/0 ZP:+08=]"&%?\KQTC%SFHJ$B<5C* MEJBI/[TQ",XV7'#W-4+(200W1*FV0%8$+VB,<+F[@CN:3T4C<$!7'5&?@@$5 M#O$<*P=N,<=J0R3=23SHD^5IF0AA@SLN)4'W7-SD)+ FG:J YY",)N$X&;E5 MEH3CV62P:GV!%3^H4VE46:^_[C[(43;,LG T&T,V"V>3;+!F!V=J*(<%PLOQ M,!RG,5S RV$6QJ,Q7/PC.*1J?2JLZ930DY, _U6YT3NH*;>4*0,"M^0:7TYHM.EV^+4;JVH_<#;*TOCRRY+^%ZB= M =UOE;+'C2/H_T#+7U!+ P04 " TA*U2&"X)W>X" !;!@ &0 'AL M+W=O"A3=UV'80;%I6Y@LNA*=M/]^I)QF&;#E,.P2BQ+Y^$CI,8LMA1^Q161X MZIR/RZQE[B_R/)8M=B9.J$3&=OLX[8WVV6J2] M^[!:T,#.>KP/$(>N,^'Y"AUME]DL>]EXL$W+NI&O%KUI\"/RY_X^B)7O42K; MH8^6/ 2LE]GE[.+J3/V3PQ>+VWBP!JUD3?1#C=MJF4V5$#HL61&,?#9XC+A^0;])M4LM:Q/QFMQ76W&[S-YF4&%M!L2LUTOYR$%.K<3QZIJZSK)TF2,87\$U>;:^05]:C(N<)84Z MYN4.[FJ$*_X"-X<[ 6@CO/<55K_'YT)MSZ]XX7=5' 6\,V$"\]DI%--B=@1O MOJ]WGO#F_U(OO+.Q=!2'@/#MU/B M,A,E1@P;S%:S8G)RO+I/+:I';_PS& 86<4588TGZ-=";P,_ !*4SMHM@/7"+ M0*&R7O0*)0TABEW#>HC"*,8)W!DOTM6$ N0L;@2)6P672!&&%=V@B#>2&Y(* M)5KFB2 V)Q3$2P8)H\<*^D EHAY$D8!SX(FA-1L49@H2K'& =2UJ!AJ9U<)+ M*I/]GJ)5^%--)6FCYI'!%8SNBA7 VX17, M)G.]AP.DDQV2D4>WD:!*NT)#TRJ98@)_>G[Y@> [#$T::U%OR/.H_?WN?G)> MC@/CE_LX=D5@C946.:PE=#IY6! _ D !D !X;"]W;W)K M&ULI5;?;]LV$'[W7W'P@&$#C-A6TC5MDP!.VJ%[ M"!HDZ_8P[(&2SA8;BE1)RHK_^WU'R8J-M<& /=B2R+OOOOM)7G3./X:*.=)3 M;6RXG%8Q-F_G\U!47*MPXAJVV%D[7ZN(3[^9A\:S*I-2;>;98O'+O%;:3J\N MTMJ=O[IP;33:\IVGT-:U\KMK-JZ[G"ZG^X5[O:FB+,RO+AJUX0>.GYL[CZ_Y MB%+JFFW0SI+G]>5TM7Q[?2;R2> /S5TX>"?Q)'?N43Y^*R^G"R'$AHLH" J/ M+=^P,0($&E\'S.EH4A0/W_?HOR;?X4NN M\X\ZO'MH\\->6;:0/6_R'BWD$K&S. MBP'BNH?(O@-Q2K?.QBK0!UMR>:P_!YV14[;G=)V]"'BK_ F=+F>4+;+E"WBG MHX^G">_TO_I(?ZWR$#TJXN\7X,]&^+,$?_9_0O@RQ/+T9/)OEI\LK1JO#65O M^EC,)HJ:-BHI9"J,"B%5-8J[<'5CT(*1.A5HK0V7I"V]9Z,ZY9EN*F4+]CNZ M<:V/E._H7A>5\B5=*^]Y1@+L&^PWXOK2[?_3P$#Q$Z=-/M4S%D8N(1V60BNB2X=9%)Q4,E M05R^?A>2 JVL;96A6S2JMAOQ_B&ZXK$/% \7) M@#>R#\R/@A^>94@UB,,6QF%4A]!**ITCTZ!A572OQ"VS2FSW-RYCB_D]Y-Q,+H M0N6&":TQ.TIRGWEU!.2^A;5/T7*?(E66B&20P(OX-PIUI\\YN2H>]$YDOR8MLF"Z)1]^N>KU.:'"K2\NU2W,&&9=1 MX0?NZ%QMOX!E?\+*++ EPBM39,SSB#C! TV=BGWK3&NC0DOM)$PUZG*6+ KX MEQ8@$@)C]E42<#^!<>P/73Y.EAEBD7_!T!'8(HVWL>"%$1+#?@N')Z+FY906 M22F$7>\/F*<*1TNHB-EE>1>&YJ4U(_ ]C*Z1HS 4P'J?J'#RK2-D?G BHY@W MZ=X1A)Z-_>$\KHY7FU5_HC^+]_L1N6*M=EH-[%;T\ O2]MN= =_ MMJM7;ML:7=)+F_K5?#J]?K715?/BA^_HNX_M#]_9OJNKQGQLE>LW&]WNWIC: M/G__8O;"?_&I6JT[_.+5#]]M]S MUV]FE_@"/?'?E7EVR6>%6UE8^QG_>%]^_V**&)G:%!V"T/#/DWDP=8V0 (_? M!>B+L":^F'[VT'^DS<-F%MJ9!UO_6I7=^OL7MR]4:9:ZK[M/]OD_C6SH"N$5 MMG;T?_7,S]Y,7ZBB=YW=R,N P:9J^%_]10B1O'![[(6YO# GO'DAPO*M[O0/ MW[7V6;7X-$###[15>AN0JQKDRF/7PJ\5O-?]\,C<4':I'JM54RVK0C>=NB\* MVS==U:S41UM7166<>ND_G7WWJH.E$<"K0I9YP\O,CRQSH?YFFV[MU+NF-.7P M_5> [#5SVN3:=C69JN;'6ZL;W1?5ITIU;)J=%-4NE8.'C:@91WA]MB9UMA. M?ZEXL<5.(4J$"I*M-IT9)=4$:$-@[+9J$#4@W48W M8,7P9UE9EE2XI"Y_ U6F=W, #3;-$5%L4Y/J-;C)&C I^K9%5@U>:$QAG$,M M1HPIQ?3(N+V7^I6[= M&J,VJ*[RHC*HM I4KE@'G5,@"T1:CUU5XYY+L!]H9_=1ZM:Z QKM0):4^;(% MFXQB*$ONC&YQ$23)6P"W69@V+@0/X8/+O@-V "C@LYMOG;IG*)_,UK:= OA>;O_K@ Z X#X9IDH#7ZL:?@IX/:*X5!V:*D3C MW9=BK9L5K;RI'/K-[.7CNX+3] MENQ/!D\A*PR\9C=@= #XLT&-=VK1.]BH8Q(5>EMUP'YPMI\-RDT+AI%E$L*6 MNB0I!AF'5\V7#D3+*U %4E2$O\(^PW90^_LV\XOE0>/@#=$5M).(0Q1@P!8< M 0LYK%@:"/)*!-7T&P.8.66>;/V$6K:$U6TK"OQL2(=1[4%I]*(F,H&5[V$= M("!8>0,6H -+#+P35 YPA^!P 0KW.4=XY�(K25 4:7D6P)F7/1+D0(/#)R M'V!W;25> ##O>8] "UBL:LMS<%;=+@,@\-BBQSW >NL*M("6;,R*#!6ZJ^62 M[1&^S(;_BW(:7%4N_()U<_([8,R)H+D*@+UK0KFM"@3<82#*IH80MAD"WK:V M!*_ETH?9>(UP%:F<2N(!ML"S#?$43,?"@D' )=S.@5V*A Z(+!)_ M#R^B[*] 0]L&321(F^Z[M15#A42LNKXS("JVMF"N2O5[KUN->T6"C["7M11B M7%#9]KQJSKL!#FTSVQCBL,CX MRH)L[RPI)\)@4!0='-L5Q@.9+EFE4&::0$\ P8H?<,N)9\]KNR'Z;WLPS)!6 M! 80#P$[5$"T[ /3X\U(>(LE6APKBCR&@5K5NEV9ED(-'RNA"/R&D@-[Q(4] M0@ ?PIR7W6X+2V#T1C^F+Q+$!A*L15_5J(-G.:T(#VX@OT(L87$P9P",#6%5 MH"5P%%^AB(.%)8G6/:!<@F+L'+*MP A2-(H,%H8_:/LB48C'+-"P'*DGL#3Z M7@1KOH XM NP0(0[2A7]]@1!"0I_QD+-3(\ZK(I=@=\C.Y#RK05%(MU;@0[# M!W0N*WY4-&NB?F4+J&MG$ZLUX!&80!^=@M)$/TV' O3^YLSU.=0X!-XOA/ID('%I;HA'3=PBX\R< D@A0CF@Y6+9 P MS["C90L"V=CF/'6K@(L.9O,9(R&@2[5%2I/CJ#%L$A<(M*!8' M6.:Z^B<]D5C?'#P;)#,5T&1 V"P0EO# W;'M]OLB:?>D*"AN)"$@;IN$S6*M M2.3L,C]FB,E%BF!XS_(@2Y,71D,N&$= MP*%'A]T3,?;[(Z%T#N3AF>2&2*\C5%T"J<#8&?;L'-&%. APV<_5\F/A M')(W.^I[]V/.@04)CEE%QXPBK2%R EY(LIPK9VE)#']P==Y>9[$.->JFLZ&; M!BOUA-*.K@IQPA 47>$S,88B<-ZN&1 !/ (F\8H]/P9\RZ6X'(F'\.%$QRA';?4/Q:B)2Y(KW,@>&<0!@'_565RZ\3&HW!@R52Y;D?!PR+DY M, F5]!]M$>@1;?X9<3=E7,$;:A1#!@XRTJ.-#$O%A.%)5S590:K'8I&(X+$/_D32)0H:($0"H75;KHI0\.IC(WDUQS / M]=0'[13.D.W#6,T_!NH%=MB'A &!&$=A^NO-'QN6TA3H]V']),DX$;SXA!=$ M!](T?E6UD+]S2"=AII3*'3ML"@%1H?6.@SF_AD1:>39,MWQVA2:K#3'\J%_] MU62I80.5KU&'\87<4V,+CX,I@J\AX]"?#74'1,3$HQ?6^63-QFDE!-*[N[4; 8DV*T(DI"58P MD::TH)96,)>FQ"ILSD4J,KNUA<#^N%L@U"*P"O/?#94)$1ZN#Q%32?DS>>8* MXU+;IAF-!_&,@1!J,Z!+MD6<_P*R.?:7\('"'@1K8"6[,VAW$UAQ#:(]F/?/ M:UNC#SE9M;H.5:OKDU6K!^W6!)D^O /"@7R@!([5K4Z"&J];(=AL##Y5KJ0H M&.)81^5A![SHSI%NF/<9*?R&+$A*?L"O5=60W>M\W8_"Q%"O);;4*"@=.D)0 M=D#!1!2DVL X9.1+00G1I^"#M,BZ6JW/"ZSB=.?@^L@ IN5X]J?!GC&ZY-8W MO@2,N)B=6&?? CC-O)O O)O3)4>I"A@F[QC+3@(X4FH,4#-B6O(W$29N3DKW MG*OB3SX8]D1%8VH7-::-["1#L##2-?&V#,O"\A(2=L E7S[.VKAUYA88W&_4 M;'*I_FY/D?8VD/;VM%[ >J9Q'&<2&>[;%LO)*(MCA#X)[HAN)&MD^VM@#>6O M/1 9J]WY@*B&+ =*&]I5D/".+"/P@ 05Z8Q6 ],CG7HV>(*U80VNZ1LUG5S0 M?R>H=1>H=7>26C\&E7A/A9+-,0MR$LPXE0+L+(&MXK=5\JT(9)!'CC&&6I^K M/=G)@U)BQ\G <^! DR_!)\LW% PL.I;(0KR"OU0;^H,Z6@1V,C"3&X@E*)F7#D!BBC0D5.*? MZXI#- M."(,RIW4;SH+01 \PP;TA#V83>,+RC>)82*%HA\,&WLB![LYRL+KMG")>S?BO&,>DG MA8R'B":7%Z9[-F;0M0XZ M[B&R0VYQQBF4+7T-AP)],B;+"G-(:2 P<&RWHDLV+;?.^P45CL2[%+;&^:RD M"35XV8?)+(L5QIEV@<@3+8#](,U&,+M;) M3AM#Y@;)T.DO5$0@+(TP,E;GT=IGFHJ*$'-(R!<3K6&/Z$?;9C%]I5X4"#NP M?P-I,?J>\1;A,!0::#:.6SQ59<\%A<-744<<3NU0Q2W6Y[,DVL12.%5SI10$ MQJ#H?)V[HI]UJ&5A<5;$LHJ@,>H7]I-@$9&X(%.1ROHL$"PP6ETP:Y_URN1D MQPA^D-L" K4%V(4E1'5L#J@>BCD*EONP<4:I$ &/'0S.EUN>X\! /5::?,U( M5A@$UVA [*I!/YV)!!'-#MH9";EP%8Q@'8D3V +@9^-\_X'X:VLOR"-THP@V M8H-"H6,0+/8R2L0X%GDT)I1!0H(OPD>B//Y65(Z*PK6:!W4<&?X:7&7F#'<] M*&R8B$O 7]3@%R9"@)9X?/]SY_UL0NM$6A":2PGD$@JY2?8>9<(=61VWC/7$ ML@+N=3@_%=8G51G:,8@%),8D^WT,IC<7I(X4+V2AJ,XZA?+=[<[%DA1A+B)8 M<^Z8(&;4=29VY&II,%D7D[Z4T2*=&KLCFDOEH3U$]H5WU=<:6T,@##BM>G1[ M#,X[EP['I1+"@ :&";.)^JEOO2YX]>#N,4Y%^ND#IN82S*)]3MVOPZXC*_R@ M;H6S2_2P>ZT>V8^_CC%"YJ>R1%>][_8>/[:FQ6A&HY9JII^B*DV-'6*[<8*FI3.PA=?Q:"U;5!+<,O%^C+K&"5MP%( \;S0R5+QL9X8J$ M21>=A%"-*JYB>1A2ELJLMR@NF),](Y:8YV3HDM.N+404G6#'%7:R CBB(W92 MAO30KPD\B"H^-_89;//*Y\V1B.W^X(M)BM+4:<;JO9?FQ);%_8:H3.BM!O3. M9*T_1>\A"4$6X%M %L%P%[6%G.$$,SR^+""9&/W@AS@O%JM!40\5&3R"495: MVZ_6MN^\S\!^BU*(!P.I[K1L52B*#;P M-7J)K/TS&(R-P(ZN,IVHMR&/ $LV2'U"PC+6+3G4_*#C\%,():(M3 KCK/.1 MIZ+3HO?4H4.+MZZHUYAGZ(XPGJ+F%SV\_VR@Q(%.!T48Z//;L?X/CJLDTM7L M2564)2F-D.1&:\URR]B@:\&0).GEC @B*D#HG9^0O@1;$8,L%;'YI;JX5)\H M[=N]SM+TN7+L[FMI=/(S2:\*^;R? ^:^;D;S;#RS$6(D3"E"A#D4$TY'8NZ8 MA=QQXK$[3&_'D\V!"MVHV93M3G9@=U[+#X<)M!@M-US2Q[%4S38-,7=;:PQ$ M.10'0G?!?J2/Y7%L?\SV>WG(_JROU4E.Q[S/DSCA*YYX.&OG)GL*G,9@1_!R M,G-DV-KKC6T[4NG@@7R\CZ,HY"T"FL%W'^(;,4E"HH"/A/4L49JT^!Q6/_?* MX+C .69DPJL3<46'G!^8WVMU-5>//5 ;)#@+4G.?88TWH:#4335.+0-$F?Q? M^@11 )2<]=!<+E4-=MYSBLU^_\=*4]DO3,F7]X^_G,&KL^OSZ3P4H#[@4K[" MI%YRY>KV&58NU*?N:2NO>=8(1TZM5:[BA! ;V9[2I/],:Z9&JN$9&:R#\S,<"WZAY M?@V4NIK-X?-YECBOV%DG.2XP#[ M5G6N\IN;"W@%1"&_FM[E-[-9%N@RO[S. MK\!)R[_9SUA0#:3X1MWFUW-8[^H6/@.@J^M\?CE3/Z-_XQYWQGG7('=MS48J M(L>2;]8*JJ3[ML, PG@NQ?.V/A_U2*ZUR]"5[$S'!YRBSN#,5SK1F0@]#>7Q MVBDV8P<^?/HR'%E(M\,]-SEH"81XX)8G4!%PMK+ MLR7K @\N.YX*YN(72+[A62.,%39ZET&8H!UEJ%@LI#D@&3*9I-R3K#EH16I' MN/4,RS5LJ+[.U3!?&TF58?R6M(@ FV_ GTUF5.9.K7H\'\8'2T/399\=8=?C MW0Y(3/DH)&J?3TW5?7SV0WPVVU/H@\,ZV3Z <]4W\#8&%+'E1HHYO]'\<88ZFVQX.I)'WS2++^Z!+A7 M-^KZ\BJ?3Z?96_]3JNZ0T5,$LS2 RW4^G5WDTXM;4-C9[75^>7LE:AW 1OV^ M0\.07UVS?M_"OJ_A\0]@/%ZK#R O/,QP\.++67XQO\WG-W-UIEY>7=[F=[,K M=2;K^ FGD?5N 25X[^Z:UIO?SL$X30O$T%*A M I^7 ?&D#C>),B#R$J< @M@CT*RLEH N38&GA?2@#J3C(,VB$;Y()-* GLF>F/2#7,6?G Q08$]),D5O3*)$)Z70_>72^"E2+]_S"/X!4@,J M;3)O^NTY4!\/=$;C&F)[FA"F(WUXUM1/R7FO)!"PY58^$7GQUP,V1CPGB]@]4:5 R.E5!\;#9[5"A^@#_//L# MR^V'HBQ_7_,)@S+[L.Y95G3DDL:H,U)]^+YJJ7)56YJSEAKWOLG_>JDBU:=_ M): +VIX6?[@HN4<9/Q,A*?G"K*JFX5<=[:/T'KWRCS:[3ZX[WNQF9++_ M'S(#%X&MR#">6#*OV/Q@(-3XTL.JQ1*VY_Y!5$W5!C5SU,E90'Q;.3>R,\CJ'.J>4?7%VE*?5!.680L>Z! M).]"K&V11Z+2R_I0T_XEYDT&/3%5U&MD8S Z7%0$*OV:7NZ;2C@FJV5^3%L> M"&\4M$Q.:*Q32]+8-+?_J8['C^AG M+',-ZU5\CE&2VC>U+CZ?/Q9KBS2(TX0;6_)A[3A^?TB#@;#$Z?J!O&0L+YXD M_F0BD8:-*9]28;^3;,B38QCQ!>(0N^BD\3"P'&UE+O%& ZI83))A;)%;[F4W M00]D[L&?)2"K0%L.1H:H(%. 3(SCNPLZ)Q5=EXU#Z*PZ$(#]D/E](G82T?8+ M.H(=CY5*X/L;.RQA_3B)LX3$(P7G>#:W).E*(D=I2":KQ_MEAFFCY'H0?^*9 M4M\,COBQQ#(E]F269&E,U+\B&73\M-_L40^G&P N-1T! [#MY"3Q<)/EO%O8 MT>&QIBZ=#DCJ=Y';TP_HC'E7AI/HK!8 MXU%!.I,M]+0XHG'*L\7[KF87)SW;WX%H[W3;T,4'+S] \'.&I*?+8X $M*E1 M+W<2[+B7@[6RKZVE\!*K(C/AL3H\5O!CI$?(*Z1&+^5P&H#S=UE@EVT?P##G MHX$M//]*M[6A]((8ZI7!BT\6?HX35\M$:Y.&$1HU+GPRR2?+.C]SB;AP M9X%.:6LZTDPAS[,]+VJ(D"%_Z-:6V%SHNNBI/H(=G$+.MM5T<#4"2FG"Q CH MLO;EX2(,V^ 9_XH[M:'T1R)'\Z TNDG6@NIA?)&01,L'"%:.3H5ZPDK%'54; M+1C@S:D4W3AP'#CB!BD[E8K9Q]"XF@ E"/%497)0FFKSH?F7T14]<6\(,KW49R^.E?P!/O5^G/](H)KH M9W:@GZ1'<4.5<[V_GD)@;&V8!\8S^$EG\[0*N5XZOX?V(8OK0S;W!3LL42+# M&7]Q0"Y>X?7LSX:C(_<4F^SU._B\M"]F2;#-@A."WP,3HMY]?'P=NHN*^AN# M-]Z$-][Z-[P6? 0VDWU.VHI_L/OX=]$Z2.5?SO*KBWE^<7>CSOC/NQO\:J;. MLH>>?>F386,N-U$]&NI"WF-I)S#B8V $N\^7%Q?899QA-^'B\B*_F5\ Q+"P M[OB*)C\(/&(X&)O;Z\O\[O*6D0,\9U?Y_.H20/WZ-3^1!J7),937ZN8JG\%_ ME[.YNK[+;V^F^?1RFC&E@1^XT'0RG?.2\ D1?QOY-?;[("E,:AE\S2!\E_0I M^T;Z#2-Y7RJS?R1U]-I(AWXC-[(#M1!=$FJ67+D+,W6_K2QYWCMZQGKJ)/#WF 5?84:LN)G=7"@3\XO9* M32FZ)9\!O(= M/ @>=(T7%7@74)LO,E:>2*WS"'-L!]A2MK/THW9TVK%R> J0$NXL-B+8QP?: M@,C([.,@3RXM71U"E9_&^ILUCHQ$'+M,-?LKV"L:Z!FA/J!,HSZSBT#?T>.W MYP]\&O@#%W*%[!?SZ[-<_2TYQ8G^;_ D7JDT=N8V,*"1&T0$(SS#!+:>^B_P M8!GJ_FGA?=577!-C@R*[N#U' 9,_[LZGEP0\_GW%#M]S#>LZ../&X5QZ%)5F M([!-1)?5\G9B\VMX8E^VLW>)8FG2482WCW\&'B:?IS.(W1EKZ6=[A+[(6-+&9\ER74+L+5/LE 2+K? M=04NJJ7#KO'6MCSL:.^LAZ;KQ0KM.IF8=YF<+^>S9P/D3ZJ3^IHZS5,L]^_K M]?,[Y"(8+)?%OD7/58OV^:-Q&,IWG:]V1!'J'5^^(YJ*0[J8QQ!.0($0?24U M(3(N'7<;O8\<7AX1JTU.L!"#%NG2))/XTC9'W8--@R+C57^#I=J"FX\O2P[?*WS5_SS>LQ\?YHGKP MM"N\EZPV2W@5/.C5"XZ4_!^=W=)]ZPO;=79#']<&U*W%!^#WI86,1/[ !<(- M_#_\'U!+ P04 " TA*U2M/$>^KP$ #P"@ &0 'AL+W=OZ:M38 M+;7>W T&*B^A9NI6;*#!-RLA:Z9Q*]<#M9' "BM45X/ \Y)!S7CC3D;V;"XG M(]'JBC^(/#3IVLB?%D*<2+V?Q:C%W/ ((*I!$\71^T_VQ]1U^63,&#J#[S0I=C-W-) 2O65OI)['Z!O3^Q MT9>+2ME_LNON)I%+\E9I4>^%$4'-F^[)ON[C<"*0>>\(!'N!P.+N#%F4,Z;9 M9"3%CDAS&[69A7752B,XWIBD++3$MQSE]&31)8.(%5GP=<-7/&>-)M,\%VVC M>;,FWM.=^RYSR7$N!-?@A&-R]->!T37A-CSUF\*@VU(A](0!,OH+$? MX/K&0:4;H2PQ*#'&>0Z$-0666PY*"6E"&=,T#5$DP57L#6GJ^\ZB11DL)Q)$ M"8U#[_!TGH5F%=9[!_H#R6@2H+TXPS4JBA,:1#ZYD).XSTE\.2='ZC^@^R;5 M9*H4:&4=>.1LR2NNT8%S2;FH^WQ2GDMP5J+"/FB(QINNI9K>U+5$_C?&2I> M<.H-:UY__"$+_/0G1?(#/':$5QWAW9&]*\ZW77'ZY-K:(3/(H5Z"/)QXSK\5 MW)"V0>D*B2'Q,M_:9!LB>"D=)I%991&-_-AYL/T*E16 I.#:W/+I,,:LIZ&E MRUR*HD7=JN2;#12TSS,V4I 2;?@TCE!OG)(DBBE^6YS9X=4IO;!(\'U(OS) @?I;0*(OW-.K5'ODT-$2D<=+Q*4._$[S^B&2](X^B6=]HD/5_ M!:]\&@89#=* 7).K.,KHT(_)]=Y.WN)E[)MG[&4(">6&B;479 $6@W>)OTG/ MW^2[>XIA3*L[,N'VGBF>VSC->-6:DJ'KZT6*@54A)9G6)5X"_"EIT,:99Z MU(L\IXLTYL,8\FZ]H#.)*P-\=LS7N??GZ#LXF4*P":SMK&6:%WY9NX&D/^W' MN6DWQ1RO=[,@YG#-&T4J6*&H=YMBMY7=?-5MM-C8F68I-'8&ULA51-3^,P$+WW5XPB#B!%),U'O]16HK!H M.2"APBZ'U1[<9-I8.';6=BG\^QT[;;9(T+TD8WOFS9NQWTQW2K^8"M'"6RVD MF065M,RF$_]WH.> M3]76"B[Q08/9UC73[PL4:C<+^L%A8\DWE74;T7S:L T^HOW1/&A:11U*R6N4 MABL)&M>SX*H_663.WSO\Y+@S1S:X2E9*O;C%73D+8D<(!1;6(3#ZO>(U"N& MB,:?/6;0I72!Q_8!_=;73K6LF,%K)9YY::M9, J@Q#7;"KM4N^^XKR=W>(42 MQG]AU_JF20#%UEA5[X.)0;>)/,L;9ME\JM4. MM/,F-&?X4GTTD>/27R5M9>";++'\&!\1HXY6E06-6?"P!DDX6B4ALDH]_8XC\-Q/^D]D[Z 2VBT*M 8 M&,5Q&*<99&D:QLF@=\LEIY=8PD:ITE!@/AB'@SQS$*,AN8Y[R[8@(JT!WSP* MDR6HE5'T\@J4!<)Y$@[[@W P3.$"S@EZF(=Y$L-%[TE9)HC!X2[/( WS=!"F M<>SM9)R'63Z$SZXS.M)(C7KC)X&!0FVE;>72[7;#YJK5V#_W=E)1.S=<&A"X MIM#X&ULC551;YLP$'[/KSBA/K02*F @)%$2J6TZ;=*Z5FVW/4Q[<. 2K )FMM-T M^_4[ V'9VG1]@?/YON^^\^%CNI7J0>>(!I[*HM(S)S>FGGB>3G,LN3Z5-5:T MLY*JY(:6:NWI6B'/&E!9>,SWAU[)1>7,IXWO1LVG&- KTI2ZY^GF,A MMS,G<':.6['.C75X\VG-UWB'YG-]HVCE]2R9*+'20E:@<#5SSH+)>63CFX O M K=ZSP9;R5+*![OXD,TNWIBRY?*0C=/V+:Q2>) NM%&EAV8 M%)2B:M_\J3N'/<#(/P!@'8 UNMM$C;0_=6H'M'9]7^ ^WED MDX>WU::2;J V5A2Y824+NLBB6D]@IW?P%KT#:EZ:]]V#!:98+FF[\_B#'44O MY0B&_LB-1C%921RY_I#U0:DL2Z'M:-# HL@=)Q&P)'"#)!HLL)9:D/1Q,G;] M40"C.*8 ?W"]7U? ANYXZ$,0A6[(PL&]I-9#_:^(9^<1N.-X[,:^#\SU6>3& M;#SXB%I/X).LT@U]3Y5Y \TQ&Y'J: @GZX @ W@4 !D !X;"]W;W)K&ULA53;;MLP#'W/5Q#&'EK JZ])G2 )D%ZB'H-WE8=B#8C.Q4-GR)+EI M_WZ4G+@IT&0O-BF1ASRT#Z=;J1YUB6C@N1*UGGFE,8L7TA6RPIINU M5!4SY*I-H!N%K'!)E0CB,!P%%>.U-Y^ZLZ6:3V5K!*]QJ4"W5<74RQ4*N9UY MD;<_N.>;TMB#8#YMV 8?T/QHEHJ\H$(6UYK(&A>N9MX@F5ZF-=P$_.6[U M@0V6R4K*1^M\*69>:!M"@;FQ"(Q>3WB-0E@@:N/O#M/K2]K$0WN/_LEQ)RXK MIO%:BE^\,.7,RSPH<,U:8>[E]C/N^ PM7BZ%=D_8=K$I5L:)PTO^P]B'I6!$]2WQ MWXN5-HK^E3\G2J5]J=252H^4>B )%:U D&MX?]#OS?DLDEB4<;6]Z4"&LI2(.\WDQ@W]G@:&<#FGM>]H.'&\RQ6J':GX2# MUSH?8.2G6>:/L_30'GQ%TDLI10&\:I1\0ANM(?:3)//3-'JU!M?4JE%M)U5> M X7GJ#4DJ1^-8_@XR/QL%/FCZ!+(BB_]-!X2OM836.1Y6[6"&2Q(CS24G#,' M: MJU!MW&;1-/*V-IW\^M-^>2TZS;Z&=YN/)KWAM0:!:TH-+RZ''JANFW2.D8U3 M\$H:V@?.+&D!H[(!=+^6TNP=6Z!?Z?-_4$L#!!0 ( #2$K5*CL)B9:@, M ",( 9 >&PO=V]R:W-H965T&"ST/:V/:ZSC690T-U9>R!8$W&ZD::G"KMK%N%=#* M*34\3I.DB!O*1+B8N;.E6LQD9S@3L%1$=TU#U?,M<+F;AZ-P?_"5;6MC#^+% MK*5;6('YMUTJW,4#2L4:$)I)011LYN'-Z/HVM_).X!N#G3Y8$QO)6LI?=G-? MSX0XXMT#HQG\]9CB8M(J'ZSWZ1Q<[QK*F&NXD_\XJ4\_# M24@JV-".FZ]R]P_T\3@'2\FU^R4[+YNG(2D[;633*Z,'#1/^2Y_Z/!PH3))7 M%-)>(75^>T/.R[^HH8N9DCNBK#2BV84+U6FCF;Q"3 D32X> MZ)J#?C^+#8+:J[CL 6X]0/H*0$8^2V%J3?X6%53'^C$Z,WB4[CVZ3<\"?J;J MDF2CB*1).CJ#EPT19@XO.Q_ACYNU-@I)\/,,YGC '#O,\2N8*^R-JN- Y(8X M?'(GM=&$BHI\,36H_O1>^+9!_IW*[%DCMAVO=4M+F(?8;QK4(X2+AQJ"C>38 M2TQLB;%5P]YP]P(=X,YL.3@CG3/^E+TX:DJ.MDGPI06%!C"<%^_).Y)/TNAJE+I5'N63(EC54ID/!E1S*#DJHJ+( MR"B/QE=)L.K6^VA+V0"Y2,=%E&<)>7^P#!ZDH9P(?/..3&9Y&DW&N5N-HSPM M@CNJ:])25F%;FIH)(@=G2WNUP4)HE"\PFF12N%4197E"SK L'UB6OYEE'SO3 M*4PK$ZSI&O*2,U^F)7UN+ %.L>RLD=,L\]:"IK?6]N@$N7"0 >X[RV8&T\T, MPYRB@ ([#!P]L53:>B\%D&>@REXW$N.@[OB8%Q&!IY)WE=74QV6,@AUX+<]] M?7U$X#!N['4\$;&^)\1T;1U:2(IM,\^ 0:S=T+# :0)1?(D71:((F6 MONG((^6=JY$'X8RN&<=L0(^3C:-B.CU)B/C@X6Y ;=UXTDC'3AC_A@^GPP2\ M\0__B[@?GQC;E@G[ FQ0-;F\PK(K/Y+\QLC6C8&U-#A4W++&*0[*"N#]1DJS MWU@#P_^"Q6]02P,$% @ -(2M4C89PM<- P >P8 !D !X;"]W;W)K M&UL?55+;]LX$+[[5PR$'A) B-Z69-@&DG87NT"* M#9JV>UCL@9)&EE"*]))4G?[[#BE+]0).+N9KOL>,R/'V)-4WW2$:>!FXT#NO M,^:X"0)==S@P?2>/*.BDE6I@AI;J$.BC0M8XT,"#. S7PVW;N])[;=R M-+P7^*1 C\/ U(\'Y/*T\R)OWOC4'SIC-X+]]L@.^(SFR_%)T2I86)I^0*%[ M*4!AN_/NH\U#:N-=P-<>3_IB#C:32LIO=O%GL_-":P@YUL8R,!J^XWODW!*1 MC?_.G-XB:8&7\YG]=Y<[Y5(QC>\E_[MO3+?S"@\:;-G(S2=Y^@//^626KY9< MNU\X3;%)XD$]:B.',Y@<#+V81O9RKL,%H A? <1G0.Q\3T+.Y0=FV'ZKY F4 MC28V.W&I.C29ZX7]*,]&T6E/.+._KVLU8@.//:MZWIL>-=Q\9A5'?;L-#"G8 MN* ^LSU,;/$K; E\E,)T&GX3#3;_QP?D;+$7S_8>XC<)/S)U!TGD0QS&T1M\ MR9)NXOB25_B>V ^7&S#1@,N=<0W_W%?:*+H@_[XAD2X2J9-(7Y%XIG?3C!Q! MMG"ENM>*^B:A?98;?60U[CQZ=QK5=_3F[[;B%]^MEO16M+'"ID-H):5E3FNEOJ#!^PQJ%"->^$JQFD&6>*$#Y44HPTV#I6*+#MC89W$/E) M6OAAGM,\]L,T]8MXO:!Y7]-S/E??=@R#@HF:K")MID7B%WDYCPOJQ)1BPF48 M%86?E1%$6>ZOHVP),>S%GI:9GY%TE,=^GJ;+Z5')%K5M(XR#K1_9T!#'B1^7 M!41)X2=9N?J+:D89D_TRCVE,R'ZR^BP-@=B2P*]JDP:Y2O5( M,AMXE.( !M5P%7<31Z$?EFNXA9N("APG$=R>=>I1*13F*LX6-,L+Y_D=:<9A M2=@,KEW9X*(A#*@.KNW9"S(*,_6&97?IK/=30_D5/K5ENAJ'7FC@V!(TO,LS M#]34ZJ:%D4?77BIIJ%FY:4?_#JAL )VW4IIY8066_YO]3U!+ P04 " T MA*U2C"L0RJ'06K0Q)*&G1F,-[\^ M/2,0R+%9IU(Y",W7>]T]O&[U:"/D@\H1-3R51:7.G5SKU9GGJ33'DBE7K+"B MG860)=,TE4M/K22RS(+*P@M]/_%*QBMG/+)K4SD>B;4N>(53"6I=EDQ^O\!" M;,Z=P-DMW/!EKLV"-QZMV!)GJ.]64TDSKV')>(F5XJ("B8MS9Q*<723FO#UP MSW&C#L9@(ID+\6 FOV7GCF\E+RJW^QI>P\'@('_"B#< D+K=VW(>OF!:38>2;$!:4X3FQG84"V:G..5 M^5-F6M(N)YP>7XKJ$:7F\P)A2A>"4F(&,RW2!V#5=I2+(D.I?GXW"(/^+W#U M;.Y2Q"N4C.F/XSXYT;B4A6,^(GYOF?E&V@!4QG=S_D M@9/@M!- T/5]WSSPTWYLGDY(\_A@+S[8BUI[80O7V\_MWB$N;MF+6KCDV=XA MKM_:Z[5P@Y:]7@LW;.'B%B[PGVT> F\%7=H9!(V+<$2$<2/"^*TB_+*JR^(N MR6&R(I&DO/Z7;'56,#%%DU+A)>T=M?2R]B8=M7= DX+$W@E5UYQ#)V3M!-LZ M :15B]*Y1(32U!!8H>0B S25Q"@NS9M" )RPBE %?7K4V4[XG7\;?.?SNIRC MW%^:\F:3&P4WK%JB6;UZ0IER92HHITSZ:C\%Y,Z$2BM]V9K]SI>U5IJ,\FK9 MA0^8HN7=^NN3BGIQTAWVAR0&W^WW((K=T$K8'?J=3Y1UAG40Q%O!).XPV;XZ M.QL99542=X=)"*<[FIX;AR:!W$'G'W4$TW!_;64O<)&F[^NQ> M29*1WPWZ@P89NI%-&7<8'Y-ITL@T>:M,;ZA8T*WJYJMT5W%]5)='J=^H2[FW M6NMR;:S^#T(\'MZ!\EX\J/ZI-:L2H%X X2/C$NY9L4;CG 7\2(%!-PA(A?W( MBJZ7-*(+_9WH8C=(.O?DC9$0R2",?2LA6@\/U/6>EMX?55'0#0?];AC6M@;1 MB\+Q#EJ;$N72-G *4K&N=-WE-*M-CSBI6Z/]\;K!)/-+7BDH<$%0TBT5,%DW M;?5$BY5ME.9"4]MEASGUN2C- =I?"*%W$V.@Z9S'?P-02P,$% @ -(2M M4LB.^_6O @ S08 !D !X;"]W;W)K&ULS55- M;]LP#+WG5Q!>,6Q 42=VNG59$B!I5W3 F1-/P[##HI-QT)ER9/DI/GWHV3' M38$VVV7 +C9)D8^/$D4--TH_F!S1PF,AI!D%N;7E( Q-DF/!S(DJ4=)*IG3! M+*EZ%9I2(TM]4"'"J-O]$!:,RV \]+:Y'@]59067.-=@JJ)@>CM%H3:CH!?L M#-=\E5MG",?#DJUP@?:VG&O2PA8EY05*PY4$C=DHF/0&T[[S]PYW'#=F3P97 MR5*I!Z=\34=!UQ%"@8EU"(Q^:SQ'(1P0T?C58 9M2A>X+^_0+WWM5,N2&3Q7 MXIZG-A\%9P&DF+%*V&NUN<*FGE.'ERAA_!+_USR!3>)4*YJ S\F2V,U="+D]:"025P<08I!UMMC<%9F&/@NM,N,:DTIK+%4R9X0:6 M6_B&:Q1PSVW.Y;[_%4?-=))O7SJ9@Z3<_1Z8DB4X"N@"&]1K#%JFG7_'M/-R MD\&M(9S.C;),P/=*6.>W&DX$K69 V\;8] Y9R:G MR#4:AT00A9*XIOL(^@=]Z-/QW'<@[=OSJ)>]/F9[6AG;9BQ M-F'FREC[,OX>Y(GO!298+%'O*'?_4\KP4O^'>R.F0+WR@]2 )UA/F];:SNI) M/:*>W.M!3^>VXM* P(Q"NR M:127H'W!QK\!4$L#!!0 ( #2$K5*+9E5CR ( /D% 9 >&PO=V]R M:W-H965T76 MEHL@,&F.!3,WJD1)-WNE"V;IJ ^!*36RK'$J1!"%X20H&)?>>MGH=GJ]5)45 M7.).@ZF*@NG7+0I5K[RA=U3<\T-NG2)8+TMVP >TW\J=IE/0HV2\0&FXDJ!Q MO_(VP\4V=O:-P7>.M3F1P662*/7D#E^RE1\9;U$(!T0T?G>8 M7A_2.9[*1_2/3>Z42\(,WBKQR#.;K[R9!QGN627LO:H_8Y?/V.&E2ICF"W5K M&X\]2"MC5=$Y$X."R_;/7KHZG#C,P@L.4><0-;S;0 W+]\RR]5*K&K2S)C0G M-*DVWD2.2]>4!ZOIEI.?7>^TRJK4PB/3FDG["J1XYJ[D!JZ^LD2@N5X&EB(Y M^R#M4+98?:O?T ,>YK1D>8V>A/PCND;& U]B,)H^ ;> MJ$][U."-+N!]JIA+%]$ DQG\5P5.ZA^;Q%A-C^;G&^'B/ES71(!K4S^BM.]A!W<'Z4.<\S8$;X#(5 M%?6!!% V1TVST'(0G"5<<)>P#RGUG!MK'$FR@KT2-+)<'A9PY#\XPW] O:$X MQ^; >TRQ2"A(IPD'_=MJPC+A0X('+B5!][&X29F $C57&;R#X7CJ3X9C)\5# M?S*?#C:M+[#L%TT%K05+!#647>>.:<,\]L?S"<1S?SZ-!SOVZDP-C4R&<#49 M^9,HA&NX&L5^.)[ ]1ER2 _B$JW9C-"')P3//8[@9!P+U(=FZ1BJ;R5M.YF] MMM]KFW:<_YJW2Y%J2Y4R('!/KN'-E-:(;A=->["J;(8[499612/FM)M1.P.Z MWRMECP<7H-_VZS]02P,$% @ -(2M4HT-7K3I @ FP@ !D !X;"]W M;W)K&ULM5;?;YLP$/Y7++2'5NH*F$#2*D%JDDVK MM$I1TVX/U1XOB< 7@WP3*"5 M,A/6E$@2#CG;(*ZM%9L>F+,Q:!5-FNLTSB57NZG"R7"NOHNXI(#8$MW#&O(2 MT#05)$DX)$1"C!9;]+ M )U-09*4BG/T%3W.I^CLR_G0EDJ")K*CVMVX0SQ/MY6TAO]>*=_C#L)[PB_1)Y[@;"#W2-Z)N^'.QURO.8X M/";<1:7D42W>55A^DM]^JF,T*V$3/SI<-%K7/2,B]X)%P],$JHJR.3J M6 8J>&#@NHK7X2# V/<'0WO=/IFW=G[?#W#/;>SV]/F-/K]3W[Q<( JJLHYI MJZ!^RR?N!;[G'$C[K]F>LJ!1%G0KVPJ=!/1T!]D">%AV<2T*$L'(4OU %^#%:(._5>-_JM._>HV*9@@"PKB M LT5;QH!(GF,;J((A& \A7>EQ'5>KS3GLY+BMNY-]V-IJ?'[]=7W?#&*ZGT 1*W-9W9C-:M-A;TQ?.5@?Z\YKVL"P &0 'AL+W=O V5?K/DHJ1*;\7*E;4 FEM06;B^YT5N25GE3$;VV8.8C/A&%:R" M!X'DIBRI^/,!"KX;.]AY?O#(5FME'KB344U7, ?UM7X0>N=V7G)60B49KY" MY=AYCV^GF!B M?C&8"-(]? MK5.GBVF A^MG[Q^M>"UF025,>?&=Y6H]=A('Y;"DFT(]\MTG: 59@ADOI/U% MN\8V"AR4;:3B90O6#$I6-?_T=YN( P .SP#\%N!?"@A:0&"%-LRLK!E5=#(2 M?(>$L=;>S,+FQJ*U&E:9,LZ5T&^9QJG)O"D?XDLTY942.JWHO92@)*)5CNX9 M7;""*082O9V!HJR05^@:?9W/T-LW5R-7:0[&DYNU\3XT\?PS\3Y3<8,"_ [Y MGH][X--A^ RR#NZ]A+M:>2??[^3[UE]PQM^#X/E&2[ZKFA-AOJRG>VV$[A24 M\L= B* +$=@0X9D0QVF]1IM*Y[2 7!^##-B6+@J0?9EL_$;6KSF.VXGOQ6D4 MCMSM8<9ZS)(PQ*0S>T$[[&B'@[2_<$4+RIIF M,';T[2I!;,&9H $AV-LW;&]0RG.VYFM6UY"_0X^-&%V:5MT%I<$']P-^K>+@ M?1?&_G\J3^OH17U(&*+B?=VF>ZZJR#-I[,M.C M#:"/ !<=#;QOPSA\M?SO6R@>[J'_D']R&PO=V]R:W-H M965T8CXX-43[H&,.2YX4)/@MJ8W7T8 MZK*&ANH[N0.!3S92-=3@5FU#O5- *P=J>)A$T2!L*!/!=.S.EFHZEJWA3,!2 M$=TV#56_Y\#E81+$P>G@"]O6QAZ$T_&.;F$%YNMNJ7 7]EXJUH#03 JB8#,) M9O']8F3MG<$W!@=]MB96R5K*)[OY6$V"R!("#J6Q'BC^[6$!G%M'2./7T6?0 M7VF!Y^N3]_=..VI94PT+R;^SRM238!B0"C:TY>:+/'R HY[<^BLEU^Z7'(ZV M44#*5AO9','(H&&B^Z?/QSB< ="/'Y < K-.#1(S+H/RR.) M>433TUV6G]-,TR3/ MXPLY/KLL+9+4KV;0JQF\*-2$&J/8&NO%\C:2E+)I4):VO&O)*U#>US'P1'DX MR$;9\(*_QS!)XSS),[^ HA=0W!3PW74VC##%J&.C)J)MUEC/6/$G";:RM:M\ M^-6R/>4@C+[WJ2G^"W*1QT6>QA%S/Q6E\S"L^[?@-JZH:B):SE= MR^Q/^[D[<^/FXGR.\[@;GW_==,,<&^*6"4TX;-!E=%?@BU3=@.PV1N[&ULO9G;;N,V$(9?A3!: M8 MD;8F4?%@X 1(G05,DNT&,[5XL>D'+M$U$$EV2BI.B#U]2DD7;DBBE7347 M\8DS_#E#?AR*TQWCSV)#B 2O41B+\]Y&RNVGP4 $&Q)AT6=;$JM?5HQ'6*J/ M?#T06T[P,C6*P@%TG.$@PC3N74S3[Q[YQ90E,J0Q>>1 )%&$^=L5"=GNO.?V M]E\\T?5&ZB\&%],M7I,YD5^WCUQ]&A1>EC0BL: L!IRLSGN7[J=;'VJ#M,7O ME.S$P7N@A[)@[%E_N%N>]QRMB(0DD-H%5B\O9$;"4'M2.O[,G?:*/K7AX?N] M]]MT\&HP"RS(C(7?Z%)NSGOC'EB2%4Y"^<1VOY)\0+[V%[!0I/_!+FL[0CT0 M)$*R*#=6"B(:9Z_X-0_$@8'R4VT Z%7IF[.5LF@01W<08O#8'O]ZH1N),D$G]8NO"*+KRT"Z^FBR!)$L0 M8+&IFD"9@V'J0"/RY<+U'/TW';P%A2XCKN<6B/M(P*+:.&P,62J]U"44QNP"SE%^%GX)[B!0VI?#L# M3^2%Q E1KP%3P/GK=.UG D?E4 TK4C\;E5)_VNYH'.-B'&/[./"62AQJ=: 8 MTXP)>08^D\HI,"X+J9JJY6;((G=2R)U8Y7Y+-U"E%;\0K@H"0%X)#Z@@8*N6 M&*G2FSD<'PKI3_P3M>5&L#^IENHZ9L=QK&)OCK3IG6>G-Y18BLI-Q"EII!;#!7XR2O09BH71:L.(O DH:)GBP$OIRU9G0P <[U?8Y58=2@.:92D]6XHVLP$:]L'.V <- M^^#_SSY89A]RD...QC6Y,.B#=O3]BQT[]UB[91\K,4B$]EKWH YO#5QH6 B' MG:7>( S:$?8YT8+UHDK4/B+T4+@959I=]0NM66OE4M.%XQ&$J":R!H+07D3N M*]U;/?'F;TI7!*Y)J [.ZL"ME]]=+%21&>91:1%V@T8XZ2KLR# -V9F6CR]= M0X%:>VH:5P6XP0MR^H[SLTV0 1RR ^Z:BBT36%<1^]BWB"HR'$.=<0P=G+SM M'&L;5;L7Z)6CFIV8&@Q1A>'Q2 SC4,,)G[WA4+Z]*Q<&6ZBS2@X9>J&FHW6[ M7-B]C&I38;=S&U>&(22R$_*+W"A JB-WPKE^4O">E!C>HG7K9[MRJ[/4.'G!ZG67 <-"SEV\/+"9O(,+\F4BP2N)E99&3 M.VGQ*+6YX;%0PU+/3K/3$(._P0-^I5$2M8JZ09TWZBSJ!G6>O;3;=Y(?GM_ MS:M^8%P]^-_@R7>ZBJ-O(.7;*[9[ M%J\_JD%$(/5<#*7J_B5W=11'5#&';RL:VAZR^H9VOITW[[P6N,W=-0H9'-S? M182OTYM6 =(KN.S^J_BVN,V]3.\P3[Z_DNX8%*R*'V[(7A)N&Z@?E\Q=;[./^@.BKOOBW\ 4$L# M!!0 ( #2$K5(UJT/,J ( /4& 9 >&PO=V]R:W-H965TC'MPH&3Q*JQ MF>TD[;^?#02E"8EV S:<]SW/L69W!C.!#PII#=51=7' M/7"YFWB!MW_PS%9KXQ[X>5;3%RXF''1!P*(QSH/:VA2EP[HPLQM_.T^M3.N'A>._^ MT-1N:UE0#5/)7UEIUA-OY*$2EG3#S;/NGMCY%9+KYHIV;6P4>:C8:".K M3FP)*B;:.WWOUN% $)P3A)T@_%\!Z02D*;0E:\J:44/S3,D=4B[:NKE!LS:- MVE;#A-O%N5'V+;,ZD\_ML2@W')!Q!6&D8J#1U0P,95Q?HV_H93Y#5U^N M,]_8A$[F%YWY?6L>GC'_0=4-(L%7%.(P&)!/+\MG4/1R_%GNVS+[6L.^UK#Q M(V?\]O5]H!G3!9=ZHP#]OEMHH^QI^G,A ^DSD"9#=";#,]W9S3&@&.5Z:+U: M>=+(W0>VS.\3@(^[A/?%'/%UWD>[6?%&("U4H6H <) M6X/X(/,(8TRB(\#3L(@0'";#?''/%U_D>V""V;-?)(WC)-Q$A_S M#<2-1RDFXV' I =,+F\P:%!;0+9](GAW:XBH*)%<:,E!%R *&*).3FB^A6F0 M)"DYPAX()#B-8W?^A[C3GCN]R/U3&LKMSGG+D2$P2@O$1XD"&PO M=V]R:W-H965T;1>:@ J85- MF[0'5-;MQ;07)CG :A)GMBG=/OUL)T0T":S:WA [N?_=[RYW..,]XP]B"R#1 M4Y&78F)MI:RN;5ND6RB(N&(5E.K)FO&"2+7E&UM4'$AF1$5N>XX3V@6AI34= MFWL+/AVSGLK>6KJ<"1P@Q,"KQ%X+Q7XC< W MB=9D)JTYD60ZYFR/N+96WO3"U,:H53:TU&]Q*;EZ2I5.3I>J+;)=#HBMT8)# M16B&WCRI'A$@$"DS]%EN@:,;(4 *=#$'26@N+M%K=+^R\? YI*W>>RVV5?%L!KZV 9_SY)_VM@7/( MT(P)*49H1BHJ24Y_0S8ZE&34+\6!:M;B)@6&H(+>U%=+TQ"IP,W8!;XON>W&0!&$GB0$[WXFQBX>32-HDDA>4_[\R2'H3[X91@'%WZ@;L(C=T MW.[8V4<'BS[4U5_WAI8"Y;!62NKYF3!XV^OAJOU:F?P!02P,$% @ -(2M4C<2;-$/ P >0H !D !X M;"]W;W)K&ULO5;;;IM $/V5%>I#(J6!Y68+Y2^88X&.9O#':C[?"+P M9-8L49Q")F.>$0&SH7%.S\;4U8#2XF<,*]FX)CJ4*>L/^M0P>@YDR"6.>_(HCM1@:@4$BF+$B4;=\ M]1W6 7F:+^2)+'_)JK+U/(.$A50\78-101IGU3][6B>B *8%/8\2IT1WV150D0/B, M3 1VAU#/A&41^?)8Q#G62Y&C2U L3N0Q^4SN[R[)T:?C@:G0MV8PP[6?B\J/ M_8J?&R9.B4-/B&W9M 4^[H9?0EC#K6VXB1'78=MUV';)Y[S"MPGUA$P2AC%N M1_S[&LW)E8)4_NEPYM3.G-*9^XJS;X)+2?)F=F'CJRV3%9M?LNG7<#D* I_Z MM#PU2GI'S,"S2(F$*(GPM<$2$,=,O7IO@ MBL]K"/D<^%Z?4F='<:NA8]M]OUVR5TOV.B7_P'EW>'Z]/17859[E[HC=-Z-] MC]K]=JE^+=7OE-KHLAM(IR"Z.JQ7D_8^OIV#VEGPKNT<[.71=X.@'^SF^VV[ M+;G]6F[_C7;&*;_@242N4A2]!*U3'I)]:KT,4>OC\T\;,YN^:P76=%L=[SB! MZ]*=$AQ@N"WY9=Y2NU/RF&=2B:+Z=L>9_M;,!0Z:@^KP,FBI\Q_J\#(H:?>D M_.K@I3KG#Q*"\7N!N"T ;X?,:YVAST]E%OFZ._4$L# M!!0 ( #2$K5*2-9%ZS@( +(' 9 >&PO=V]R:W-H965T-O%$F )MVP BM:-.MV&'90;"86:DN> MI#3=OQ\E.UZ:.NXNL43Q/3Y2"CG9"?FD"@!-7JJ2JZE3:%U?NJ[*"JBH&HD: M.)ZLA:RHQJWC'^E[BSNU8'+1*GL+]DUOHGOD&RKM*A: M,"JH&&^^]*6MPP$ >?H!?@OPCP'A"4#0 @*;:*/,IG5--9U-I-@1:;R1S2QL M;2P:LV'9"&45H3RG-SI F1KO>'-BS&E M/[L&35FISLD%>5Q>D[,/YQ-7HQA#Z69MX'D3V#\1.""W@NM"D4\\A_PUWL4D MNDS\?29S?Y#PELH1"<8?B>_YXQX]B_^'>P-R@JZP@>4+3O#9LBGR\VJEM,3' M^FN ,^PX0\L9GN"\JT'B%? -*>VE9'A5?95O6&++8O[&S[,H]9.Q/W&?#PO2 MYQ9%:=RYO1(9=2*C09'+0DA]H4%6[ZAL:**#\.,XCH,CD3U>49AX_1KC3F,\ MK'&[:K0QGHD*^M3%;^)>^&$PYQ4%T7%KWH/U5(#=V*B@LV9;KIG]TUF[P7-E^>V2?XT!JYL<_ MFF::87?8,*[P,M9(Z8T2+*5L)D2ST:*V378E-+9LNRQPJ((T#GB^%D+O-R9 M-Z9G?P%02P,$% @ -(2M4L:/#A8Q @ V00 !D !X;"]W;W)K&UL?51?;]HP$/\J5K2'3MH("806%"*5HFJ56@V5=7N8 M]F#(!:PZ<69?2/OM>W9"A*K 2^*S[WY_;)_C6NE7LP= ]I;+PLR]/6(Y\WVS MW4/.S4"54-!*IG3.D4*]\TVI@:>N*)=^.!Q._)R+PDMB-[?22:PJE** E6:F MRG.NWQ<@53WW N\X\2QV>[03?A*7? =KP)=RI2GR.Y14Y% 8H0JF(9M[M\%L M$=E\E_!;0&U.QLPZV2CU:H.'=.X-K2"0L$6+P.EW@#N0T@*1C/\MIM=1VL+3 M\1']WGDG+QMNX$[)/R+%_=R[\5@*&:\D/JOZ![1^G,"MDL9]6=WD3D*/;2N# M*F^+24$NBN;/W]I]."D(@S,%85L0.MT-D5.YY,B36*N::9M-:';@K+IJ$B<* M>RAKU+0JJ Z3-9UR6DE@*F/W%58:V),H1%[E[&<)FJ,H=NP1R#=;\7LJLOGU!\,M"Y"#L7 MH8,=G8%U @W[>[LQJ.F@_UW ''68(XQ2&TTD_;]3Q1A=Y M5T1'5MF!R\K=BF8'I. ;(04*Z-V$J&<31F/:A4]B_).;:IN>[L-.%(9(,JH< M#JX)2#>-U 2H2G=Y-PJI%=QP3V\/:)M ZYE2> QL/W2O6?(!4$L#!!0 ( M #2$K5)45E&PO=V]R:W-H965T1F71 L/G!UH7G.]^Y\'SF9"/59[U"-'!7Y$*?=%;&K-\&@8Y7 M6'!])->*,BCR(PG 8%#P3G>G$/;M4TXDL39X)O%2@ MRZ+@ZGZ&N=R<=%AG^^ J6ZZ,?1!,)VN^Q<-^M+17=!@Y)D!0J=20$*TY/. M*7L[9V-KX%;\G>%&[UV##64AY6=[\SXYZ826$>88&PO!Z><6SS#/+1+Q^%*# M=AJ?UG#_>HO^S@5/P2RXQC.9?\@2LSKIC#J08,K+W%S)S>]8!S2P>+',M?N& M3;TV[$!<:B.+VI@8%)FH?OE=G8@]@][X@$%4&T3_,(C8 8->;=![JD&_-NB[ MS%2AN#S,N>'3B9(;4'8UH=D+ETQG3>%GPM;]VBAZFY&=F9XC)4W#ZSD:GN4: M_N1*<5N*-Y/ $+Y=%<0UUJS"B@Y@77!U!"'K0A1&[.9Z#J]_?I.:5S^QX]&O M+6AG3T#K?8_6@C)_.DK8BA)0QIJT14W:(@?;.Y@VK1&[X-+7A3GJ6&5KU\D? MSVDMO#=8Z$\>3[W&4\]YZA_P],%U+B; ;U'13H0DT[$LA0&J$P+M?* A8&LF MEI"[:K;EVN]D?!2&OWC(]ANR_1\CJ]#.GH8:&%1%&V?WHHVWW]\8"BG,2GNH M#QKJ R_4C=@FENBGI2D50LSU"E(:C1J,A(4-)T;:&PF4(D$%9H4T,!=5!+;! MVB*HW Z=6SN%;Z>CT'XFP6T+W6%#=^BE>RI$R7,B1(VP(V.SJ+M52MNX#!]P M&8RB8Q8U7*HMU;9L,!@-VRD?-Y2/O93_2M,LQFK+P.E2(1:6_<<++!:H/L%7 M^"V7E.19F>6)[8PS6:RYN-]?46-LPIHL%>C?H\=ZBH6[N0@]#*H MJH-IBDZ0(:$ATZH$?I@_N#@"UGWYX@5MB\B3&;8G5,S?/M]/C&XU2RA9,8T M12W02M./R4*X1ZY\\X/M)(%%/T905CU"HP/O#(JDE: ?TVRDW>.XH;U>P6D; M>F8 _)XY:._TQGFUX ']+=^#XSFV2-X@\=3NY,5YI_S_\WH(*,+$J^B M+* >MU?6:R;LK(^>,F'83GW8X)EG#-M)!WL&[9BQAZK@$S*VDP7V?]0%7W%[ M[$G%W>D'>VX!83L%88](R+\K[OA!<5G85MU@[ZAA#X;T_WJ9T5#*,27+\.B8 MVEQ59ZWJQLBU.WTLI*&SC+M3(/($X& TGH7S+T>X0J$\)XND+L"'!\0$ Z 3E50#L!;1)MR9JTKIEELXE66Z2]M?/F&TUM&K7+ MADL_C/=6N[_SLWLV+Q48 4A6Z+$N]@06ZX6S.!;<<#'I[#99Q8=ZA]^C[ M_35Z^^;=)+0NL)>'91?D0QN$' CRA>ES1/$9(A'!(_*KX_)K*'MY]%H>NG3[ MG$F?,VG\T0/^;MDSFPN7').+-FDF#/IU.3=6NVGU^T@(VH>@38CX0(B74AHF MF'9U/$-S)3?NY4/.04+%K1DK9.LV;=SZ)?@XPS3.HRR;A(^[%1O:D2B.P()DL 54 H]RMVV2')\YIGA5[V/\U>T6=]-3) M2=1;IC63?MZ.(2:#V#C/DP+O(8Z8)5F*DW'$M$=,3T*T[&F<+AV&+9)D,.XC M9AG)XGB<+NOILI/HUEI58/P6S00RH!_=-!BES088A%!2Y'NT0S-,S(W'NZ7298/9^R((2510>C^^@]WSEQ_ MX7%GW))+@P143AF=9RYUW=XAVHY5Z^88GBOK#O6FN7+W+M#>P/VOE+(O'7^R M]S>YV5]02P,$% @ -(2M4E*?Y1)% P " D !D !X;"]W;W)K&ULM59=;],P%'UFO\**0 *I-!_=NH+:2J,%,310M0EX M0#RXR6UCS;&#?=.N$C^>:R>$;K1A+SRT\75\SO']\'7&6VUN;0Z [*Z0RDZ" M'+%\'88VS:'@MJ]+4/1FI4W!D4RS#FUI@&<>5,@PB:)A6'"A@NG8SRW,=*PK ME$+!PC!;%04WNS<@]782Q,'OB6NQSM%-A--QR==P _BY7!BRPI8E$P4H*[1B M!E:3X")^/8L]P*_X(F!K]\;,N;+4^M89E]DDB-R.0$**CH+38P,SD-(QT3Y^ M-*1!J^F ^^/?[.^\\^3,DEN8:?E59)A/@E' ,ECQ2N*UWKZ'QJ$SQY=J:?T_ MV]9KAZ285A9UT8#)+H2JG_RN"<0>8!0= 20-('D B(=' (,&,/".UCOS;LTY M\NG8Z"TS;C6QN8&/C4>3-T*Y--Z@H;>"<#B=PQ(95QF;&<@$LG<\%5*@ ,N> MSP&YD)9]XL9P%^T7["7[?#-GSY^^&(=(ZHXC3!NE-[52WA\'QZ2SZWC2>MXXOE.C_#-N"$?+U)DWSY"L03SO8-TT)(. M/.G@".D5V4RO'@1SQ[[Y%Y<(A>V2.6UE3COW?J6YHEJUJ1&E.PR'DM'-<.D. M4*I-QE4*5'*8,\R!24=,O6%-R59@+1W4'Y4P0.<6K7/,+9I=7+^]<9'KU:8N M2JYV)Y6%S$^L*BE9:70*D%FV,KKPTXO%@OF-ET90QQ!RYY18R7=&$R#5%FV/ M!%5=CQ4V=>A4*GM/BQ:@2$7)D5*(.<=V\R=;05Q+H+:TM.B6<5D+>9?Z'<$_ M:X-_UAFZ!=]1+TUOV<)H;)H1#=>&%X\II6$K,_R?I73>RIQW>W,O3TNN;@\5 M4\TQ]!SN8MA,D_AL-(CI'&\.B(]:\=$_JA"!3B$R:B]P2+<;'O>CZ%E'#%ZU MVWC5R7,-&RTW0JW_#G:33_:34NRJ=L>N0&5@'I/I./K3@Z/_F>MXK]G'W8WC ML%"/O;TKA>OQ5,OSP[F8_8/Z0Z6H/T>]DR=/_F[P]7;#O6O*?2-02U\+99F$ M%5%&_7,Z>*:^=FL#=>EOKJ5&N@?],*=/%3!N ;U?:3J!C>$NP_;C9_H+4$L# M!!0 ( #2$K5((R:!Y5@0 8; 9 >&PO=V]R:W-H965THC!.)I8OQ/:] M;269->,1$7*7;^QDRRGQ]* HM*'C#.R(!+$U'>MC4H132D*Z%*$/GOD5[1 M,%25I(X?65$KOZ<:6-P^5+_1DY>369*$7K'PO\ 3_L0:6<"C:[(+Q5>V_T"S M"?55O14+$_T7[+-K'0NL=HE@4398*HB"./U/GK*%* R PS,#8#8 :MWIC;3* M:R+(=,S9'G!UM:RF-O14]6@I+HA55Q:"R[.!'">FB[0;@*W!G'+=Y7A%P6Q/ MN =FL0=N"7^0YK@BVT"0,/A%]&+>!B&5VF*:@-?75) @3-Z =V"^N >S#:=4 M]DV ;[Y6)O4S%PC-B;^BR!R!Z"Z # MW?O%-7C]ZDWB$TZ3XUJV7(1\)6"^$E 71V>*R[Z&9,DX438!,\Y)O$GG0>0R M%/>_")]R('P2@^-!WS[)FN"CH%'RO4(1RA4AK0B?4?29]51?%GJ&8+%;_B^M M# 33R_P;G)IYNHIIV;XNJ[Z6CU,7.?HSMA]/",*Y(%PIJ-8+O\&K4WK2JH.B M'N?P.:VHGROJ5RK2:_-.?2T],"<_=7L*K7H+[N2V=!WX(AMSVGA']QWD]QUT MQ"S#7-&P';,,RV:IZLPHUS-JQ2NC9WOE(E=T\3)>N=NS)EYQ'<-8IR-N<0O< M=]OQ2U;WR##]BO:X!L N;,4R6=E!6=%Y48;!;C6$F[O&E[][C7QC<.OBKOC& M ->M)N[?^Z;_3-\8%KN#=GPS*/D&UK#&-3AVJWFL%PA<:M]=UJ]/Z]:2Y*IH%5_8&&R=!IQ319V2/3U, &&BC# M:B@W-8UN4KUI8"'[=B7\0D->V%+\A2?R;V5_#)!A.P$8EA,PJB$--$2)P MO6D6P5,CSQCLPJYD8&BH"UM*P?"9,1@:'L-V@C L)V%4!QH#9-@@"S?P#'VD M<1/7(,-=U)4LC QV44M9&)W(PE4-0@;(J)TLC,I9&->0!A6>1S3(PO6N^4<] M"6OD&@->U)4DC QW44M)&)63<&6H00;)J)TDC,I)&->P!ADFHQ=)PI^#9H]H MD"$OZDH21@:\J*4DC,I)N!(UV! 9MY.$<3D)]VM0@PV2\8LDX;MF/T_84@W#\'&KOP5D.](9+WW 1Q D*ZEH.=WE#. MBZ2"<$BO>E3XE&N+I#GUXR)PXYZ=Y*_^IK^ 5!+ P04 M" TA*U2CX!"!!\$ "4$0 &0 'AL+W=OUBDU+ )A X2B(E/=U6:=FI&IV=BZ-=N. D5@$SVS2M MM \_&RC0!=PT[<6Y"7_]^N?G]?LX9G9@_%[L"9'@,4TR,1_MI,IENJ2[VR18C.'J^<4MW>ZEOV(M9CG=D0^37_(:K*[N)$M.49(*R#'"RG8^6 M\-,*^;I!^<9?E!Q$YQSHH=PQ=J\OKN/YR-%$)"&1U"&P.CR02Y(D.I+B^*<. M.FKZU V[Y\_1?RT'KP9SAP6Y9,DW&LO]?!2,0$RVN$CD+3O\3NH!>3I>Q!)1 M_H)#_:XS E$A)$OKQHH@I5EUQ(^U$)T&[E #5#= )7?544GY&4N\F'%V %R_ MK:+IDW*H96L%1S.=E8WDZBE5[>1B4V4#L"WXDE.9D=UGZNJ3S30IPO6+)-[ :ZRF,0OV]N* MOQD$>A[$"AD#KC&W@ O' #D(_@1L(/:8$U']&N*[C4AN&=\=$NGJ$FQ4/<1% M0L8 H@L8C,&FR/.$J DJ<0*NLZI E%)C<,-5T7#Y='&)18$3)=9U)@J.LXB MKVK(_,"I)%R [W^HCL"U)*GXVX Y:3 G)>9D ///(KTCO$VEL#?+6S$&7PHI MI$HKS79CL"([FF7J%*QP4B+]"_J$JG2O.O3*#G6!/RS0Q//#:3BS'WI(O8;4 M,Y)^*XN%Q&#Y0+@J?G#U2'A$!5':486DY ,;#?4:?!]SU7709;8&>/V&US]+ MV=]44O4P3!+Z1Q(&T',0A0U9>%;.G@'-60N/LG8!?2_T43\4=%J_=3Y*L(:TUV*=(\V@ M%7@#>)WE )ZEFEH"MX2^-M?KX"]DFWJ!.U!^$+58Z*-4:TA[ 5'/3/,'9AIL MUP?HOM]YK\KC2;9;=]?5T75)O@82FFU^$,;L ^$;8%!K[LAL[L/*O%H^=>03B5H_1V8_ M7^/'4\L'M6Z,T(]53QV\FQ+7LP;^ :#6@I'9@L\KGSIH%V9B M>4,PK;TBL[V>5SYUT!.5:6T9F?]FOZ=\_./5!UGN_XCLSD8Y)7Q7?@X0(&)% M)JL]2PK#;:[>O5]PJUYU132("$;%535:I*$EY] J@N),O+;?<=DVH3 M7Y[N"5:S7;^@GF\9D\\7NH/F0\SB/U!+ P04 " TA*U2GKH)!$<# ^ M"P &0 'AL+W=O4E$P5*(Y0$C8MA,(XO)W'B#/R*>X$[<]0&%\I2(,,?4.A><7EN\PCQWGHCCW[W3H-K3&1ZWG[Q_],%3,'-N\$KE7T1F M5\.@'T"&"[[)[:W:_8W[@#K.7ZIRXY^PVZ^- D@WQJIB;TP$A9#EFW_?"W%D MD)PR8'L#YKG+C3SE>V[Y:*#5#K1;3=Y$-URU(XC-@ M$8O_@!#,BFLTY;/!?U+)EWC_R2GYG*-S]UED<*4*^E<,]U_;6&LNETC?KX7Y M(QROF_)'/SS><9W!UT_D$JXM%N9; U"[ FI[H/8)H'\V3OJ3QVG.X//&&LME M)N3R#":X%%)2$WY G2BEQN66';^E^\VWHSB.6;N7#,)M#6NG8NTTLG[QOPSQ MC;>H*07 7Z29!?J.$3YRH>&>YQN$*<7CV!O0#R=;AU]2](_P6:O=K6?O5NS= M5^KL@Z'!)F&[SX1E42>*HGJV7L76>UM=#ZC-0O:>"=EIQ2>$[%>P_5<*>4_C M+^C8?Z;C>1*QS@D=+RJTB[?5L2)MEO&B3D96SQI'AT0>O5)(NL86*%[2LGD; M5R5IV/6[S%V(AW'A\LL3O['A%RAOW 424TZ[O_*'AZ5- 7JI2_<#*1J(VU9 MW52C57$X+DNBP_*RLJ0:@&X* SDNR#1J]4@Y719K9<>JM2^0YLI2N>6;*RIP M4;L%-+]0RCYUW 95R3SZ#U!+ P04 " TA*U2[Q]Z7\L' #\(@ &0 M 'AL+W=OZV=3?GJ<%S)A&9UR)(HT)?SNG";YS4G'[]P_N&++ ME50/^J?':[*D,RH_KZ<<[OI;+W.6TDRP/$.<+DXZ9_[;]Q%6!OJ-+XS>B,HU M4E.YSO-OZN;#_*3C*40TH;%4+@C\MZ%CFB3*$^#X;IQVMF,JP^KUO?=W>O(P MF6LBZ#A/_F)SN3KIC#IH3A>D2.15?O.>F@E%RE^<)T+_BV[,NUX'Q860>6J, M 4'*LO)_WR"NW@9OZD(GA+:&)629RMV9Y/ I M SMY.LZS#>6272<432%M*.=TCF8RC[\ADIFK59[,*1>__C3"_O W=/&]8/(. MO9I025@BT)^$T>L>PD$7 M80_[->9CM_E'17E.NW(M*EJ)-+JGH H&)F+.U M8LBZ%7&[SC/J !AN 89.+Q.V87.:S06 B1,".ZL.2>ECH'THJ=F9J"+.B8=]&40(@XW!$)._L+20K8Z1"VV0H U>$IG0^K>'J>YV\Q ME3G5]M8.\L$6^: %N66C]9:-1#F1-4QDH^#7@2[]^EX+ZL%C4 ^WJ(=.U--= MI"#IW@) )M0(LUKOW1A%\)D5=X$M?HYV(#NOC>;0%<.0$ M\)<9#M$2"5'I,(?TK1O?[4H3,S[JOGSQ8I];=\#YGE5,S^U3;1Q=,,W5"D(5 M*4@3RQA7U^FO 947"Q^Y%UE4EA)# CH+D:31NSQ9DN6J!@TSM3I7DS M0*L>OEL^2H!G0%=S'6EQ4*@MS?O#9PZUI6#?S<%75%"^48JBR$8\%(O:>)<> MHRK5^'[HC08-6]72L>\FT>GL,SI;P52XU'T%!>EE((>%,!;5 %VWI[\S0WQ55G095)T 1)#F]XR*]]K93)?=Q%BIL\ML7"IYKA6,<^-J)PL#SZ$8V!(J=A,J M,,8W(/R8K!E(PKU2I"RAL"_5\#+LO V%WE [MS"GF! M&*!Y L9P+W)1"T3+W+B-;&]96J1/@A?MA3!JPV>)&[<0]],W8$Q!:USMU*FN%+"*A]V*][0ZU3C?RK@@M$88M1%AUWU5T M""-3<_B^@HJ J7,B7'^"5!!E=5+W]8D99F>G1BZN#BUSAN[*_("H@S!6V](' MK4:ES?[,/9#0,F78T@/Y,>8>&[>[NS$:14%#KS2T5!FV]6 M.L.6HG(W;:>:/MU(]NDS[#7AL.P9NMD3!MZH&GJ:D'BOA#-%QOE3BXS04F=X M]+RI&EDNC%KZU#^6JA/C=N<@.O ]'S>L1619,W*7EC]<9DR,XP.S-++D&KG) MM8I(T+C@3#+UY6&LGXO#A']B!JEF+NYY#X6_7_F67OTNY"/A2Y8)E- %F'F] M(42&ULS5A=;YL\%/XK1V@7F]05;))^*8G4III6J7U5M?NXF';AP$FP"G9F MFV25WA\_FU @4TO)RD5N$@SG/'[.A_V 1VNI'G2":.!WE@H]]A)CEF>^KZ,$ M,Z8/Y1*%?3*7*F/&#M7"UTN%+"ZKS 5*[''O&>;MSQ16+<#7\R6K(%WJ/YNKQ5=N17*#'/4&@N!2B.P%CA&F&!D'P>S?"J>8I@[)\OA5@GK5 MG,ZQ>?V$_JD(W@8S8QJG,OW.8Y.,O1,/8IRS/#5WH00G( M-*#D&?=IN_LE1I5[L.WNVYQ6B:558FF!%[Z UPRT3"P3,5QS-N,I-QP;B;:I MK7/AK/Z30OV5Z1_7=@*X,ICIGRWTPHI>6- ;O$#OBS0L!582,S!W=%>.[G.9 MWV =%5AN8UA-R(">AJ'-\ZJ9XM?MML@.*K*#5K+-7%Z)96[T0=EVI&J=EIP, MJVF&^UBRHXK>48\E:\5RXG"FERS"L6=W?XUJA=X$GELU;\?9"O:X"O;X'TM. MNY3\I)KF9!]+?EK1.^VQY!NLX:NK]'6[+;(DJ+4D^,>BA5V*1AJB1?:Q;*3> M_ GML7#M8#LLUAZ M@.NY82TZ\F4Z02X6*$V-N?V3>!&"GP$*\H/]EWT/(ID M+FPJNG1!K0IDL)==4.L)&?;9!<..Z[>#X3;A6F%(N\3L6$7X']XHS:36 W*\ ME\6NE82<]%GL5K!=EOS;@;8#KK6)M(M3G\W22=1I+40TV,=FH;6 4=)CLY1@ MK^\,'0RW"3>^9MH%K<]B=WH9H+7TT' OBUWK%&W_?-FQV*U@.^P,/0!M O8; MQPON;,<6?<&%AA3G%CDX/+;]IC;')9N!D&PO=V]R M:W-H965T!3?]Z\G Y?N$)XY['Q@O_7>R.+U/"^"_L MV]PH@*PV5I4MF!247#9_]MSNPQ&@/W@'$+> ^+. I 4DWFBCS-N:,LO2H59[ MT"Z;V-S [XU'DQLNW2D^6$VKG' VO65S&156].#.]RA@!A^S[%ARH,988E9KS>7&9]TKJ;N),3.PA<9W4/:?H/4$L# M!!0 ( #2$K5+>H62OQP( &D' 9 >&PO=V]R:W-H965TF?'18&5GHJ]*TL!.+.@@KK^:!2[!2;,F4WLVEK,)KQ2E#!8"R2KHL#B=0&4 MUU/'C9%1LN7\R4QNLZDS,H2 0JJ,!ZQ_S[ $2HTC3>-WZ]/I0AK@\?C@_8O5 MKK5LL80EIX\D4_G4N790!CM<477/ZV_0ZHF,OY13:;^H;FS#L8/22BI>M&#- MH""L^>.7]AR. -I//\!O ?Y[0'P"$+2 P IMF%E9*ZSP;")XC82QUM[,P)Z- M16LUA)DL;I30NT3CU&RCRR*K*""^0_,T%15DZ!$+@9EZ168XNT<-F MA_'(8[_D##EPMM]/L'S0O M_$&/=UAH&VL">,$;8W1:!R0#LB M4TQ1"8+POHPMF@BQC6#ZQ//,BY+8BR;N\_$Y]IB%7CQ..K,W J).0#0H8-[P M1CC[I>^'[B@*Z6Z&RO;T>]Q^QMU334W:-N5H#8VR8O4V-6ZYTI[7#7+^%((R!WM]QK@X3$Z![76=_ %!+ M P04 " TA*U2(@L]KPT" "&! &0 'AL+W=O%)N)A>KP M*#IN_WTIV?&RHX3WV-(,L(,CK-QN-WJ9'*)OD\QM:8SUU#6EE8H_"-,1*?5J!=NT@F MR3%PI_85A4":SVNYAPW0]WJ-O$L'EE(9L%XY*Q!VBV0YN5K-0GY,^*&@]2=K M$2K9.O<0-E_+13(.AD!#08%!\NL UZ!U(&(;?WK.9) ,P-/UD?U3K)UKV4H/ MUT[?JY*J1?(A$27L9*/ISK5?H*_G;> KG/;Q*=HN=\;)1>/)F1[,#HRRW5L^ M]GTX 3#/RX"L!V31=R<47=Y(DOD<72LP9#-;6,12(YK-*1L^RH:03Q7C*%^C M*YN"Q+U$E):>! <.*K37.[Q7/A88= M0\>C]SRBV$U]MR%7QTG;.N*YC&UL?91-;QHQ$(;O_16C50Z)E+ ?D#2* "DAC=H(VB@T[2'*P>P.NU;\0>T! MDG]?V[ML205<8&W/^^XS,^OIK[5YM14BP9L4R@ZBBFAQ%<H7WXI!E'@@%)B3=V#N;X4C%,(;.8P_C6?4OM(+MY\W[GT1=!M!-R1:DX6T;AFQ8=_H-1@?[=S\0ZA-4+ML MN/)=G))QI]SI:#C24G)R;2$+3!4PTHJX*E'E'"T1P8(3/$]0SM"\N+.GZ2T<'YW $7 %$RZ$ZY7MQ^10_0OCO,&ZJ;&R M/5@I3!Q(9>&+*K#XJ(]=BFV>V2;/F^R@X1W..I!=GD*69.D.GM%A^?U2=*"; M!GER *?;EKT;_+I[_'[,!"]9^)#7G"JXUUQ1:, 45VB8@#%G,RXXO<.U*[WK MB.\1/(^=$7PCE/;E $:OQ>@%C-X>C+%6Y9GKI83@VW9T5\-JI[3^D/QP6 W3 M3K0IX?AFS0\H!VZBZIS0U?^.+MXCQL]K-"$.'[M<[S M4^T)S""LF. %4&7TLJQ\G[/.K@K'6W=-HBG#"+*0ZZ6B^MJUN^V4NPZ7._X7 M7H_("3,E5];QS)TTZ7QVZ*8>._6"]"+6QES[?-]]]EVPQ; T:\'N%HR98)4+68[(PICB0QB6LP7+:7FI M"B8MDBF=4V.[>AZ6A68T+<$I%V&OTXG#G'))QD.YS&]R4P8SM91F1/J-*7"/ MS^F(=./W)'!T$Y6R$7DX?_MCJ+J[W[><5<$%"+VG_"-++ M3@V"8*:%T8&S96"E=L)1/#NZZ'E14S9-SJ705VT5P MW]-Z^!ZPZ8% +D0CL$><83PLJ#%,RQO;J097QF=04+?OUX55.-=TW>WUR=:A M>M@@4Z53IILP7;(QC8>"92!'\_D"GD85(8#&J-PV4D[G2M)*P\:C;EC:&1/B M#EZW[]D.]RIKY;0#&95-TPJJFX[&=8"_S>:XV[2]%_$&!7]4YM/23D=6?:@5 M=JM9QE=5?Y4U C#V+LY.BT*L/PH^ESESDS\ZX'A(-W[!0FG^9*-!J\RB]6'%W]*\G5 MK\J^8*_&>@\]=9']UR R/GV147+Z&NN3S*F+')RDR+#>OUN'A)TC0F,-X"@V M(M_@T">V08/ID@O#9=U;\#1E\ME)P=(;.K7'_1U^.SYE&5T*<]^ ([)M?V4I M7^9),^H6%J(>M6U_@>EUX^8<:&-QF;(52R=U5\^G53.P#1NUOL!A'[FI+C^" M^3C,CP"&Q<$48#[."XOS/\UG@,['89BV@1<9H#X#U,=Y^9!)=6-Q_#Z)O?PS M39(HBF-L12<3KX()MFYQ#!\_&Z8-/+ X$.G/UAK/-EXAA^L R^FA"L%FBE-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%B MM/XU@LD/['X 4$L#!!0 ( #2$K5)O?>/BB@0 &DA / >&PO=V]R M:V)O;VLN>&ULQ9K?<]HX$(#_%0U/N9<#_TC:9DIG*"1WF4D;)ES3QQMA+Z") M+;F2G#3]Z[NR0[(T9*V-OE\;NL:"+-T&P-?5,!V-3H:U5'KPX?VVKKD=T@/C MH?#*:"P,!3<*[MWS^7 H[I132U4I_S >=-\K&(A::56K'U".!Z.!!DA!6NE'6^NZ*K M7R+C'>#%_5'KS;FJ/-B9]/"/-6VC]#I4@T\Q)(_1Q6'[V0?QU/Y.&,UJI0J8 MF:*M0?L^CA:J *C=1C5N(+2L83R8FCNPX7GP!R[*_MD\0I%(V5.%)^Q%V>'% M0_DH*ZD+$%W4'&%*&:;TD$SB:"XMWK"!KCW\11@SAC&+R[@(OQNN<<*LQ%4# MMK]&''W1LBT)9,Y YH>$G!I]%SH5(HBYA140R&,&\OB@D-)MQ'EE[O=$\H2! M/(D+.0-76-6$\D#YL75*@Z/]Y0T#]R9R!-NZEO8A@"W46BN\36HO)D5A6NT5 M@7S+0+Z-"WF!C4]['.V!1NT= _0N+A!V@4:J4IQ]QTH<."%U*:YPF+%BXASM M',F(&Y]'L3'Q;NL?.KRS;ZUJP@V4CK5'9'U<@G0[+S3AO)%$%@>V>-M"*2Z5 M[%*/W;:6<+I((OMB!DO?O<*IA5)Y<2Z+/82<*Y+(LGBA!XND8N%-<1O *29G MBR2R+LZELN)&5BV(3]CX6MN[@^)QGD@BBP*[:]D67GR5UN(@_("A-($"+Z.( MG"V2R+J8FKI6OC=NUR(Q_<9,&'3Q2VOD;)%$UL6B73KXUN)%XNSNUQ?,62.) MK U6MO^G-(/FM)%&U@:/F5%,SA]I9'^0K$ +TTD:62=[4H:]C)Q3TLA.89-+9GL(ZRQ3>.(_@UX"B)89TI)]=K"VM) M)P 9YYGL<)X)>825&-DP?7K,+2@FYYDLLF=H-#'_:5HOG^;RTM$IJHIB8G(*RV M@.Y@O9$XQ M.0MED2U$,3N98T=R_BDKHIBPZM'6W2DLQ.0MED2VT M38?Z'N/$YV"CL%VQL[[-"2@[H(#XA96<$U >64"O+ZQTP:68G(#RV )Z'MGG M8+LJPA;'Y%[:4DSH6)1S LH/)Z"K?K4[A+9/-2=-0S$Y >6Q!?2,>0W.6U7X MIXSXBZ8ZS]GMES^YI+8S"<\Y >4'%-!C[O:8P)=">IK#Y9R \L@">G5^\2+K MR#D!Y0<4T';@_$].@V9T^R/G+)1'MA"[6"F.Z!8F9Z'CSD+# M[=9^"2NEH?R,/^&PO)!5,;^9H[=3'_\SL5NO=ZOX MTJT^]_&0_Q@7!E&ULS=G);L(P% 707T'95L1X@ X"-FVW+8O^@)L\ M("*)+=M0^/LZ89!:T:B(2KV;1(GM=U]LZ6PR?MM9\KUM5=9^DBQ#L ^,^6Q) ME?:IL53'D;EQE0[QT2V8U=E*+XB)P6#$,E,'JD,_-#62Z?B)YGI=AM[S-K[V MA:DGB:/2)[W'_<0F:Y)H:\LBTR&.LTV=?TOI'Q+2N+*=XY>%]3=Q0L+.)C0C M/P<M.='.(.T_[*K\YORW0%QIDS9ZR/)^;H\KCCD32K^S86(A>*[D\\ M)<;25W\?-:>=4_[+[+B]'\:MVO/PK+U=O\=?S_A4_\(^!$@?$J0/!=+'$*2/ M$4@?MR!]W('T<0_2!Q^@-((B*D&UL4$L! A0#% @ M-(2M4AS8/ 'N *P( !$ ( !KP &1O8U!R;W!S+V-O M&UL4$L! A0#% @ -(2M4IE&PO=V]R:W-H965T&UL4$L! A0#% @ -(2M4MXGGE.Z!@ \QH !@ M ("!C T 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ -(2M4I<]N:YL!@ Z1T !@ ("!N!T 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ -(2M4ADUF88F'P M&ED !@ ("!T# 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M-(2M4A>\?.\M" F!, !D ("!&ED 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -(2M4A@N"=WN @ 6P8 !D M ("!Z7T 'AL+W=O&PO=V]R:W-H M965T\#R (U? 9 M " @=N% !X;"]W;W)K&UL4$L! M A0#% @ -(2M4K3Q'OJ\! \ H !D ("!(:8 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -(2M M4B=0F>ZX @ W@4 !D ("!*;$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -(2M4HPK'+\L! 10L M !D ("!_;H 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -(2M4HT-7K3I @ FP@ !D M ("!1<4 'AL+W=O"P &0 @(%ER >&PO=V]R:W-H965T M[+ !X;"]W;W)K&UL4$L! A0# M% @ -(2M4I3F+C5=!@ !Q\ !D ("!5L\ 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ -(2M4C<2 M;-$/ P >0H !D ("!]=L 'AL+W=OLX" "R!P &0 M @($[WP >&PO=V]R:W-H965T&UL4$L! A0#% @ -(2M4E165P\"! _0X !D M ("!J.0 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ -(2M4@C)H'E6! !AL !D ("! MP>\ 'AL+W=O&PO=V]R:W-H965TN@D$1P, #X+ 9 M " @:3X !X;"]W;W)K&UL4$L! A0#% M @ -(2M4N\?>E_+!P _"( !D ("!(OP 'AL+W=O&PO=V]R:W-H965T(' 0!X M;"]W;W)K&UL4$L! A0#% @ -(2M4MZA9*_' M @ :0< !D ("!>0H! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -(2M4IHJ/"6QE&PO=V]R M:V)O;VLN>&UL4$L! A0#% @ -(2M4CB#;R;$ 0 #1X !H M ( !BAL! 'AL+U]R96QS+W=O XML 64 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 65 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 152 320 1 false 60 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://stereotaxis.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets Sheet http://stereotaxis.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://stereotaxis.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Statements of Cash Flows (Unaudited) Sheet http://stereotaxis.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Description of Business Sheet http://stereotaxis.com/role/DescriptionOfBusiness Description of Business Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Inventories Sheet http://stereotaxis.com/role/Inventories Inventories Notes 9 false false R10.htm 00000010 - Disclosure - Prepaid Expenses and Other Assets Sheet http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets Prepaid Expenses and Other Assets Notes 10 false false R11.htm 00000011 - Disclosure - Property and Equipment Sheet http://stereotaxis.com/role/PropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 00000012 - Disclosure - Leases Sheet http://stereotaxis.com/role/Leases Leases Notes 12 false false R13.htm 00000013 - Disclosure - Accrued Liabilities Sheet http://stereotaxis.com/role/AccruedLiabilities Accrued Liabilities Notes 13 false false R14.htm 00000014 - Disclosure - Debt and Credit Facilities Sheet http://stereotaxis.com/role/DebtAndCreditFacilities Debt and Credit Facilities Notes 14 false false R15.htm 00000015 - Disclosure - Convertible Preferred Stock and Stockholders??? Equity Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity Convertible Preferred Stock and Stockholders??? Equity Notes 15 false false R16.htm 00000016 - Disclosure - Fair Value Measurements Sheet http://stereotaxis.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 00000017 - Disclosure - Product Warranty Provisions Sheet http://stereotaxis.com/role/ProductWarrantyProvisions Product Warranty Provisions Notes 17 false false R18.htm 00000018 - Disclosure - Commitments and Contingencies Sheet http://stereotaxis.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 00000019 - Disclosure - Subsequent Events Sheet http://stereotaxis.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Inventories (Tables) Sheet http://stereotaxis.com/role/InventoriesTables Inventories (Tables) Tables http://stereotaxis.com/role/Inventories 22 false false R23.htm 00000023 - Disclosure - Prepaid Expenses and Other Assets (Tables) Sheet http://stereotaxis.com/role/PrepaidExpensesAndOtherAssetsTables Prepaid Expenses and Other Assets (Tables) Tables http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets 23 false false R24.htm 00000024 - Disclosure - Property and Equipment (Tables) Sheet http://stereotaxis.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://stereotaxis.com/role/PropertyAndEquipment 24 false false R25.htm 00000025 - Disclosure - Leases (Tables) Sheet http://stereotaxis.com/role/LeasesTables Leases (Tables) Tables http://stereotaxis.com/role/Leases 25 false false R26.htm 00000026 - Disclosure - Accrued Liabilities (Tables) Sheet http://stereotaxis.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://stereotaxis.com/role/AccruedLiabilities 26 false false R27.htm 00000027 - Disclosure - Convertible Preferred Stock and Stockholders??? Equity (Tables) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables Convertible Preferred Stock and Stockholders??? Equity (Tables) Tables http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity 27 false false R28.htm 00000028 - Disclosure - Fair Value Measurements (Tables) Sheet http://stereotaxis.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://stereotaxis.com/role/FairValueMeasurements 28 false false R29.htm 00000029 - Disclosure - Product Warranty Provisions (Tables) Sheet http://stereotaxis.com/role/ProductWarrantyProvisionsTables Product Warranty Provisions (Tables) Tables http://stereotaxis.com/role/ProductWarrantyProvisions 29 false false R30.htm 00000030 - Disclosure - Schedule of Revenue Disaggregated by Type (Details) Sheet http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails Schedule of Revenue Disaggregated by Type (Details) Details 30 false false R31.htm 00000031 - Disclosure - Summary of Contract Assets and Liabilities (Details) Sheet http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails Summary of Contract Assets and Liabilities (Details) Details 31 false false R32.htm 00000032 - Disclosure - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://stereotaxis.com/role/ScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails Schedule of Computation of Basic and Diluted Earnings Per Share (Details) Details 32 false false R33.htm 00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 00000034 - Disclosure - Schedule of Inventories (Details) Sheet http://stereotaxis.com/role/ScheduleOfInventoriesDetails Schedule of Inventories (Details) Details 34 false false R35.htm 00000035 - Disclosure - Schedule of Prepaid Expenses and Other Assets (Details) Sheet http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails Schedule of Prepaid Expenses and Other Assets (Details) Details 35 false false R36.htm 00000036 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 36 false false R37.htm 00000037 - Disclosure - Schedule of Lease Costs and Other Lease Information (Details) Sheet http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails Schedule of Lease Costs and Other Lease Information (Details) Details 37 false false R38.htm 00000038 - Disclosure - Schedule of Future Minimum Operating Lease Payments (Details) Sheet http://stereotaxis.com/role/ScheduleOfFutureMinimumOperatingLeasePaymentsDetails Schedule of Future Minimum Operating Lease Payments (Details) Details 38 false false R39.htm 00000039 - Disclosure - Leases (Details Narrative) Sheet http://stereotaxis.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://stereotaxis.com/role/LeasesTables 39 false false R40.htm 00000040 - Disclosure - Schedule of Accrued Liabilities (Details) Sheet http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails Schedule of Accrued Liabilities (Details) Details 40 false false R41.htm 00000041 - Disclosure - Debt and Credit Facilities (Details Narrative) Sheet http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative Debt and Credit Facilities (Details Narrative) Details http://stereotaxis.com/role/DebtAndCreditFacilities 41 false false R42.htm 00000042 - Disclosure - Summary of Performance Award And Market Capitalization Milestones (Details) Sheet http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails Summary of Performance Award And Market Capitalization Milestones (Details) Details 42 false false R43.htm 00000043 - Disclosure - Summary of Option and Stock Appreciation Rights Activity (Details) Sheet http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails Summary of Option and Stock Appreciation Rights Activity (Details) Details 43 false false R44.htm 00000044 - Disclosure - Summary of Restricted Stock Unit Activity (Details) Sheet http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails Summary of Restricted Stock Unit Activity (Details) Details 44 false false R45.htm 00000045 - Disclosure - Convertible Preferred Stock and Stockholders??? Equity (Details Narrative) Sheet http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative Convertible Preferred Stock and Stockholders??? Equity (Details Narrative) Details http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables 45 false false R46.htm 00000046 - Disclosure - Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy (Details) Sheet http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy (Details) Details 46 false false R47.htm 00000047 - Disclosure - Fair Value Measurements (Details Narrative) Sheet http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative Fair Value Measurements (Details Narrative) Details http://stereotaxis.com/role/FairValueMeasurementsTables 47 false false R48.htm 00000048 - Disclosure - Schedule of Accrued Warranty (Details) Sheet http://stereotaxis.com/role/ScheduleOfAccruedWarrantyDetails Schedule of Accrued Warranty (Details) Details 48 false false R49.htm 00000049 - Disclosure - Product Warranty Provisions (Details Narrative) Sheet http://stereotaxis.com/role/ProductWarrantyProvisionsDetailsNarrative Product Warranty Provisions (Details Narrative) Details http://stereotaxis.com/role/ProductWarrantyProvisionsTables 49 false false R50.htm 00000050 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://stereotaxis.com/role/CommitmentsAndContingencies 50 false false All Reports Book All Reports form10-q.htm ex10-1b.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm stxs-20210331.xsd stxs-20210331_cal.xml stxs-20210331_def.xml stxs-20210331_lab.xml stxs-20210331_pre.xml http://fasb.org/us-gaap/2021-01-31 http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 true true JSON 69 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 19, "contextCount": 152, "dts": { "calculationLink": { "local": [ "stxs-20210331_cal.xml" ] }, "definitionLink": { "local": [ "stxs-20210331_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "stxs-20210331_lab.xml" ], "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml" ] }, "presentationLink": { "local": [ "stxs-20210331_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml" ] }, "schema": { "local": [ "stxs-20210331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd" ] } }, "elementCount": 435, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 28, "http://stereotaxis.com/20210331": 2, "http://xbrl.sec.gov/dei/2021": 6, "total": 36 }, "keyCustom": 25, "keyStandard": 295, "memberCustom": 37, "memberStandard": 22, "nsprefix": "STXS", "nsuri": "http://stereotaxis.com/20210331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://stereotaxis.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Prepaid Expenses and Other Assets", "role": "http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets", "shortName": "Prepaid Expenses and Other Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Property and Equipment", "role": "http://stereotaxis.com/role/PropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Leases", "role": "http://stereotaxis.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Accrued Liabilities", "role": "http://stereotaxis.com/role/AccruedLiabilities", "shortName": "Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Debt and Credit Facilities", "role": "http://stereotaxis.com/role/DebtAndCreditFacilities", "shortName": "Debt and Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Convertible Preferred Stock and Stockholders\u2019 Equity", "role": "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity", "shortName": "Convertible Preferred Stock and Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Fair Value Measurements", "role": "http://stereotaxis.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Product Warranty Provisions", "role": "http://stereotaxis.com/role/ProductWarrantyProvisions", "shortName": "Product Warranty Provisions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Commitments and Contingencies", "role": "http://stereotaxis.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Subsequent Events", "role": "http://stereotaxis.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Balance Sheets", "role": "http://stereotaxis.com/role/BalanceSheets", "shortName": "Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Inventories (Tables)", "role": "http://stereotaxis.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Prepaid Expenses and Other Assets (Tables)", "role": "http://stereotaxis.com/role/PrepaidExpensesAndOtherAssetsTables", "shortName": "Prepaid Expenses and Other Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Property and Equipment (Tables)", "role": "http://stereotaxis.com/role/PropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Leases (Tables)", "role": "http://stereotaxis.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Accrued Liabilities (Tables)", "role": "http://stereotaxis.com/role/AccruedLiabilitiesTables", "shortName": "Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "STXS:SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Convertible Preferred Stock and Stockholders\u2019 Equity (Tables)", "role": "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables", "shortName": "Convertible Preferred Stock and Stockholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "STXS:SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Fair Value Measurements (Tables)", "role": "http://stereotaxis.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:ProductWarrantyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Product Warranty Provisions (Tables)", "role": "http://stereotaxis.com/role/ProductWarrantyProvisionsTables", "shortName": "Product Warranty Provisions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ProductWarrantyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Balance Sheets (Parenthetical)", "role": "http://stereotaxis.com/role/BalanceSheetsParenthetical", "shortName": "Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Schedule of Revenue Disaggregated by Type (Details)", "role": "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "shortName": "Schedule of Revenue Disaggregated by Type (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Summary of Contract Assets and Liabilities (Details)", "role": "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails", "shortName": "Summary of Contract Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "role": "http://stereotaxis.com/role/ScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "shortName": "Schedule of Computation of Basic and Diluted Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "p", "STXS:RestrictedCashPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RestrictedCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "role": "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "STXS:RestrictedCashPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RestrictedCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Schedule of Inventories (Details)", "role": "http://stereotaxis.com/role/ScheduleOfInventoriesDetails", "shortName": "Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Schedule of Prepaid Expenses and Other Assets (Details)", "role": "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails", "shortName": "Schedule of Prepaid Expenses and Other Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Schedule of Property and Equipment (Details)", "role": "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "Schedule of Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Schedule of Lease Costs and Other Lease Information (Details)", "role": "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails", "shortName": "Schedule of Lease Costs and Other Lease Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "0", "lang": null, "name": "us-gaap:ShortTermLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Schedule of Future Minimum Operating Lease Payments (Details)", "role": "http://stereotaxis.com/role/ScheduleOfFutureMinimumOperatingLeasePaymentsDetails", "shortName": "Schedule of Future Minimum Operating Lease Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Leases (Details Narrative)", "role": "http://stereotaxis.com/role/LeasesDetailsNarrative", "shortName": "Leases (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Statements of Operations (Unaudited)", "role": "http://stereotaxis.com/role/StatementsOfOperations", "shortName": "Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Schedule of Accrued Liabilities (Details)", "role": "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails", "shortName": "Schedule of Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-192020-04-20_custom_CaresActMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Debt and Credit Facilities (Details Narrative)", "role": "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative", "shortName": "Debt and Credit Facilities (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-192020-04-20_custom_CaresActMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "STXS:SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-02-222021-02-23_custom_PerformanceShareUnitAwardAgreementMember_custom_Mr.FischelMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Summary of Performance Award And Market Capitalization Milestones (Details)", "role": "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails", "shortName": "Summary of Performance Award And Market Capitalization Milestones (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "STXS:SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-02-222021-02-23_custom_PerformanceShareUnitAwardAgreementMember_custom_Mr.FischelMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Summary of Option and Stock Appreciation Rights Activity (Details)", "role": "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails", "shortName": "Summary of Option and Stock Appreciation Rights Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Summary of Restricted Stock Unit Activity (Details)", "role": "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails", "shortName": "Summary of Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "STXS:NumberOfStockholdersVotesDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Convertible Preferred Stock and Stockholders\u2019 Equity (Details Narrative)", "role": "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "shortName": "Convertible Preferred Stock and Stockholders\u2019 Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "STXS:NumberOfStockholdersVotesDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy (Details)", "role": "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails", "shortName": "Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31_us-gaap_FairValueMeasurementsRecurringMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31_us-gaap_FairValueInputsLevel2Member_custom_RestrictedCashandCashInvestedInMoneyMarketAccountsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Fair Value Measurements (Details Narrative)", "role": "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "shortName": "Fair Value Measurements (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-03-31_us-gaap_FairValueInputsLevel2Member_custom_RestrictedCashandCashInvestedInMoneyMarketAccountsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:ProductWarrantyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Schedule of Accrued Warranty (Details)", "role": "http://stereotaxis.com/role/ScheduleOfAccruedWarrantyDetails", "shortName": "Schedule of Accrued Warranty (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:ProductWarrantyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31", "decimals": "0", "lang": null, "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Product Warranty Provisions (Details Narrative)", "role": "http://stereotaxis.com/role/ProductWarrantyProvisionsDetailsNarrative", "shortName": "Product Warranty Provisions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31_custom_ConvertiblePreferredStockSeriesAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited)", "role": "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity", "shortName": "Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31_custom_ConvertiblePreferredStockSeriesAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-02-28_us-gaap_LetterOfCreditMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCredit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Commitments and Contingencies (Details Narrative)", "role": "http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-02-012021-02-28_us-gaap_LetterOfCreditMember", "decimals": null, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Statements of Cash Flows (Unaudited)", "role": "http://stereotaxis.com/role/StatementsOfCashFlows", "shortName": "Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": "0", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Description of Business", "role": "http://stereotaxis.com/role/DescriptionOfBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Inventories", "role": "http://stereotaxis.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-01-01to2021-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 60, "tag": { "STXS_AccruedLicensesAndMaintenanceFeesCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for license and maintenance fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued licenses and maintenance fees" } } }, "localname": "AccruedLicensesAndMaintenanceFeesCurrentAndNoncurrent", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "STXS_CaresActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cares Act [Member]", "label": "Cares Act [Member]" } } }, "localname": "CaresActMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_CashInvestedInMoneyMarketAccountsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash invested in Money Market Accounts [Member]", "label": "Cash invested in Money Market Accounts [Member]" } } }, "localname": "CashInvestedInMoneyMarketAccountsMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "STXS_CompensatingCashArrangementPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensating Cash Arrangement" } } }, "localname": "CompensatingCashArrangementPolicyTextBlock", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "STXS_ContractAssetAndLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Recognized from the Costs to Obtain a Contract with a Customer" } } }, "localname": "ContractAssetAndLiabilityPolicyTextBlock", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "STXS_ContractWithCustomerLiabilityNoncurrent1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract with customer liability noncurrent.", "label": "ContractWithCustomerLiabilityNoncurrent1", "negatedLabel": "Less: Long-term deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent1", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "STXS_ConvertiblePreferredStockSeriesAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Series A [Member]", "label": "Convertible Preferred Stock Series A [Member]" } } }, "localname": "ConvertiblePreferredStockSeriesAMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "domainItemType" }, "STXS_ConvertiblePreferredStocksSeriesBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stocks Series B [Member]", "label": "Convertible Preferred Stocks Series B [Member]" } } }, "localname": "ConvertiblePreferredStocksSeriesBMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "domainItemType" }, "STXS_ConvertibleSecuritiesConversionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible securities, Conversion price per share.", "label": "Convertible securities, conversion price per share" } } }, "localname": "ConvertibleSecuritiesConversionPricePerShare", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "STXS_CostOfSublease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of subleased portion of operating lease.", "label": "CostOfSublease", "verboseLabel": "Sublease" } } }, "localname": "CostOfSublease", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "STXS_CustomerDepositsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Deposits [Member]", "label": "Customer Deposits [Member]" } } }, "localname": "CustomerDepositsMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "STXS_DeferredServiceAndLicenseFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Service and License Fees [Member]", "label": "Deferred Service and License Fees [Member]" } } }, "localname": "DeferredServiceAndLicenseFeesMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "STXS_DirectRegisteredOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Direct Registered Offering [Member]", "label": "Direct Registered Offering [Member]" } } }, "localname": "DirectRegisteredOfferingMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_DisposableRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposable Revenue [Member]", "label": "Disposable Revenue [Member]" } } }, "localname": "DisposableRevenueMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_DisposablesServiceAndAccessoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposables, Service and Accessories [Member]", "label": "Disposables, Service and Accessories [Member]" } } }, "localname": "DisposablesServiceAndAccessoriesMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "STXS_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognitionDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of total compensation cost not yet recognized, description.", "label": "Weighted average amortization period of total compensation cost not yet recognized, description" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognitionDescription", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "STXS_GlobeBuildingCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Globe Building Company [Member]", "label": "Globe Building Company [Member]" } } }, "localname": "GlobeBuildingCompanyMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_IncreaseDecreaseCompensatingCashArrangement": { "auth_ref": [], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Compensating cash arrangement.", "label": "IncreaseDecreaseCompensatingCashArrangement", "negatedLabel": "Compensating cash arrangement" } } }, "localname": "IncreaseDecreaseCompensatingCashArrangement", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "STXS_IncreaseInMarketCapitalizationMilestone": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase in market capitalization milestone, amount.", "label": "Increase in market capitalization milestone, amount" } } }, "localname": "IncreaseInMarketCapitalizationMilestone", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "STXS_LeaseEffectiveDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease effective date.", "label": "Lease effective date" } } }, "localname": "LeaseEffectiveDate", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "dateItemType" }, "STXS_LesseeOperatingSubLeaseReceivableOnUndiscountedExcessAmountReminderofFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Undiscounted future cash flows to be received under the sublease reminder of fiscal year.", "label": "Undiscounted future cash flows to be received under the sublease 2020" } } }, "localname": "LesseeOperatingSubLeaseReceivableOnUndiscountedExcessAmountReminderofFiscalYear", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "STXS_MarketCapitalizationMilestone": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Market Capitalization Milestones", "verboseLabel": "Market capitalization milestone, amount" } } }, "localname": "MarketCapitalizationMilestone", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "monetaryItemType" }, "STXS_MaximumMarketCapitalizationMilestone": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum market capitalization milestone, amount.", "label": "Maximum market capitalization milestone, amount" } } }, "localname": "MaximumMarketCapitalizationMilestone", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "STXS_MinimumAnnualRentInTwoThousandThirtyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum Annual Rent in 2031 [Member]", "label": "Minimum Annual Rent in 2031 [Member]" } } }, "localname": "MinimumAnnualRentInTwoThousandThirtyOneMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_MinimumAnnualRentInTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum Annual Rent in 2022 [Member]", "label": "Minimum Annual Rent in 2022 [Member]" } } }, "localname": "MinimumAnnualRentInTwoThousandTwentyTwoMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_Mr.FischelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mr. Fischel [Member]", "label": "Mr. Fischel [Member]" } } }, "localname": "Mr.FischelMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_NumberOfStockholdersVotesDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of stockholders votes, description.", "label": "Number of stockholders votes, description" } } }, "localname": "NumberOfStockholdersVotesDescription", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "STXS_OfficeLeaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office Lease Agreement [Member]", "label": "Office Lease Agreement [Member]" } } }, "localname": "OfficeLeaseAgreementMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_OfficeSpaceAndManufacturingFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office Space and Manufacturing Facilities [Member]", "label": "Office Space and Manufacturing Facilities [Member]" } } }, "localname": "OfficeSpaceAndManufacturingFacilitiesMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_OtherRecurringRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Recurring Revenue [Member]", "label": "Other Recurring Revenue [Member]" } } }, "localname": "OtherRecurringRevenueMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_PaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program [Member]", "label": "Paycheck Protection Program [Member]" } } }, "localname": "PaycheckProtectionProgramMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_PerformanceShareUnitAwardAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PSU Agreement [Member]", "label": "PSU Agreement [Member]" } } }, "localname": "PerformanceShareUnitAwardAgreementMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_PreferredStockParValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock par value per share.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParValuePerShare", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "STXS_PreferredStockRedemptionTriggeringEventPercentOfCommonStockSoldThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred stock redemption, triggering event, percent of common stock sold threshold" } } }, "localname": "PreferredStockRedemptionTriggeringEventPercentOfCommonStockSoldThreshold", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "STXS_PrepaidCommissionsCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepaid commissions, current and noncurrent.", "label": "Prepaid commissions" } } }, "localname": "PrepaidCommissionsCurrentAndNoncurrent", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "STXS_PrimaryLenderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary Lender [Member]", "label": "Primary Lender [Member]" } } }, "localname": "PrimaryLenderMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_ProductShippedRevenueDeferredMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Shipped, Revenue Deferred [Member]", "label": "Product Shipped, Revenue Deferred [Member]" } } }, "localname": "ProductShippedRevenueDeferredMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "STXS_RestrictedCashPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Cash" } } }, "localname": "RestrictedCashPolicyTextBlock", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "STXS_RestrictedCashandCashInvestedInMoneyMarketAccountsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Cash and Cash Invested In Money Market Accounts [Member]", "label": "Restricted Cash and Cash Invested In Money Market Accounts [Member]" } } }, "localname": "RestrictedCashandCashInvestedInMoneyMarketAccountsMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_RevenueFromSystemDeliveryAndInstallationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue From System Delivery and Installation [Member]", "label": "Revenue From System Delivery and Installation [Member]" } } }, "localname": "RevenueFromSystemDeliveryAndInstallationMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_RisksAndUncertaintiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties" } } }, "localname": "RisksAndUncertaintiesPolicyTextBlock", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "STXS_RoyaltyRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty Revenue [Member]", "label": "Royalty Revenue [Member]" } } }, "localname": "RoyaltyRevenueMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_SeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series A Convertible Preferred Stock [Member]", "label": "Series A Convertible Preferred Stock [Member]" } } }, "localname": "SeriesAConvertiblePreferredStockMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_SeriesBConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B Convertible Preferred Stock [Member]", "label": "Series B Convertible Preferred Stock [Member]" } } }, "localname": "SeriesBConvertiblePreferredStockMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_ShareBasedCompensationAwardTrancheEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Award Tranche Eight [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheEightMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_ShareBasedCompensationAwardTrancheFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Award Tranche Five [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheFiveMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_ShareBasedCompensationAwardTrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Award Tranche Four [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheFourMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_ShareBasedCompensationAwardTrancheNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Award Tranche Nine [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheNineMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_ShareBasedCompensationAwardTrancheSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Award Tranche Seven [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheSevenMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_ShareBasedCompensationAwardTrancheSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Award Tranche Six [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheSixMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_ShareBasedCompensationAwardTrancheTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Award Tranche Ten [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheTenMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "STXS_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range of Exercise Price, Exercised" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceExercised", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "perShareItemType" }, "STXS_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range of Exercise Price, Forfeited" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceForfeited", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "perShareItemType" }, "STXS_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range of Exercise Price, Granted" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceGranted", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "perShareItemType" }, "STXS_StandardProductWarrantyCoverageTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Standard product warranty coverage term.", "label": "Standard product warranty coverage term" } } }, "localname": "StandardProductWarrantyCoverageTerm", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ProductWarrantyProvisionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "STXS_StockAwardPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Award Plans [Member]", "label": "Stock Award Plans [Member]" } } }, "localname": "StockAwardPlansMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_StockOptionsandStockAppreciationRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Options and Stock Appreciation Rights [Member]", "label": "Stock Options and Stock Appreciation Rights [Member]" } } }, "localname": "StockOptionsandStockAppreciationRightsMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_StockPlanExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock plan expiration date.", "label": "Stock plan expiration date" } } }, "localname": "StockPlanExpirationDate", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "dateItemType" }, "STXS_SubleaseRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sublease Revenue [Member].", "label": "Sublease Revenue [Member]." } } }, "localname": "SubleaseRevenueMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of Performance Award And Market Capitalization Milestones", "label": "Summary of Performance Award And Market Capitalization Milestones" } } }, "localname": "SummaryofPerformanceAwardAndMarketCapitalizationMilestonesTableTextBlock", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "STXS_SystemsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Systems [Member]", "label": "Systems [Member]" } } }, "localname": "SystemsMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "http://stereotaxis.com/role/StatementsOfOperations", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "STXS_TwoThousandAndTwelveStockIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2012 Stock Incentive Plan [Member]", "label": "2012 Stock Incentive Plan [Member]" } } }, "localname": "TwoThousandAndTwelveStockIncentivePlanMember", "nsuri": "http://stereotaxis.com/20210331", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r423", "r425", "r426" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Series [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://stereotaxis.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MaximumMember": { "auth_ref": [ "r197", "r219", "r249", "r251", "r340", "r341", "r342", "r343", "r344", "r345", "r364", "r396", "r398", "r411", "r412" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r197", "r219", "r249", "r251", "r340", "r341", "r342", "r343", "r344", "r345", "r364", "r396", "r398", "r411", "r412" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r138", "r236", "r239", "r367", "r395", "r397" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "http://stereotaxis.com/role/StatementsOfOperations", "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r138", "r236", "r239", "r367", "r395", "r397" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "http://stereotaxis.com/role/StatementsOfOperations", "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r197", "r219", "r240", "r249", "r251", "r340", "r341", "r342", "r343", "r344", "r345", "r364", "r396", "r398", "r411", "r412" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r197", "r219", "r240", "r249", "r251", "r340", "r341", "r342", "r343", "r344", "r345", "r364", "r396", "r398", "r411", "r412" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r96", "r101", "r250" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r96", "r101", "r174", "r250", "r332" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r141", "r327" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/AccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r39", "r330" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r23", "r142", "r143" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net of allowance of $122,570 and $123,614 at 2021 and 2020, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxes": { "auth_ref": [ "r16", "r18", "r276", "r372", "r385" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.", "label": "Accrued taxes" } } }, "localname": "AccruedIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued liabilities", "verboseLabel": "Total current accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r376", "r392" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities [Default Label]", "totalLabel": "Total accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": { "auth_ref": [ "r376", "r392" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.", "label": "Accrued professional services" } } }, "localname": "AccruedProfessionalFeesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r37", "r168" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r24", "r272", "r330" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r88", "r89", "r90", "r269", "r270", "r271", "r288" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r29", "r144", "r153" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts receivable, allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Potential common shares excluded from diluted earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of Land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative", "http://stereotaxis.com/role/LeasesDetailsNarrative", "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r86", "r127", "r130", "r136", "r151", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r283", "r285", "r303", "r328", "r330", "r370", "r384" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r57", "r86", "r151", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r283", "r285", "r303", "r328", "r330" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets at fair value", "verboseLabel": "Fair value of asset" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r253", "r268" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedContractCostNet": { "auth_ref": [ "r165" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Net" } } }, "localname": "CapitalizedContractCostNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r35", "r77" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r10", "r78" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r72", "r77", "r79" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of cash, cash equivalents, and restricted cash to balance sheet as of March 31st:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r72", "r304" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r84", "r86", "r105", "r106", "r107", "r110", "r112", "r118", "r119", "r120", "r151", "r185", "r189", "r190", "r191", "r194", "r195", "r217", "r218", "r220", "r221", "r303", "r429" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format.", "label": "Warrants exercisable date" } } }, "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price of warrants" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Common stock issuable from warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r171", "r172", "r173", "r175", "r407" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Reserved shares of common stock" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r88", "r89", "r288" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical", "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22", "r330" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, par value $0.001; 300,000,000 shares authorized,74,089,659 and 73,694,203 shares issued at 2021 and 2020, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensatingBalanceAmount": { "auth_ref": [ "r35" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of a specific compensating balance arrangement that is maintained under an agreement for a bank loan or future credit availability.", "label": "Compensating cash arrangement", "verboseLabel": "Compensating Balance, Amount" } } }, "localname": "CompensatingBalanceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r122", "r123", "r140", "r301", "r302", "r406" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r122", "r123", "r140", "r301", "r302", "r404", "r406" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r122", "r123", "r140", "r301", "r302" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Revenues percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Summary of Contract Assets and Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r230", "r232", "r237" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract Assets - unbilled receivables" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r230", "r231", "r237" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Total deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r230", "r231", "r237" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred revenue", "verboseLabel": "Total current deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r230", "r231", "r237" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Long-term deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r238" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r66", "r86", "r151", "r185", "r186", "r187", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r303" ], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Total cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of revenue:" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r83", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r206", "r208", "r209", "r211", "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt and Credit Facilities" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r15", "r17", "r224", "r371", "r373", "r381", "r382" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Loan description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r45", "r196" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.", "label": "Schedule of Prepaid Expenses and Other Assets" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/PrepaidExpensesAndOtherAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepositsAssets": { "auth_ref": [ "r38" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.", "label": "Deposits" } } }, "localname": "DepositsAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r75", "r166" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Schedule of Revenue Disaggregated by Type" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per share attributable to common stockholders:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r64", "r93", "r94", "r95", "r96", "r97", "r102", "r105", "r110", "r111", "r112", "r115", "r116", "r289", "r290", "r378", "r394" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic", "verboseLabel": "Basic EPS" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares and equivalents:" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r64", "r93", "r94", "r95", "r96", "r97", "r105", "r110", "r111", "r112", "r115", "r116", "r289", "r290", "r378", "r394" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted", "verboseLabel": "Diluted EPS" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r113", "r114" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Earnings (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r376", "r392" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accrued salaries, bonus, and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r267" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Total compensation cost not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r60", "r61", "r62", "r88", "r89", "r90", "r92", "r98", "r100", "r117", "r152", "r223", "r226", "r269", "r270", "r271", "r277", "r278", "r288", "r305", "r306", "r307", "r308", "r309", "r310", "r399", "r400", "r401", "r440" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r291", "r292", "r293", "r297" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Assets Measured at Fair Value on a Recurring Basis by Level Within Fair Value Hierarchy" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r205", "r212", "r213", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r292", "r337", "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r291", "r292", "r294", "r295", "r298" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r205", "r241", "r242", "r247", "r248", "r292", "r337" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r205", "r212", "r213", "r241", "r242", "r247", "r248", "r292", "r338" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r205", "r212", "r213", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r292", "r339" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r205", "r212", "r213", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r337", "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r296", "r298" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r210", "r222", "r287", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r429", "r430", "r431", "r432", "r433", "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r67" ], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r65", "r86", "r127", "r129", "r132", "r135", "r137", "r151", "r185", "r186", "r187", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r303" ], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteesAndProductWarrantiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Guarantees and Product Warranties [Abstract]" } } }, "localname": "GuaranteesAndProductWarrantiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r74" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r74" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r74" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r74", "r365" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r74" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r74", "r321" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liability" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r74" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r74" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "verboseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r74" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r379" ], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest (expense) income, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r53" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r56", "r330" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://stereotaxis.com/role/ScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories, net", "totalLabel": "Total inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r55" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r56", "r163" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfInventoriesDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Reserve for excess and obsolescence" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r54" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r324", "r326" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total net lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Schedule of Lease Costs and Other Lease Information" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of Future Minimum Operating Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfFutureMinimumOperatingLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfFutureMinimumOperatingLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfFutureMinimumOperatingLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseOptionToExtend": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.", "label": "Operating lease, option to extend" } } }, "localname": "LesseeOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating lease, renewal term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating lease, term of contract" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r42", "r86", "r131", "r151", "r185", "r186", "r187", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r284", "r285", "r286", "r303", "r328", "r329" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r28", "r86", "r151", "r303", "r330", "r374", "r389" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r44", "r86", "r151", "r185", "r186", "r187", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r284", "r285", "r286", "r303", "r328", "r329", "r330" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r17", "r373", "r382" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityDescription": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.", "label": "Line of credit, description" } } }, "localname": "LineOfCreditFacilityDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r41", "r85" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Money market funds" } } }, "localname": "MoneyMarketFundsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r121", "r124" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Description of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r72" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r72" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r72", "r73", "r76" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r58", "r59", "r62", "r63", "r76", "r86", "r91", "r93", "r94", "r95", "r96", "r99", "r100", "r108", "r127", "r129", "r132", "r135", "r137", "r151", "r185", "r186", "r187", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r290", "r303", "r377", "r393" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://stereotaxis.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Components of net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://stereotaxis.com/role/StatementsOfCashFlows", "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r93", "r94", "r95", "r96", "r102", "r103", "r109", "r112", "r127", "r129", "r132", "r135", "r137" ], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net loss attributable to common stockholders", "totalLabel": "Loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ObligationWithJointAndSeveralLiabilityArrangementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Obligation with Joint and Several Liability Arrangement [Line Items]" } } }, "localname": "ObligationWithJointAndSeveralLiabilityArrangementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r127", "r129", "r132", "r135", "r137" ], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r318", "r326" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost", "verboseLabel": "Annual rent under the terms, lease" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r314" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Non-cash lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r313" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfFutureMinimumOperatingLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r313" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r315", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Cash paid within operating cash flows" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r312" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r323", "r326" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r322", "r326" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining lease term for operating lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r376", "r392" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other.", "label": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "auth_ref": [ "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Noncurrent", "negatedLabel": "Less: Long term accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r13", "r369", "r383" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "verboseLabel": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Prepaid Expenses and Other Assets" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/PrepaidExpensesAndOtherAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Dividends declared" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r68", "r279", "r280", "r281" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "negatedLabel": "Purchase of equipment" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r253", "r268" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred stock dividend rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedLabel": "Cumulative dividend on Series A convertible preferred stock", "negatedTerseLabel": "Cumulative dividend on Series A Convertible Preferred Stock" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r21", "r217" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Series B Convertible Preferred Stock, par value", "verboseLabel": "Convertible preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical", "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionPricePerShare": { "auth_ref": [ "r216", "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.", "label": "Redemption price per share" } } }, "localname": "PreferredStockRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Series B Convertible Preferred Stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Series B Convertible Preferred Stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r21", "r330" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Convertible preferred stock, Series B, par value $0.001; 10,000,000 shares authorized, 5,610,121 shares outstanding at 2021 and 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "totalLabel": "Total prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r33", "r34" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets", "verboseLabel": "Total current prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrent": { "auth_ref": [ "r13", "r369", "r383" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Noncurrent", "negatedLabel": "Less: Noncurrent prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrentAndNoncurrent": { "auth_ref": [ "r375", "r391" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPrepaidExpensesAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromBankDebt": { "auth_ref": [ "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from bank borrowing during the year.", "label": "Proceeds from bank" } } }, "localname": "ProceedsFromBankDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r69" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of stock, net of issuance costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r181", "r182", "r376" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Accrued warranties" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r43", "r176", "r177" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "periodEndLabel": "Warranty accrual, end of the fiscal period", "periodStartLabel": "Warranty accrual, beginning of the fiscal period" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r178" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedLabel": "Payments made" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": { "auth_ref": [ "r180" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.", "label": "Accrual adjustment for product warranty" } } }, "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfAccruedWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyDisclosureTextBlock": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.", "label": "Product Warranty Provisions" } } }, "localname": "ProductWarrantyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ProductWarrantyProvisions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProductWarrantyExpense": { "auth_ref": [ "r74", "r179" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers.", "label": "Product Warranty Expense" } } }, "localname": "ProductWarrantyExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r37", "r169" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r170", "r408", "r409", "r410" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r36", "r167" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Gross property and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r12", "r169", "r330", "r380", "r390" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "verboseLabel": "Net property and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r11", "r169" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r11", "r167" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/LeasesDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r274", "r366", "r413" ], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r79", "r368", "r387" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash [Default Label]", "verboseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r2", "r10", "r79" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash - current", "periodEndLabel": "Restricted cash - current" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r7", "r13", "r79", "r405" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted cash", "periodEndLabel": "Restricted cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r226", "r272", "r330", "r388", "r402", "r403" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r88", "r89", "r90", "r92", "r98", "r100", "r152", "r269", "r270", "r271", "r277", "r278", "r288", "r399", "r401" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r125", "r126", "r128", "r133", "r134", "r138", "r139", "r140", "r235", "r236", "r367" ], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r81", "r82" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue and Costs of Revenue" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r234" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Remaining performance obligation" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of stock, number of shares sold" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/AccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Computation of Basic and Diluted Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r8", "r30", "r31", "r32" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "http://stereotaxis.com/role/SummaryOfContractAssetsAndLiabilitiesDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Accrued Warranty" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ProductWarrantyProvisionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r37", "r169" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r253", "r268" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Summary of Restricted Stock Unit Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.", "label": "Summary of Option and Stock Appreciation Rights Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://stereotaxis.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r74" ], "calculation": { "http://stereotaxis.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share based compensation", "verboseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "auth_ref": [ "r254" ], "lang": { "en-us": { "role": { "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Number of Restricted Stock Units, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Weighted Average Grant Date Fair Value Per Unit, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "No. of Shares Subject to PSU", "terseLabel": "Number of shares granted", "verboseLabel": "Number of Restricted Stock Units, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails", "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Weighted Average Grant Date Fair Value Per Unit, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Number of unvested restricted share units", "periodEndLabel": "Number of Restricted Stock Units, Outstanding, Ending", "periodStartLabel": "Number of Restricted Stock Units, Outstanding, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant Date Fair Value Per Unit, Outstanding, Ending", "periodStartLabel": "Weighted Average Grant Date Fair Value Per Unit, Outstanding, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Number of Restricted Stock Units, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Weighted Average Grant Date Fair Value Per Unit, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of Options/SARs, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of Options/SARs, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r259", "r268" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of Options/SARs, Outstanding, Ending Balance", "periodStartLabel": "Number of Options/SARs, Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Weighted average exercise price", "periodEndLabel": "Weighted Average Exercise Price per Share, Outstanding, Ending Balance", "periodStartLabel": "Weighted Average Exercise Price per Share, Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r252", "r255" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfRestrictedStockUnitActivityDetails", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Exercise Price per Share, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Exercise Price per Share, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average Exercise Price per Share, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche One [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche Three [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheThreeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche Two [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r253", "r256" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Range of Exercise Price, Ending Balance", "periodStartLabel": "Range of Exercise Price, Beginning Balance" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r229", "r273" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Convertible Preferred Stock and Stockholders\u2019 Equity" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r14", "r330", "r371", "r386" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term debt" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r319", "r326" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r80", "r87" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r20", "r21", "r22", "r84", "r86", "r105", "r106", "r107", "r110", "r112", "r118", "r119", "r120", "r151", "r185", "r189", "r190", "r191", "r194", "r195", "r217", "r218", "r220", "r221", "r223", "r303", "r429" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r51", "r60", "r61", "r62", "r88", "r89", "r90", "r92", "r98", "r100", "r117", "r152", "r223", "r226", "r269", "r270", "r271", "r277", "r278", "r288", "r305", "r306", "r307", "r308", "r309", "r310", "r399", "r400", "r401", "r440" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity", "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r88", "r89", "r90", "r117", "r367" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity", "http://stereotaxis.com/role/StatementsOfOperations", "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r50", "r207", "r223", "r224", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Preferred stock conversion, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r21", "r22", "r223", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Employee stock purchase plan, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Share-based compensation, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r21", "r22", "r223", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of common stock, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r21", "r22", "r223", "r226", "r260" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Number of Options/SARs, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfOptionAndStockAppreciationRightsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r51", "r223", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Preferred stock conversion" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r21", "r22", "r223", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Share-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r21", "r22", "r223", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r26", "r27", "r86", "r145", "r151", "r303", "r330" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets", "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r320", "r326" ], "calculation": { "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease", "negatedLabel": "Sublease income", "verboseLabel": "Sub lease" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfLeaseCostsAndOtherLeaseInformationDetails", "http://stereotaxis.com/role/ScheduleOfRevenueDisaggregatedByTypeDetails", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r331", "r333" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series A - Convertible preferred stock:" } } }, "localname": "TemporaryEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r185", "r189", "r190", "r191", "r194", "r195" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Convertible preferred stock, Series A, par value $0.001; 22,408 and 22,513 shares outstanding at 2021 and 2020, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r9", "r215" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Series A Convertible Preferred Stock, par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Series A Convertible Preferred Stock, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r210", "r222", "r287", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r429", "r430", "r431", "r432", "r433", "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/FairValueMeasurementsDetailsNarrative", "http://stereotaxis.com/role/ScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury stock, shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r52", "r227", "r228" ], "calculation": { "http://stereotaxis.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "negatedLabel": "Treasury stock, 4,015 shares at 2021 and 2020" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r49", "r227" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfConvertiblePreferredStockAndStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ConvertiblePreferredStockAndStockholdersEquityDetailsNarrative", "http://stereotaxis.com/role/DebtAndCreditFacilitiesDetailsNarrative", "http://stereotaxis.com/role/LeasesDetailsNarrative", "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfPerformanceAwardAndMarketCapitalizationMilestonesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r104", "r112" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average number of common shares and equivalents:", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/ScheduleOfComputationOfBasicAndDilutedEarningsPerShareDetails", "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r102", "r112" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://stereotaxis.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r124": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r164": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3,4))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(4))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249" }, "r184": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "460", "URI": "http://asc.fasb.org/topic&trid=2155896" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r229": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r311": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r333": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.10)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r414": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r415": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r416": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r417": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r418": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r419": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r421": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r422": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r423": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r424": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r425": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r426": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r427": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r428": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r429": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r431": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r432": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r433": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r434": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r435": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r436": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r437": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r438": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r439": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r87": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" } }, "version": "2.1" } ZIP 70 0001493152-21-011314-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-011314-xbrl.zip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end